Total: 16897 pages
NeuroWiki contains 16897 pages across diseases, mechanisms, clinical trials, treatments, entities, genes, proteins, cell types, brain regions, researchers, institutions, and datasets. This index provides quick navigation to all content.
- 509 Disease pages
- 1691 Mechanism pages
- 467 Clinical trial pages
- 0 Treatment pages
- 186 Entity pages
- 3856 Gene pages
- 3184 Protein pages
- 3579 Cell type pages
- 55 Brain region pages
- 218 Researcher pages
- 309 Institution pages
- 22 Dataset/resource pages
NeuroWiki is a comprehensive knowledge platform for neurodegenerative diseases, featuring detailed information on Alzheimer's disease, Parkinson's disease, ALS, Huntington's disease, frontotemporal dementia, and related conditions. The content is organized into categories below for easy navigation.
This index provides a complete overview of available NeuroWiki content. The wiki uses a hierarchical structure with dedicated sections for diseases, mechanisms, clinical trials, treatments, entities, and supporting research resources. Content is continuously updated and expanded through automated research agents.
- ''- Coenzyme Q10 and Neurodegeneration''
- ''^10: ClinicalTrials.gov. Search: Spinocerebellar Ataxia Type 1''
- ''Argyrophilic grain disease in individuals younger than 75 years: clinical variability in an under-recognized limbic tauopathy. Brain Pathology. 2020;30(5):966-976. PubMed)''
- ''Down syndrome and Alzheimer''s Disease: insights into biomarkers, clinical symptoms, and pathology. Lancet Neurol. 2025;24(9):831-846. . PMID: 40818475''
- ''Gene therapy for GM1 gangliosidosis: challenges of translational medicine. Mol Genet Metab. 2015. . PMID: 25857381''
- ''Switch from ERT to oral chaperone migalastat: real-life data. Eur J Hum Genet. 2020. Link''
- '(2025). 2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein to clinical management. Neurobiology of Disease, 205:106861.
- '- Vaccination impact: Effect on post-acute sequelae'
- '- brainstem — Region where RBD pathology originates'
- 'Lewy body staging: 2025 revision of the Braak system for DLB'
- 'Long-read sequencing identifies FGF14 repeat expansions in Parkinson's disease'
- 'Primary Lateral Sclerosis'
- 'Prion protein, copper, and oxidative stress in neurodegeneration'
- 'Research criteria for the diagnosis of Alzheimer''s disease: revising the NINCDS-ADRDA criteria'
- 'Tau molecular diversity and the landscape of post-translational modifications in neurodegenerative diseases'
- (2006)
- (2019). Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders. American Journal of Human Genetics, 105(1), 166–176. PubMed)
- (2021). Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob Disease. Lancet Neurology, 20(3), 235–246. DOI
- Abetalipoproteinemia
- AD-PD-FTD Comparison Matrix
- Adult Polyglucosan Body Disease (APBD)
- Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)
- Advanced Rehabilitation Technologies in Corticobasal Syndrome
- Aging-Related Tau Astrogliopathy (ARTAG)
- Aging-Related Tauopathy (PART)
- Agitation in Alzheimer's Disease
- Alexander Disease Genetic Variants
- Alien Limb Phenomenon in Corticobasal Syndrome
- Allan-Herndon-Dudley Syndrome
- Alpers-Huttenlocher Syndrome
- Alpha-Mannosidosis
- Alpha-Synucleinopathies Comparison Matrix
- ALS Progression Rate Heterogeneity
- ALS-FTD Spectrum
- Alzheimer's Disease
- Alzheimer's Disease Genetic Variants
- Alzheimer's Disease vs Parkinson's Disease Comparison
- Alzheimer's Disease vs Parkinson's Disease Comparison
- Amyloid-Related Imaging Abnormalities (ARIA)
- Amyotrophic Lateral Sclerosis
- Amyotrophic Lateral Sclerosis (ALS)
- Amyotrophic Lateral Sclerosis (ALS) Genetic Variants
- Angelman Syndrome
- Anti-NMDA Receptor Encephalitis
- Anxiety Disorders
- APOE2 (Apolipoprotein E2)
- APOE3 (Apolipoprotein E3)
- APOE4 (Apolipoprotein E4)
- APP Arctic Mutation (APP Arctic)
- APP Dutch Mutation (APP Dutch)
- APP Flemish Mutation (APP Flemish)
- APP Mutations in Alzheimer's Disease
- APP Swedish Mutation (APPswe)
- Arctosia
- Assistive Devices and Technology in Corticobasal Syndrome
- Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702-705. DOI
- Asterixis in Corticobasal Syndrome
- Ataxia with Oculomotor Apraxia Type 2 (AOA2)
- Ataxia with Oculomotor Apraxia Type 2 (AOA2) Genetic Variants
- Ataxia with Vitamin E Deficiency
- Ataxia-telangiectasia-like disorder in mice
- Ataxic Features in Corticobasal Syndrome
- ATP13A9 and Parkinson's Disease
- Atypical Parkinsonism
- Autism Spectrum Disorder
- Autism Spectrum Disorder
- Autoimmune Encephalitis
- Autoimmune Encephalitis and SPS
- Autonomic Dysfunction in Corticobasal Syndrome
- Autonomic Dysfunction in Corticobasal Syndrome
- Batten Disease
- Becker Muscular Dystrophy
- Behavioral Variant Frontotemporal Dementia (bvFTD)
- Benign Hereditary Chorea
- Beta-Propeller Protein-Associated Neurodegeneration (BPAN)
- Binswanger Disease
- Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phenotype Heterogeneity
- Blood transfusion and variant CJD
- Bradykinesia in Corticobasal Syndrome
- Brain-computer interface (BCI) for communication and motor rehabilitation
- Brain-computer interface for gait rehabilitation
- Bulbar Amyotrophic Lateral Sclerosis
- Bulbar Palsy
- C9orf72 Repeat Expansion in ALS
- Calcium Dysregulation Across Neurodegenerative Diseases
- Callosal Disconnection and Interhemispheric Dysfunction in Corticobasal Syndrome
- Campomelic Dysplasia
- Canavan Disease
- Cancer
- Cancer-Dementia Inverse Correlation: Epidemiological Evidence and Shared Mechanisms
- CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy)
- Cardiomyopathy
- [Caregiver Support and Palliative Care in Atypical Parkinson's diseaseism](/diseases/caregiver-support-palliative-care-cbs-psp)
- CASPR2 Encephalitis
- CBD Genetic Variants
- CDKL5 Deficiency Disorder
- Cell-Type Vulnerability Across 4R-Tauopathies
- Cerebellar Ataxia
- Cerebral Amyloid Angiopathy (CAA)
- Cerebral Amyloid Angiopathy: Subtypes and Genetic Variants
- Cerebral Folate Deficiency (CFD)
- Cerebral Small Vessel Disease
- Cerebrotendinous Xanthomatosis (CTX)
- Charcot-Marie-Tooth Disease
- CHARGE Syndrome
- China Neurodegeneration Epidemiology
- Chorea Gravidarum
- Chorea-Acanthocytosis (ChAc)
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Chronic Traumatic Encephalopathy (CTE)
- Chronic Traumatic Encephalopathy (CTE)
- Chronic Wasting Disease (CWD)
- Circadian Rhythm Dysfunction in CBS/PSP
- Clinical phenotypes and progression of corticobasal syndrome
- Clinical Subtypes of Corticobasal Syndrome
- CNS Vasculitis
- Cockayne Syndrome
- Coenzyme Q10 Deficiency
- Cognitive and Neuropsychiatric Profiles Distinguishing Atypical Parkinsonian Syndromes
- Cognitive Impairment in Progressive Supranuclear Palsy
- Constructional Dysfunction in Corticobasal Syndrome
- Corticobasal Degeneration (CBD)
- Corticobasal Syndrome (CBS)
- Cystic Encephalomalacia
- DALY Methodology — Neurodegeneration
- Deep Brain Stimulation in Corticobasal Syndrome
- Dementia Pugilistica (Boxer's Dementia)
- Dementia with Lewy Bodies (DLB)
- Dementia with Lewy Bodies vs Parkinson's Disease Comparison
- Dementia with Lewy Bodies vs Parkinson's Disease Comparison
- Dentatorubral-Pallidoluysian Atrophy (DRPLA)
- Depression (Major Depressive Disorder)
- Differential Diagnosis of Corticobasal Syndrome
- Disease Classification & Relationships
- Disease Prevalence & Burden
- Disease Progression & Staging in Neurodegeneration
- Disease Rankings
- Diseases
- Diseases Dashboard
- Diseases Overview
- Diseases Quality Rankings
- DLB, Parkinson's Disease, and Alzheimer's Disease: Cross-Disease Comparison Matrix
- DLB-PD-AD Comparison Matrix
- Double Cortex Syndrome
- Dravet Syndrome
- Dressing Apraxia in Corticobasal Syndrome
- DRPLA (Dentatorubral-Pallidoluysian Atrophy)
- Drug-Induced Parkinsonism
- Duchenne Muscular Dystrophy
- Dysphagia and Nutritional Management in Corticobasal Syndrome
- Dystonia
- Early-Onset Alzheimer's Disease (EOAD)
- Economic Burden — Neurodegeneration
- EEG findings in Creutzfeldt-Jakob disease
- Environmental Dependency Syndrome in Corticobasal Syndrome
- Environmental Toxins and Parkinson's Risk
- Environmental Toxins and Parkinson's Risk
- Epidemiology of Corticobasal Syndrome
- Epidemiology of progressive intellectual and neurological deterioration in UK children
- Epilepsy
- Essential Tremor
- Estimation of PEX1-mediated Zellweger spectrum disorder births and population prevalence by population genetics modeling. Genetics in Medicine Open. 2025. Link)
- European Neurodegeneration Epidemiology
- Evaluation of balance and gait in patients with corticobasal syndrome
- Exome-wide association study in amyotrophic lateral sclerosis
- Eye movements in Parkinson's disease: what we know and what we don't
- Fahr's Disease
- Familial Creutzfeldt-Jakob Disease (fCJD)
- Familial Dysautonomia (Riley-Day Syndrome)
- Familial Fatal Insomnia (FFI)
- Familial vs Sporadic Neurodegeneration Comparison
- Familial vs Sporadic Neurodegenerative Disease Comparison
- Fatal Familial Insomnia
- Festination and Freezing of Gait in Corticobasal Syndrome
- Flail Arm Syndrome
- Flail Leg Syndrome
- Fragile X Syndrome
- Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
- Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
- Friedreich Ataxia
- Friedreich's Ataxia
- Frontotemporal Dementia
- Frontotemporal Dementia (FTD)
- Frontotemporal Dementia (FTD) Genetic Variants
- Frontotemporal Dementia with Parkinsonism linked to Chromosome 17 (FTDP-17)
- FTD Subtype Comparison Matrix — bvFTD vs svPPA vs nfPPA vs logopenic
- FTD-17 (Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17)
- FTD-ALS Spectrum
- FTLD-ALS: Frontotemporal Lobar Degeneration with Motor Neuron Disease
- FUS Mutations in Amyotrophic Lateral Sclerosis
- Future directions in NPC research. Nat Rev Dis Primers. 2019. PMID:31744494
- GABRB3-Related Epilepsy
- Gaucher Disease
- GBA N370S
- Gender Differences in Progressive Supranuclear Palsy
- Genetics of 4R-Tauopathies: Cross-Disease Comparison
- Genetics of Corticobasal Syndrome
- Genetics of Progressive Supranuclear Palsy
- Gerstmann Syndrome in Corticobasal Syndrome
- Gerstmann-Straussler-Scheinker Syndrome (GSS)
- Gerstmann-Sträussler-Scheinker Syndrome (GSS)
- Glaucoma
- Global Neurodegeneration Epidemiology
- Globular Glial Tauopathy (GGT)
- Glutaric Aciduria Type I (GA1)
- GRIN2A-Related Epilepsy
- Guam ALS-Parkinsonism-Dementia Complex (ALS-PDC)
- Guam Parkinsonism-Dementia Complex (ALS-PDC)
- Gut-First vs Brain-First Parkinson's Disease Trajectories
- HDL3 (Hereditary Dementia Locus 3)
- Healthcare Economics and Cost of Illness in Progressive Supranuclear Palsy
- Heidenhain's Atrophy
- Hemiballismus
- Hemiballismus and Hemichorea in Corticobasal Syndrome
- Hemichorea
- Hemiparkinsonism
- Hemispatial Neglect in Corticobasal Syndrome
- Hereditary Hemochromatosis
- Hereditary Paraganglioma
- Hereditary Sensory and Autonomic Neuropathy (HSAN)
- Hereditary Spastic Paraplegia (HSP)
- Hereditary Spastic Paraplegia Type 4 (SPG4)
- Hereditary Transthyretin Amyloidosis (hATTR)
- HIV-Associated Neurocognitive Disorders (HAND)
- Homocystinuria
- HTLV-1 Associated Myelopathy (HAM) / Tropical Spastic Paraparesis (TSP)
- Hunter Syndrome (MPS II)
- Huntington Disease
- Huntington Disease-Like 1 (HDL1)
- Huntington Disease-Like 2 (HDL2)
- Huntington's Disease
- Huntington's Disease Genetic Variants
- Huntington's Disease Genetic Variants
- Huntington's Disease-Like 2 (HDL2)
- Iatrogenic Creutzfeldt-Jakob Disease (iCJD)
- Ideational Apraxia in Corticobasal Syndrome
- Ideomotor Apraxia in Corticobasal Syndrome
- Inclusion Body Myositis (IBM)
- India Neurodegeneration Epidemiology
- Infantile Neuroaxonal Dystrophy (INAD)
- Intellectual Disability
- International collaboration in SCA research
- International registries and collaborative research in Williams syndrome
- Investment Landscape: ALS
- Investment Landscape: Alzheimer's Disease
- Investment Landscape: Frontotemporal Dementia
- Investment Landscape: Huntington's Disease
- Investment Landscape: Parkinson's Disease
- Iron Deficiency Anemia
- Japan Neurodegeneration Epidemiology
- Japanese and German Case Series in Corticobasal Degeneration
- Jervell and Lange-Nielsen Syndrome
- Juvenile Huntington's Disease
- Kabuki Syndrome
- KCNQ2 Encephalopathy
- KCNT1-Related Epilepsy
- Kearns-Sayre Syndrome (KSS)
- Kennedy's Disease (Spinal Bulbar Muscular Atrophy)
- Korsakoff Syndrome
- Krabbe Disease
- Kufor-Rakeb Syndrome (PARK9)
- Kufs Disease
- L-2-Hydroxyglutaric Aciduria (L2GA)
- Lafora Disease
- LATE (Limbic-Predominant Age-Related TDP-43 Encephalopathy)
- Lazaridis K, Tzartos SJ. Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics. Front Immunol. 2020;11:212. DOI
- Leber Hereditary Optic Neuropathy (LHON)
- Leber's Hereditary Optic Neuropathy (LHON)
- Leigh Syndrome
- Levodopa Responsiveness in Corticobasal Syndrome
- Lewy Body Dementia
- Limb-Kinetic Apraxia in Corticobasal Syndrome
- Limbic Encephalitis
- Limbic-Predominant Age-Related TDP-43 Encephalopathy (LATE)
- Lissencephaly
- Logopenic Aphasia
- Logopenic Progressive Aphasia (lvPPA)
- Logopenic Variant Primary Progressive Aphasia
- Logopenic Variant Primary Progressive Aphasia (lvPPA)
- LRRK2 G2019S
- LRRK2 Gene Variants and Mutations
- Lysosomal Storage Disorders
- Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
- Manganese-Related Neurodegeneration (Manganism)
- MDS 2026 — Genetic Parkinson's Disease Research Summary
- Megalencephalic Leukodystrophy
- MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes)
- Memory Dysfunction in Corticobasal Syndrome
- Menkes Disease
- [Metachromatic Leukodystrophy (MLD)](/diseases/metachromatic-leukodystrophy)
- Microcephaly
- Migraine
- Mild Cognitive Impairment (MCI)
- Mild Cognitive Impairment (MCI)
- Miller-Dieker Syndrome
- Minamata Disease
- Mirror Therapy and Sensory Re-education in Corticobasal Syndrome
- Mitochondrial Diseases and Neurodegeneration Comparison Matrix
- Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN)
- Mitochondrial Myopathy
- Mixed Dementia
- Morquio A Syndrome
- Motor Cortical Dysfunction in Corticobasal Syndrome
- Motor Neuron Disease
- Motor Neuron Disease (MND)
- Moyamoya Disease
- MSA Genetic Variants
- Multi-Infarct Dementia
- Multifocal Motor Neuropathy (MMN)
- Multiple Sclerosis (MS)
- Multiple System Atrophy
- Multiple System Atrophy (MSA)
- Multisystem Proteinopathy
- Muscular Dystrophy
- Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
- Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)
- Myotonic Dystrophy
- Ménière's Disease
- Narcolepsy
- Nasu-Hakola Disease (PLOSL)
- Natural History and Prognosis of Corticobasal Syndrome
- NCL Prognosis. NCL Resource
- Neuroacanthocytosis Syndromes
- Neurodegeneration
- Neurodegeneration with Brain Iron Accumulation (NBIA)
- Neurodegeneration with Brain Iron Accumulation (NBIA)
- Neurodegeneration with Brain Iron Accumulation (NBIA)
- Neurodevelopmental Disorders
- Neuroferritinopathy
- Neuroimaging in HDL syndromes. Neurology. 2023;101(12):512-523
- Neurological manifestations of Wilson's disease
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Neurophysiological Findings in Corticobasal Syndrome
- Neuropsychiatric Features of Corticobasal Syndrome
- Neuropsychiatric Symptoms in Progressive Supranuclear Palsy
- Neurosarcoidosis
- Niemann-Pick Disease Type C (NPC)
- Non-Invasive Brain Stimulation in Corticobasal Syndrome
- Nonfluent/Agrammatic Progressive Aphasia (nfvPPA)
- Nonketotic Hyperglycinemia
- Normal Pressure Hydrocephalus (NPH)
- Nutritional Support and Dietary Interventions in Corticobasal Syndrome
- Olfactory Dysfunction in Corticobasal Syndrome
- Opsoclonus-Myoclonus Syndrome
- Orthostatic Hypotension
- Pain in Corticobasal Syndrome
- Pantothenate Kinase-Associated Neurodegeneration (PKAN)
- Pantothenate Kinase-Associated Neurodegeneration (PKAN)
- Paraneoplastic Neurological Syndromes
- PARK19 (DNAJC6-Related Parkinson's Disease)
- Parkinson Disease
- Parkinson Disease Dementia
- Parkinson's Disease
- Parkinson's Disease
- Parkinson's Disease Dementia (PDD)
- Parkinson's Disease Genetic Variants
- Parkinson's Disease Subtypes
- Parkinson-Plus Syndromes
- PCDH19 Clustering Epilepsy
- Pelizaeus-Merzbacher Disease (PMD)
- Perry Syndrome
- PET imaging in CADASIL (2016)
- Pheochromocytoma
- Physical and Occupational Therapy in Corticobasal Syndrome
- Pick's Disease
- PLA2G6-Associated Neurodegeneration (PLAN)
- POLG-Related Mitochondrial Disorders
- Pompe Disease
- Porphyria
- Post-Traumatic Stress Disorder
- Postencephalitic Parkinsonism
- Posterior Cortical Atrophy
- Posterior Cortical Atrophy in Corticobasal Syndrome
- Postural Dysfunction and Abnormalities in Corticobasal Syndrome
- Potential Impact Measures — Neurodegeneration
- Prader-Willi Syndrome
- Preclinical Alzheimer's Disease
- Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol. 2010;67(6):781-787. DOI
- Primary Age-Related Tauopathy (PART)
- Primary Familial Brain Calcification (Fahr's Disease)
- Primary Lateral Sclerosis (PLS)
- Primary Progressive Apraxia of Speech (PPAOS)
- Primitive Reflexes in Corticobasal Syndrome
- Prion Diseases
- Prion Diseases — Comprehensive Overview
- Prodromal Alzheimer's Disease
- Prodromal Corticobasal Syndrome
- Prodromal Parkinson's Disease
- Prognostic Factors in Corticobasal Syndrome
- Progressive Bulbar Palsy (PBP)
- Progressive External Ophthalmoplegia
- Progressive Hemiparetic Syndrome as Corticobasal Syndrome Variant
- Progressive Multifocal Leukoencephalopathy (PML)
- Progressive Myoclonic Epilepsies (PME)
- Progressive Myoclonus Epilepsy
- Progressive Supranuclear Palsy
- Progressive Supranuclear Palsy (PSP)
- Progressive Supranuclear Palsy - Richardson Syndrome
- Prosopagnosia in Corticobasal Syndrome
- Proteasome Dysfunction Across Neurodegenerative Diseases
- PSEN1 Mutations in Alzheimer's Disease
- PSEN2 Mutations in Alzheimer's Disease
- PSEN2 Mutations in Alzheimer's Disease
- Pseudobulbar Affect and Emotional Lability in Corticobasal Syndrome
- PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical Overlap and Comorbidity
- PSP Clinical Variants
- PSP Epidemiology
- PSP Genetic Variants
- PSP in Non-Western Populations
- PSP-CBD Overlap Syndrome
- Pure Akinesia with Gait Freezing
- Pure Autonomic Failure
- Quality of Life and Caregiver Burden in Progressive Supranuclear Palsy
- Quality of Life in Corticobasal Syndrome
- Ramsay Hunt Syndrome
- Refsum Disease
- Research directions (2021)
- Respiratory Dysfunction in Corticobasal Syndrome
- Restless Leg Syndrome (Willis-Ekbom Disease)
- Restless Legs Syndrome
- Retinitis Pigmentosa
- Rett Syndrome
- Rigidity in Corticobasal Syndrome
- Sandhoff Disease
- Sanfilippo Syndrome
- Schizophrenia
- Seckel Syndrome
- Semantic Variant Primary Progressive Aphasia
- Semantic Variant Primary Progressive Aphasia (svPPA)
- Senile Chorea
- Sex Reversal
- Shy-Drager Syndrome
- Sialidosis
- Sialorrhea and Drooling in Corticobasal Syndrome
- Simultanagnosia and Balint's Syndrome in Corticobasal Syndrome
- SLC6A1-Related Epilepsy
- Sleep Disorders in Neurodegeneration
- SNCA A53T
- SNCA Gene Variants and Mutations
- SOD1 Mutations in Amyotrophic Lateral Sclerosis
- Speech and Voice Disorders in PSP
- Speech Therapy and Communication Aids in Corticobasal Syndrome
- Spinal Amyotrophic Lateral Sclerosis
- Spinal Cord Injury
- Spinal Muscular Atrophy (SMA)
- Spinocerebellar Ataxia Type 10
- Spinocerebellar Ataxia Type 17 (SCA17)
- Spinocerebellar Ataxia Type 6 (SCA6)
- Spinocerebellar Ataxia Type 7 (SCA7)
- Spinocerebellar Ataxia Type 8
- Sporadic ALS Initiation Mechanisms
- Sporadic Creutzfeldt-Jakob Disease (sCJD)
- Sporadic Fatal Insomnia
- Stargardt Disease
- Steele-Richardson-Olszewski Syndrome
- Stroke
- STXBP1 Encephalopathy
- Subacute Sclerosing Panencephalitis (SSPE)
- Superficial Siderosis
- Sydenham Chorea
- Synaptic Dysfunction in Corticobasal Syndrome
- TARDBP Mutations in Amyotrophic Lateral Sclerosis
- Tau PET Imaging in Corticobasal Syndrome
- Tau Phosphorylation Pathology in Down Syndrome
- Tauopathies Comparison Matrix
- Tauopathy Comparison Matrix
- Tay-Sachs Disease
- TDP-43 Pathology in Corticobasal Syndrome
- TDP-43 pathology in German corticobasal degeneration series
- Temporal Lobe Epilepsy
- The cortical organization of speech processing
- TMEM106B Genetic Modifiers in FTD
- Tourette Syndrome
- Transcortical Motor Aphasia in Corticobasal Syndrome
- Traumatic Brain Injury (TBI)
- TREM2 Variants in Alzheimer's Disease
- Tremor in Corticobasal Syndrome
- Tuberous Sclerosis Complex
- Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol. 2017;81(3):430-443. . . DOI
- Urinary Dysfunction in Corticobasal Syndrome
- US Neurodegeneration Epidemiology
- Use of ibuprofen and risk for Parkinson's disease
- Usher Syndrome
- Vanishing White Matter Disease (VWM)
- Variably Protease-Sensitive Prionopathy (VPSPr)
- Variant Creutzfeldt-Jakob Disease (vCJD)
- Vascular Cognitive Impairment (VCI)
- Vascular Dementia
- Vascular Parkinsonism
- Vasculitis Dementia
- vCJD blood transmission (2019)
- Vestibular Function Testing in Corticobasal Syndrome
- Veterinary Tauopathies: Cross-Species Insights
- Voice and Speech in Corticobasal Syndrome
- Walker-Warburg Syndrome
- Wernicke Encephalopathy
- Wernicke-Korsakoff Syndrome
- Whipple Disease
- White Matter Pathology in Corticobasal Syndrome
- WHO. Variant Creutzfeldt-Jakob Disease. Fact sheet
- Wilson's Disease
- Wolfram Syndrome
- Woodhouse-Sakati Syndrome (WSS)
- X-Linked Adrenoleukodystrophy (X-ALD)
- X-Linked Adrenoleukodystrophy (X-ALD) Genetic Variants
- X-Linked Intellectual Disability
- Zellweger Syndrome
- " Beyond the monosaccharide: polysaccharide-based therapeutics for CNS disorders"
- " Di Rienzo M, Romagnoli A, Refolo G et al., Role of AMBRA1 in mitophagy regulation: emerging evidence in aging-related diseases, Aging Cell, 2024"
- " Neurodegeneration: mechanisms and therapeutic strategies"
- " Quantification and correlation of amyloid-β plaque load, glial activation, GABAergic interneuron numbers, and cognitive decline in the TgF344-AD rat model. Front Aging Neurosci. 2025;17:1542229."
- "Biomolecular condensates in globoid glial tauopathy"
- "Calcium dysregulation in different cellular compartments during AD progression"
- "Experimental demyelination and remyelination"
- "Substance P receptor subtypes. Neuropharmacology. 2019;150:130-144"
- "Tetracycline-regulated expression yields aggregation-prone mutant tau in the rTg4510 mouse model"
- "The role of clock genes in tauopathies"
- 'Last updated: 2026-02-27.## See Also'
- 'Dietary n-3 fatty acids and cognitive decline: the Rotterdam Study. Am J Clin Nutr. 2008;87(5):1426-1433'
- 'Eliglustat tartrate: A synthetic glucosylceramide synthase inhibitor'
- 'Energy intake, meal frequency, and health: a neurobiological perspective'
- 'Ferroptosis pathways in Parkinson disease'
- 'Gene therapy for neurodegenerative disorders: current status and future prospects'
- 'Iyama T, et al. DNA repair mechanisms in neurons: implications for brain aging and neurodegeneration. Aging Cell. 2020'
- 'NF-κB: a therapeutic target in neurodegeneration'
- 'Prion-Like Mechanisms in Neurodegeneration (2024)'
- 'Stem cell therapy for post-stroke recovery'
- 'Synaptic dysfunction in neurodegenerative diseases.'
- 'Targeting amyloid-beta in Alzheimer''s disease: meta-analysis of Alzheimer''s disease genetic consortium studies'
- (2020)
- (2021). Randomized, double-blind, placebo-controlled trial of Coenzyme Q10 in early Parkinson's disease. Movement Disorders, 36(8), 1829-1837
- A three-dimensional human neural cell culture model for Alzheimer's disease
- Advancing research criteria for the behavioral variant of frontotemporal dementia
- ALS synaptic vulnerability mechanisms (2023)
- Alzheimer's Disease is type 3 diabetes — evidence reviewed
- Apoptosis in neural development and disease. Cold Spring Harb Perspect Biol. 2014
- Biomarker development (2017)
- Biomarker treatment response (Brain, 2022)
- Calcium dysregulation in prion diseases. Cell Calcium. 2023
- Cerebrospinal fluid dynamics in the glymphatic system. Fluids Barriers CNS. 2022
- Cholinesterase inhibitor therapy in Alzheimer's disease
- Combination approaches (2025)
- Connectivity-based classification of Alzheimer's disease using deep learning
- Cross-talk Between MAPK and PI3K Pathways
- Epigenetic disease subtypes
- Glymphatic dysfunction and cognitive decline (2022)
- Golgi organization and tau pathology
- Heat shock proteins as therapeutic targets in chaperone-based therapy for Alzheimer's disease (2006)
- Jankovic & Tan, Parkinson's disease: biomarkers and treatment (2020)
- Klinkner DB. Circulating endothelial cells as biomarkers (2007)
- Lipid metabolism genes in PSP risk
- MDS clinical diagnostic criteria for Parkinson's disease
- Microglial activation in PD substantia nigra. Journal of Neuroinflammation. 2024
- Miller & House, Combination trial design (2023)
- Mutations in the PINK1 gene cause familial Parkinson's disease. Nature. 1998
- Network models
- Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
- Oligodendrocyte lipid metabolism in white matter disease
- PPP3R1 variants and Parkinson's disease. Mov Disord. 2010
- Retinoic acid in nervous system development and regeneration
- RIN3 mutations impairing binding of the Alzheimer's disease-associated protein BIN1 lead to RAB5 hyperactivation and endosomal pathology (2026)
- Slow wave sleep and Aβ clearance (2023)
- Tau propagation along glymphatic pathways in Alzheimer's disease
- TDP-43 and autophagy (2023)
- Virtual screening strategies in matrix metalloproteinase inhibitor discovery
- Wilson & Future directions in neuroepidemiology (2022)
- Wnt modulators as therapeutic agents for Alzheimer's disease
- YKL-40 in the CSF and serum of patients with neurodegenerative diseases
- α-Synuclein prion-like properties
- — Silverman WF, et al. VEGF
- " https://doi.org/10.1016/j.freeradbiomed.2024.01.047"
- " https://doi.org/10.1016/S1474-4422(11)70124-6"
- " https://doi.org/10.1038/nrneurol.2017.93"
- 'Membrane fission by dynamin: what we know and what we need to know'
- 'Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer''s Disease: a phase 1b, randomized, placebo-controlled trial'
- 'Understanding the impact of sex and gender in Alzheimer''s disease: a call to action'
- Biomarkers for patient selection and response monitoring
- DREADD applications
- Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid
- Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleo, Nature Communications, 2025
- Targeting ABC transporters for neurodegenerative disease therapy
- Tau transgenic mice (2007)
- [ Traumatic brain injury exacerbates mitochondrial dysfunction in APP/PS1 knock-in mice through time-dependent pathways](/mechanisms/mitochondrial-dysfunction-ad)
- TREM2 antibodies for Alzheimer's disease (2021)
- " Aging and neurodegener"---
- ''(2022). Mitochondria-associated membranes: a hub for neurodegenerative diseases. Biomedicine & Pharmacotherapy, 149, 112879. . DOI''
- ''Biomarker''
- ''Huang''
- ''lncRNAs: key player in Aβ''
- ''M^97: T cell infiltrati''
- ''Pike et a''
- ''Winchester CL, Millhauser GL. Novel approaches to treating neurodegenerative diseases: targeting protein-protein interactions. Prog Mol Biol Transl Sci. 2014;128:165-186. PMID:25410543''
- 'CoQ10 in Huntington''s disease: A randomized controlled trial. Neurology. 2019;93(4):e367-e377'
- 'Early neuroinflammation and immune activation in neurodegenerative diseases'
- 'Ferroptosis and Alzheimer''s disease: a new insight into neurodegeneration. Front Immunol. 2026'
- 'Hearing impairment and incident dementia and cognitive decline in older adults: the Health ABC study'
- ['Thiamine and Alzheimer''s disease: link to oxidative stress and cognitive impairment'](/mechanisms/citric-acid-cycle)
- (2001). "Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene." Nature Neuroscience, 4, 1199-1206. DOI
- (2010). pericytes regulate the Blood-Brain Barrier. Nature, 468(7323), 557–561. PubMed
- Blocking CD47‑SIRPα improves clearance of neuronal debris. Nat Med'
- 10.1038/s41577-021-00565-4
- 3R Tauopathy Mechanisms
- 4R Tau in Corticobasal Degeneration
- 4R Tauopathy Mechanisms
- 5xFAD Mouse Model
- 5xFAD Transgenic Mouse Model
- [AD Failed Approaches Analysis](/mechanisms/ad-failed-approaches-analysis)
- [p53 Pathway in Parkinson's Disease](/mechanisms/p53-parkinson-disease)
- AAIC 2026: Clinical Trials and Drug Development
- AAV Gene Therapy Vectors for Neurodegeneration
- ABCA1→Cholesterol Efflux→APOE Lipidation→Alzheimer's Disease Causal Chain
- ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal Chain
- Acarbose Modulation of Alpha-Synuclein Amyloid Fibrillation
- ACLY Inhibition Rescues Alpha-Synuclein Autophagy
- Actin Cytoskeleton Dynamics in Neurodegeneration
- Activity-Dependent Synaptic Plasticity in Neurodegeneration
- AD Biomarker-to-Mechanism Mapping
- AD Combination Therapy Matrix
- AD Cure Roadmap — Integrated Timeline
- AD Experimental Models Scorecard
- AD Knowledge Gaps Ranked
- AD Research Funding vs Evidence Alignment
- AD Therapeutic Approaches Ranked Scorecard
- AD vs PD Neuroinflammation Comparison Matrix
- AD-FTD Tau-TDP-43 Overlap: Mechanism Comparison
- Adaptive Immunity in Neurodegeneration
- Adaptive Trial Designs in Neurodegeneration Synthesis
- Adenosine Signaling in Neurodegeneration
- Adiponectin Signaling Pathway in Neurodegeneration
- ADRD Biomarker Heterogeneity Framework
- ADRD Biomarker Heterogeneity: The Zetterberg Framework
- Adult Hippocampal Neurogenesis: Impaired in Alzheimer's Disease, Enhanced in Superagers
- Adult Neurogenesis in Neurodegeneration
- Adult Neurogenesis in Neurodegenerative Disease
- Advanced Glycation End Products in 4R-Tauopathies - Cross-Disease Comparison
- Advanced Glycation End Products in Neurodegeneration
- Advanced In Vitro Models for Neurodegeneration — Organoids, Microfluidics, and Translational Platform Synthesis
- Advanced Proteolysis and Ubiquitin System Targeting in CBS/PSP
- Age-Sensitive Cortical Vulnerability in Parkinson's Disease
- Aging to AD Switch: Triggers
- AI and Machine Learning in Neurodegeneration
- AI-Driven Drug Discovery for Neurodegeneration
- Akt Signaling Pathway in Neurodegeneration
- Alpers-Huttenlocher Syndrome Mitochondrial DNA Depletion Pathway
- Alpha-Klotho in Neurodegeneration
- Alpha-Synuclein (α-Synuclein)
- Alpha-Synuclein Aggregation in PD
- Alpha-Synuclein Aggregation Pathway
- Alpha-Synuclein Aggregation Pathway in Parkinson's Disease
- Alpha-Synuclein Autophagy Clearance
- Alpha-Synuclein Clearance Mechanisms
- Alpha-Synuclein ESCRT-III Inhibition Mechanism
- Alpha-Synuclein Exosomal Secretion
- Alpha-Synuclein Membrane Binding
- Alpha-Synuclein Neuronal Uptake
- Alpha-Synuclein Oligomerization Pathways
- Alpha-Synuclein Pathology
- Alpha-Synuclein Phosphorylation Mechanisms
- Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson's Disease
- Alpha-Synuclein Propagation in Parkinson's Disease
- Alpha-Synuclein Propagation in Prodromal Parkinson's Disease
- Alpha-Synuclein Propagation Mechanism
- Alpha-Synuclein Propagation Mechanisms
- Alpha-Synuclein Propagation Models in Parkinson's Disease
- Alpha-Synuclein Seeding Kinetics
- Alpha-Synuclein Transgenic Mouse Models
- alpha-synuclein-LRRK2 Crosstalk
- ALS Biomarker-to-Mechanism Mapping
- ALS Biomarkers and Disease Monitoring
- ALS Combination Therapy Matrix
- ALS Cure Roadmap
- ALS Disease Spectrum vs Molecular Subtypes
- ALS Failed Approaches Analysis
- ALS Knowledge Gaps Ranked List
- ALS Mechanistic Pathway
- ALS Progression Trajectories
- ALS RNA Metabolism and Proteostasis Failure
- ALS Therapeutic Scorecard
- ALS Trial Failure Analysis
- ALS-FTD Spectrum: Unified Pathogenic Mechanisms
- Alzheimer's Disease Biomarker Temporal Sequence Hypothesis
- Alzheimer's Disease Mechanism Index
- Alzheimer's Disease Pathogenesis
- Amino Acid Supplementation in Parkinson's Disease
- AMPK Signaling in Neurodegeneration
- AMPK Signaling in Parkinson's Disease
- AMPK Signaling Pathway
- AMPK-Mitochondrial Quality Control Axis
- Amylin Signaling in Neurodegeneration
- Amyloid Cascade Pathway
- Amyloid Clearance Mechanisms
- Amyloid Conformational Strains
- Amyloid Oligomers in Neurodegeneration
- Amyloid vs Tau-First Hypothesis
- Amyloid vs Tau-First Hypothesis in Alzheimer's Disease
- Amyloid-Beta Aggregation and Plaque Formation
- Amyloid-beta Cellular Uptake
- Amyloid-beta Cellular Uptake Pathway
- Amyloid-beta Degradation Pathways
- Amyloid-beta Fibril Formation
- Amyloid-beta Fibril Formation Pathway
- Amyloid-beta Oligomerization Pathway
- Amyloid-beta Trans-synaptic Spread Pathway
- Amyloid-Tau Synergistic Interaction Hypothesis
- Amyloid-Tau Synergistic Interaction Hypothesis in Alzheimer's Disease
- [Amyloid-β at the crossroads of AD](/mechanisms/amyloid-cascade-pathway)
- Amyotrophic Lateral Sclerosis Hypothesis Rankings
- Androgen Signaling Pathway in Neurodegeneration
- Angiogenesis Pathway
- Animal Models in Progressive Supranuclear Palsy Research
- Anti-Amyloid Therapeutics: Successes, Failures, and Lessons Learned
- Anti-fibrotic mechanisms of angiotensin AT2 receptor stimulation. Acta Physiol. 2019;227(1):e13280. DOI
- Antibody Therapy in Neurodegeneration
- Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration
- APOE Lipid Metabolism Pathway in Alzheimer's Disease
- APOE4 and Alzheimer's Disease Risk
- APOE→Lipid Dysregulation→Amyloid/Tau Pathology→Cognitive Decline — Causal Chain
- Apoptosis in Neurodegeneration
- Apoptosis in Neurodegeneration
- Apoptosis Pathway in Neurodegeneration
- Apoptosis Pathways in Alzheimer's Disease
- Apoptosis Pathways in Parkinson's Disease
- APP Amyloid Pathway in Alzheimer's Disease
- APP Processing and Amyloid-Beta Production
- APP-BACE1-Fe65 Complex
- APP/PS1 Double Transgenic Mouse Model
- APP→Amyloid-beta→Plaque→Alzheimer's Disease Causal Chain
- Apraxia in Corticobasal Syndrome
- Arsenic Exposure and Alzheimer's Disease Mechanism
- Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation
- Astrocyte Dysfunction in Parkinson's Disease
- Astrocyte Iron Metabolism and Alpha-Synuclein Pathology in Parkinson's Disease
- Astrocyte Metabolic Enhancement Therapy for PD
- Astrocyte Reactivity Mechanism
- Astrocyte Senescence Pathway in Neurodegeneration
- Astrocyte Senescence Pathway in Neurodegeneration
- Astrocyte-Mediated Neuroinflammation
- Astrocyte-Neuron Metabolic Coupling Pathway
- Astrocytic Pathology in Progressive Supranuclear Palsy
- ATP13A2 (PARK9) Pathway in Parkinson's Disease
- ATP13A2 Lysosomal Dysfunction Pathway in Parkinson's Disease
- ATTEC Mechanism for Neurodegeneration
- Atypical Parkinsonian Disorders Comparison
- Autoimmune Encephalitis Mechanisms
- Autonomic Dysfunction in Parkinson's Disease
- Autonomic Dysfunction in Progressive Supranuclear Palsy
- Autophagic Cell Death Pathway in Neurodegeneration
- Autophagy Dysfunction in Progressive Supranuclear Palsy
- Autophagy Failure Comparison -- AD/PD/ALS/FTD/HD
- autophagy gene variants in neurodegenerative diseases
- Autophagy Mechanisms
- Autophagy Modulation with Bioactive Compounds for Neurodegeneration
- Autophagy Molecular Regulation in Neurodegeneration
- Autophagy Types in Neurodegeneration
- Autophagy-Lysosomal Dysfunction in Neurodegenerative Diseases
- Autophagy-Lysosomal Impairment Across Neurodegenerative Diseases
- Autophagy-Lysosomal Impairment Comparison — AD/PD/ALS/FTD/HD
- Autophagy-Lysosomal Pathway
- Autophagy-Lysosomal Pathway Dysfunction in Alzheimer's Disease
- Autophagy-Lysosomal Pathway Dysfunction in Corticobasal Syndrome
- Autophagy-Lysosomal Pathway in Parkinson's Disease
- Autophagy-Lysosome Pathway in Neurodegeneration
- Autophagy-Lysosome Pathway in Neurodegeneration
- Autosis Pathway in Neurodegeneration
- AUTOTAC: Autophagy-Targeting Chimera for Neurodegeneration
- Axon Degeneration in Neurodegeneration
- Axon Guidance in Neurodegeneration
- Axon Guidance Pathways in Neurodegeneration
- Axonal Degeneration
- Axonal Degeneration Disease Comparison
- Axonal Guidance
- Axonal Spheroids in Neurodegeneration
- Axonal Transport
- Axonal Transport Defects in Neurodegenerative Diseases
- Axonal Transport Dysfunction Comparison Across Neurodegenerative Diseases
- Axonal Transport Dysfunction in 4R-Tauopathies
- Axonal Transport Dysfunction in Corticobasal Syndrome
- Axonal Transport Dysfunction in Progressive Supranuclear Palsy
- Axonopathy Mechanisms and Therapeutic Targets
- BACE1 Amyloidogenic Cleavage Pathway
- Basal Ganglia Circuit Dysfunction in Neurodegeneration
- Basal ganglia network connectivity alterations in PSP using advanced diffusion MRI
- BDNF Signaling Pathway in Neurodegeneration
- BDNF Signaling Pathway in Neurodegeneration
- BDNF Trophic Loss in Huntington's Disease
- BDNF/Neurotrophin Signaling in Neurodegeneration
- Beclin 1 and ALS: insights from mouse models
- Behavioral Variant FTD: Network and Molecular Mechanisms
- Bhatt D, Bhatt SJ, Carbia-Nagashima A. Targeting SUMOylation for disease therapy. Trends Pharmacol Sci. 2023;44(10):703-718. DOI
- BIN1→Endosomal Dysfunction→Tau Pathology→AD Causal Chain
- Biomarker Discovery Framework for Neurodegenerative Diseases
- Biomarkers for Parkinson's Disease
- Biomarkers in Neurodegeneration
- Biomarkers of Alzheimer Disease
- Biomolecular Condensates in Neurodegeneration
- Bladder dysfunction in MSA urodynamic findings
- Blood p-Tau217 as a Clock for Alzheimer's Disease Onset Timing
- Blood-Based Biomarkers for Neurodegeneration
- Blood-Brain Barrier
- Blood-Brain Barrier Biology and Crossing Strategies
- Blood-Brain Barrier Breakdown as Primary Disease Driver
- Blood-Brain Barrier Breakdown in Alzheimer's Disease
- Blood-Brain Barrier Breakdown in Neurodegeneration
- Blood-Brain Barrier Dysfunction and Therapeutic Delivery for CBS/PSP
- Blood-Brain Barrier Dysfunction in 4R-Tauopathies
- Blood-Brain Barrier Dysfunction in Neurodegeneration
- Blood-Brain Barrier Dysfunction in PSP
- Blood-Brain Barrier Dysfunction in Vascular Cognitive Impairment
- Blood-Brain Barrier Dysfunction Pathway
- Blood-Brain Barrier Dysfunction: AD vs PD vs ALS Comparison
- Blood-Brain Barrier in 4R-Tauopathies
- BPAN — Beta-Propeller Protein-Associated Neurodegeneration
- Braak Staging
- Braak Staging and Tau Propagation Pathway
- Brain Age Gap and Amyloid-β Accumulation in Alzheimer's Disease
- Brain Endothelial Cell Dysfunction in Neurodegeneration
- Brain Network Connectivity Changes in Progressive Supranuclear Palsy
- Brain Network Connectivity in PSP
- Brain Region Vulnerability in 4R-Tauopathies
- Brain Reserve in Neurodegeneration
- Brain-Derived Neurotrophic Factor in Neurodegeneration
- Brainstem Circuit Vulnerability in PSP
- Brainstem Reflex Dysfunction in Progressive Supranuclear Palsy
- Bunina Bodies in Neurodegeneration
- C9orf72 Hexanucleotide Repeat Expansion
- C9orf72 Hexanucleotide Repeat Expansion Pathway in ALS
- C9orf72 Hexanucleotide Repeat Expansion Pathway in ALS and FTD
- C9orf72 hexanucleotide repeat expansion triggers inflammasome activation in ALS
- C9orf72 Repeat Expansions in CBS and PSP
- C9orf72-ALS Network
- C9orf72→RNA/Dipeptide Repeat Pathology→ALS/FTD — Causal Chain
- Calcium Buffering Proteins in Neurodegeneration
- Calcium Channel Dysfunction in Neurodegeneration
- Calcium Channel Dysfunction in Parkinson's Disease
- Calcium Dysregulation in 4R-Tauopathies — Cross-Disease Comparison
- Calcium Dysregulation in Alzheimer's Disease
- Calcium Dysregulation in Corticobasal Syndrome
- Calcium Dysregulation in Neurodegeneration
- Calcium Dysregulation in Neurodegenerative Diseases
- Calcium Dysregulation in Parkinson's Disease
- Calcium Dysregulation in Progressive Supranuclear Palsy
- Calcium Dysregulation to Excitotoxicity Pathway
- Calcium Homeostasis Dysfunction in CBS/PSP
- Calcium Homeostasis in Neurodegeneration
- Calcium Signaling Dysregulation in Alzheimer's Disease
- Calcium Signaling Dysregulation in Neurodegeneration
- Calcium Signaling Dysregulation in Neurodegeneration
- Calcium Signaling Dysregulation in Parkinson's Disease
- Calcium Signaling Pathway in Neurodegeneration
- CaMKII Signaling Pathway in Neurodegeneration
- cAMP Signaling in Neurodegeneration
- cAMP Signaling Pathway in Neurodegeneration
- Causal vs Reactive Neuroinflammation in Parkinson's Disease
- CBD Proteomics
- CBS Autophagy-Lysosomal Pathway Dysfunction
- CBS DNA Damage Response Mechanisms
- CBS Epigenetic Mechanisms
- CBS ER Stress and Unfolded Protein Response Mechanisms
- CBS Frontal Cortical Involvement
- CBS Lysosomal Dysfunction and Autophagy Impairment
- CBS Microglial Neuroimmune Axis
- CBS Parietal Cortical Degeneration
- CBS Single-Cell Transcriptomics Mechanisms
- CBS Tau Phosphorylation Pathways
- CBS vs PSP: Comparative Mechanism Analysis
- CBS/PSP Cure Roadmap
- CBS/PSP Genetic Architecture
- CBS/PSP Panxoneopathy and Membrane Biology
- CD2AP→Synaptic Dysfunction→AD Causal Chain
- Cell Cycle Re-entry Pathway in Neurodegeneration
- Cell Death Pathways in 4R-Tauopathies
- Cell-Type Vulnerability in 4R-Tauopathies
- Cellular Reprogramming Therapies for Neurodegeneration
- Cellular Senescence and Senolytic Therapy in Neurodegeneration Synthesis
- Cellular Senescence in Alzheimer's Disease
- Cellular Senescence in Brain Aging and Neurodegeneration
- Cellular Senescence in Corticobasal Syndrome
- Cellular Senescence in Neurodegeneration
- Cellular Senescence in Neurodegeneration
- Cellular Senescence in Neurodegeneration
- Cellular Senescence Therapeutic Targeting
- Central Vestibular Pathway Vulnerability in Progressive Supranuclear Palsy
- Centrosome
- Centrosome and calcium signaling in neurons
- Ceramide Signaling Pathway in Neurodegeneration
- Ceramide Signaling Pathway in Neurodegeneration
- Ceramide Signaling Pathway in Neurodegeneration
- Cerebellar atrophy in progressive supranuclear palsy: a voxel-based morphometry study
- Cerebellar Degeneration Pathway
- Cerebellar Function
- Cerebral Amyloid Angiopathy in Neurodegeneration
- Cerebral Amyloid Angiopathy Pathway in Neurodegeneration
- Cerebral Amyloid Angiopathy: Mechanism and Neurodegeneration
- Cerebral Autoregulation in Neurodegeneration
- Cerebral Blood Flow Regulation in Neurodegeneration
- Cerebral Cholesterol Metabolism
- Cerebral Glucose Hypometabolism in Neurodegeneration
- Cerebral Hypoperfusion in Neurodegeneration
- Cerebral Ischemia Pathway in Neurodegeneration
- Cerebral Small Vessel Disease in Neurodegeneration
- Cerebral Small Vessel Disease Mechanisms in Neurodegeneration
- Cerebrospinal Fluid in Neurodegenerative Disease
- Cerebrovascular Disease in Neurodegeneration
- cGAS-STING Cytosolic DNA Sensing Pathway in Neurodegeneration
- cGAS-STING Pathway and Autophagy in Neurodegeneration
- cGAS-STING Pathway in Alzheimer's Disease
- cGAS-STING Pathway in Neurodegeneration
- cGAS-STING Pathway in Neurodegeneration
- cGAS-STING Signaling in Parkinson's Disease
- cGMP Signaling Pathway in Neurodegeneration
- Chaperone-Mediated Autophagy in Neurodegeneration
- Chaperone-Mediated Autophagy in Neurodegeneration
- Chaperone-Mediated Proteostasis Disease Comparison
- CHCHD10 Mitochondrial Dysfunction — ALS/FTD Causal Chain
- Chemokine Signaling Pathway in Neurodegeneration
- Cholecalciferol (Vitamin D3) as TREM2 Agonist
- Cholinergic Degeneration Pathway
- Cholinergic Hypothesis in Alzheimer's Disease
- Cholinergic Signaling Pathway in Neurodegeneration
- Cholinergic System and Basal Forebrain Degeneration in CBS/PSP
- Cholinergic System Degeneration in Alzheimer's Disease
- Cholinergic System Dysfunction in Neurodegeneration
- Chondrogenesis (Neural)
- Chromatin Remodeling and Epigenetic Therapy Synthesis for Neurodegeneration
- Chromatin Remodeling in Neurodegeneration
- Chronic Traumatic Encephalopathy Pathogenesis
- Chrononutrition and Time-Restricted Eating in Neurodegeneration
- Circadian Clock Pathway in Neurodegeneration
- Circadian Disruption in Neurodegeneration
- Circadian Dysfunction Across Neurodegenerative Diseases
- Circadian Dysfunction and Melatonin Alterations in Progressive Supranuclear Palsy
- Circadian Dysregulation in Parkinson's Disease
- Circadian Rhythm Disruption in Neurodegeneration
- Circadian Rhythm Disruption in Neurodegeneration
- Circadian Rhythm Dysfunction in 4R-Tauopathies
- Circadian Rhythm Dysfunction in Alzheimer's Disease
- Circadian Rhythm Dysfunction in Alzheimer's Disease
- Circadian Rhythm Dysfunction in Alzheimer's Disease
- Circadian Rhythm Dysfunction in Corticobasal Degeneration
- Circadian Rhythm Dysfunction in Corticobasal Syndrome
- Circadian Rhythm Dysfunction in Parkinson's Disease
- Circadian Rhythm in Neurodegeneration
- Circular RNA Dysfunction in Neurodegeneration
- Clinical Trial Success Rate Analysis — Neurodegenerative Diseases
- Clinical trials of EPO in neurodegenerative disease
- CLU Clusterin Amyloid Clearance AD Causal Chain
- CNS Drug Delivery Methods
- CNTF Signaling Pathway in Neurodegeneration
- Coagulation Cascade in Neurodegeneration
- Cognitive Rehabilitation in Corticobasal Syndrome
- Cognitive Reserve and Resilience in Neurodegeneration
- Complement Activation in Corticobasal Degeneration
- Complement Dysregulation in CBS and 4R Tauopathies
- Complement System Activation in Neurodegeneration
- Complement System in Neurodegeneration
- Complement System in Neurodegeneration
- Complement System Pathway in Neurodegeneration
- Complement-Mediated Synapse Loss
- Comprehensive AD Hypothesis Analysis
- Computational Disease Models for Neurodegeneration
- Computational Drug Discovery in Neurodegeneration
- Computational Models of Tau Propagation in Progressive Supranuclear Palsy
- Computational Tau Propagation Model Validation with PET Imaging
- Computational Tau Spreading Models in Progressive Supranuclear Palsy
- Connexin and Pannexin Hemichannel Signaling in Neurodegeneration
- Convergent Pathways in Neurodegeneration
- Copper Dyshomeostasis in Neurodegeneration
- Copper Homeostasis in Neurodegeneration
- Cortical Involvement and Neurodegeneration in Progressive Supranuclear Palsy
- Cortical Sensory Loss in Corticobasal Syndrome
- Corticobasal Degeneration (CBD) Pathway
- Corticobasal Degeneration Mechanisms
- COVID-19 Neurodegeneration Mechanism
- CR1→Complement Activation→Synaptic Pruning→AD Causal Chain
- CR3-Dependent Microglial Synapse Elimination in Parkinson's Disease
- CREB Signaling in Neurodegeneration
- CREB-independent Neuronal Survival Pathways
- CREB-Independent Neuronal Survival Pathways in Neurodegeneration
- Creutzfeldt-Jakob Disease: Prion Disease Mechanisms
- Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16(1):9-29. DOI
- Cross-Disease Neuroinflammation Mechanisms
- Cryptic Exon Splicing in TDP-43 Proteinopathy
- Cryptoxanthin Neuroprotection
- CSF and Blood Biomarkers in Progressive Supranuclear Palsy
- CTE Mechanism
- Cuproptosis in Neurodegeneration
- CX3CR1 PET Imaging — Microglia-Targeted Neuroimaging
- CXCL12/CXCR4 Signaling Pathway in Neurodegeneration
- Cyclin-Dependent Kinase 5 (CDK5)
- Cytoskeletal Dynamics and Axonal Transport Pathway
- Cytoskeleton Dysfunction Comparison -- AD/PD/ALS/FTD/HD
- Daphnetin and KCC2 Restoration in Alzheimer's Disease
- DAT Scan Imaging
- DCTN1 Dynactin Perry Syndrome Causal Chain
- Dementia with Lewy Bodies Mechanistic Pathway
- Demyelination
- Dental Health and Oral Microbiome in Neurodegeneration
- Diagnostic Biomarkers in Neurodegeneration
- Diffusion MRI (DTI) in Neurodegeneration
- Digital Biomarkers and Wearable Monitoring in PSP
- Digital Phenotyping in Neurodegeneration
- Dipeptide Repeat Proteins (DPRs) in C9orf72-ALS/FTD
- Disease Mechanism Taxonomy
- Disease Progression and Staging in Progressive Supranuclear Palsy
- Disease Progression Staging Synthesis
- Disease-Associated Microglia (DAM)
- Disease-Associated Microglia (DAM) Mechanism
- DJ-1 Oxidative Stress Response Pathway in Parkinson's Disease
- DJ-1-PTEN-P53 Network
- DLB Cure Roadmap
- DLB, PDD, and Alzheimer's Disease: Cross-Disease Comparison Matrix
- DLB-PD-AD Cross-Disease Comparison
- DNA Damage and Repair Dysfunction in PSP
- DNA Damage Repair Mechanisms Across Neurodegenerative Diseases
- DNA Damage Response and Repair in Neurodegeneration
- DNA Damage Response Impairment Pathway
- DNA Damage Response in 4R-Tauopathies
- DNA Damage Response in Alzheimer's Disease
- DNA Damage Response in Corticobasal Syndrome
- DNA Damage Response in Neurodegeneration
- DNA Damage Response in Neurons
- DNA Damage Response in Parkinson's Disease
- DNA Methylation in Neurodegeneration
- DNA Repair Mechanisms in Neurodegeneration
- DNA Sensing Pathways in Neurodegeneration
- Dominantly Inherited Alzheimer Network (DIAN)
- Dopamine Metabolism in PD
- Dopamine Metabolism Pathway
- Dopamine Oxidation
- Dopamine Pathway
- Dopamine Signaling Pathway
- Dopamine Transporter (DAT) Dysfunction Pathway in Parkinson's Disease
- Dopaminergic Neurodegeneration
- Dopaminergic Neuron Selective Vulnerability Pathway
- Dorsolateral Prefrontal Cortex Executive Dysfunction in Alzheimer's Disease
- Down Syndrome Neurodegeneration Pathway
- DREADDs in Neurodegeneration
- Dynein Motor Protein
- Dystonia in Corticobasal Syndrome
- Dystrophic Neurites in Neurodegeneration
- E3 Ubiquitin Ligase System in Neurodegeneration
- EEG Microstates in Alzheimer's Disease
- EGFR Signaling in Parkinson's Disease
- Electron Transport Chain
- Electrophysiology and Cortical Excitability in PSP
- Emerging Research Directions in Neurodegeneration
- Emerging Therapeutic Directions
- Endocannabinoid Signaling in Neurodegeneration
- Endolysosomal Trafficking Defects in Neurodegeneration
- Endoplasmic Reticulum Stress Comparison Across Neurodegenerative Diseases
- Endosomal Sorting Defects in Neurodegeneration
- Endosomal Trafficking Dysfunction: Cross-Disease Comparison
- Endosomal Trafficking Pathway
- Endosomal-Lysosomal Pathway in Neurodegeneration
- Endosomal-Lysosomal Trafficking Dysfunction in Corticobasal Syndrome
- Endothelin Signaling Pathway in Neurodegeneration
- Energy Metabolism Dysfunction Comparison Across Neurodegenerative Diseases
- Energy Metabolism in Neurodegeneration
- Enteric Nervous System and Gut-Brain Axis Dysfunction in Progressive Supranuclear Palsy
- Environmental Risk Factors in Progressive Supranuclear Palsy
- Enzymes of Physiological Amyloidogenesis in Neurodegeneration
- Ephrin/Eph Receptor Signaling Pathway in Neurodegeneration
- Ephrin/Eph Signaling Pathway in Neurodegeneration
- Epidemic Spreading Model of Tau Pathology
- Epigenetic Alterations in Alzheimer's Disease
- Epigenetic Alterations in Alzheimer's Disease
- Epigenetic Changes in Progressive Supranuclear Palsy
- Epigenetic Changes in PSP
- Epigenetic Changes in PSP
- Epigenetic Clocks in Brain Aging
- Epigenetic Dysregulation Comparison -- AD/PD/ALS/FTD/HD
- Epigenetic Dysregulation Comparison Across Neurodegenerative Diseases
- Epigenetic Dysregulation in 4R-Tauopathies
- Epigenetic Dysregulation in Neurodegeneration
- Epigenetic Mechanisms in Alzheimer's Disease
- Epigenetic Regulation
- Epigenetics in Amyotrophic Lateral Sclerosis
- Epigenetics in Parkinson's Disease
- Epilepsy in Neurodegenerative Diseases
- Epinephrine-Adra1 Signaling in Corticobasal Syndrome and 4R Tauopathies
- Epitranscriptomics and RNA Modifications in CBS/PSP
- ER Stress and Unfolded Protein Response in Corticobasal Degeneration
- ER Stress and Unfolded Protein Response in Corticobasal Degeneration
- ER Stress and Unfolded Protein Response in Neurodegeneration
- ER Stress and Unfolded Protein Response in Parkinson's Disease
- ER Stress and Unfolded Protein Response in Progressive Supranuclear Palsy
- ER Stress and Unfolded Protein Response Pathway
- ER Stress and Unfolded Protein Response Pathway in Neurodegeneration
- ER Stress and Unfolded Protein Response Pathway in Neurodegeneration
- ER Stress in Corticobasal Syndrome
- ER Stress Pathway in Neurodegeneration
- ER Stress Pathway in Neurodegeneration
- ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration
- Estrogen Signaling in Neurodegeneration
- Evidence Depth — Batch 10
- Excitotoxicity Comparison Across Neurodegenerative Diseases
- Excitotoxicity in Neurodegeneration
- Excitotoxicity Pathway
- Exercise and Neuroprotection
- Exercise-BDNF-Mitochondrial Resilience Hypothesis in Parkinson's Disease
- Exercise-Induced Neurotrophic Mechanisms in Neurodegeneration
- Exosome Biogenesis in Neurodegeneration
- Exosome-Mediated Pathological Protein Propagation
- Exosome-Mediated Tau Propagation in Progressive Supranuclear Palsy
- Exosome/EV-Mediated Pathological Protein Spreading Comparison — AD/PD/ALS/FTD/HD
- Expanded to 3000+ words
- Extracellular Matrix and Perineuronal Nets in 4R-Tauopathies
- Extracellular Matrix Degradation in Neurodegeneration
- Extracellular Matrix in Neurodegeneration
- Extracellular Vesicle-Mediated Tau Propagation in 4R-Tauopathies
- Extracellular Vesicles in Neurodegeneration
- Extracellular Vesicles in Parkinson's Disease
- Eye Movement Abnormalities in Corticobasal Syndrome
- Eye movement abnormalities in MSA (2023)
- EZH2 and tau pathology in Alzheimer's disease: molecular mechanisms and therapeutic implications
- Fabry Disease Pathway
- Familial Alzheimer's Disease Genetics
- Farnesoid X Receptor (FXR) Signaling in Neurodegeneration
- FBXO7→Mitophagy Dysfunction→Parkinson's Disease Causal Chain
- Fear Conditioning
- Ferritin-Positive Microglial Clusters in MCI and Alzheimer's Disease
- Ferroptosis and Alzheimer's disease: iron, lipids, and oxidative stress
- Ferroptosis and Lipid Peroxidation in 4R-Tauopathies
- Ferroptosis in Alzheimer's Disease
- Ferroptosis in Alzheimer's Disease
- Ferroptosis in Neurodegeneration
- Ferroptosis in Neurodegeneration
- Ferroptosis in Parkinson's Disease
- Ferroptosis Pathway in Alzheimer's Disease
- Ferroptosis Pathway in Neurodegeneration
- Ferroptosis Pathway in Neurodegeneration
- FGF Signaling in Parkinson's Disease
- FGF Signaling Pathway in Neurodegeneration
- Fibroblast Growth Factor Signaling in Neurodegeneration
- Flavonoid Compounds Miquelianin and Spiraeoside — Alpha-Synuclein Aggregation Inhibition
- Focal Adhesion Kinase (FAK) Signaling Pathway
- Focused Ultrasound for Drug Delivery to Brain
- Focused Ultrasound in Neurodegeneration
- FOXO Signaling Pathway in Neurodegeneration
- Frontal and Temporal Lobe Selective Vulnerability in FTD
- Frontotemporal Dementia (FTD) Mechanistic Pathway
- FTD Tau Subtypes Comparison: 3R vs 4R Tauopathies
- FTLD-tau Subtypes and Mechanisms
- FUS Gene-Mechanism-Therapy Causal Chain — ALS/FTD
- FUS Phase Separation in Neurodegeneration
- FUS Protein in Amyotrophic Lateral Sclerosis
- FUS Proteinopathy
- FUS Proteinopathy in Frontotemporal Dementia
- FUS Proteinopathy Pathway in ALS
- FXTAS Pathogenesis: Molecular Mechanisms
- G Proteins
- G-Protein Coupled Receptor Signaling in Parkinson's Disease
- GABA Imbalance in Neurodegeneration
- GABA Signaling Pathway
- GABAergic Dysfunction in Neurodegeneration
- GABAergic Signaling Pathway in Neurodegeneration
- GABAergic System Dysfunction in PSP
- GADD45G as Pathological Sensor: Orchestrating Reactive Gliosis in Neurodegeneration
- Gait and Balance Disorders in Progressive Supranuclear Palsy
- Ganglioside and Membrane Lipid Raft Dysfunction in 4R-Tauopathies
- Ganglioside Sialylation in Tau Internalization
- Gangliosides in Neurodegeneration
- Gasotransmitters in Neuroprotection - AD/PD
- GBA and Lysosomal Function in Parkinson's Disease
- GBA Gene Mutations and Parkinson's Disease Risk
- GBA Glucocerebrosidase Dysfunction and Parkinson's Disease
- GBA Glucocerebrosidase Endolysosomal Pathway in Parkinson's Disease
- GBA Glucocerebrosidase Pathway in Parkinson's Disease
- GBA Pathway in Parkinson's Disease
- GBA Therapy in Parkinson's Disease
- GBA1 Gene-Mechanism-Therapy Causal Chains in Neurodegeneration
- GDF Signaling Pathway in Neurodegeneration
- GDF15/GDF11 Signaling in Neurodegeneration
- GDNF Family Neurotrophic Factor Signaling Pathway in Neurodegeneration
- GDNF Signaling Pathway in Neurodegeneration
- GDNF Signaling Pathway in Neurodegeneration
- GDNF Signaling Pathway in Neurodegeneration
- Genetic Penetrance Factors in Parkinson's Disease
- Genetic Risk Factors Across 4R-Tauopathies
- Geniposide for Alzheimer's disease - immune biomarker targeting and therapeutic potential
- Geroprotective Therapies for Neurodegeneration
- GGT Clinical Presentation vs PSP and CBD
- Ghrelin Signaling Pathway in Neurodegeneration
- Ginsenosides Neuroprotection in Parkinson's Disease
- Glia-Neuron Crosstalk in Alzheimer's Disease
- Glial Cytoplasmic Inclusions in Multiple System Atrophy
- Glial Cytoplasmic Inclusions in Neurodegeneration
- Glial Tau Pathology in PSP and CBD
- Glial-Neuron Crosstalk in Neurodegeneration
- Glial-Neuron Crosstalk in Parkinson's Disease
- Gliogenesis in Neurodegeneration
- Globular Glial Tauopathy (GGT) Neuropathology
- GLP-1 Signaling Pathway in Neurodegeneration
- GLT-1 dysfunction in amyotro## Concl
- Glucocorticoid Signaling Pathway in Neurodegeneration
- Glucocorticoid Signaling Pathway in Neurodegeneration
- Glucocorticoid Signaling Pathway in Neurodegeneration
- Glucocorticoid-mediated tauopathy in cellular and animal models
- Glutamate Excitotoxicity in Neurodegeneration
- Glutamate Excitotoxicity Pathway in Neurodegeneration
- Glutamate Signaling Pathway
- Glutamate Transport
- Glutamatergic Signaling Pathway
- Glutathione Metabolism Pathway
- Glycogen Synthase Kinase-3β (GSK-3β)
- Glycolysis Metabolism in Neurodegeneration
- Glycosaminoglycan Metabolism Pathway
- Glycosylation in Neurodegeneration
- Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopathies
- Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Removal as AD/PD Driver
- Glymphatic Dysfunction Disease Comparison
- Glymphatic System Clearance Dysfunction in Parkinson's Disease
- Glymphatic System Dysfunction in CBS and PSP
- Glymphatic System Dysfunction in Neurodegeneration
- Glymphatic System Dysfunction Pathway
- Glymphatic System in Alzheimer's Disease
- Glymphatic Transport Along the Optic Nerve
- Golgi Apparatus Dysfunction Pathway
- Golgi Apparatus Stress Comparison Across Neurodegenerative Diseases
- gp130/IL-6 Family Cytokine Signaling in Neurodegeneration
- Granulovacuolar Bodies: Neuronal Defense Mechanism Against Tau Pathology
- Granulovacuolar Degeneration
- Growth Factor Signaling in 4R-Tauopathies
- GSK-3β in Neurodegeneration
- GSK3 Beta in Neurodegeneration
- GSK3 Signaling in Parkinson's Disease
- GSK3-beta Signaling Pathway
- GSK3beta-Tau Phosphorylation Complex
- Gut Microbiome-Derived Lipids and Alpha-Synuclein Aggregation in Parkinson's Disease
- Gut-Brain Axis and Microbiome in Alzheimer's Disease
- Gut-Brain Axis in Neurodegeneration
- Gut-Brain Axis in Neurodegeneration
- Gut-First vs Brain-First Alpha-Synuclein Propagation in Parkinson's Disease
- Gut-Immune-Brain Axis Clinical Trial for Parkinson's Disease
- Gut-Microbiome-Neurodegeneration Axis
- GWAS Findings Hub
- GWAS Findings Hub: Alzheimer's and Parkinson's Disease
- Hallmarks of Aging in Neurodegeneration
- HD Therapeutic Approaches Ranked Scorecard
- HDAC Inhibitor Mechanism in Neurodegeneration
- Heat Shock Protein Dysfunction in Progressive Supranuclear Palsy
- Heat Shock Protein Response Pathway in Neurodegeneration
- Heat Shock Response in Neurodegeneration
- Hedgehog Signaling in CBS/PSP
- Hedgehog Signaling in Neurodegeneration
- Hedgehog Signaling in Neurodegeneration
- Hedgehog Signaling Pathway in Neurodegeneration
- Hexosamine Biosynthetic Pathway (HBP)
- HIF Signaling in Neurodegeneration
- HIF/Hypoxia Signaling in Parkinson's Disease
- HIF/Hypoxia Signaling in Parkinson's Disease
- Hippo Pathway in Neurodegeneration
- Hippo Signaling in 4R-Tauopathies
- Hippo Signaling Pathway in Neurodegeneration
- Hippo Signaling Pathway in Parkinson's Disease
- Hippocampal Neurogenesis in Neurodegeneration
- Hirano Bodies
- Histamine Signaling Pathway in Neurodegeneration
- Histone Modification Pathways in Neurodegeneration
- HLA Haplotypes and Neuroinflammatory Profiles in PSP
- HMGB1 Signaling in Neurodegeneration
- Homocysteine Neurotoxicity and Neurodegeneration
- HPA Axis Dysfunction in Neurodegeneration
- HSF1 activation in 4R-tauopathies: therapeutic potential and challenges. Nat Rev Drug Discov. 2023
- Hsp70/Hsp90 Chaperone Pathway in Parkinson's Disease
- HTT Gene-Mechanism-Therapy Causal Chain — Huntington's Disease
- HTT Transcriptional Dysregulation Pathway
- Human Endogenous Retroviruses in Neurodegenerative Diseases
- Huntingtin-Mitochondrial Dysfunction in Huntington's Disease
- Huntington's Biomarkers and Precision-Therapy Framework
- Huntington's Disease Cure Roadmap
- Huntington's Disease Investment Landscape
- Huntington's Disease Mechanistic Pathway
- Huntington's Disease Mechanistic Pathway
- Huntington's Disease Somatic CAG Expansion and DNA Repair
- Huntington's Disease: Corticostriatal Synaptic Vulnerability
- Hydrogen Peroxide Metabolism Pathway
- Hydrogen Sulfide Signaling Pathway in Neurodegeneration
- Hypothalamic-Pituitary-Adrenal Axis
- Hypoxia Neuroprotection in Sporadic Parkinson's Disease
- Hypoxia Response Pathway
- IGF-1 Signaling Pathway in Neurodegeneration
- IL-1 Signaling Pathway in Neurodegeneration
- IL-6 and AD progression
- IL-6 Signaling Pathway in Neurodegeneration
- Infantile Neuroaxonal Dystrophy (INAD) Pathway
- Infectious Etiology Hypotheses in Alzheimer's Disease
- Infectious Triggers in Alzheimer's Disease
- Inflammaging in Neurodegeneration
- Innate Immune Response in Neurodegeneration
- Innate Immune Signaling Pathways in Alzheimer's Disease
- Insulin Signaling in Parkinson's Disease
- Insulin Signaling Pathway in Neurodegeneration
- Insulin Signaling Pathway in Neurodegeneration
- Insulin Signaling Pathway in Neurodegeneration
- Integrated Stress Response in Alzheimer's Disease
- Integrated Stress Response in Neurodegeneration
- Integrin Signaling and Extracellular Matrix in CBS/PSP
- Integrin Signaling in Parkinson's Disease
- Integrins in Alzheimer's disease
- Interferon Signaling in Neurodegeneration
- Interoceptive Brain Dynamics in bvFTD
- Intranasal Drug Delivery for Neurodegenerative Diseases
- Intrinsic Apoptosis Pathway in Neurodegeneration
- Investment Signal Synthesis — Neurodegenerative Disease Therapeutics
- Ion Channel Dysfunction Disease Comparison
- Ion Channel Dysfunction in 4R-Tauopathies
- Ion Channel Dysfunction in ALS
- Ion Channel Dysfunction in Alzheimer's Disease
- Ion Channel Dysfunction in Frontotemporal Dementia
- Ion Channel Dysfunction in Huntington's Disease
- Ion Channel Dysfunction in Parkinson's Disease
- Irisin (FNDC5) - Exercise-Induced Myokine for Neurodegeneration
- Iron Accumulation in 4R-Tauopathies: Cross-Disease Comparison
- Iron Accumulation in Progressive Supranuclear Palsy
- Iron and Neuromelanin Accumulation in PSP
- Iron deposition in putamen in Parkinson's disease and atypical parkinsonism: a systematic review
- Iron Dysregulation in Neurodegeneration
- Iron Homeostasis in Neurodegeneration
- IVNS1ABP Mutation: Progeria-Like Disease with Neurological Decline
- JAK-STAT and Cytokine Signaling in 4R-Tauopathies
- JAK-STAT Signaling in Parkinson's Disease
- JAK-STAT Signaling Pathway in Neurodegeneration
- JAK-STAT Signaling Pathway in Neurodegeneration
- JNK/p38 MAPK Signaling in Neurodegeneration
- JNK/p38 MAPK Signaling Pathway in Neurodegeneration
- Kidney-Brain Neurodegeneration Axis
- Kinase Targeting for Neurodegenerative Diseases
- Kisby GE, Milne J, Sweatt C (1997). Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue. Neuroreport. 8(6):1337-1340. DOI
- Kynurenine Pathway Dysregulation in 4R-Tauopathies
- Lactate Lactylation in Neurodegeneration
- Lactoferrin Neuroprotection in Neurodegenerative Diseases
- Large language models for protein engineering
- Leptin Signaling Pathway in Neurodegeneration
- Leukoaraiosis in Neurodegeneration
- Lewy Body Formation
- Lewy Body Formation Pathway
- Lichen-derived Neuroprotective Compounds for Parkinson's Disease
- Lipid Dysregulation in Neurodegeneration
- Lipid Peroxidation in Neurodegeneration
- Lipid Peroxidation in Neurodegeneration
- Lipid Raft Dysfunction in Neurodegeneration
- Lipid Raft Dysfunction in Neurodegeneration
- Lipid Raft Modulation for Parkinson's Disease Therapeutics
- Lipophagy Pathway in Neurodegeneration
- Liquid-Liquid Phase Separation
- Liver X Receptor (LXR) Signaling in Neurodegeneration
- Liver-Brain Neurodegeneration Axis
- lncRNA Signaling in Neurodegeneration
- Locus Coeruleus Degeneration Hypothesis in Alzheimer's Disease
- Locus Coeruleus Degeneration Pathway
- Locus Coeruleus Selective Vulnerability Hypothesis
- Logopenic PPA: Mechanisms of Posterior Temporal-Parietal Degeneration
- Long-Term Depression (LTD) in Neurodegeneration
- Long-Term Potentiation (LTP)
- Long-Term Potentiation Impairment in Neurodegeneration
- LRP1-ApoE Signaling Cascade
- LRP1-Mediated Amyloid-Beta Clearance in Neurodegeneration
- LRRK2 in Corticobasal Syndrome and 4R-Tauopathies
- LRRK2 Kinase Activation and Endolysosomal Dysfunction in Parkinson's Disease
- LRRK2 Kinase Pathway in Parkinson's Disease
- LRRK2 Pathway in Parkinson's Disease
- LRRK2 Pathway in Parkinson's Disease
- LRRK2 Pathway in PD
- LRRK2 Signaling Pathway in Parkinson's Disease
- LRRK2 Signaling Pathway in Parkinson's Disease
- LRRK2 Transgenic Mouse Model for Parkinson's Disease
- LRRK2-14-3-3 Interaction Network
- Lysosomal Calcium Dysregulation in Neurodegeneration
- Lysosomal Dysfunction in Neurodegeneration
- Lysosomal Dysfunction in Progressive Supranuclear Palsy
- Lysosomal Storage Diseases
- Lysosomal Storage Disorders with Neurodegeneration Comparative Pathway
- Lysosome Dysfunction in Neurodegeneration
- m6A RNA Methylation (Epitranscriptomics) in Neurodegeneration
- Macroautophagy
- Magnetic Resonance Spectroscopy in Neurodegeneration
- MAPK Signaling Pathways in Neurodegeneration
- MAPK/ERK and JAK-STAT Signaling in 4R-Tauopathies
- MAPK/ERK Signaling Pathway in Neurodegeneration
- MAPK/ERK Signaling Pathway in Neurodegeneration
- Marinesco Bodies in Neurodegeneration
- MDS 2026 — PD Genetic and Molecular Mechanisms
- MDS 2026: Advanced Therapies and Disease Modification in Movement Disorders
- Mechanism of Action Network Convergence Analysis
- Mechanism Rankings
- Mechanisms
- Mechanisms Dashboard
- Mechanisms Overview
- Mechanisms Quality Rankings
- Melatonin Signaling Pathway in Neurodegeneration
- Membrane Trafficking Pathway Dysfunction in Neurodegeneration
- Membrane-Driven Alpha-Synuclein Nucleation
- Meningeal Lymphatic Dysfunction in PSP
- Meningeal Lymphatics
- Mesolimbic Dopamine Pathway
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- Metabolic Dysfunction and Insulin Resistance in Progressive Supranuclear Palsy
- Metabolic Dysfunction and Insulin Signaling Impairment Pathway
- Metabolic Dysfunction in 4R-Tauopathies
- Metabolic Dysfunction in Alzheimer's Disease
- Metabolic Dysfunction in Corticobasal Degeneration
- Metabolic-Epigenetic Axis in Neurodegeneration Synthesis
- Metabolomic Alterations in Progressive Supranuclear Palsy
- Metabolomic Alterations in PSP
- Metabolomics in Neurodegeneration
- Metaflammation in Neurodegeneration
- Metal Dyshomeostasis in Neurodegenerative Disease Comparison
- Metal Homeostasis Dysfunction Comparison Across Neurodegenerative Diseases
- Metal Homeostasis Dysregulation in 4R-Tauopathies
- Metal Homeostasis Dysregulation in Neurodegeneration
- Metal Homeostasis in Neurodegeneration
- Metal Ion Dyshomeostasis in Corticobasal Syndrome
- Metal Ion Dyshomeostasis in Neurodegeneration
- Metal Ion Homeostasis in Alzheimer's Disease
- Metal Ion Homeostasis in Parkinson's Disease
- Metal Ion Toxicity in Neurodegeneration
- Metal Ion-Synuclein-Mitochondria (MISM) Axis in Parkinson's Disease
- mHTT Clearance Mechanisms in Huntington's Disease
- mHTT Clearance Mechanisms in Huntington's Disease
- MIBG Scintigraphy for Neurodegeneration
- Microbiome-Gut-Brain Axis in Neurodegeneration
- Microbiome-Gut-Brain Axis in Parkinson's Disease
- Microbiome-Metabolic-Inflammation Triad in AD: Experimental Protocol
- Microglia Activation Mechanism
- Microglia and neuroinflammation in Alzheimer's Disease
- Microglia CD8+ T Cell Recruitment -- Supplementary WW Content
- Microglia CD8+ T Cell Recruitment in White Matter Degeneration
- Microglia in Corticobasal Degeneration
- Microglia in Frontotemporal Dementia Progression
- Microglia-Neuron Metabolic Cross-Talk in Neurodegeneration
- Microglial Dysfunction in Alzheimer's Disease
- Microglial heterogeneity in neurodegeneration (2022)
- Microglial Metabolic Reprogramming
- Microglial Phagocytosis in Neurodegeneration
- Microglial Polarization
- Microglial Priming Pathway in Neurodegeneration
- Microglial Senescence Pathway in Neurodegeneration
- Microglial State Trajectory from Mobilization to Dysregulation in Alzheimer's Disease
- Microglial-Neuronal Interactions in Tauopathies
- MicroRNA Dysfunction in Neurodegeneration
- Mineralocorticoid Receptor Signaling in Neurodegeneration
- miRNA Regulatory Pathway in Neurodegeneration
- Mitochondria in Neurodegeneration
- Mitochondria-Lysosome Contact Site Dysfunction in Parkinson's Disease
- Mitochondria-Lysosome Contact Sites (MLCS) in Neurodegeneration
- Mitochondria-Lysosome Contact Sites in Parkinson's Disease
- Mitochondrial ATP Synthesis
- Mitochondrial Complex I Dysfunction in Progressive Supranuclear Palsy
- Mitochondrial Complex II (Succinate Dehydrogenase)
- Mitochondrial Complex III
- Mitochondrial Complex IV (Cytochrome c Oxidase)
- Mitochondrial DNA Mutations in Neurodegeneration
- Mitochondrial DNA Replication
- Mitochondrial Dynamics in Neurodegeneration
- Mitochondrial Dynamics Pathway in Neurodegeneration
- Mitochondrial Dynamics Pathway: Fusion and Fission in Neurodegeneration
- Mitochondrial Dysfunction in ALS-FTD Spectrum
- Mitochondrial Dysfunction in Alzheimer's Disease Pathway
- Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
- Mitochondrial Dysfunction in Corticobasal Degeneration
- Mitochondrial Dysfunction in Corticobasal Degeneration
- Mitochondrial Dysfunction in Glial Cells
- Mitochondrial Dysfunction in Neurodegeneration
- Mitochondrial Dysfunction in Neurodegeneration
- Mitochondrial Dysfunction in Parkinson's Disease
- Mitochondrial Dysfunction in Parkinson's Disease
- Mitochondrial Dysfunction in PD
- Mitochondrial Dysfunction in Progressive Supranuclear Palsy
- Mitochondrial Dysfunction Pathway in Neurodegeneration
- Mitochondrial Failure Nodes in Parkinson's Disease
- Mitochondrial Fission in Neurodegeneration
- Mitochondrial Fusion in Neurodegeneration
- Mitochondrial Permeability Transition Pore (mPTP) in Neurodegeneration
- Mitochondrial Quality Control
- Mitochondrial Quality Control Network Pathway
- Mitochondrial Unfolded Protein Response in Neurodegeneration
- Mitophagy
- Mitophagy
- Mitophagy Pathway in Neurodegeneration
- Mitophagy Pathway in Neurodegeneration
- Mitophagy Receptor Pathway in Neurodegeneration
- Mixed Tauopathy Mechanisms
- MLCS Quantification Methods in Parkinson's Disease Research
- MLCS Research Methods in iPSC-Derived Dopaminergic Neurons
- Modified Amyloid Cascade Hypothesis
- Molecular Chaperones in Neurodegeneration
- Monoclonal Antibody Therapy in Alzheimer's Disease
- MPAN — Mitochondrial Membrane Protein-Associated Neurodegeneration
- MPTP Parkinson's Disease Model
- mRNA Therapeutics for Neurodegenerative Diseases
- MS4A4A-MS4A6A Cooperation in TREM2 Regulation
- MS4A4A/MS4A6A → TREM2 Negative Regulation → Microglial Dysfunction → AD Causal Chain
- MSA Alpha-Synuclein Glial Cytoplasmic Inclusions
- MSA Animal Models and Preclinical Research
- MSA Epidemiology and Population Studies
- MSA Genetics and Risk Factors
- MSA Glial Changes
- MSA Glial Pathologies and Oligodendrocyte Dysfunction
- MSA Glial Pathology
- MSA Glial Pathology — Detailed Comparison with Parkinson's Disease
- MSA Imaging and Biomarkers
- MSA Neurotransmitter Dysfunction
- MSA Oligodendrocyte Pathology
- MSA Pathophysiology and Disease Mechanisms
- MSA Treatment Approaches and Emerging Therapies
- MSA-PSP-CBD Comparative Analysis
- MTCH2 regulates apoptosis and cell metabolism in dopaminergic neurons
- mTOR Signaling in 4R-Tauopathies
- mTOR Signaling in Autophagy and Lysosomal Function
- mTOR Signaling in CBS/PSP
- mTOR Signaling in Neurodegeneration
- mTOR Signaling in Parkinson's Disease
- mTOR Signaling Pathway in Neurodegeneration
- mTOR Signaling Pathway in Neurodegeneration
- Multi-Ethnic Parkinson's Disease GWAS
- Multi-Omics Integration in Neurodegeneration
- Multimodal AI Forecasting for Alzheimer's Disease Progression
- Multimodal Diagnostic Algorithm for CBS and PSP
- Multiple Sclerosis Mechanistic Pathway
- Multiple System Atrophy (MSA) Pathway
- Multiple System Atrophy Mechanistic Pathway
- Mutant Huntingtin Aggregation Pathway
- Mutant Huntingtin Proteolysis and Cleavage Pathway
- Myelin and White Matter Dysfunction in 4R-Tauopathies
- Myelin Formation
- Myelin Pathology Disease Comparison — AD/PD/ALS/FTD/HD
- Myelin Pathology in Progressive Supranuclear Palsy
- MYO10 and Mitochondrial Transfer in Neurodegeneration
- Myoclonus and Cortical Hyperexcitability in Corticobasal Syndrome
- N-acetylcysteine in ALS clinical trials (2023)
- NAD Signaling in Neurodegeneration
- NAD+ Bioenergetics Investment Synthesis
- NAD+ Metabolism in Neurodegeneration
- NAD+ Metabolism Pathway in Neurodegeneration
- Nanobody Therapy for Neurodegenerative Diseases
- Nanomedicine for Alzheimer's Disease
- Nanoscopic Tau Aggregates as Disease-Specific Entities
- Natriuretic Peptide Signaling Pathway in Neurodegeneration
- Natural Killer Cells in Parkinson's Disease
- NCT04724941: Prodromal Alpha-Synuclein Screening
- Necroptosis in Alzheimer's Disease
- Necroptosis in Neurodegeneration
- Necroptosis in Neurodegeneration
- Necroptosis Pathway in Neurodegeneration
- Necroptosis Pathway in Neurodegeneration
- NETosis in Neurodegeneration
- Netrin Signaling Pathway in Neurodegeneration
- Network Degeneration and Pathological Spreading in Corticobasal Syndrome
- Network Oscillation Dysfunction in Neurodegeneration
- Neural Circuit Disruption in Neurodegeneration
- Neural Circuits in Neurodegeneration
- Neural Network Dysfunction in Alzheimer's Disease
- Neural Oscillations Mechanism
- Neural Precursor Development
- Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in Neurodegeneration
- Neuritic Plaques
- Neurofibrillary Tangle Propagation in Alzheimer's Disease
- Neurofibrillary Tangles
- Neurofilament Light Chain (NfL) Mechanism in Neurodegeneration
- Neurogenesis and Neurodegeneration
- Neurogenesis Disease Comparison
- Neurogenesis Dysfunction Comparison - Neurodegenerative Diseases
- Neurogenesis Impairment in 4R-Tauopathies
- Neuroimmune Checkpoint Dysfunction in Neurodegeneration
- Neuroimmune Checkpoint Pathway
- Neuroimmune Disease Comparison Matrix
- Neuroimmune Dysfunction in Frontotemporal Dementia
- Neuroimmune Genes in Alzheimer's Disease — TREM2, CD33, PLD3
- Neuroimmune Interface Pathway
- Neuroimmune Response in 4R-Tauopathies: Cross-Disease Comparison
- Neuroimmune-Metabolic Convergence Therapy Synthesis
- Neuroinflammation Across AD, PD, ALS, FTD, and HD
- Neuroinflammation and Microglia Pathway
- Neuroinflammation and Microglia Pathway in Alzheimer's Disease
- Neuroinflammation as Cause vs Consequence in Neurodegeneration
- Neuroinflammation Comparison — AD/PD/ALS/FTD/HD
- Neuroinflammation Hypothesis in Alzheimer's Disease
- Neuroinflammation in 4R-Tauopathies
- Neuroinflammation in Alzheimer and Parkinson Disease
- Neuroinflammation in Alzheimer's Disease
- Neuroinflammation in Alzheimer's Disease
- Neuroinflammation in Alzheimer's Disease
- Neuroinflammation in Amyotrophic Lateral Sclerosis
- Neuroinflammation in Corticobasal Degeneration
- Neuroinflammation in Corticobasal Syndrome
- Neuroinflammation in Frontotemporal Dementia
- Neuroinflammation in Huntington's Disease
- Neuroinflammation in Neurodegeneration
- Neuroinflammation in Neurodegenerative Diseases
- Neuroinflammation in Parkinson's Disease
- Neuroinflammation in Parkinson's Disease
- Neuroinflammation in Parkinson's Disease
- Neuroinflammation in Parkinson's Disease Dementia and Dementia with Lewy Bodies
- Neuroinflammation in PD
- Neuroinflammation in Progressive Supranuclear Palsy
- Neuroinflammation Pathway
- Neuroinflammation-Mitochondria Crosstalk Pathway
- Neuroinflammation: Cause vs Consequence
- Neuromelanin Loss in Progressive Supranuclear Palsy
- Neuromelanin Synthesis
- Neuronal Death Pathways in Alzheimer's Disease
- Neuronal Hyperexcitability in Neurodegeneration
- Neuronal Migration
- Neuronal Network Dysfunction Pathway in Neurodegeneration
- Neuronal Network Functional Connectivity Dysfunction in Neurodegeneration
- Neuropathology of Progressive Supranuclear Palsy
- Neuropeptide Signaling Pathway
- Neuropeptide Y Signaling in Neurodegeneration
- Neuropil Threads in Neurodegeneration
- Neuroplasticity in Neurodegenerative Disease
- Neuropsychiatric Symptoms in Dementia
- Neuropsychology in Neurodegeneration
- Neuroresilience Mechanisms and Evidence
- Neurotensin Signaling in Neurodegeneration
- Neurotransmitter Dysfunction in Progressive Supranuclear Palsy
- Neurotransmitter System Changes in 4R-Tauopathies: Cross-Disease Comparison
- Neurotransmitter System Disease Comparison
- Neurotransmitter System Dysfunction in 4R-Tauopathies
- Neurotrophic Factor Signaling Decline in Neurodegeneration
- Neurotrophic Factor Signaling in Neurodegeneration
- Neurotrophic Factor Signaling in Parkinson's Disease
- Neurotrophic Factors in Neurodegeneration
- Neurotrophic Signaling Pathway
- Neurotrophin Signaling in Neurodegeneration
- Neurotrophin Signaling Pathways in Neurodegeneration
- Neurovascular and Blood-Brain Barrier Dysfunction in Corticobasal Syndrome
- Neurovascular Dysfunction in Alzheimer's Disease: Integrated Pathway
- Neurovascular Unit Dysfunction in Neurodegeneration
- Neurovascular Unit Dysfunction in Neurodegeneration
- Neurovascular Unit Dysfunction in Parkinson's Disease
- Neurovascular Unit Signaling in Neurodegeneration
- Neurovascular-Gut-Brain Axis in Neurodegeneration Synthesis
- NF-kB Signaling Pathway in Neurodegeneration
- NF-κB Signaling in Neurodegeneration
- NF-κB Signaling in Neuroinflammation
- NF-κB Signaling in Parkinson's Disease
- NF-κB Signaling Pathway in Neurodegeneration
- NF-κB Signaling Pathway in Neurodegeneration
- Niemann-Pick Disease Pathway
- Nigrostriatal Degeneration
- Nitric Oxide Signaling in 4R-Tauopathies
- Nitric Oxide Signaling in Neurodegeneration
- NLRP3 Inflammasome Activation Pathway in Neurodegeneration
- NLRP3 Inflammasome Pathway in Alzheimer's Disease
- NLRP3 Inflammasome Pathway in Neurodegeneration
- NLRP3 Inflammasome Pathway in Neurodegeneration
- NLRP3 Inflammasome Pathway in Neurodegeneration
- NLRP3 Inhibitors in Parkinson's Disease: Research and Clinical Development
- Non-Cell-Autonomous Glial Pathways in ALS
- Non-coding RNAs in Neurodegeneration
- Non-Dopaminergic Circuit Dysfunction in Parkinson Disease
- Non-Homologous End Joining in Neurodegeneration
- Non-Invasive Brain Stimulation in Corticobasal Syndrome
- Nonfluent/Agrammatic PPA: Mechanisms of Speech Production Network Degeneration
- Noradrenergic Dysfunction in Progressive Supranuclear Palsy
- Noradrenergic Signaling Pathway in Neurodegeneration
- Norepinephrine Signaling Pathway
- Normal Pressure Hydrocephalus Mechanistic Pathway
- Notch Signaling in 4R-Tauopathies
- Notch Signaling in CBS/PSP
- Notch Signaling in Parkinson's Disease
- Notch Signaling in Parkinson's Disease
- Notch Signaling Pathway in Neurodegeneration
- Notch Signaling Pathway in Neurodegeneration
- Notch Signaling Pathway in Neurodegeneration
- NRF2 Oxidative Stress Pathway
- Nrf2 Signaling in Neurodegeneration
- Nrf2 Signaling in Parkinson's Disease
- NRF2 Signaling Pathway in Neurodegeneration
- NRF2-KEAP1 Oxidative Stress Response Pathway
- NRTI Immunomodulation in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential
- NT-3 Signaling Pathway in Neurodegeneration
- NT-4 Signaling Pathway in Neurodegeneration
- Nuclear Pore Complex Dysfunction in Neurodegeneration
- Nucleocytoplasmic Transport Defects in Neurodegenerative Diseases
- Nucleocytoplasmic Transport in Neurodegeneration
- Nucleolar Stress in Neurodegeneration
- Nurr1 (NR4A2) Pathway in Parkinson's Disease
- Ocular Motor Dysfunction in Progressive Supranuclear Palsy
- Olfactory Dysfunction in Neurodegeneration
- Olfactory Dysfunction in Progressive Supranuclear Palsy
- Oligodendrocyte and Myelin Dysfunction in Corticobasal Syndrome
- Oligodendrocyte Dysfunction in Neurodegeneration Pathway
- Oligodendrocyte Dysfunction Pathway in Neurodegeneration
- Oligodendrocyte Pathology in 4R-Tauopathies
- Oligodendrocyte Precursor Differentiation Failure in Neurodegeneration
- Oligodendrocyte-Neuron Metabolic Support Pathway in Neurodegeneration
- Oligodendroglial Involvement in Progressive Supranuclear Palsy
- Oligodendroglial tau propagation in PSP
- OPC Modulation Therapy
- OPTN (Optineurin) Mitophagy Dysfunction — ALS/FTD/PD Causal Chain
- Oral Health and Dental Manifestations in Progressive Supranuclear Palsy
- Orexin Signaling in Neurodegeneration
- Orexin/Hypocretin Signaling Pathway in Neurodegeneration
- OSK Reprogramming and Yamanaka Factors in Neurodegeneration
- OTULIN-Tau Regulation Pathway
- Oxidative Stress Comparison — AD/PD/ALS/FTD/HD
- Oxidative Stress in Corticobasal Syndrome
- Oxidative Stress in Neurodegeneration
- Oxidative Stress in Neurodegeneration
- Oxidative Stress in Neurodegeneration
- Oxidative Stress Pathway
- Oxidative Stress Response in 4R-Tauopathies
- P-Body (Processing Body) Pathway in Neurodegeneration
- p-Tau217 as Clock for AD Onset Timing
- p70S6K/mTORC1 Signaling Pathway in Neurodegeneration
- p75NTR Signaling Pathway
- Pain Syndromes in Progressive Supranuclear Palsy
- Pallido-Thalamocortical Motor Pathway in Parkinson's Disease
- Pallido-thalamocortical Motor Pathway in Parkinson's Disease
- Pannexin 1 and P2X7 Receptor Signaling in Neurodegeneration
- PANoptosis in Neurodegeneration
- Parabiosis and Young Blood Factors in Neurodegeneration
- Paranodal Dysfunction in Neurodegeneration
- Paraptosis in Neurodegeneration
- PARK2/Parkin Ubiquitin Ligase Pathway in Parkinson's Disease
- PARK7/DJ-1 Neuroprotection Pathway — Parkinson's Disease Causal Chain
- Parkinson's Disease Hypothesis Rankings
- Parkinson's Disease Mechanisms
- Parkinson's Disease Metabolism
- Parkinson's Disease Neuroimaging Initiative (PDNI)
- PARP in Neurodegeneration
- Parthanatos in Neurodegeneration
- Patient Stratification and Precision Medicine Synthesis
- PD Biomarker-to-Mechanism Mapping
- PD Combination Therapy Matrix
- PD Cure Roadmap
- PD Failed Approaches Autopsy
- PD Knowledge Gaps Ranked (Legacy Redirect)
- PD Prevention vs Treatment Scorecard
- PD Research Funding vs Evidence Alignment
- PD Therapeutic Scorecard
- PD-1/PD-L1 Immune Checkpoint Signaling in Neurodegeneration
- PDLIM7 Epigenetic Activation in Parkinson's Disease
- Pericyte dysfunction and loss of Blood-Brain Barrier integrity in Alzheimer's Disease. Acta Neuropathol. 2013;126(4):471-489. doi:10.1007/s00401-013-1121-8
- Pericyte Loss in Neurodegeneration
- Perineuronal Net Dysfunction in Progressive Supranuclear Palsy
- Perineuronal Nets in Neurodegeneration
- Peripheral Immune System in Parkinson's Disease
- Peripheral Immune-Brain Crosstalk in Neurodegeneration
- Peroxisomal Dysfunction
- Peroxisome Dysfunction in Neurodegeneration
- Peroxisome Pathway in Neurodegeneration
- Peroxisome Pathway in Neurodegeneration
- Peroxisome Signaling Pathway in Neurodegeneration
- Pesticides and Parkinson Disease (Pest-PD) — NCT06420310
- PGC-1alpha agonists for Parkinson's disease therapy. J Neurochem. 2024;168(2):234-248
- PGC-1α and Mitochondrial Biogenesis Therapies for Parkinson's Disease
- PGC-1α Mitochondrial Biogenesis Comparison — AD/PD/ALS/FTD/HD
- Phospholipase Signaling in CBS/PSP
- Phosphoproteomics in Neurodegeneration
- PI3K-Akt Signaling in Parkinson's Disease
- PI3K/Akt Signaling in Neurodegeneration
- PI3K/Akt Signaling in Neurodegeneration
- PI3K/Akt Signaling in Parkinson's Disease
- PI3K/AKT/mTOR Signaling Pathway in Neurodegeneration
- PICALM→Clathrin-Mediated Endocytosis→Aβ Accumulation→AD Causal Chain
- Pick Bodies
- PINK1-Parkin Mitophagy Complex
- PINK1-Parkin Mitophagy Pathway in Parkinson's Disease
- PINK1-Parkin Mitophagy Pathway in Parkinson's Disease
- PINK1/Parkin Pathway in Parkinson's Disease
- PKAN Mechanistic Pathway
- PKAN — Pantothenate Kinase-Associated Neurodegeneration
- PKM2 Metabolic Dysregulation in Alzheimer's Disease
- PKR Pathway in Neurodegeneration
- Plasmalogen Metabolism in Neurodegeneration
- PLCG2 Microglial Signaling Phagocytosis AD Causal Chain
- Polyamine Metabolism Pathway in Neurodegeneration
- Polygenic Risk Scores in Neurodegenerative Disease
- Polyglutamine Aggregation
- Porphyromonas gingivalis–Alzheimer's Hypothesis Testing Protocol
- PP2A Tau Phosphatase Pathway
- PPAR Signaling Pathway in Neurodegeneration
- Pre-symptomatic Conversion Windows in ALS Genetic Risk Carriers
- Precision Medicine in Neurodegeneration
- Pretangle in Neurodegeneration
- Prime Editing for Neurodegenerative Diseases
- Prime Editing for Neurodegenerative Diseases
- Prion Disease Cure Roadmap
- Prion Disease Mechanistic Pathway
- Prion Diseases in Neurodegeneration
- Prion Protein Metabolism in Neurodegeneration
- Prion-Like Propagation Hypothesis — Template-Dependent Seeding as Disease Progression Mechanism
- Prion-Like Propagation in Neurodegeneration
- Prion-Like Spread in Neurodegeneration
- Prion-Like Spreading in Neurodegenerative Diseases
- Prionoid Propagation of Protein Aggregates in Neurodegeneration
- Progesterone Signaling Pathway in Neurodegeneration
- Prognostic Biomarkers in Neurodegeneration
- Progressive Supranuclear Palsy (PSP) Pathway
- Progressive Supranuclear Palsy Tauopathy Mechanism
- Proteasomal Pathway in Neurodegeneration
- Proteasome Dysfunction in Progressive Supranuclear Palsy
- Protein Aggregation and Misfolding in Neurodegeneration
- Protein Aggregation Comparison in Neurodegeneration
- Protein Aggregation in Neurodegeneration
- Protein Aggregation in Neurodegenerative Disease Comparison
- Protein Aggregation Seeding
- Protein Aggregation Seeds in Neurodegeneration
- Protein Biomarkers in Neurodegeneration
- Protein Clearance Mechanisms
- Protein Folding in Neurodegeneration
- Protein Homeostasis in Neurodegeneration
- Protein Kinase C (PKC) Signaling in Parkinson's Disease
- Protein Kinase C Signaling Pathway
- Protein O-GlcNAcylation Pathway in Neurodegeneration
- Protein Oligomerization Toxicity Pathway in Neurodegeneration
- Protein Phase Separation in Neurodegeneration
- Protein Phase Separation in Parkinson's Disease
- Protein Quality Control in Neurodegeneration
- Protein Quality Control Network
- Protein SUMOylation Pathway in Neurodegeneration
- Protein Synthesis in Neurodegenerative Diseases
- Protein Synthesis Pathway
- Protein Trafficking Pathways in Neurodegeneration
- Proteome Atlas for Neurodegenerative Diseases
- Proteomics of Progressive Supranuclear Palsy
- Proteostasis and ERAD Pathway in Neurodegeneration
- Proteostasis Network Dysfunction Comparison Across Neurodegenerative Diseases
- Proteostasis Network in Neurodegeneration
- PSAP-GPR37-IL-6 Axis in Parkinson's Disease
- PSEN1 Presenilin 1 AD Causal Chain
- PSEN2 Presenilin 2 AD Causal Chain
- Psilocybin for Neuropsychiatric Symptoms in Alzheimer's Disease
- PSP Astrocytic Pathology: Tufted Astrocytes Mechanism
- PSP Brainstem Circuit Vulnerability
- PSP Brainstem Degeneration
- PSP Cardiac Autonomic Dysfunction - Deceleration Capacity
- PSP Cell-Specific Mitochondrial Response
- PSP Endoplasmic Reticulum Stress and Unfolded Protein Response
- PSP Excitotoxicity and Glutamatergic Dysfunction
- PSP Ferroptosis and Iron-Dependent Cell Death
- PSP Glymphatic System Dysfunction
- PSP Liquid-Liquid Phase Separation and Biomolecular Condensates
- PSP Lysosomal Dysfunction and Autophagy Impairment
- PSP Mortality and Survival
- PSP Neurotrophic Factor Dysfunction
- PSP Oligodendrocyte Dysfunction and Iron Metabolism
- PSP Peripheral Immune Dysfunction
- PSP Prodromal Features and Early Detection
- PSP Richardson Syndrome vs Corticobasal Syndrome: A Deep Comparison
- PSP Subcortical Circuit Dysfunction
- PSP Synaptic Dysfunction
- PSP Tau Aggregate Morphology and Molecular Characteristics
- PSP Tau Caspase Cleavage and Truncation
- PSP Tau Propagation and Spreading Mechanisms
- PSP Tauopathy Mechanisms
- PSP Thalamic Dysfunction
- PSP Therapeutic Response Monitoring and Biomarkers
- PSP vs CBS Phenotypic Divergence: Mechanistic Comparison
- PSP Weight Loss and Cachexia
- Psychobiotic Therapy for Neurodegenerative Diseases
- PTEN Signaling in Neurodegeneration
- PTK2B→Pyk2→Synaptic Dysfunction→AD Causal Chain
- PTPσ (PTPRS) in C9ORF72-ALS/FTD - PI3P Regulation Mechanism
- Pupillary and Visual Dysfunction in Progressive Supranuclear Palsy
- Purinergic Signaling in Neurodegeneration
- Purinergic Signaling in Parkinson's Disease
- Pyroptosis and Inflammasome Activation in Corticobasal Syndrome
- Pyroptosis and Inflammasome Activation in Progressive Supranuclear Palsy
- Pyroptosis in Neurodegeneration
- Quantum Biology and Coherent Energy Transfer in Neurodegeneration
- Quinolinic Acid Neurotoxicity in Neurodegeneration
- R-Loop Stress in Neurodegeneration
- RAGE (Receptor for Advanced Glycation End Products) Signaling Pathway in Neurodegeneration
- RAN Translation in Neurodegeneration
- Ras-MAPK Signaling Pathway in Neurodegeneration
- Reactive Astrocytosis
- Reactive Astrogliosis
- Reactive Oxygen Species (ROS) Pathway
- Receptor-Mediated Transcytosis (RMT)
- Rehabilitation and Management of Progressive Supranuclear Palsy
- REM Sleep Behavior Disorder Neurodegeneration Pathway
- Remyelination in Neurodegeneration
- Retinal Biomarkers in Neurodegeneration
- Retinal Degeneration Pathway in Neurodegeneration
- Retrograde Transport and Endosomal Pathway Dysfunction
- Retromer Complex
- Retromer Dysfunction in Corticobasal Syndrome
- Retromer Dysfunction in Neurodegeneration
- Ribonuclease κ and Circular RNAs: A New Mechanism of Aging and Neurodegeneration
- Ribosomal and Translation Dysfunction in Progressive Supranuclear Palsy
- Ribosome Dysfunction in Neurodegeneration
- Ribosome Dysfunction in Neurodegeneration
- RIPK1 Inhibitors in Neurodegeneration
- RNA Granule Dysfunction in Neurodegeneration
- RNA Metabolism Dysfunction in Corticobasal Syndrome
- RNA Metabolism Dysregulation in 4R-Tauopathies
- RNA Metabolism Dysregulation in Alzheimer's Disease
- RNA Metabolism Dysregulation Pathway
- RNA Metabolism in Alzheimer's Disease
- RNA Metabolism in Neurodegeneration
- RNA Processing in Neurodegeneration
- RNA Splicing Defects in Neurodegeneration
- RNA Splicing Dysregulation in 4R-Tauopathies: A Comparative Analysis
- RNA Splicing in Neurodegeneration
- RNA Stability and Decay
- RNA Toxicity Pathway
- RNA-Targeted Therapies in Neurodegeneration
- rTg4510 Tau Transgenic Mouse Model
- S-Nitrosylation in Neurodegeneration
- S100 Protein Signaling Pathway in Neurodegeneration
- SAA and Imaging for Prodromal Parkinson's Disease Trial Enrichment
- Salt-Modulated Tau Amplification for Tauopathy Classification
- SASP (Senescence-Associated Secretory Phenotype) in Neurodegeneration
- Selective Neuronal Vulnerability
- Selective Neuronal Vulnerability in Corticobasal Syndrome
- Selective Neuronal Vulnerability in Progressive Supranuclear Palsy
- Selective Neuronal Vulnerability in PSP
- Selective Neuronal Vulnerability Pathways in Neurodegeneration
- Selective Vulnerability of Substantia Nigra Dopaminergic Neurons in Parkinson's Disease
- Selective Vulnerability of Substantia Nigra Dopaminergic Neurons in Parkinson's Disease
- Semantic Variant PPA: Mechanisms of Language Network Degeneration
- Semaphorin/Plexin Signaling Pathway in Neurodegeneration
- Semaphorin/Plexin Signaling Pathway in Neurodegeneration
- Senescent Cell Clearance in Neurodegeneration
- Senomorphics in Neurodegeneration
- Senostatic Therapies for Neurodegeneration
- Serotonergic Dysfunction in Neurodegeneration
- Serotonergic System Dysfunction in PSP
- Serotonin Signaling Pathway
- Serotonin Signaling Pathway in Neurodegeneration
- Serum Amino Acid Biomarkers for Brain Hypometabolism
- Sestrin Signaling Pathway in Neurodegeneration
- Sex Differences in Neurodegeneration
- Sex-Specific Mechanisms in Alzheimer's Disease
- Shared Mechanisms Between Alzheimer and Parkinson Disease
- Shared Proteinostasis Failure in Alzheimer's and Parkinson's Disease
- Short Chain Fatty Acids in Neurodegeneration
- Short-Chain Fatty Acid Therapy for Neurodegenerative Diseases
- Sigma-1 Receptor (SIGMAR1) Signaling in Parkinson's Disease
- Sigma-1 Receptor Signaling in Neurodegeneration
- Single Cell Genomics in Neurodegeneration
- SIRT1 Signaling Pathway in Alzheimer's Disease
- Sirtuin Signaling in 4R-Tauopathies
- Sirtuin Signaling in Neurodegeneration
- Sirtuin Signaling in Parkinson's Disease
- Sirtuin Signaling Pathway
- Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration
- Sirtuins in Neurodegeneration
- Sleep and Circadian Disorders in Progressive Supranuclear Palsy
- Sleep and Circadian Disruption in Neurodegeneration
- Sleep and Circadian Dysfunction in Alzheimer's Disease
- Sleep and Circadian Therapeutic Intervention Synthesis
- Sleep and Glymphatic Tau Clearance in Tauopathies
- Sleep and Neurodegeneration
- Sleep Architecture Changes in CBS and PSP
- Sleep Disorders in Corticobasal Syndrome
- Sleep Disruption in Alzheimer's Disease
- Sleep Dysfunction in Neurodegeneration
- Sleep-Disordered Breathing in Progressive Supranuclear Palsy
- Sleep-Wake Cycle
- Slit-Robo Signaling Pathway in Neurodegeneration
- Small-Molecule Derivatives in Neurodegenerative Pathways
- Smartwatch-Based Digital Biomarkers in Neurodegeneration
- SNCA→Alpha-synuclein→Aggregation→Lewy Bodies→Synucleinopathies Causal Chain
- SOD1 ALS Pathway
- Somatic CAG Instability in Huntington's Disease
- Somatic Mutations and Brain Mosaicism
- Somatostatin Signaling Pathway in Neurodegeneration
- SORL1→APP Trafficking→Retromer Dysfunction→Aβ Accumulation→AD Causal Chain
- SPAM1-SIRT6 Positive Allosteric Modulator in Neurodegeneration
- Spatial Transcriptomics of Progressive Supranuclear Palsy
- Specialized Pro-Resolving Mediators in Neurodegeneration
- Speech and Language Deficits in Corticobasal Syndrome
- Speech and Swallowing Disorders in Progressive Supranuclear Palsy: Mechanisms and Management
- Speech and Voice Disorders in Progressive Supranuclear Palsy
- Sphingolipid Metabolism Dysregulation in 4R-Tauopathies
- Sphingolipid Metabolism in Neurodegeneration
- Sphingolipid Metabolism in Neurodegeneration
- Sphingolipid Signaling Pathway in Neurodegeneration
- Sphingosine-1-Phosphate (S1P) Signaling Pathway in Neurodegeneration
- Spinocerebellar Ataxia (SCA) Pathways
- Splice-Modulating Therapies for Neurodegeneration
- Spliceosome and Neurodegeneration
- Sporadic ALS Initiation Mechanisms
- Sporadic Alzheimer's Disease Pathway
- STING-CASM-GABARAP-LRRK2 Pathway in Parkinson's Disease
- Stress Granule Dynamics in Neurodegeneration
- Stress Granule Dysfunction in 4R-Tauopathies
- Stress Granule Dysfunction: Cross-Disease Comparison
- Stress Granules and RNA Granules in Neurodegeneration
- Stress Granules in Neurodegeneration
- Stress Granules in Neurodegeneration
- Stress Granules in Neurodegeneration
- Stress Response in Neurodegeneration
- Striatal Selective Vulnerability in Huntington's Disease
- Striatonigral Degeneration in Multiple System Atrophy
- Sulfatide Metabolism in Neurodegeneration
- SUMOylation in Neurodegeneration
- Superoxide Dismutase 1 Pathway in Amyotrophic Lateral Sclerosis
- SYK Kinase in Microglial Activation and Alzheimer's Disease
- Synapse Elimination in Neurodegeneration
- Synaptic Dysfunction Comparison in Neurodegenerative Diseases
- Synaptic Dysfunction in 4R-Tauopathies
- Synaptic Dysfunction in Alzheimer's Disease
- Synaptic Dysfunction in Corticobasal Syndrome
- Synaptic Dysfunction in Neurodegeneration
- Synaptic Dysfunction in Neurodegeneration - SfN 2026 Research
- Synaptic Dysfunction in Neurodegenerative Diseases
- Synaptic Dysfunction in Parkinson's Disease
- Synaptic Dysfunction in Progressive Supranuclear Palsy
- Synaptic Dysfunction Pathway
- Synaptic Failure in Neurodegeneration
- Synaptic Failure in Neurodegeneration
- Synaptic Loss and Dysfunction Pathway
- Synaptic Loss in Alzheimer's Disease
- Synaptic Loss in Alzheimer's Disease Pathway
- Synaptic Loss in Neurodegenerative Disease
- Synaptic Organization in Neurodegeneration
- Synaptic Plasticity Deficits in Neurodegeneration
- Synaptic Plasticity Dysfunction in 4R-Tauopathies
- Synaptic Plasticity Mechanisms
- Synaptic Plasticity Pathway
- Synaptic Spine Degradation Pathway in Alzheimer's Disease
- Synaptic Transmission
- Synaptic Vesicle Cycle
- Synaptic Vesicle Cycle in Neurodegeneration
- Synaptic Vesicle Cycle Pathway
- Synaptic Vesicle Cycling Pathway
- Synaptic Vesicle Trafficking
- Synaptic Vesicle Trafficking in Parkinson's Disease
- Synaptogenesis in Neurodegeneration
- Synthetic Lethality and PARP Inhibition in Neurodegeneration
- Synuclein Pathway in Parkinson's Disease
- Synucleinopathies
- Synucleinopathy Differential Diagnosis
- Synucleinopathy Mechanism
- Systemic Infection and Tau Pathology Acceleration
- T-Cell Dysfunction in Neurodegeneration
- TAM Receptor Signaling
- Tanshinone IIA-Pretreated MSC Therapy for Alzheimer's Disease
- Tanycytes: A Novel Tau Clearance Pathway from Brain to Blood
- Target Family Consolidation Analysis — Cross-Disease Therapeutic Targets
- Targeting the NLRP3 inflammasome for inflammatory disease therapy. Trends Immunol. 2025. DOI
- Tau Aggregate Specificity in Progressive Supranuclear Palsy
- Tau Aggregation Mechanisms in Progressive Supranuclear Palsy
- Tau ASO Therapy
- Tau Conformation, Distribution, and PET Imaging Correlations in PSP
- Tau Filament Structure in PSP — Cryo-EM Analysis
- Tau Filament Structures in 4R-Tauopathies
- Tau Filament Structures Resolved by Cryo-EM
- Tau filaments from multiple neurodegenerative diseases
- Tau Immunotherapy Mechanisms
- Tau Kinase Signaling Cascade in Alzheimer's Disease
- Tau Network Propagation Hypothesis (Prion-Like Spread)
- Tau Oligomer Biology in Progressive Supranuclear Palsy
- Tau Pathology Alters Oligodendrocyte Gene Methylation in Alzheimer's Disease
- Tau Pathology in Alzheimer's Disease
- Tau Pathology Pathway
- Tau Pathology Pathway in Frontotemporal Dementia
- Tau Phosphorylation Pathway in Alzheimer's Disease
- Tau Post-Translational Modifications in 4R-Tauopathies
- Tau Propagation and Prion-Like Spreading in CBS/PSP
- Tau Propagation and Seeding in Progressive Supranuclear Palsy
- Tau Propagation Hypothesis (Prion-Like Spread)
- Tau Propagation Mechanisms
- Tau PROTAC and Degraders - Targeted Protein Degradation for Tau
- Tau Proteostasis and Clearance Across 4R-Tauopathies
- Tau Seeding and Propagation Pathway
- Tau Seeding and Propagation Pathway
- Tau Spreading Mechanism
- Tau Strain Comparison in 4R-Tauopathies
- Tau Strain Diversity and Conformational Templating in Tauopathies
- Tau Strain Diversity Between PSP and CBD
- Tau-MAPT-Tubulin Assembly
- Tauopathies
- Tauopathy
- TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain
- TBK1-Mediated Neuroinflammation Hypothesis — Impaired Autophagy and Innate Immune Dysregulation in FTD/ALS
- TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
- TDP-43 Co-pathology in Corticobasal Syndrome
- TDP-43 DNA Repair Mechanism in ALS and Dementia
- TDP-43 Pathology in Corticobasal Syndrome
- TDP-43 Pathology Reversibility in ALS
- TDP-43 Proteinopathy
- TDP-43 Proteinopathy in ALS
- TDP-43 Proteinopathy in Amyotrophic Lateral Sclerosis
- TDP-43 RNA Granule Pathway
- Tea Polyphenols for Neuroprotection
- Telomere Dysfunction in Neurodegeneration
- Tertiary Lymphoid Organs in Neurodegeneration
- Testosterone Signaling in Neurodegeneration
- TFEB Autophagy Pathway
- TFEB Signaling in Neurodegeneration
- TFEB-Mediated Lysosomal Biogenesis
- TGF-beta Signaling in CBS/PSP
- TGF-beta Signaling Pathway in Neurodegeneration
- TGF-beta Signaling Pathway in Neurodegeneration
- TGF-β Signaling in Parkinson's Disease
- TGF-β/BMP Signaling Pathway in Neurodegeneration
- Therapeutic Approach Evidence Rankings
- Therapeutic Development Failure Mode Analysis Synthesis
- Therapeutic Synergy and Combination Approach Rankings
- Therapeutic Targetability Rankings
- Therapeutic Targets in Neurodegeneration
- Therapeutic Timing Windows in Neurodegeneration
- Thioflavin-T Fluorescence Assay for Protein Aggregation
- Thyroid Hormone Signaling Pathway in Neurodegeneration
- Thyroid Hormone Signaling Pathway in Neurodegeneration
- Thyroid Hormone Signaling Pathway in Neurodegeneration
- TLR Signaling in Parkinson's Disease
- TLR Signaling Pathway in Neurodegeneration
- TLR5-Mediated Microglial Neuroinflammation Hypothesis
- TMEM175 Lysosomal Overflow Valve in Parkinson's Disease
- TNAP/P2X7R/CTCF Signaling Axis in Tauopathies
- TNF Signaling Pathway in Neurodegeneration
- Toll-Like Receptor Signaling in Neurodegeneration
- Transcription Regulation in Neurodegenerative Diseases
- Transcription Regulation Pathway
- Transcriptional Dysregulation in Neurodegeneration
- Transcriptional Regulation in Neurodegeneration
- Transdiagnostic Proteomic Changes in Neurodegeneration
- Translational Dysregulation in 4R-Tauopathies
- Traumatic Brain Injury and Neurodegeneration Pathway
- TREM2 Gene-Mechanism-Therapy Chain — From Genetic Risk to Therapeutic Target
- TREM2 in ALS
- TREM2 in Amyotrophic Lateral Sclerosis
- TREM2 in Frontotemporal Dementia
- TREM2 in FTD
- TREM2 in Parkinson's Disease — Cross-Disease Therapeutic Opportunity
- TREM2 Mechanism Hub
- TREM2 Microglia Pathway in Alzheimer's Disease
- TREM2 Microglial Signaling Pathway in Neurodegeneration
- TREM2 protects against complement-mediated synaptic loss
- TREM2 Signaling in Neurodegeneration
- TREM2-Mediated Amyloid Clearance Pathway
- TREM2-SYK Signaling Cascade
- TREM2→Microglial Dysfunction→Alzheimer's Disease Causal Chain
- Tremor Mechanisms in Parkinsonian Syndromes
- Trinucleotide Repeat Expansion Disorders
- Tripartite Synapse
- tRNA Metabolism in Neurodegeneration
- TSLP Signaling in Neuroinflammation
- TSPO PET Imaging for Neuroinflammation
- Tumor-Derived Cystatin C Enables Amyloid Clearance
- Tunneling Nanotubes in Neurodegeneration
- Type 3 Diabetes Hypothesis of Alzheimer's Disease
- TYROBP/DAP12 Microglia Signaling Pathway in Alzheimer's Disease
- Ubiquitin Signatures on Aggregating Proteins
- Ubiquitin-Proteasome System Dysfunction in 4R-Tauopathies
- Ubiquitin-Proteasome System Dysfunction in 4R-Tauopathies
- Ubiquitin-Proteasome System Dysfunction in Alzheimer's Disease
- Ubiquitin-Proteasome System Dysfunction in Corticobasal Syndrome
- Ubiquitin-Proteasome System Dysfunction in Neurodegeneration
- Ubiquitin-Proteasome System Dysfunction in Parkinson's Disease
- Ubiquitin-Proteasome System in Neurodegeneration
- UCHL1 (PARK5) Pathway in Parkinson's Disease
- UCHL1 Ubiquitin-Proteasome Parkinson's Disease Causal Chain
- Ultrastructural analysis of GCI in MSA
- Unfolded Protein Response (UPR)
- UPS Dysfunction in Neurodegeneration: Cross-Disease Mechanisms
- Vagus Nerve Pathway in Neurodegeneration
- Validation of Computational Tau Propagation Models Against PET Imaging in PSP
- Vascular and Endothelial Dysfunction in Progressive Supranuclear Palsy
- Vascular Cognitive Impairment Mechanistic Pathway
- Vascular Contributions to Alzheimer's Disease
- Vascular Dementia Mechanism Pathway
- Vascular Dementia Mechanisms — Overlap with Alzheimer's Disease
- Vascular Risk Factors in Alzheimer's Disease
- VEGF and Angiogenesis Dysregulation in CBS/PSP
- VEGF Signaling and Cerebral Angiogenesis in Neurodegeneration
- VEGF/Angiogenesis Pathway in Neurodegeneration
- Vesicle Trafficking Dysfunction in Corticobasal Syndrome
- Vesicular Monoamine Transporter 2 (VMAT2) Pathway in Parkinson's Disease
- Vestibular Dysfunction in Progressive Supranuclear Palsy
- Vestibular System Degeneration in Neurodegenerative Diseases
- Vestibular-Ocular Reflex Deficits in Progressive Supranuclear Palsy
- Veterinary Tauopathies in Progressive Supranuclear Palsy Research
- Viral Involvement in Neurodegeneration Pathway
- VIRMA (KIAA1429) in Neurodegeneration
- Visual Hallucinations in Dementia With Lewy Bodies
- Vitamin D Signaling Pathway in Neurodegeneration
- VPS35 Pathway in Parkinson's Disease
- VPS35/Retromer Pathway in Parkinson's Disease
- Wallerian Degeneration
- White Matter Degeneration
- White Matter Hyperintensities in Neurodegeneration
- White Matter Hyperintensities in Neurodegeneration
- Wilson's Disease Copper Dysregulation Mechanistic Pathway
- WNK1 Kinase in Neurodegeneration
- WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegeneration
- Wnt Non-Canonical Signaling Pathways in Neurodegeneration
- Wnt Signaling Dysfunction in Neurodegenerative Diseases
- Wnt Signaling in Neurodegeneration
- WNT Signaling in Neurodegeneration
- Wnt Signaling in Parkinson's Disease
- Wnt Signaling Pathway in Neurodegeneration
- Wnt/β-Catenin Signaling Pathway in Neurodegeneration
- Xenophagy in Neurodegeneration
- YAP/TAZ (Hippo) Signaling in Neurodegeneration
- YAP/TAZ Signaling Pathway in Neurodegeneration
- Yin-Yang Hypothesis (O-GlcNAcylation vs. Phosphorylation Competition)
- Zinc Signaling Pathway in Neurodegeneration
- ZIP8 and ZIP14 in neurodegeneration, PMID:25612689
- Zombosomes — Anucleated Cell Couriers in Alpha-Synuclein Propagation
- 'Ambroxol and the GBA1 gene: The beginning of a new therapeutic era'
- 'Amyloid-related imaging abnormalities in anti-amyloid antibody trials'
- 'Bangabandhu Sheikh Mujib Medical University'
- 'Best medical treatment definitions in PD clinical trials'
- 'GV-971 improves neuroinflammation and synaptic dysfunction in 5xFAD mice'
- 'Microglia in Alzheimer''s disease: from pathogenesis to therapeutic modulation'
- 'Neuropsychiatric symptoms in Alzheimer's disease'
- 'Physical Activity and Neuroinflammation in PD'
- 'Tau biomarker changes in remternetug-treated patients'
- 'Urate and risk of neurodegenerative diseases: A meta-analysis'
- 18F-OP-801 Ashvattha Neuroinflammation PET Imaging Trial
- 18F-PM-PBB3 PET Study in Tauopathy (NCT03625128)
- 4R-Tau & PSP Therapeutics Pipeline
- [18F]ACI-15916 PET Alpha-Synucleinopathies Imaging Trial
- [F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disease Prediction
- A 52-Week, Open-Label Extension Study of ACP-204 in Adults With Alzheimer's D... (NCT06194799)
- A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014)
- A Multicenter, Phase III, Randomized, Double Blind, Placebo-Controlled Study ... (NCT05143528)
- A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the ... (NCT06335173)
- A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study t... (NCT05348785)
- A Phase 3, Randomised, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Tolerability, and Safety of Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease
- A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study... (NCT06947941)
- A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study ... (NCT04777331)
- A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial ... (NCT05021536)
- A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Op... (NCT03887455)
- A4 Study (Anti-Amyloid Treatment in Asymptomatic Alzheimer's)
- AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial
- AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial
- AB-1005 GDNF Gene Therapy Long-Term Follow-up Study
- ABBV-951 (foslevodopa/foscarbidopa) for Parkinson's Disease
- ACI-35 Alpha-Synuclein Vaccine for Parkinson's Disease
- Acoramidis Clinical Trials
- ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)
- Active tau immunotherapy: mechanisms and clinical outcomes
- AD04 Immunotherapy (NCT07107074)
- Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzheimer's Disease (NCT06775964)
- AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm,... (NCT04468659)
- ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT07392723)
- Allopregnanolone Regenerative Therapeutic (NCT04838301)
- ALS biomarkers for clinical trials
- ALSENLITE: Senolytics Trial for AD (NCT04785300)
- Alzheimer's disease: new concepts on neuropathology and treatment
- Ambroxol to Slow Progression in Parkinson Disease (NCT05778617)
- AMDX-2011P Phase 2 Trial for Alzheimer's Disease
- AMDX-2011P Retinal Amyloid Tracer in Alzheimer's Disease
- Amino Acid Supplement in Parkinson's Disease (NCT06954662)
- AMX0035 CENTAUR Trial
- AMX0035 for Progressive Supranuclear Palsy
- Anesthesia Choice in STN-DBS for Parkinson's Disease (NCT05550714)
- Apocynin for Parkinson's Disease
- APOE, ARIA, and anti-amyloid therapy
- ARC-IM Adaptive Neurostimulation for Parkinson's Disease
- ARC-IM Adaptive Neurostimulation for PD
- ARO-MAPT-SC Tau ASO Trial (NCT07221344)
- ARO-MAPT-SC Tau ASO Trial (NCT07221344) - Arrowhead Pharmaceuticals
- Art therapy neuroplasticity aging neurodegeneration 2024
- ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05693982)
- Autologous iNSC-DAP Cell Therapy for Parkinson's Disease (NCT05901818)
- Autologous Stem Cell-Derived Dopaminergic Neurons for Parkinson's Disease (NCT06687837)
- Autonomic Function in PSP (NCT06490926)
- Bacillus Subtilis for Parkinson Disease (NCT06487975)
- Ban2401 Phase 2b Trial (201 Study)
- Basal ganglia-thalamocortical circuit dysfunction in Parkinson's disease - Brain
- BEACoN Study - Biomarker Exploration in Aging, Cognition and Neurodegeneration
- Bemdaneprocel for Parkinson's Disease
- Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT06223360)
- Bepranemab — Phase 2 for PSP
- BIA 28-6156 for GBA-Parkinson's Disease
- BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer's Disease
- BIIB080 (MAPTRx) ASO Therapy for PSP
- BIIB122 (LUMA) LRRK2 Inhibitor Trial
- Bilingualism Cognitive Reserve AD Trial
- Bioenergetic rescue in PD models
- Biomarker trajectories in preclinical AD
- Biomarker Validation Study for AD Combination Therapy
- Biomarkers in Parkinsonian Syndromes (NCT06501469)
- BLAAC PD - Black and African Americans Connections to PD (NCT06719583)
- Blood Flow Restriction for PD Balance
- BMS-986368 Phase 2 - Agitation in Alzheimer's Disease
- Botulinum Toxin for CBS-Associated Dystonia (NCT05678901)
- Brain Activity During Complex Walking in Atypical Parkinsonian Syndromes (NCT06906276)
- Buntanetap Phase 3 Parkinson's Disease Trial (NCT07284784)
- Caffeine for Cognition in AD (NCT04570085)
- Calcium imaging in living motor neurons
- Cannabidiol for Alzheimer's Disease Prevention (NCT05822362)
- CBD (Cannabidiol) for Alzheimer's Disease Agitation - NCT06014424
- Ceftriaxone ALS Trial
- Cell therapy for Alzheimer's disease: progress and challenges
- Centella asiatica Phase 1 Trial for Alzheimer's Disease (NCT05591027)
- Cepharanthine PD Trial
- Cholesterol level and statin use in Alzheimer disease (2011)
- Cionic Neural Sleeve for Parkinson's Disease (NCT07284823)
- Circuit-Based DBS for Parkinson's Disease (NCT05658302)
- Circuit-Based Deep Brain Stimulation (NCT05658302)
- Citalopram Depression AD Trial
- Clinical Efficacy and Mechanism of tDCS for Dysphagia in Parkinson's Disease (NCT07153692)
- Clinical efficacy of MAO-B inhibitors in Alzheimer's disease: a meta-analysis
- Clinical meaningfulness of donanemab treatment effects
- Clinical Trial Rankings in Neurodegenerative Diseases
- Clinical Trials
- Clinical Trials Dashboard
- Clinical Trials in Parkinson's Disease
- Clinical Trials in Progressive Supranuclear Palsy
- Clostridium Butyricum for Motor and Non-motor Symptoms in Parkinson's Disease
- CNversyt and Megan Rodden ALS Trials
- Coenzyme Q10 PSP NICE Trial (NCT04564555)
- Coenzyme Q10 PSP Trial (NCT00532571)
- Cognitive composite endpoints in Alzheimer's disease clinical trials
- Cognitive Training to Reduce Incidence of Cognitive Impairment in Older Adults (NCT03848312)
- Combination therapy approaches with peptides for Alzheimer's
- COMMETS - Semaglutide for MCI/Metabolic Syndrome (NCT06072963)
- Constant Current vs Voltage Subthalamic DBS for PD (NCT06742450)
- CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD
- Corticosteroids in FTD Trial
- CpG1018 TLR9 Agonist Phase 1 Trial (NCT05606341)
- Creatine ALS Trial
- CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Parkinson's Disease (NCT06482268)
- CUE1 Device for Parkinson's Disease (NCT06174948)
- CVN424 Phase 3 ARISE Trial for Parkinson's Disease
- D-Cycloserine ALS Trial
- D-SPARK: D-Serine for Modifying PD Progression
- DANU Sports System for Gait/Balance Assessment in Parkinson's Disease (NCT07281794)
- DAOIBplusAO Phase 2 (NCT06467539) - Novel Antioxidant Augmentation for Early Dementia
- Daridorexant for Post-Cardiotomy Delirium Prevention (NCT07217912)
- Davunetide (AL-108) PSP Trial
- DBS for Visuomotor Function in Parkinson's Disease (NCT05400499)
- DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD
- DBS-fMRI Cognitive Decline Study (NCT06960096): Neural Basis for Cognitive Decline Following STN-DBS
- Dexmedetomidine DMTS Phase 2 (NCT06052254) - Teikoku Pharma Agitation Trial
- Dexmedetomidine Transdermal System (DMTS) for AD Agitation
- Diagnosing Frontotemporal Lobar Degeneration (NCT02964637)
- DIAN-TU-001 Trial (NCT01760005)
- Digital biomarkers in Alzheimer's disease: Remote monitoring approaches (2024)
- Digital Diagnostic Devices for Parkinson's Disease (NCT06663826)
- Digital endpoints in clinical trials
- Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's Disease (NCT04664634)
- Disease modification in Parkinson's disease: where are we now?
- DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer's Disease
- DMF metabolites and Nrf2 activation in the brain
- DNL628 Phase 1 AD Trial (NCT07328451) — Denali Tau ASO
- Donanemab Dosing Regimens Phase 3 for Early Alzheimer's (NCT05738486)
- Donanemab TRAILBLAZER Open-Label Extension
- Donanemab TRAILBLAZER-ALZ 2 Trial
- Dual muscarinic/sigma-1 compounds for neurodegeneration
- Dual orexin receptor antagonists: from bench to bedside
- Dyadic Mindfulness for PD Carers (NCT06821230)
- E2814 (Etalanetug) Anti-Tau Therapy
- E2814 — 4R-Tauopathy Development (No Active 4R-Tauopathy Trial)
- EC5026 (STEP Study) - Parkinson's Disease Clinical Trial
- EC5026 (STEP Study) Phase 1 Parkinson's Disease Trial (NCT07142044)
- Edaravone ALS Trial
- Edmond J Safra Accelerating Clinical Trials in Parkinson's Disease (NCT07207057)
- Efficacy of Acupuncture for Treatment of Parkinson's Disease Related Conditions (NCT06390761)
- EI-1071 Immunomodulator for Alzheimer's Disease (NCT06745583)
- EMST with SpiroGym App for Parkinson's Disease (NCT06942533)
- ES-Park: Parkinson Specialized Teams Intervention
- Escitalopram for Agitation in Alzheimer's Disease (NCT03108846)
- Etanercept in Alzheimer's disease: a randomized controlled trial
- ETX101 (Encoded Therapeutics) — Dravet Syndrome Gene Activation Therapy
- EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer's Disease
- Exciva Alzheimer's Disease Phase 2/3 Trial
- Exercise as Treatment of Fatigue in Parkinson's Disease (NCT06324422)
- Exercise Brain Energetics PD Trial
- Exercise-induced neuroplasticity in Parkinson's disease
- Exercise-induced neuroplasticity in Parkinson's disease
- Exergaming With Physical Objects for Upper Limb Rehabilitation in Parkinson's Disease (NCT07475741)
- ExPlas — Exercise Plasma Transfusion for Alzheimer's Disease (NCT05068830)
- Fasudil for Parkinson's Disease (ROCK-PD)
- FEEMSA Study: Laryngopharyngeal Function in Neurodegenerative Diseases (NCT04706234)
- First-in-Human 4R Tau Ligand Study in PSP
- First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)
- Flornaptitril PET Phase 3 - NCT06254469
- FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear Palsy
- FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear Palsy
- Foralumab Phase 2 Trial for Alzheimer's Disease
- Freezing of gait a gap between concept and pathophysiology
- Frequency-Specific Subthalamic DBS (NCT07022522)
- Gabapentin ALS Trial
- Gait Analysis Parameter and Upper Limb Evaluation in Neurological Disease
- Gait and Upper Limb Evaluation in PSP (NCT07136844)
- Gait Pattern Analysis in Neurological Disease (NCT02994719)
- Galcanezumab AD (NCT07323927)
- Gamma tACS for AD (NCT05326750)
- GBA Brain Molecular Imaging and Blood Biomarkers for Precision Medicine in PD (NCT06167603)
- Genetic Frontotemporal Dementia Study
- Genistein for Mild Cognitive Impairment (NCT07385937)
- Genome-wide association studies in neurodegenerative diseases
- GLP-1/GCG Dual Agonist LIGHT-COG (NCT07083154)
- GM-CSF Sargramostim Phase 2 (NCT04902703) - AD Immunotherapy
- GnRH Therapy for Cognition in Down Syndrome (NCT04390646)
- Gosuranemab (BIIB092) PSP Trial
- GSK4527226 (AL101) for Early Alzheimer's Disease (NCT06079190)
- GSK4527226 (AL101) for Early Alzheimer's Disease (NCT06079190)
- GSK4527226 (AL101) Open-Label Extension (NCT07105709)
- GT-02287 for Parkinson's Disease
- GTX-102 (GeneTx/Ultragenyx) — Angelman Syndrome Phase 1/2 Trial
- Guanfacine NorAD - Phase 3 Trial for Alzheimer's Disease
- Gut-Brain Axis in Neurodegeneration (NCT05934188)
- GV1001 for Moderate to Severe Alzheimer's Disease (NCT05303701)
- High-Dose Vitamins ALS Trial
- High-Intensity tDCS for AD (NCT05509387)
- HRG2010 for Parkinson's Disease With Motor Fluctuations (NCT06596876)
- Hydralazine Phase 3 AD Trial (EHSAN)
- Idebenone ALS Trial
- IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543681)
- IL-2 Immunotherapy for AD Neuroinflammation (NCT06384378)
- Inclisiran for Lewy Body Disorders Trial
- Integrated Management of Atypical Parkinsonism - Home-Based Care (NCT05792332)
- Interleukin-2 Phase 2 (NCT06096090) — Immunomodulation for AD
- Intranasal Insulin and Glutathione for PD (NOSE-PD)
- Intravenous Immunoglobulin (IVIG) in ALS Trial
- Investigating Complex Neurodegenerative Disorders (NCT03225144)
- IPAT Study Phase 2 (NCT05331144)
- IRL757 for Parkinson's Disease Apathy
- ITI-1284 for Alzheimer's Agitation (NCT06651567)
- ITI-1284 for Alzheimer's Disease Psychosis (NCT06540833)
- JNJ-63733657 Janssen Pipeline
- KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's Disease Psychosis
- KarXT for Alzheimer's Disease Cognitive Impairment - MINDSET 1 (NCT06976216)
- KarXT for Alzheimer's Disease Cognitive Impairment - MINDSET 2 (NCT06976203)
- KarXT for psychosis in Alzheimer's disease. N Engl J Med. 2024
- KarXT Phase 3 AD Agitation (NCT06585787)
- KarXT+EC Phase 3 (NCT07011732): Enhanced Formulation for AD Agitation
- KCNQ2 Encephalopathy — Gene Therapy Preclinical Programs
- Kenai RNDP-001 Dopaminergic Progenitor Cell Therapy for Parkinson's Disease (NCT07106021)
- Kinetic modeling approaches for tau PET
- KP405 Phase 1 PD trial (NCT06189170)
- Lactococcus lactis CKDB001 for Alzheimer's Disease (NCT07496021)
- Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Disease
- LEAF Trial - THC+CBD for Alzheimer's Disease Agitation (NCT05644262)
- Lecanemab CLARITY Open-Label Extension
- Lecanemab CLARITY-AD Trial
- Lemborexant for AD Biomarkers (NCT06274528)
- Lenrispodun Phase 2 PD Trial (NCT05766813)
- Levodopa challenge test methodology
- LHP588: P. gingivalis Targeting for Alzheimer's Disease (NCT06847321)
- Lighthouse Pharmaceuticals - LHP588 Program
- LIPUS-Brain Phase 3 — Low-Intensity Pulsed Ultrasound for Early Alzheimer's Disease
- Lithium Carbonate in Amyotrophic Lateral Sclerosis
- Lithium Carbonate PSP Trial
- Lithium for Parkinson's Disease - SUNY Buffalo Trial (NCT06339034)
- Lithium for PSP/CBS — Phase 2 Trial
- Lithium Orotate for Alzheimer's Disease — Phase 1/2 Trial (LiO-AD)
- Local Field Potentials of Subthalamic Nucleus in Parkinson's Disease (NCT05820425)
- Long-term Effects of Hearing Intervention on Brain Health in the Aging and Co... (NCT05532657)
- Longitudinal Multicenter Head-to-Head Harmonization of Tau PET Tracers (NCT05361382)
- Low-Dose Naltrexone ALS Trial
- LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for APOE4 Homozygote AD
- LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE4 Homozygote AD
- LY-3372689 LOTUS Trial - Phase 2 in Progressive Supranuclear Palsy
- LY-3372689 MAGNOLIA Trial - Phase 2 in Alzheimer's Disease
- LY03020 - Luye Pharma Phase 1 Trial
- LY4006896 Phase 1 Parkinson's Disease Trial
- MAR Polypill for Alzheimer's Disease (NCT06597058)
- MAR Polypill Phase 2 Alzheimer's Trial (NCT06597058)
- MARKERS-NDD Progression Markers (NCT06596746)
- Masitinib ALS Trial
- Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies (NCT07177352)
- Masupirdine for Agitation in Alzheimer's Disease (NCT05397639)
- Masupirdine for Alzheimer's Disease Agitation
- Mediterranean Diet in PD DBS Patients (NCT07187739)
- Metformin for Parkinson's Disease - Phase 2/3 Trial (NCT07229651)
- Methylphenidate + iTBS for Apathy in AD (PRIME Trial)
- Mevidalen (LY3154207) Phase 2 — NCT06538116
- Microtubule-stabilizing agents in neurodegenerative disease: from bench to bedside
- Minocycline ALS Trial
- MK-1167 Phase 2 AD Trial (MK-1167-008)
- MK-1167 Phase 2 Alzheimer's Disease Trial
- MK-2214 for Early Alzheimer's Disease
- MK-6837 Phase 1 Solid Tumor Trial (NCT06460961)
- Modifiable Variables in Parkinsonism Study
- MOTIVE-PSP Initiative (NCT04691635)
- Motor and non-motor speech impairment in Parkinson's disease
- mTOR signaling in Parkinson's disease: Therapeutic implications
- Myrosinase Bioactivated Glucoraphanin for Neurodegenerative Diseases (GRA-MYR-ND NCT07360977)
- Myrosinase Bioactivated Glucoraphanin for Neurodegenerative Diseases (NCT07360977)
- NAB-IT: Nabilone for Agitation in Alzheimer's Disease
- Nabilone for Agitation in Alzheimer's Disease (NCT04516057)
- NADAPT Study: NAD Replenishment Therapy for Atypical Parkinsonism
- NCT03875638 - Levetiracetam for Alzheimer's Disease
- NCT04661280: CHOLINE-2 Study - Donepezil vs Non-drug Approach
- NCT05881460: Vibrotactile Coordinated Reset for Parkinson's Disease
- NCT06129942: Light Therapy in Parkinson's Disease
- NCT06274528 - Lemborexant for Alzheimer's Disease Biomarkers
- NCT06487975: Bacillus Subtilis Gut Microbiome Intervention for PD
- NCT06530290: Mirtazapine for Anxiety in Parkinson's Disease
- NCT06582706: Nicotinic Acid for Alzheimer's Disease
- NCT06803823 - ONO-2020 for Agitation in Alzheimer's Disease
- NCT07138677: MCI Network Guided TMS for Early Alzheimer's Disease
- NCT07172295: Low-Intensity Focused Ultrasound for PD Tremor
- NCT07217665: PSP Clinical Trial Platform - Regimen A (AADvac1)
- NCT07262645: Near-Infrared Light Therapy for Mild-Moderate Alzheimer's Disease
- NCT07264283: PSP Clinical Trial Platform - Regimen B (LM11A-31)
- NCT07279740: Methylphenidate + tDCS for AD
- NCT07477431 - Levetiracetam for Persons at Risk for Alzheimer's Disease
- ND0612 Subcutaneous Levodopa Infusion PD Trial (NCT04006210)
- NE3107 (Bezisterim) Early Parkinson's Trial
- Neuro-immune Interactome in Parkinson's Disease (NCT07026929)
- Neurodegenerative Drug Development Pipeline
- Neuroimaging for Parkinsonian Syndromes (NCT03872102)
- Neurologic Stem Cell Treatment Study for Progressive Supranuclear Palsy (NCT02795052)
- Neuroprotective effects of antiepileptic drugs in neurodegenerative diseases
- Neuroprotective strategies in Alzheimer's disease drug development (2024)
- NIH CTSA PSP Biospecimen Repository (NCT05067192)
- Nilotinib for Parkinson's Disease (NCT03744468)
- NIO752 Antisense Oligonucleotide (NCT04539041)
- NIO752 Phase III PSP Trial (NCT07498426)
- NIO752 Tau ASO PSP Trial
- NMDA receptor-dependent excitotoxicity in neurodegeneration
- Noradrenergic Arousal System Phase 3 PD Trial (NCT07316296)
- North American Prodromal Synucleinopathy Consortium (NAPOS) Stage 2 — NCT05826457
- NouvNeu001 Cell Therapy for Parkinson's Disease
- Novel therapeutic approaches for neurodegenerative diseases
- NRTIs for Alzheimer's Disease: Targeting Type-I Interferon-Driven Neuroinflammation (NCT04500847)
- NTRX-07 Phase 2 (NCT07058688) - NeuroTherapia cholinergic anti-inflammatory
- NurOwn Stem Cell Trial
- NYSCF Scientific Discovery Biobank (NCT06203106)
- Olfactory Mucosa, Blood and Urine for Identification of Early Neurodegeneration (NCT06846658)
- Oligomeric tau as a toxic species
- ONCOGBA: Malignant Neoplasms Incidence in GBA-PD (NCT06814431)
- ONO-2020 for Alzheimer's Disease (NCT06881836)
- Osteopathic Manipulative Medicine for Parkinson's Disease (NCT05884944)
- Ozanimod for Alzheimer's Disease (NCT06862960)
- p38 MAPK and mitochondrial dysfunction
- Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms (NCT05748028)
- Pain in Parkinson's Disease: Exploration of the Serotonin System in PET
- Pallido-thalamocortical Motor Pathway DBS Study (NCT06692920)
- Parkinson's disease
- Parkinson's Foundation — DBS Information
- PAROPE Study - Oculometric Patterns (NCT06597071)
- PDE4 Inhibitor PD Trial
- PDR-001 Alpha-Synuclein Removal PD Trial
- Peripheral Biomarkers in Neurodegenerative Dementia (NCT06529744)
- Personalized Parkinson Project (NCT03364894)
- Pexidartinib (PLX3397) CSF1R Inhibitor Parkinson's Disease Trial (NCT04888966)
- Phase 2 safety and efficacy of crenezumab in Alzheimer's disease
- Phase 3 Study to Compare the Efficacy and Safety of Masitini... (NCT03127267)
- Physical Activity Effects on Mitochondrial Function in Parkinson's Disease (NCT05963425)
- PI-2620 Tau PET in PSP
- PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD
- PI-2620 Tau PET Phase 3 - NCT05641688
- PI3K/Akt Activator Clinical Trials for Parkinson's Disease
- Piromelatine 20 mg for Mild Dementia Due to Alzheimer's Disease (NCT05267535)
- Plasma α-Synuclein Aggregation Seeding Activity as Biomarker — NCT07498686
- PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Disease
- PMN310 Anti-Amyloid for AD (NCT06750432)
- Portable Driving Simulator for PD Assessment (NCT03969927)
- Portable Exoskeleton for PD Mobility (NCT06028529)
- Pramipexole Early Parkinson's Trial
- Prasinezumab Phase 3 Parkinson's Disease Trial (NCT07174310)
- Prevalence and treatment of psychosis in Alzheimer's disease
- PRI-002 (PRImus-AD) Phase 2 Trial
- Probiotic Treatment for Depression in Parkinson's Disease (NCT05568498)
- Probiotics in Mild Alzheimer's Disease (NCT06181513)
- Psilocybin for Depression in MCI/AD (NCT04123314)
- Psilocybin Therapy for Depression in Parkinson's Disease (NCT06455293)
- PSP Clinical Trial Platform (NCT07173803)
- PSP Clinical Trials Platform Overview
- Purinergic Receptor Targeted Trials in Parkinson's Disease
- Quality of Life and Caregiver Burden in PSP (NCT03638505)
- Rapamycin ALS Trial - mTOR Inhibition for Amyotrophic Lateral Sclerosis
- Rasagiline for motor complications in Parkinson's disease
- Real-world evidence in Alzheimer's disease: Applications in clinical research (2024)
- Real-world evidence in Alzheimer's disease: Applications in clinical research (2024)
- Recombinant Human Serum Albumin for Alzheimer's Disease (NCT06489015)
- Recombinant Human Serum Albumin Phase 1 AD (NCT06489015)
- Regional tau burden in PSP: neuropathological correlates
- Regulatory considerations for Alzheimer's disease drug approval
- Remote Monitoring in PSP (NCT04753320)
- Remternetug Phase 3 Alzheimer's Trial (NCT06653153)
- Retigabine PD Trial
- Retinal Imaging in PSP (NCT07000851)
- Rifaximin SSD in Dementia Trial (RIDE)
- Riluzole ALS Trials
- Riluzole and glutamate excitotoxicity
- RO7269162 Tau Biomarker Phase 2 (NCT06402838)
- RO7812653 for Early Symptomatic Alzheimer's Disease
- Roche/Neurocrine SCN1A AAV Gene Therapy — Dravet Syndrome
- ROCK2 in neuroprotection: molecular pathways
- Rotigotine and Rivastigmine Combination Therapy for Alzheimer's Disease (NCT06702124)
- Safety and Clinical Outcomes Study: Amniotic and Umbilical Cord Tissue Admini... (NCT03899298)
- Sargramostim (GM-CSF) ALS Trial
- Self-administered tDCS for Parkinson's Disease Gait
- Semaglutide EVOKE Plus (NCT04777409)
- Semaglutide Phase 3 Alzheimer's Trial (EVOKE Plus, NCT04777409)
- Semaglutide Phase 3 Alzheimer's Trial (EVOKE, NCT04777396)
- Senicapoc Alzheimer's Disease Trial - NCT04804241
- SER-252 (PEOZ-Apomorphine) for Parkinson's Disease - NCT07422675
- SHR-1707 for Alzheimer's Disease (NCT06199037)
- Silymarin for Neuroprotection and Symptom Management in Parkinson's Disease (NCT07001150)
- Simufilam for Alzheimer's Disease
- Siponimod for Alzheimer's Disease (NCT06639282)
- Sirtuin activation and NAD+ metabolism in PD
- Skin biopsy as tool for disease progression monitoring
- SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
- SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheimer's Disease (NCT05081219)
- Social Behaviors and Quality of Life in Parkinson's Disease (NCT06385184)
- Sodium Phenylbutyrate ALS Trial
- Solanezumab A4 Trial
- Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease (NCT06798844)
- STK-001 (Stoke Therapeutics) — Dravet Syndrome Phase 1/2 Trial
- SToP-AD: Suvorexant for Alzheimer's Disease Prevention
- STXBP1 Encephalopathy — Preclinical Gene Therapy Program
- Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration (NCT03174938)
- Syde® Digital Endpoints for PSP (NCT07389018)
- Synaptic Loss in Multiple System Atrophy (NCT05121012)
- Synaptic plasticity and traditional Chinese medicine in Alzheimer's disease
- Synaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease (NCT05531656)
- T-cell mediated neuroprotection: emerging concepts
- Tai chi and dual-task training in Parkinson's disease
- Tau PET for therapy monitoring
- Tau-targeted immunotherapy for Alzheimer's disease
- Tauraso (Nimodipine) ALS Trial
- taVNS Brain Mechanism PD Motor Symptoms trial (NCT06409338)
- TB006 for Parkinson's Disease
- TB006 Phase 2a Parkinson's Disease Trial (NCT06773962)
- tDCS + Nordic Walking for Parkinson's Disease Motor Symptoms (NCT07381907)
- tDCS as Treatment for Motor Function in PSP (NCT07291687)
- Telephone Cognitive Assessment in PSP (NCT06932809)
- Terazosin for Cardiac Autonomic Changes in Early Parkinson's Disease (NCT04386317)
- The Alzheimer's Disease Tau Platform Clinical Trial (NCT06957418)
- The relationship between associative learning and iTBS aftereffects in major depression
- Therapeutic targeting of SOD1
- Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease (NCT06518824)
- Thoracic Epidural SCS for Parkinson's Disease Freezing of Gait (NCT06630702)
- Tilavonemab PSP Trial Failure Analysis
- Tocotrienols in Parkinson's Disease Trial (NCT04491383)
- Tofersen VALOR Trial
- Tolfenamic Acid PSP Trial (NCT04253132)
- TPN-101 for Progressive Supranuclear Palsy
- TPN-101 in PSP (NCT04993768)
- TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical Alzheimer's Disease
- TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Disease (NCT05463731)
- Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy
- TRAP-AD: Transcranial Photobiomodulation for Alzheimer's Disease (NCT04784416)
- Trazodone for Sleep and Cognition in Early Alzheimer's Disease (NCT05282550)
- TREM2 expression in human brain and modulation by amyloid
- Tributyrin for Parkinson's Disease
- Tricaprilin Phase 3 ALTER-AD Study (NCT05809908)
- Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT07170150)
- TTYP01 Phase 2 Alzheimer's Disease Trial
- Typhaneoside for Progressive Supranuclear Palsy
- UAB TSPO PET Neuroinflammation in PD Trial
- UB-311 Alzheimer's Vaccination Trial
- UCB0107 for Progressive Supranuclear Palsy
- Udall Project 2: Pallidal DBS LFP Study (NCT05656586)
- Ultrasonographic Respiratory Muscle Assessment in Parkinson's Disease (NCT07308795)
- UPenn Observational Research Repository (NCT04715399)
- Urolithin A for Parkinson's Disease (MUSIC Trial NCT06033890)
- Utilisation of Health Services and Quality of Life in Atypical Parkinsonian Syndromes (NCT06645626)
- Vagal Nerve Stimulation PD trial (NCT07226284)
- Valacyclovir for HSV-1-Positive Parkinson's Disease
- Valbenazine for hyperkinetic disorders
- Valproic Acid in PSP (NCT00385710)
- Varenicline for Falls in Hypocholinergic Parkinson Disease (NCT06679374)
- Vascular Dementia Clinical Trials
- VCYCLE Virtual Cycling Trial (NCT04804202)
- Vigonvita CDKL5 Deficiency — Preclinical Program
- Vitamin D3 Cardiac Autonomic PD Trial (NCT07084597)
- Vutiglabridin for Parkinson's Disease
- VY7523 Phase 1/2 Alzheimer's Disease Trial
- Whole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease
- X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer's Disease
- Xanamem Phase 2 Alzheimer's Trial (NCT06125951)
- Xenon Gas Inhalation for Neuroinflammation (NCT06945614)
- XTR006 Tau PET for AD (NCT07115238)
- XTR006 Tau PET for Alzheimer's Disease (NCT07115238)
- "DCC/netrin-1 in neural circuit refinement." Curr Opin Neurobiol
- "Dynamic regulation of SNX1 expression during aging and neurodegeneration." Aging Cell. 2019;18(4):e12967.
- "Dynamic regulation of SNX2 and SNX1 expression in the aging brain." Aging Cell. 2019;18(4):e12967.
- "Epigenetic regulation of BDNF/TrkB expression in neurodegenerative diseases." Mol Neurobiol. 2019;56(12):8254-8267.
- "FOXP4 in cerebellar development and ataxia." Cerebellum
- "MYC depletion extends lifespan in mouse models." Aging Cell (2022)
- "Neurotrophin structure and receptor binding." Curr Opin Struct Biol
- "Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification." Pathologica. 2022;114(2):108-120.
- "Perisomatic inhibition and network hyperexcitability in epilepsy." Brain Res. 2019;1708:22-31.
- "Peroxisome biogenesis and ABCD transporters: update." J Cell Sci
- "Regulation of synaptic vesicle cycling by SNARE complexity." Neuron. 2019;102(4):727-738.
- "ROBO2 mutations disrupt axonal crossing in the corpus callosum." Brain Pathol
- "Sall1 in neural stem cells." Stem Cells (2019)
- "Small molecule inhibitors of Pyk2 for neuroprotection." J Med Chem
- "Synaptic vesicle proteins in ALS." Molecular Neurobiology
- "TRIM2 as a biomarker for protein quality control in neurodegeneration." Molecular Neurobiology. 2021;58(11):5679-5692
- "VGLUT3 in the auditory system: cochlear hair cell transmission." Hear Res. 2019;378:52-63.
- '"Frizzled-7 mediates age-associated memory decline." Aging Cell'
- '"Genetic variants of ABCB1 and risk of Alzheimer's disease: a meta-analysis." Molecular Neurobiology'
- '"Metabolic rewiring in neurodegenerative diseases." Cell Metabolism (2023) DOI:10.1016/j.cmet.2023.04.017'
- '"NPC1 in amyloid processing and AD." Acta Neuropathol Commun'
- '"Protective Effects of Resveratrol on Adolescent Social Isolation-Induced Anxiety-Like Behaviors via Modulating Nucleus Accumbens Spine Plasticity and Mitochondrial Function in Female Rats."
- '"The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome." Journal of inherited metabolic disease
- '"UBE2L3 and CHOP cooperate in ER stress-induced neurodegeneration." Cell Death & Disease. 2023;14(8):546'
- ''"Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson''s disease." Neuroscience (2014) DOI:10.1016/j.neuroscience.2013.11.038''
- ''"ER stress and protein disulfide isomerase in neurodegenerative diseases." Cell Mol Neurobiol. 2023;43(5):1921-1936. PMID:37402847''
- ''"Mitochondrial chaperones in Alzheimer''s disease: therapeutic targets." J Alzheimers Dis. 2025;87(2):567-582. PMID:38976321''
- ''"Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology." Journal of proteomics (2013) DOI:10.1016/j.jprot.2013.08.017''
- ''"T817MA Regulates Mitochondrial Dynamics via Sirt1 and Arc Following Subarachnoid Hemorrhage." Neuroscience (2023) DOI:10.1016/j.neuroscience.2023.06.020''
- '': : ^: - See: SRC Protein - Protein product''
- '': : ^:''
- ''ApoE4 ex'
- ''Lysosomal calcium dysregulation in neurodegeneration (2023)''
- ''The role of XBP1 in Alzheimer''s disease''
- 'Cell Death & Differentiation, 2023'
- 'Age-related changes in neuronal AE3 expression'
- 'AIM2-like receptors: sensors of cytosolic DNA in antiviral and autoimmune responses'
- 'ALDH1A2 genetic variations and risk of Parkinson's disease in Chinese population'
- 'Allen Brain Atlas: UNC13A'
- 'Ambra1 knockdown enhances alpha-synuclein aggregation in yeast and neurons'
- 'BSN variants in neurodevelopmental disorders'
- 'Cathepsin inhibitors as therapeutic agents in neurodegenerative diseases'
- 'Clathrin adaptor proteins in synaptic function'
- 'DDB1 expression in human brain and disease'
- 'EGFR and brain aging'
- 'Elongation factor 1 alpha: a key component in neuronal translation and disease'
- 'Emerging therapeutic strategies targeting adenosine receptors in neurodegenerative diseases'
- 'Ensembl: ENSG00000196549'
- 'ERK and mitochondrial dysfunction in neurodegeneration'
- 'Extracellular thioredoxin: therapeutic potential in neurodegenerative diseases'
- 'GeneCards: RPL30'
- 'GluD2 interacts with CaMKII in Purkinje cell dendritic spines'
- 'Glutathione biosynthesis pathway
- 'GM-CSF for Alzheimer's disease: a phase 2 clinical trial'
- 'GPR137 in Huntington disease models'
- 'GSK3β in PD models'
- 'How many mitochondrial proteins does it take to make a disease?'
- 'IL-17A as a potential biomarker and therapeutic target for Alzheimer's disease'
- 'IL1RAP mediates the crosstalk between amyloid and tau pathology'
- 'Kinesin dysfunction and synaptic loss in AD (2025)'
- 'Kusik G, Hammond L, Martinez P, Lee J, Kim M, Kim S, Kim H, Park J, Kim J, Lee J, Kim H, Park S, Kim D, Kim J, Park S, Son D, Lee S, Kim K, Park S, Lee H, Kim J, Park J, Park Y, Kim S, Lee K, Kim Y, Park S, Kim J, Lee S, Kim K, Kim J, Lim J, Kim J, Lee K
- 'Lysosomal dysfunction in GBA-associated Parkinsonism: From mechanisms to therapy'
- 'MAML1 in microglial activation and CNS homeostasis'
- 'MCC expression in human brain tissue'
- 'Metabolism and mitochondria in neurodegeneration'
- 'Microglial APP expression and neuroinflammation'
- 'Mitochondria and neurodegeneration'
- 'Na+/K+-ATPase and mitochondrial dysfunction in neurodegeneration'
- 'Neuroinflammation in ALS'
- 'Neuronal vulnerability and age-related neuronal loss in the substantia nigra pars compacta'
- 'Notch pathway in neuroinflammation'
- 'Pharmacological inhibition of NNMT enhances NAD+ repletion therapy'
- 'PPARδ activation ameliorates tau phosphorylation and cognitive deficits in Alzheimer's disease model'
- 'Presynaptic calcium channels and synaptic transmission in neurodegeneration'
- 'Protein aggregation in neurodegenerative diseases: mechanisms and therapeutic targets'
- 'RPS29 and axonal protein synthesis in regeneration'
- 'Systematic review and meta-analysis of the efficacy of interleukin-1 receptor antagonist in preclinical models of ischemic stroke'
- 'Therapeutic targeting of IL-27/IL-30 pathway'
- 'TRPV2 and autophagy in neurodegeneration'
- (2007)
- (2011)
- (2013)
- (2013) Molecular mechanisms of GABRA2 variant effects on GABAergic signaling
- (2015)
- (2015)
- (2017). "SCN2A-associated neurodevelopmental disorders." Neuron. DOI:10.1016/j.neuron.2017.09.037
- (2018). KIF23 in neuronal development. Developmental Neurobiology. PMID:29873456
- (2020) GABA-A alpha4 subunit in memory and cognition
- (2020) GABAergic mechanisms in cerebellar development
- (2022)
- (2022). NBEA in Alzheimer's disease: altered expression and function
- (2022). Targeting RIG-I in neurodegeneration. Trends in Neurosciences. PMID:35863754
- (2023). Netrin-1/UNC5 signaling in neurogenesis and brain repair. Stem Cell Reports
- (2024). KLK6-mediated protein cleavage in Alzheimer's disease. EMBO Molecular Medicine. PMID:38412457
- 14-3-3 proteins in SCA3 pathogenesis
- 14-3-3 theta in protein aggregation disorders
- 5-Hydroxytryptamine Receptor 1F
- A novel complex containing SMN and gemin proteins (2004)
- A20 expression in astrocytes and its protective role in CNS disorders
- A2M and aging brain (2019)
- AAV-mediated BAI1 gene therapy in mouse models
- AAV-mediated delivery of MAP6 improves neuronal function in AD models
- ABCA1 Gene
- ABCA1 Gene
- ABCA2 Gene - ATP Binding Cassette Subfamily A Member 2
- ABCA7 deficiency and neuroinflammation in mouse models
- ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 1
- ABCD2 — ATP Binding Cassette Subfamily D Member 2
- ABCD3 Gene
- ABCG1 Gene
- ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2
- ABCG4 Gene — ATP-Binding Cassette Subfamily G Member 4
- Abelson Helper Integration Site 1
- ABHD12 Gene
- ABI3 Gene
- ABIN1 (TNIP1) Gene
- ACAD9 Gene
- ACE Gene
- ACO2 — Aconitase 2
- ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Member 4
- ACTB Gene
- ACTG1 Gene
- Activin A Receptor Type 1B (ACVR1B)
- ACTN2 — Actinin Alpha 2
- ACVR1 Gene
- ACVR2A Gene
- ACVR2B Gene
- Adam, Nuclear import mechanisms (2019)
- ADAM10-mediated ectodomain shedding as therapeutic target
- ADAM12 Gene
- ADAM15 Gene
- ADAM17 activation reduces amyloid pathology in mouse models. Acta Neuropathologica
- ADAM19 Gene
- ADAM22 — ADAM Metallopeptidase Domain 22
- ADAM23 Gene
- ADAM8 Gene
- ADAM9 in astrocyte-mediated synaptic pruning. Glia
- ADAMTS13 Gene
- ADAMTS4 Gene
- ADAR Gene
- ADARB1 Gene
- ADCY1 Gene
- ADCY2 — Adenylate Cyclase 2
- ADCY3 — Adenylate Cyclase 3
- ADCY5 Gene
- ADCY6 Gene
- ADCY7 — Adenylate Cyclase 7
- ADCY8 Gene
- ADCY9 Gene
- ADGRV1 Gene
- ADNP Gene
- ADORA1 Gene
- ADORA2A Gene
- ADORA2B Gene
- ADRA1A Gene
- ADRA1B — Alpha-1B Adrenergic Receptor
- ADRA1D Gene
- ADRA2A Gene
- adra2b Gene
- ADRA2C — Alpha-2C Adrenergic Receptor
- ADRB1 Gene
- ADRB2 Gene
- ADSS1 — Adenylosuccinate Synthetase 1
- ADSS2 — Adenylosuccinate Synthetase 2
- AFG3L2 Gene
- AGER Gene
- AGGF1 Gene - Angiogenic Factor
- AGO1 (Argonaute-1)
- AGO2 (Argonaute-2)
- AHCYL1 Gene
- AHCYL2 — Adenosylhomocysteine Hydrolase Like 2
- AHSA1
- AHSA2 Gene
- AIF Gene
- AIF1 Gene
- AIFM1 Gene
- AIFM2 — Apoptosis-Inducing Factor Mitochondria-Like 2
- AIFM3 — Apoptosis-Inducing Factor Mitochondria 3
- AIS plasticity in health and disease
- AKT1 Gene
- AKT2 Gene
- AKT3 Gene
- ALDH1A1 Gene
- ALDH1A3 — Aldehyde Dehydrogenase 1 Family Member A3
- ALDH1L1
- ALDH2 — Aldehyde Dehydrogenase 2
- ALEX1 Gene - ARM Repeat Expressed 1
- ALOX15 - Arachidonate 15-Lipoxygenase
- ALS genetics and therapy
- ALS10 - Amyotrophic Lateral Sclerosis 10 (TARDBP)
- ALS2 (Alsin)
- ALS7 - Amyotrophic Lateral Sclerosis 7
- ALS8 - Amyotrophic Lateral Sclerosis 8
- ALS9 - Amyotrophic Lateral Sclerosis 9
- Alsin (ALSIN)
- ALSINC — ALS IncRNA
- ALZFORUM Gene
- AMPD2 — Adenosine Monophosphate Deaminase 2
- Amyloid-\u03B2 and tau: the prions versus the proteins in AD
- Amyloid-beta reduces VGLUT1 expression through epigenetic mechanisms
- ANG — Angiogenin
- ANK1 — Ankyrin 1
- ANKRD1 — Ankyrin Repeat Domain 1
- ANKRD11 — Ankyrin Repeat Domain 11
- ANKZF1 Gene
- ANO1 (Anoctamin 1 (TMEM16A))
- ANO10 (Anoctamin 10 (TMEM16J))
- ANO2 (Anoctamin 2 (TMEM16B))
- ANO3 Gene
- ANO4 (Anoctamin 4 (TMEM16D))
- ANO5 (Anoctamin 5 (TMEM16E))
- ANO7 (Anoctamin 7 (TMEM16G))
- ANO8 (Anoctamin 8)
- ANT2 (Adenine Nucleotide Translocator 2)
- Anti-inflammatory effects of MCC950 (NLRP3 inhibitor) in AD models
- ANXA1 — Annexin A1
- ANXA11 expression
- ANXA2 — Annexin A2
- AOX1 - Aldehyde Oxidase 1
- AP1G1 Gene
- AP2A2 — Adaptor-Related Protein Complex 2 Subunit Alpha 2
- AP2B1 — Adaptor Related Protein Complex 2 Subunit Beta 1
- AP2M1 Gene
- APAF1 Gene
- APBB1
- APC Gene
- APE1 — AP Endonuclease 1
- APE2 Gene
- APEX1 Gene
- APEX2 Gene
- APH1A Gene
- APH1A Gene - Anterior Pharynx Defective 1 Homolog A
- APH1B Gene - Anterior Pharynx Defective 1 Homolog B
- APLP1 Gene
- APLP2 Gene
- APOA1 Gene
- APOA2 Gene
- APOB Gene
- APOC1 Gene — Apolipoprotein C-I
- APOC2 Gene
- APOC3 Gene
- APOC4 — Apolipoprotein C-IV
- Apoptosome-based therapeutics in neurodegenerative disease
- APPBP2 Gene
- AQP1 Gene
- AQP4 (Aquaporin-4 Gene)
- ARAF Gene
- ARC Gene
- ARF1 Gene
- ARF3 Gene
- ARF5 Gene
- ARG1 — Arginase 1
- ARH Gene
- ARHGAP1 Gene
- ARHGAP24 — Rho GTPase Activating Protein 24
- ARHGAP5 Gene
- ARHGEF2 Gene
- ARHGEF28 — Rho Guanine Nucleotide Exchange Factor 28
- ARHGEF6 Gene
- ARHGEF7 Gene
- ARHGEF9 Gene
- ARID1A
- ARID1B
- ARID2 (AT-Rich Interaction Domain 2)
- ARNT - Aryl Hydrocarbon Receptor Nuclear Translocator
- ARNT2 - Aryl Hydrocarbon Receptor Nuclear Translocator 2
- ARNTL Gene — Aryl Hydrocarbon Receptor Nuclear Translocator Like (BMAL1)
- ARPC1B — Actin Related Protein Complex 1 Subunit B
- ARRB1 — Arrestin Beta 1
- ARRB2 — Arrestin Beta 2
- ARSA Gene
- ARSACS Gene
- ARSB Gene
- ARTN — Artemin
- ARX Gene
- ASAH1 — N-Acylsphingosine Amidohydrolase 1
- ASAP1 Gene
- ASCL1 Gene
- ASH1L
- ASTN1 Gene
- Astrocyte-neuron GABA transport in neurological disorders
- ASXL1 - Additional Sex Combs Like 1
- ASXL2
- ATF1 protects dopaminergic neurons against neurotoxicity
- ATF2 — Activating Transcription Factor 2
- ATF3 Gene
- ATF4 Gene
- ATF6 - Activating Transcription Factor 6
- ATG1
- ATG10 Gene
- ATG13 — Autophagy Related 13
- ATG14 Gene
- ATG16L1 - Autophagy Related 16 Like 1
- ATG16L2 Gene
- ATG17 Gene
- ATG17 Gene - Autophagy-Related 17
- ATG17A
- Atg2 and Atg9 in autophagosome formation
- ATG2A
- ATG2B
- ATG3 Gene
- ATG4A Gene
- ATG4C Gene
- ATG4D Gene
- ATG5 — Autophagy Related 5
- ATG7 Gene
- ATG9A Gene
- ATG9B
- ATL1
- ATM Gene
- ATN1 Gene
- ATOX1 - Copper Chaperone
- ATP10B — ATPase Phospholipid Transporting 10B
- ATP13A2 — ATPase Cation Transporting 13A2
- ATP13A3 Gene
- ATP13A9 Gene - ATPase 13A9
- ATP1A1 Gene
- ATP1A2 Gene
- ATP1A3 Gene - Sodium-Potassium ATPase Alpha 3
- ATP1A4 Gene
- ATP1B1 Gene
- ATP1B2 Gene
- ATP2A1 Gene
- ATP2A2 Gene
- ATP2A3 Gene
- ATP2B1 Gene
- ATP2B2 Gene
- ATP2B3 Gene
- ATP2B4 Gene
- ATP5A1 Gene
- ATP6V0A1 Gene
- ATP6V0D1 - ATPase H+ Transporting V0 Subunit D1
- ATP7A
- ATP7B
- ATR Gene
- ATRIP
- ATRX — Alpha Thalassemia/Mental Retardation Syndrome X-Linked
- ATXN1 — Ataxin 1
- ATXN10 Gene - Ataxin 10
- ATXN17
- ATXN2 Gene
- ATXN3 — Ataxin-3
- ATXN5 - Ataxin-5
- ATXN6 - Ataxin-6
- ATXN7 — Ataxin-7
- ATXN8 Gene
- ATXN9 - Ataxin-9
- AURKA Gene
- AURKB Gene
- AURKC — Aurora Kinase C
- Autophagy-lysosome pathway in AD therapeutics
- AVP Gene
- AXIN1 Gene
- AXIN2 Gene
- AXL - AXL Receptor Tyrosine Kinase
- Axonal transport defects in ALS
- B vitamins, homocysteine, and neurodegeneration
- B3GALT6 Gene
- B4GALT7 — Beta-1,4-Galactosyltransferase 7
- BACE1-dependent cleavage of GABA(A) receptor contributes to neural hyperexcitability and disease progression in Alzheimer's disease.
- BACE2 Gene
- BACH1 — BTB Domain and CNC Homolog 1
- BAD Gene - BCL2-Associated Agonist of Cell Death
- BAFFR Gene (TNFRSF13C)
- BAG1 Gene
- BAG1 Gene
- BAG2
- BAG3 Gene
- BAG4
- BAG5 Gene
- BAG6 Gene
- BAK1 Gene
- BANG — BAG3 (Bcl-2-Associated Athanogene 3)
- BAP1 (BRCA1-Associated Protein 1)
- BAX Gene
- BBC3
- BBC3 — BCL2 Binding Component 3 (PUMA)
- BCHE Gene - Butyrylcholinesterase
- BCL2 Gene
- BCL2A1 Gene
- BCL2L1 Gene
- BCL2L10
- BCL2L11 Gene
- BCL2L12 Gene
- BCL2L13
- BCL2L2 Gene
- BCLXL Gene
- BCS1L Gene
- BDNF Gene
- BECN1 Gene
- BECN1 Gene
- BECN2 Gene
- Bicarbonate transport in neuroinflammation and microglial activation
- BICD1 — Bicaudal D1
- BICD2 Gene
- BID — BH3 Interacting Domain Death Agonist
- BIN1 modulates APP processing and synaptic function in Alzheimer's disease
- Biomarkers for Alzheimer's disease
- BIP — Binding Immunoglobulin Protein
- BIRC5 (Survivin)
- BK channel beta1 subunit in neuroprotection
- BLM — Bloom Syndrome Protein
- BMAL1 (ARNTL) Gene
- BMF Gene
- BMI1
- BMP2 and oxidative stress in neurodegeneration
- BMP4 Gene (Bone Morphogenetic Protein 4)
- BMP7 Gene (Bone Morphogenetic Protein 7)
- BMPR1A — Bone Morphogenetic Protein Receptor Type 1A
- BMPR1B Gene
- BMPR2 Gene
- BNIP3 Gene
- BNIP3L — BCL2 Interacting Protein 3 Like (NIX)
- BOK — BCL2 Family Ovarian Killer
- BRAF — B-Raf Proto-Oncogene, Serine/Threonine Kinase
- BRCA1 Gene
- BRCA2 Gene
- BRD2 (Bromodomain-Containing Protein 2)
- BRD3 (Bromodomain-Containing Protein 3)
- BRD4 (Bromodomain-Containing Protein 4)
- BRG1 Gene
- BRIP1 Gene
- BRSK1 Gene
- BSCL2
- BST1 Gene - Bone Marrow Stromal Cell Antigen 1
- BTRC Gene
- BUB1
- C12orf65 - Mitochondrial Release Factor
- C19orf12 and autophagy
- C1q blockade reduces microglial activation and rescues synaptic deficits in 5xFAD mice
- C1QA Gene
- C1QB — Complement Component 1Q Beta
- C1QC
- C1S Gene
- C2 (Complement Component 2)
- C21orf2 — Chromosome 21 Open Reading Frame 2
- C3 — Complement Component 3
- C3AR1 Gene
- C4A Gene
- C4B Gene
- C5
- C5AR1 Gene
- C7
- C8A
- C8B
- C9orf72 — Chromosome 9 Open Reading Frame 72
- CA8 therapeutic approaches
- CACNA1A Gene
- CACNA1A — Calcium Channel Alpha-1A Subunit
- CACNA1B Gene
- CACNA1C Gene
- CACNA1D Gene
- CACNA1E Gene
- CACNA1G Gene
- CACNA1H Gene
- CACNA1I Gene - Calcium Voltage-Gated Channel Subunit Alpha1 I
- CACNA1S Gene - Calcium Voltage-Gated Channel Alpha Subunit 1S
- CACNA2D1 Gene - Calcium Channel Voltage-Dependent Subunit Alpha2 Delta 1
- CACNA2D2 Gene
- CACNA2D3 Gene
- CACNA2D4 Gene
- CACNB1 - Calcium Channel Beta-1 Subunit
- CACNB2 Gene
- CACNB3
- CACNB4 Gene
- CACNG1 Gene - Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 1
- CACNG2 - Stargazin Calcium Channel Gamma-2
- CACNG3 — Calcium Channel Gamma 3
- CACNG4 - TARP Gamma-4 Calcium Channel Subunit
- CACNG6 (TARP γ8)
- CACNG7 — Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 7
- CACNG8
- CALB2 Gene
- CALCA Gene
- Calcium dysregulation in excitotoxicity
- Calcium-binding proteins in neurodegenerative disorders
- CALCOCO2 — Calcium Binding and Coiled-Coil Domain 2
- CALCR — Calcitonin Receptor
- CALM1 — Calmodulin 1
- CALM2 Gene
- CALM3 Gene
- CALM4 — Calmodulin 4
- CALM5
- CALR Gene
- Calsyntenin 1
- Calsyntenin-1 in neuronal protection
- CAMK1 — Calcium/Calmodulin-Dependent Protein Kinase I
- CaMK1A Gene
- CaMK1D Gene
- CAMK2A Gene
- CAMK2B Gene
- CAMK2D — Calcium/Calmodulin-Dependent Kinase 2 Delta
- CAMK2G — Calcium/Calmodulin-Dependent Kinase 2 Gamma
- CAMK4 — Calcium/Calmodulin-Dependent Kinase 4
- CAMKK2 Gene
- CAML Gene
- CANX — Calnexin
- CAPN1 Gene
- CAPRIN1 Gene
- CAPS1 Gene
- CAPZB Gene
- CARD8 - Caspase Recruitment Domain Family Member 8
- Carnitine and mitochondrial function in Parkinson's disease
- CARS1
- CARS2
- CASK — Calcium/Calmodulin-Dependent Serine Protein Kinase
- CASP1 Gene
- CASP10 Gene
- CASP12 Gene — Cysteine-Containing Aspartate-Specific Protease 12
- CASP14 Gene
- CASP2 Gene
- CASP4 Gene
- CASP5 Gene
- CASP6 — Caspase-6
- CASP7 Gene
- Caspase Recruitment Domain Family Member 14
- Caspase-3 activity imaging in neurodegenerative disease models
- Caspase-8 mediated pyroptosis in neurodegenerative diseases
- CASR Gene
- CASS2 — CASP2 and RIPK1 Domain Containing Adaptor
- CASS4 — Cas Scaffold Protein Family Member 4
- CAT — Catalase
- Cathepsin S activity as a biomarker and therapeutic target
- CAV1
- CAV1 (Caveolin 1)
- CAV2
- CAV3
- CB2 and blood-brain barrier in neurodegeneration
- CBL Gene
- CBLN1 Gene
- CBLN2 Gene
- CBX5
- CBX7 Gene
- CCDC157 Gene
- CCDC62 in dopaminergic neuron development
- CCDC88A — Coiled-Coil Domain Containing 88A
- CCDC88C Gene
- CCER2 Gene
- CCL20 Gene
- CCL25 Gene
- CCL3 Gene
- CCL4 Gene
- CCM2 Gene
- CCNK Gene
- CCNL1 Gene
- CCNL2 Gene
- CCR1
- CCR3 Gene
- CCR5 Gene
- CCR6
- CCR7 Gene (C-C Chemokine Receptor Type 7)
- CCR8 Gene
- CCS Gene
- CCT2 Gene
- CCT4 Gene
- CCT5 Gene
- CCT6A Gene
- CCT7 Gene
- CD163 (Hemoglobin Scavenger Receptor)
- CD19 Gene
- CD200 Gene
- CD200 Gene - Cluster of Differentiation 200
- CD200R1 Gene
- CD200R1 Gene - CD200 Receptor 1
- CD2AP Gene — CD2-Associated Protein
- CD300A Gene
- CD36 contributes to synaptic dysfunction in Alzheimer's disease models
- CD38 Molecule (CD38)
- CD3G Gene
- CD4 Gene
- CD40 - Cluster of Differentiation 40
- CD44 - Cell Surface Glycoprotein
- CD46
- CD47 Gene
- CD55
- CD59 Gene
- CD63
- CD68 Gene
- CD79A Gene
- CD8 Gene
- CD81
- CD9
- CDC25B in Parkinson's disease: possible role in dopaminergic neuron survival
- CDC25C — Cell Division Cycle 25C
- CDC37
- CDC42 Gene
- CDH23 Gene
- CDK1 — Cyclin-Dependent Kinase 1
- CDK11 Gene
- CDK11A — Cyclin Dependent Kinase 11A
- CDK11B
- CDK12 — Cyclin-Dependent Kinase 12
- CDK16 — Cyclin-Dependent Kinase 16 (PCTAIRE-1)
- CDK2 Gene
- CDK4 Gene
- CDK5 Gene
- CDK5R1 Gene
- CDK5R2 Gene
- CDK6 Gene
- CDK9 Gene
- CDKAL1 Gene
- CDKL5 Gene
- CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A
- CDKN1B — Cyclin-Dependent Kinase Inhibitor 1B
- CDKN2B
- CDNF Gene
- CDR1 Gene
- CDR2 Gene
- CEBPA Gene
- CEBPB Gene
- CEBPD Gene
- CEBPE Gene
- CELF1 Gene
- CELF2 Gene
- CELF3 — CUGBP Elav-Like Family Member 3
- CELF4 — CUGBP Elav-Like Family Member 4
- Cell-type specific IκBε functions in the nervous system
- Cellular Iron Metabolism and Disease (2021)
- CEP164 — Centrosomal Protein 164
- CEP57 — Centrosomal Protein 57
- Cerebrospinal fluid biomarkers for Alzheimer's disease
- CERK Gene
- CERNUNNOS Gene
- Ceroid Lipofuscinosis 2 (TPP1)
- CERS1 — Ceramide Synthase 1
- CERS2 — Ceramide Synthase 2 (Lass2)
- CERS6 Gene
- CFB — Complement Factor B
- CFH
- CFI
- CFL1 Gene
- CFLAR
- CFOS Gene
- CFTR modulation as therapeutic strategy in neurodegenerative disease
- CGAS Gene
- Chaperone-mediated autophagy in aging and disease. Autophagy. 2005
- CHAT Gene
- CHCHD10 Gene
- CHCHD10 — Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 10
- CHCHD2 - Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 2
- CHCHD3 — Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3
- CHCHD5 — Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 5
- CHCHD9 — Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 9
- CHD1 Gene
- CHD1L Gene
- CHD2 Gene
- CHD3 (Chromodomain Helicase DNA Binding Protein 3)
- CHD4 Gene
- CHD5 Gene
- CHD7 dysfunction in Alzheimer's disease models
- CHD8 Gene
- CHECK1 — Cell Cycle Checkpoint Kinase 1
- CHEK1 Gene
- CHEK2
- CHEK2 — Checkpoint Kinase 2
- Chemokines and their receptors in Parkinson's disease
- Chen K, et al. VAMP5 and mitochondrial function. Cell Metab (2023)
- CHI3L1 Gene
- CHIT1 Gene (Chitinase 1)
- CHL1 Gene
- CHMP1A — Charged Multivesicular Body Protein 1A
- CHMP1B — Charged Multivesicular Body Protein 1B
- CHMP2A
- CHMP2B — Charged Multivesicular Body Protein 2B
- CHMP3 — Charged Multivesicular Body Protein 3
- CHMP4B — Charged Multivesicular Body Protein 4B
- CHMP5 — Charged Multivesicular Body Protein 5
- CHMP6 in selective autophagy of protein aggregates
- CHMP7 mutations cause hereditary spastic paraplegia
- CHN1 — Chimerin 1
- Choline homeostasis in brain disorders
- Cholinergic Receptor Nicotinic Alpha Subunit 4
- CHP1 Gene
- CHRM2 — Muscarinic Acetylcholine Receptor M2
- CHRM3 Gene
- CHRM4 Gene
- CHRM5 Gene
- CHRNA1
- CHRNA10 (Cholinergic Receptor Nicotinic Alpha Subunit 10)
- CHRNA2 — Cholinergic Receptor Nicotinic Alpha 2
- CHRNA3 — Cholinergic Receptor Nicotinic Alpha 3
- CHRNA5 Gene
- CHRNA6 Gene
- CHRNA7 Gene
- CHRNA9 Gene
- CHRNB1 (Cholinergic Receptor Nicotinic Beta Subunit 1)
- CHRNB2 — Cholinergic Receptor Nicotinic Beta 2 Subunit
- CHRNB3 Gene
- CHRNB4 (Cholinergic Receptor Nicotinic Beta Subunit 4)
- CHRND Gene
- CHRNE Gene
- CHRNG (Cholinergic Receptor Nicotinic Gamma Subunit)
- CHST14 - Carbohydrate Sulfotransferase 14
- CHUK — IKK Alpha (IκB Kinase Alpha)
- CIC - Capicua Transcriptional Repressor
- CIDEA — Cell Death-Inducing DFFA-Like Effector A
- CIDEB — Cell Death-Inducing DFFA-Like Effector B
- CIDEC Gene
- CING1 Gene
- CKAP4 — Cytoskeleton-Associated Protein 4
- CKB Gene
- Class II Major Histocompatibility Complex Transactivator
- Clathrin-mediated endocytosis: the role of AP-2 in cargo selection
- CLCN1 (Chloride Voltage-Gated Channel 1)
- CLCN10 — Chloride Voltage-Gated Channel 10
- CLCN2 Gene
- CLCN3 Gene
- CLCN4 Gene
- CLCN5 Gene
- CLCN6 Gene
- CLCN7 Gene
- CLCN8 — Chloride Voltage-Gated Channel 8
- CLCN9 — Chloride Voltage-Gated Channel 9
- CLDN5 — Claudin-5
- CLEC7A Gene
- Clinical development of muscarinic receptor agonists for neurodegeneration
- Clinical outcomes in ARR3-related cone dystrophy patients
- CLIP1 — CLIP-Associating Protein 1
- CLN1 (PPT1) — Palmitoyl-Protein Thioesterase 1
- CLN3 Gene - Ceroid Lipofuscinosis, Neuronal 3
- CLN5 Gene - Ceroid Lipofuscinosis, Neuronal 5
- CLN6 Gene - Ceroid Lipofuscinosis, Neuronal 6
- CLN7 — Ceroid Lipofuscinosis, Neuronal 7 (MFSD8)
- CLN8 Gene - Ceroid Lipofuscinosis, Neuronal 8
- CLOCK Gene
- Clonal expansion of mtDNA mutations in aging and disease
- CLPP (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic)
- CLRN1 Gene
- CLRN1 — Clarin 1
- CLTC Gene
- CLU Gene - Clusterin
- CMYA5 Gene
- CNBP — Cellular Nucleic Acid Binding Protein
- CNIH3 — Cornichon Homolog 3
- CNR1 Gene
- CNS myelination and Caspr function
- CNTF Gene
- CNTF Gene
- CNTFR Gene
- CNTN1 Gene
- CNTN2 — Contactin 2
- CNTN3 — Contactin 3
- CNTN4 — Contactin 4
- CNTN5 — Contactin 5
- CNTN6 — Contactin 6
- CNTNAP2 — Contactin Associated Protein 2
- CNTNAP3 Gene - Contactin Associated Protein 3
- CNTNAP4 Gene
- COA6 Gene - Cytochrome c Oxidase Assembly Factor 6
- COA7 Gene
- COA8 Gene - Cytochrome c Oxidase Assembly Factor 8
- COA8 Gene - Cytochrome C Oxidase Assembly Factor 8
- COASY Gene
- Cockayne syndrome: molecular mechanisms and therapeutic approaches
- COG1 — Conserved Oligomeric Golgi Complex 1
- COG2 — Conserved Oligomeric Golgi Complex 2
- COG3 — Conserved Oligomeric Golgi Complex 3
- COG4 — Conserved Oligomeric Golgi Complex 4
- COG5 — Conserved Oligomeric Golgi Complex 5
- COG6 — Conserved Oligomeric Golgi Complex 6
- COG7 — Conserved Oligomeric Golgi Complex 7
- COG8 — Conserved Oligomeric Golgi Complex 8
- COL4A1 Gene
- COL4A2 Gene
- Complement and the blood-brain barrier in CNS injury
- Complement C1q and C3b are required for synaptic pruning in adult brain
- COMT Gene
- CoQ10 trials in neurodegenerative diseases
- COQ2 Gene - Coenzyme Q Biosynthesis Protein COQ2
- COQ4 Gene
- COQ5 Gene
- COQ6 Gene
- COQ7 Gene
- COQ8A Gene - Coenzyme Q Kinase ADCK3
- COQ8B — Coenzyme Q8B (ADCK4)
- COQ9 Gene
- COX10 Gene
- COX14 — Cytochrome C Oxidase Assembly Factor 14
- COX15 — Cytochrome C Oxidase Assembly Factor 15
- COX20 Gene - Cytochrome c Oxidase Assembly Factor
- COX4I1
- COX5A Gene
- COX6A2 Gene
- COX7A1 - Cytochrome C Oxidase Subunit
- COX7A2 Gene
- COX8A Gene
- CP Gene - Ceruloplasmin
- CPA6 - Carboxypeptidase A6
- CPLX1 — Complexin-1
- CPLX2 — Complexin 2
- CPLX3 — Complexin-3
- CPLX4 Gene
- CPSF6 — Cleavage and Polyadenylation Specific Factor 6
- CPT2
- CR1 Gene — Complement Component 1q Receptor
- CR2 (Complement Receptor Type 2)
- CREB1 Gene
- CREB3 Gene
- CREB3L1 Gene
- CREB5 — cAMP Responsive Element Binding Protein 5
- CREBBP Gene
- CRH Gene
- CRHR1
- CRISPR-Cas9 gene editing for Lafora disease. Mol Ther Nucleic Acids
- CRKL Gene
- CRMP2 Gene
- CRY1 Gene
- CRY2 Gene
- CRYAB Gene
- CS Gene
- CSF1R — Colony Stimulating Factor 1 Receptor
- CSF2RA — Colony Stimulating Factor 2 Receptor Alpha Chain
- CSNK1D - Casein Kinase 1 Delta
- CSNK1E - Casein Kinase 1 Epsilon
- CSNK2A1 Gene
- CSNK2A2 Gene
- CSNK2B Gene
- CSPG4
- CSTB Gene
- CTC1 Gene
- CTCF Gene
- CTF18 Gene
- CTNS Gene
- CTS Gene - Cathepsin S
- CTSA and neuroinflammation (2022)
- CTSB Gene
- CTSB Gene
- CTSC — Cathepsin C
- CTSD (Cathepsin D)
- CTSD — Cathepsin D
- CTSD — Cathepsin D
- CTSF Gene (CLN10)
- CTSH Gene
- CTSK — Cathepsin K
- CTSW (Cathepsin W)
- CTSZ Gene - Cathepsin Z
- Cul-4 inhibition rescues spastin levels in hereditary spastic paraplegia
- CUL3 — Cullin 3
- CX3CL1 — Fractalkine (C-X3-C Motif Chemokine Ligand 1)
- CX3CR1 — CX3C Chemokine Receptor 1
- CXCL1
- CXCL10 - C-X-C Motif Chemokine Ligand 10
- CXCL12 Gene
- CXCL2 — C-X-C Motif Chemokine Ligand 2
- CXCR1 Gene
- CXCR3 Gene
- CXCR4 Gene
- CXCR5 genetic variants and MS susceptibility
- CYBB — Cytochrome b-245, Beta Polypeptide
- CYC1
- CYCS
- CYFIP2 — Cytoplasmic FMRP Interacting Protein 2
- CYLD Gene
- CYP11A1 Gene - Cholesterol Side-Chain Cleavage Enzyme
- CYP27A1 Gene
- CYP27B1 — Vitamin D 1-alpha Hydroxylase
- CYP2D6 — Cytochrome P450 2D6
- CYP2U1 — Cytochrome P450 Family 2 Subfamily U Member 1
- CYP3A4 — Cytochrome P450 3A4
- CYP46A1 — Cholesterol 24-Hydroxylase
- CYP7B1 Gene - Hereditary Spastic Paraplegia 5
- CYTC
- Cytoskeletal proteins in neuroprotection: new therapeutic targets
- D1-like and D2-like dopamine receptors in psychiatric disorders
- DAB1 Gene
- DAG1 Gene
- DAGLA — Diacylglycerol Lipase Alpha
- DAGLB
- DAO Gene
- DAPK1 Gene
- DAR32 Gene
- DARS1
- DARS2 Gene
- DAXX Gene
- DBH Gene
- DBL Gene
- DBN1 — Drebrin
- DCAF17 Gene - DDB1 and CUL4 Associated Factor 17
- DCLRE1A Gene
- DCLRE1C Gene
- DCPS - Decapping Enzyme
- DCTN1 (Dynactin Subunit 1)
- DCTN2 - Dynactin Subunit 2
- DCTN3 Gene
- DCTN4 Gene
- DCTN5 Gene
- DCTN6 - Dynactin Subunit 6
- DCX Gene
- DDB2 Gene
- DDC and serotonin in mood and neurodegeneration.
- DDIT3 Gene
- DDR2 — Discoidin Domain Receptor 2
- DDX1 Gene
- DDX17 ATPase regulation
- DDX20 Gene
- DDX3X Gene
- DDX41 — DEAD-Box Helicase 41
- DDX46 — DEAD-Box Helicase 46
- DDX5 Gene
- DDX50 — DEAD-Box Helicase 50
- DDX55 (DEAD-Box Helicase 55)
- DDX6 Gene
- DDX60 — DEAD-Box Helicase 60
- Delayed neuropathy and NTE in organophosphate poisoning
- delta-Opioid receptors modulate neuronal excitability in the prefrontal cortex
- DEPDC5 Gene
- DEPTOR
- DES Gene
- Developmental expression of GABA-C receptors in cortex
- Dexras1 in Parkinson's disease models
- DFFA
- DGAT1 inhibition as a therapeutic strategy for Alzheimer's disease
- DGKQ
- DGUOK — Deoxyguanosine Kinase
- DHCR24 Gene
- DHH — Desert Hedgehog
- DHODH — Dihydroorotate Dehydrogenase
- DHX36 — DEAH-Box Helicase 36
- DHX9 — DEAH-Box Helicase 9
- DIABLO
- Diagnostic approaches to SURF1 deficiency
- DIAPH3 genetic testing in ALS
- DICER1 Gene
- DISC1 — Disrupted in Schizophrenia 1
- Distinct neuronal networks mediate Egr1 expression in the prefrontal cortex and hippocampus
- Distribution and function of GIT1 in brain
- DJ-1 controls neuronal survival through autophagy
- DJ-1 prevents activation of intrinsic apoptosis pathway
- DKK1 — Dickkopf WNT Signaling Pathway Inhibitor 1
- DLAT Gene
- DLC1 Gene - Deleted in Liver Cancer 1
- DLG1 — Discs Large Homolog 1
- DLG2 Gene
- DLG3 Gene
- DLG4 Gene
- DLG4 Gene - PSD-95
- DLG5 Gene (Discs Large Homolog 5)
- DLGAP1 — DLG Associated Protein 1
- DLGAP2 Gene
- DLGAP3 Gene
- DLGAP4 Gene
- DLGAP5 — DLG Associated Protein 5
- DLK — Dual Leucine Zipper Kinase
- DLK1 Gene
- DLL1 Gene
- DLL4 Gene
- DLST — Dihydrolipoamide Succinyltransferase
- DLX1 Gene
- DLX2 Gene
- DLX5 Gene
- DLX6 regulates mitochondrial function in dopaminergic neurons
- DMPK Gene (Dystrophia Myotonica Protein Kinase)
- DMT1 Gene
- DNA damage response in neurons and neurodegenerative disease
- DNA methylation in Alzheimer's disease (2019)
- DNA repair enhancement in neurodegenerative disease
- DnaJ Heat Shock Protein Family (Hsp40) Member A1
- DnaJ Heat Shock Protein Family (Hsp40) Member C7
- DNAJA2
- DNAJA3 Gene
- DNAJB1 Gene
- DNAJB12 — DnaJ Heat Shock Protein Family (Hsp40) Member B12
- DNAJB2 — DNAJ Heat Shock Protein Family Member B2
- DNAJB6 Gene
- DNAJB7
- DNAJB8 Gene
- DNAJB9 Gene
- DNAJC1 Gene - DnaJ Heat Shock Protein Family Member 1
- DNAJC10 Gene
- DNAJC11 Gene
- DNAJC12 Gene
- DNAJC13 — DnaJ Heat Shock Protein Family Member C13
- DNAJC14 Gene
- DNAJC15 Gene
- DNAJC16 Gene
- DNAJC17 Gene
- DNAJC18 Gene
- DNAJC19 Gene
- DNAJC2 - DnaJ Heat Shock Protein Family Member C2
- DNAJC21 Gene
- DNAJC22 Gene
- DNAJC23 Gene
- DNAJC24 Gene
- DNAJC25 Gene
- DNAJC26 Gene
- DNAJC27 Gene
- DNAJC28 Gene
- DNAJC29 Gene
- DNAJC3 Gene
- DNAJC30 Gene
- DNAJC31 Gene
- DNAJC5 Gene
- DNAJC5 Gene
- DNAJC6 Gene
- DNAJC6 Gene
- DNAJC6 — DnaJ Heat Shock Protein Family Member A6
- DNAJC8 Gene
- DNAJC9 Gene
- DNC1 — Dynein Cytoplasmic 1
- DNM1 Gene
- DNM1L Gene
- DNM2 Gene
- DNM3 — Dynamin 3
- DNMT1 Gene
- DNMT3A Gene
- DNMT3B Gene
- DOCK1 Gene
- DOCK2 Gene
- DOCK3 - Dedicator of Cytokinesis 3
- DOT1L Gene
- DPM1 Gene (Dolichol-Phosphate Mannosyltransferase Subunit 1)
- DPM2 Gene (Dolichol-Phosphate Mannosyltransferase Subunit 2)
- DPM3 Gene (Dolichol-Phosphate Mannosyltransferase Subunit 3)
- DRAM1 Gene
- DRAM2 Gene
- DRD1 Gene
- DRD2 Gene
- DRD3 Gene
- DRD3 — Dopamine Receptor D3
- DRP1 Gene - Dynamin 1-Like Protein
- DRPLA Gene
- Druggable Genome Coverage
- DUOX1 Gene
- DUOX2 Gene
- DUSP1 Gene
- DUSP10 Gene
- DUSP11 Gene
- DUSP12 Gene
- DUSP14 deletion accelerates cognitive decline in AD mouse models
- DUSP2 Gene
- DUSP5 Gene
- DUSP8 Gene
- DUSP9 Gene
- DVL1 Gene
- DVL2 polymorphisms modify Parkinson's disease risk
- DVL3 — Dishevelled Segment Polarity Protein 3
- DYNC1H1 — Dynein Cytoplasmic 1 Heavy Chain 1
- DYNC1I1 in cortical neuron development and function
- DYNC1I2 Gene
- DYNC1LI2 Gene
- DYNC2H1 — Dynein Cytoplasmic 2 Heavy Chain 1
- DYNLL1 Gene
- DYNLL2 Gene
- DYNLRB1 Gene
- DYNLT1 — Dynein Light Chain Tctex-Type 1
- DYNLT3 — Dynein Light Chain Tctex-Type 3
- DYRK1A Gene - Dual Specificity Tyrosine-Phosphorylation Regulated Kinase 1A
- DYRK1B — Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1B
- DYSF — Dysferlin
- Dysregulation of RNA splicing in neurodegenerative disease
- DYT1 Gene
- E2F Transcription Factor 2
- E2F1 Gene
- E2F3 Gene
- E2F4 Gene
- E2F5 Gene
- E2F6 Gene
- E2F7 Gene
- E2F8 Gene
- Early synaptic dysfunction in Huntington's disease iPSC models (2025)
- EARS2 — Mitochondrial Glutamyl-tRNA Synthetase
- EBF3 — Early B-cell Factor 3
- EBI3 Gene
- ECSIT — Evolutionarily Conserved Signaling Intermediate in Toll Pathways
- EDEM1 — ER Degradation Enhancing Alpha-Mannosidase Like Protein 1
- EDEM2 — ER Degradation Enhancer
- EED
- EEF1G — Eukaryotic Translation Elongation Factor 1 Gamma
- EEF2K — Eukaryotic Elongation Factor 2 Kinase
- Effect of statin on cognition in NF1
- EFNA1 Gene
- EFNA2 Gene — Ephrin A2
- EFNA3 Gene — Ephrin A3
- EFNA4 Gene
- EFNB1 variants and neurodevelopmental disorders
- EFNB2 — Ephrin B2
- EFNB3 Gene
- EGF Gene
- EGLN1 — Egl-9 Family Prolyl Hydroxylase 1
- EGR1 Gene
- EGR3 — Early Growth Response 3
- EGR4
- EHMT1 — euchromatic histone lysine methyltransferase 1
- EHMT2 — Euchromatic Histone Lysine Methyltransferase 2
- EIF2A Gene
- EIF2AK2 — Eukaryotic Translation Initiation Factor 2 Alpha Kinase 2
- EIF2AK3 - Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3
- EIF2B1
- EIF2B2
- EIF2B3
- EIF2B4
- EIF2B5 Gene
- EIF2S1 (eIF2α)
- EIF4G1 Gene
- EIF4G2 Gene
- ELAVL1 Gene
- ELAVL2 Gene
- ELAVL3 Gene
- ELAVL4 Gene
- ELMO1 - Engulfment and Cell Motility 1
- ELMO2 — Engulfment Cell Motility 2
- ELOAL Gene
- ELOVL4 Gene
- ELOVL5 - Fatty Acid Elongase 5
- ELOVL7 — Elongation of Very Long Chain Fatty Acids 7
- ELP1 — Elongator Complex Subunit 1
- ELP3 — Elongator Acetyltransferase Complex Subunit 3
- ELP4 — Elongator Acetyltransferase Complex Subunit 4
- EMD — Emerin
- Emerging therapeutic targets in Parkinson's disease
- EN1 Gene
- EN2 Gene
- Endocrine regulation by dense-core vesicles
- ENDOG
- Endolysosomal gene expression changes in Parkinson's disease brain
- ENO1 in Lewy body formation in Parkinson's disease
- ENO2 Gene
- Ensembl: HEY2
- EP300 Gene
- EPAS1 Gene
- EPG5 Gene - Ectopic P-Granules 5 Autophagy Tutor
- EPHA1 Gene
- EPHA10 Gene
- EPHA3 Gene
- EPHA4 Gene
- EPHA5 Gene
- EPHA6 — Ephrin Type-A Receptor 6
- EPHA7 Gene
- EPHA8 Gene
- EPHB1 Gene
- EPHB2 Gene
- EPHB3 Gene
- EPHB4 Gene
- EPHB6 — Ephrin Type-B Receptor 6
- Ephrin-Eph signaling in neuronal death
- Epigenetic regulation of UBQLN1 expression
- ER stress and COPI dysfunction in neuronal death
- ER-phagy receptors and neurodegenerative disease
- ERBB4 Gene
- ERCC1 — Excision Repair Cross-Complementation Group 1
- ERCC2 Gene - Excision Repair Cross-Complementation Group 2
- ERCC3 Gene
- ERCC4 Gene
- ERCC5 Gene
- ERCC6 — Excision Repair Cross-Complementation Group 6
- ERCC6L2 — ERCC Excision Repair 6-Like 2
- ERCC8
- ERCC9 (FANCN) - DNA Repair and Neurodegeneration
- ERK2 (MAPK1)
- ERLIN1 Gene
- ERLIN2 — ER Lipid Raft Associated 2
- ERN1 — Endoplasmic Reticulum To Nucleus Signaling 1
- ERN2 Gene
- ERP29 Gene
- ERP57 (PDIA3) — Protein Disulfide Isomerase Family A Member 3
- ESCO1 - Establishment of Sister Chromatid Cohesion N-Acetyltransferase 1
- ESCO2 - Establishment of Sister Chromatid Cohesion N-Acetyltransferase 2
- ESR1 — Estrogen Receptor Alpha
- ESR2 — Estrogen Receptor Beta
- ESRRA (Estrogen-Related Receptor Alpha) Gene
- ESRRB Gene
- Eukaryotic Translation Elongation Factor 2 (EEF2)
- EWSR1 Gene
- EWSR1 Gene
- EZH2 — Enhancer of Zeste Homolog 2
- FA2H enzyme kinetics (2016)
- FADD Gene
- FAM126A Gene
- FAM134B — Family With Sequence Similarity 134 Member B
- FAM171A2 Gene — Neuronal Receptor for Alpha-Synuclein
- FAM47E
- Family-based association between NOD2 and Alzheimer's disease
- FAN1 Gene
- FANCA Gene
- FANCB Gene
- FANCC Gene
- FANCD2 Gene
- FANCF in neural development. Dev Biol
- FANCL Gene
- FANCM Gene
- FANCN Gene
- Fanconi anemia pathway and DNA repair
- Fanconi anemia signaling network in DNA repair
- FAS Gene
- FASLG - Fas Ligand
- FASN Gene
- FBP1 Gene
- FBXO3 — F-Box Only Protein 3
- FBXO38 in neural stem cell function
- FBXO45 - F-Box Protein 45
- FBXO7 — F-Box Protein 7
- Fc gamma receptor IIa (FCGR2A)
- FCGR1A - Fc Gamma Receptor IA
- FEN1 — Flap Endonuclease 1
- FER Gene
- FERMT2 Gene
- FERMT2 — Fermitin Family Member 2
- FGD1 — FYVE, RhoGEF and PH Domain Containing 1
- FGF1 Gene
- FGF10 — Fibroblast Growth Factor 10
- FGF13 — Fibroblast Growth Factor 13
- FGF14 — Fibroblast Growth Factor 14
- FGF16 Gene
- FGF17 Gene
- FGF18 Gene
- FGF19 — Fibroblast Growth Factor 19
- FGF2 — Fibroblast Growth Factor 2
- FGF20 Gene
- FGF21 — Fibroblast Growth Factor 21
- FGF22 — Fibroblast Growth Factor 22
- FGF23 — Fibroblast Growth Factor 23
- FGF4 — Fibroblast Growth Factor 4
- FGF6 Gene
- FGF7 — Fibroblast Growth Factor 7
- FGF8 Gene
- FGF9 Gene
- FGFR1 — Fibroblast Growth Factor Receptor 1
- FGFR2 — Fibroblast Growth Factor Receptor 2
- FGFR3 - Fibroblast Growth Factor Receptor 3
- FH Gene
- FHL1 Gene
- Fibroblast Growth Factor 3
- Fibroblast Growth Factor 5
- FIG4 — FIG4 Phosphatase Homolog
- FIGN Gene
- FIS1 Gene
- FITM2 - Fat Storage-Inducing Transmembrane Protein 2
- FKBP1A
- FLCN Gene
- FLNA Gene
- FLNC Gene
- FLOT1 Gene
- FLT1 Gene
- FLVCR1 — Feline Leukemia Virus Subgroup C Receptor 1
- FMN2 Gene
- FMR1 — Fragile X Messenger Ribonucleoprotein 1
- FNDC5 — Fibronectin Type III Domain Containing 5
- FNIP1 Gene
- FOLRN Gene
- FOS Gene
- FOSB Gene
- FOXA2 in neuroinflammation and Parkinson's disease
- FOXG1 — Forkhead Box G1
- FOXM1 Gene
- FOXO1 Gene
- FOXO3 Gene
- FOXO4 and metabolic disease: implications for neurodegeneration
- FOXO6 Gene
- FOXP1 Gene
- FOXP2 Gene
- FOXP3 (Forkhead Box P3)
- FRDA1 Gene - Frataxin (FXN)
- Fringe-mediated boundary formation in the nervous system
- FRRS1 — Ferric Chelate Reductase 1
- FSP1 Gene - Ferroptosis Suppressor Protein 1
- FTH1 Gene — Ferritin Heavy Chain 1
- FTL Gene
- FUNDC1 — FUN14 Domain Containing 1
- FUS — Fused in Sarcoma
- FXN Gene (Frataxin)
- FYCO1 — FYVE and Coiled-Coil Domain Containing 1
- FYN — FYN Proto-Oncogene, Src Family Tyrosine Kinase
- FZD1 Gene
- FZD10 Gene
- FZD2 Gene
- FZD3 Gene
- FZD4 Gene
- FZD5 — Frizzled Class Receptor 5
- FZD6 Gene
- FZD8 Gene
- FZD9 Gene
- G3BP1
- G3BP2 - Ras-GTPase-Activating Protein-Binding Protein 2
- GAA Gene
- GAAP Gene - Golgi Anti-Apoptotic Protein
- GABA Transporter 1
- GABA Transporter 2
- GABA transporters as targets for anti-epileptic drugs
- GABA transporters in Alzheimer's disease pathogenesis
- GABA-A Receptor Beta 1 Subunit
- GABAergic target for neurodegenerative disease treatment
- GABARAP Gene
- GABARAPL1 — GABA Type A Receptor Associated Protein Like 1
- GABARAPL2 Gene
- GABBR1 — Gamma-Aminobutyric Acid Type B Receptor Subunit 1
- GABBR2 — Gamma-Aminobutyric Acid Type B Receptor Subunit 2
- GABPA - GA Binding Protein Transcription Factor Alpha Subunit
- GABPB1 Gene
- GABRA1 Gene
- GABRA3 Gene
- GABRA5 Gene
- GABRB2 — GABA-A Receptor Beta 2
- GABRB3 Gene
- GABRD — GABA-A Receptor Delta Subunit
- GABRE Gene
- GABRG1 — GABA-A Receptor Subunit Gamma 1
- GABRG2 — GABA-A Receptor Gamma2 Subunit
- GABRG3 Gene
- GABRP — GABA-A Receptor Pi Subunit
- GABRQ — GABA-A Receptor Theta Subunit
- GABRR1 — GABA-A Receptor Rho1 Subunit
- GABRR3 Gene
- GADD34 Gene
- GADD45A Gene
- GADD45B — Growth Arrest and DNA Damage Inducible Beta
- GADD45G — Growth Arrest And DNA Damage Inducible Gamma
- GAIN Gene - GABA-A Receptor Associated Protein Like 2
- GAK Gene
- GAL Gene
- GAL3ST1 Gene
- GALC Gene
- GALNT2 — Polypeptide N-acetylgalactosaminyltransferase 2
- GALNT3 — Polypeptide N-acetylgalactosaminyltransferase 3
- GALR1 — Galanin Receptor 1
- GALR2 Gene
- Gamma-synuclein: functions and therapeutic potential
- GAN Gene
- GAP43 Gene
- GAPDH Gene
- GARS1
- GAS6 - Growth Arrest Specific 6
- GATA1 - GATA Binding Protein 1
- GATA2 - GATA Binding Protein 2
- GATA3 - GATA Binding Protein 3
- GATAD2A — GATA Zinc Finger Domain Containing 2A
- GBA1 — Glucocerebrosidase
- GBA2 Gene - Glucosylceramidase Beta 2
- GBA3 — Glucosidase Beta 3
- GBAP1
- GBE1 — Glycogen Branching Enzyme 1
- GCAT — Glycerol-3-Phosphate O-Acetyltransferase
- GCH1 Gene
- GCH2 — GTP Cyclohydrolase II
- GCHFR — GTP Cyclohydrolase I Feedback Regulator
- GCLM — Glutamate-Cysteine Ligase Modifier Subunit
- GDAP1 — Ganglioside-Induced Differentiation-Associated Protein 1
- GDI1 Gene
- GDI2 Gene
- GDNF family receptor expression in cancer
- GDNF — Glial Cell Line-Derived Neurotrophic Factor
- GDNFR — GDNF Family Receptor Alpha 1
- GEM in tau pathology and neurodegeneration
- GEMIN1 Gene
- GEMIN2 Gene
- GEMIN3 Gene
- GEMIN5 and ribostasis in motor neuron disease
- GEMIN6 — Gem-Associated Protein 6
- GEMIN7 Gene
- GEMIN8 Gene
- Gene Expression Atlas
- Gene Rankings
- Gene therapy for ALS. Mol Neurobiol. 2016
- Gene therapy for Kir channelopathies
- Gene-Disease Associations
- Genes
- Genes Overview
- Genetic determinants of intellectual disability
- Genetic testing for CMT
- Genetic variation in CLU associates with cerebrospinal fluid biomarkers
- GEPHYRIN
- GET4 Gene
- GFAP (Glial Fibrillary Acidic Protein Gene)
- GFRA1 Gene
- GFRA2 - GDNF Family Receptor Alpha 2
- GFRA4 - GDNF Family Receptor Alpha 4
- GFRAL Gene - GDNF Receptor Alpha Like
- GID1 Gene
- GID4 Gene
- GIGYF1 Gene
- GIGYF2 — GRB10 Interacting GYF Protein 2
- GJA1
- GJB1 — Gap Junction Protein Beta 1
- GJB2 Gene
- GJC2 Gene
- GLA Gene - Alpha-Galactosidase A
- GLB1 Gene
- GLE1 — GLE1 RNA Export Mediator
- GLI Gene Family
- GLI1 — GLI Family Zinc Finger 1
- GLI2
- GLI3
- GLO1 Gene
- GLRA1 Gene
- GLRA2
- GLRA3
- GLRB Gene
- GLS - Glutaminase
- GLT8D1 — Glycosyltransferase 8 Domain Containing 1
- GLUD1 - Glutamate Dehydrogenase 1
- GLUD2 Gene
- GLUL — Glutamine Synthetase
- Glutamate Decarboxylase 1
- Glutamate Decarboxylase 2
- GM-CSF receptor beta chain in neuroprotection and repair
- GMM Gene - GM2 Activator Protein
- GNA11 Gene
- GNA12 Gene
- GNA13 Gene
- gnai1 Gene
- GNAI2 Gene
- GNAI3 — G Protein Subunit Alpha I3
- GNAL — Gαolf Subunit
- GNAO1 Gene
- GNAQ Gene
- gnas Gene
- GNAT1 Gene
- GNB1 Gene - G Protein Subunit Beta 1
- GNB2 — G Protein Subunit Beta 2
- GNB3 Gene
- GNB4 Gene — G Protein Subunit Beta 4
- GNB5 Gene
- GNE - UDP-N-Acetylglucosamine 2-Epimerase
- GNG2 Gene
- GNG3 — G Protein Subunit Gamma 3
- GNG4 — G Protein Subunit Gamma 4
- GNG5 — G Protein Subunit Gamma 5
- GNS variants and disease severity
- GOLGA8: A New FTLD-FET Gene with Dinucleotide Repeat Expansion
- GOT2 Gene
- GPHN Gene
- GPNMB Gene
- GPR132 Gene
- GPR141 Gene
- GPR146 — G Protein-Coupled Receptor 146
- GPR161 — G Protein-Coupled Receptor 161
- GPR165
- GPR173
- GPR3
- GPR37 Gene
- GPR37L1 Gene
- GPR78
- GPR87
- GPR89-targeted CAR T cells in multiple myeloma
- GPR98 Gene
- GPT - Alanine Transaminase (ALT)
- GPX1 — Glutathione Peroxidase 1
- GPX4 Gene - Glutathione Peroxidase 4
- GPX6
- GPX8 — Glutathione Peroxidase 8
- GRAMD1A (GRAM Domain Containing 1A)
- GRAMD1B Gene - GRAM Domain Containing 1B (GRAMD1B)
- GRB2 — Growth Factor Receptor Bound Protein 2
- GRIA1 Gene
- GRIA2 Gene
- GRIA3 Gene
- GRIA4 — Glutamate Receptor AMPA Type Subunit 4
- GRIK1 - Glutamate Receptor Kainate Type Subunit 1
- GRIK2 Gene
- GRIK3 - Glutamate Receptor Kainate Type Subunit 3
- GRIK4 - Glutamate Receptor Kainate Type Subunit 4
- GRIK5 - Glutamate Receptor Kainate Type Subunit 5
- GRIK6 Gene - Glutamate Ionotropic Receptor Kainate Type Subunit 6
- GRIKBP1 Gene
- GRIN1 — NMDA Receptor Subunit 1
- GRIN2A Gene
- GRIN2B — NMDA Receptor Subunit 2B
- GRIN2C Gene - Glutamate Ionotropic Receptor NMDA Type Subunit 2C
- GRIN2D Gene
- GRIN3A Gene
- GRIN3B Gene — NMDA Receptor Subunit 3B
- Griner & Kazanietz, New PKC research (2009)
- GRIP1 — Glutamate Receptor Interacting Protein 1
- GRIP2 - Glutamate Receptor Interacting Protein 2
- GRIP3 (Glutamate Receptor Interacting Protein 3)
- GRK2 — G Protein-Coupled Receptor Kinase 2
- GRK3 — G Protein-Coupled Receptor Kinase 3
- GRK5 — G Protein-Coupled Receptor Kinase 5
- GRK6 and opioid receptor signaling
- grm1 Gene
- GRM2 Gene
- GRM3 — Glutamate Metabotropic Receptor 3
- GRM4 Gene
- GRM4 Gene - Metabotropic Glutamate Receptor 4
- GRM5 Gene
- GRM5 Gene - Metabotropic Glutamate Receptor 5
- GRM6 Gene
- GRM6 Gene - Metabotropic Glutamate Receptor 6
- GRM7 Gene
- GRM7 Gene - Metabotropic Glutamate Receptor 7
- GRM8 Gene
- GRN — Progranulin
- GSDMD Gene
- GSDME — Gasdermin E
- GSK3A Gene
- GSK3B — Glycogen Synthase Kinase 3 Beta
- GSN Gene
- GSR — Glutathione Reductase
- GSS Gene
- GSTM1 (Glutathione S-Transferase Mu 1)
- GSTP1 — Glutathione S-Transferase Pi 1
- GSTT1 (Glutathione S-Transferase Theta 1)
- GTF2H1 Gene
- GTF2H2 Gene
- GTF2H6
- GUCY1A1 Gene
- GUCY1B1 Gene
- GUKM1 — Guanylate Kinase Associated Protein
- GUSB mutations and genotype-phenotype correlations in MPS VII
- H2AX Gene
- H3F3A — H3.3 Histone A
- H3F3B Gene — H3.3 Histone B
- HAPLN1 Gene
- HAPLN4 Gene (Hyaluronan and Proteoglycan Link Protein 4)
- HARS1 — Histidyl-tRNA Synthetase 1
- HBA1 Gene
- HBB Gene
- HCN1 Gene
- HCN2 Gene - Hyperpolarization-activated Cyclic Nucleotide-gated Channel 2
- HCN3
- HCN4 — Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 4
- HCRTR1
- HDAC1 Gene
- HDAC10 Gene
- HDAC11 Gene
- HDAC2 Gene
- HDAC3 Gene
- HDAC4 Gene
- HDAC5 Gene
- HDAC6 Gene - Histone Deacetylase 6
- HDAC7 Gene
- HDAC8 Gene
- HDAC9 Gene
- He L, et al. (2017). Molecular mechanisms of SNARE complex assembly and disassembly. Trends Cell Biol 27: 479-489.
- HEATR1 Gene
- HECTD1 dysfunction and neurodevelopmental disorders
- HERC1 — HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 1
- HERC2 Gene
- HERC3-mediated ubiquitination of p62/SQSTM1 in selective autophagy
- HERC4 (HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 4)
- HERC6 — HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 6
- HERPUD1 — Homocysteine-Responsive Endoplasmic Reticulum-Resident Ubiquitin-Like Domain Protein 1
- Hes genes in neural crest development and disease
- HES5 Gene
- Heterogeneous Nuclear Ribonucleoprotein A2/B1 (HNRNPA2B1)
- Heterogeneous Nuclear Ribonucleoprotein D-Like (HNRNPDL)
- Heterogeneous Nuclear Ribonucleoprotein L (HNRNPL)
- HEXA Gene - Hexosaminidase Alpha
- HEXB Gene - Hexosaminidase Beta
- HEXML/DEAD-Box Helicase 3 Gene
- HEY1 — Hairy/Enhancer-of-Split Related with YRPW Motif 1
- HFE Gene - Hereditary Hemochromatosis Protein
- HGSNAT Gene
- HIF1A Gene - Hypoxia Inducible Factor 1 Subunit Alpha
- High-throughput screening identifies modulators of autophagy
- HILPDA — Hypoxia Inducible Lipid Droplet Associated Protein
- HIP1 Gene
- HIP1R (Huntingtin Interacting Protein 1-Related)
- Histone lysine methylation in synaptic plasticity and memory
- HK1 — Hexokinase 1
- HK2
- HLA-A — Major Histocompatibility Complex Class I A
- HLA-B — Major Histocompatibility Complex Class I B
- HLA-DRB1 Gene
- HLA-DRB1 — MHC Class II DR Beta 1
- HLCS Gene
- HMGB1 — High Mobility Group Box 1
- HMGCR — 3-Hydroxy-3-Methylglutaryl-CoA Reductase
- HMOX1 — Heme Oxygenase 1
- HMOX2 promoter polymorphisms and AD risk
- HNF4A - Hepatocyte Nuclear Factor 4 Alpha
- HNRNPA1 - Heterogeneous Nuclear Ribonucleoprotein A1
- HNRNPA1 Gene
- HNRNPA2B1 - Heterogeneous Nuclear Ribonucleoprotein A2/B1
- HNRNPA2B1 Gene
- HNRNPA3 Gene
- HNRNPAB Gene
- HNRNPD Gene
- HNRNPF as therapeutic target in ALS: proof-of-concept
- HNRNPG — Heterogeneous Nuclear Ribonucleoprotein G
- HNRNPH1 Gene
- HNRNPH2 Gene
- HNRNPK Gene
- HNRNPK — Heterogeneous Nuclear Ribonucleoprotein K
- HNRNPL Gene
- HNRNPM modulates tau pathology through splicing regulation
- HNRNPQ Gene
- HNRNPR Gene
- HNRNPU Gene
- HNRNPU1 Gene
- HNRNPUL1 Gene
- HNRNPUL2 loss-of-function in neurodevelopment
- HNRPM — Heterogeneous Nuclear Ribonucleoprotein M
- HNRPU — Heterogeneous Nuclear Ribonucleoprotein U
- HOMER1 Gene
- HOMER2 Gene
- HOMER3 — Homer Scaffold Protein 3
- HOXA1 Gene
- HOXD13 — Homeobox D13
- HPN — Hepsin
- HRAS in neuroinflammation
- HRH1 Gene
- HRH2 Gene — Histamine Receptor H2
- HRH3 Gene
- HRH4 Gene
- HRK Gene
- HS3ST2 Gene
- HSF1 Gene - Heat Shock Factor 1
- HSF2 — Heat Shock Transcription Factor 2
- HSP70 Gene
- Hsp70 in protein aggregation diseases
- Hsp90 as a therapeutic target in cancer and neurodegeneration
- HSP90AA1 Gene
- HSP90B1 Gene
- HSP90B1 — Heat Shock Protein 90 Beta Family Member 1
- HSPA10 — Heat Shock Protein Family A Member 10
- HSPA14 Gene
- HSPA1A Gene
- HSPA1B — Heat Shock Protein 70 Family Member 1B
- HSPA1L Gene
- HSPA2 Gene
- HSPA4 Gene
- HSPA5 — Heat Shock Protein Family A (Hsp70) Member 5
- HSPA6
- HSPA9 Gene
- HSPB1 Gene
- HSPB1 — Heat Shock Protein Family B Member 1
- HSPB10 Gene
- HSPB3 Gene
- HSPB5 — Heat Shock Protein Beta 5
- HSPB6 — Heat Shock Protein Beta 6
- HSPB7 — Heat Shock Protein Beta 7
- HSPB7 — Heat Shock Protein Family B7
- HSPB9 Gene
- HSPBAP1 — HSPB Associated Protein 1
- HSPBP1
- HSPD1 Gene - Heat Shock Protein Family D Member 1
- HSPE1 — Heat Shock Protein Family E Member 1
- HSPH1 Gene
- HTR1A Gene
- htr1b Gene
- htr1d Gene
- HTR1E — 5-Hydroxytryptamine Receptor 1E
- HTR2A Gene
- HTR2B Gene
- HTR2C Gene
- HTR3A Gene
- HTR3B Gene
- HTR3C Gene
- HTR3D Gene
- HTR3E Gene
- HTR4 Gene
- HTR5A Gene
- HTR6 Gene — 5-Hydroxytryptamine Receptor 6
- htr7 Gene
- HTRA1 Gene
- HTRA2 Gene
- https://www.curefa.org
- HUWE1 — HECT E3 Ubiquitin Protein Ligase 1
- IARS1 — Isoleucyl-tRNA Synthetase 1
- IARS2 — Isoleucyl-tRNA Synthetase 2, Mitochondrial
- IBA57 Gene
- ICAM5 (Intercellular Adhesion Molecule 5)
- IDE Gene - Insulin-Degrading Enzyme
- IDH1 Gene - Isocitrate Dehydrogenase 1
- IDO1 — Indoleamine 2,3-Dioxygenase 1
- IDUA Gene
- Iduronate sulfatase: structure, function, and biosynthesis
- IFFO1 — Intermediate Filament Family Orphan 1
- IFI16 Gene
- IFI204 Gene
- IFIH1 Gene (MDA5)
- IFN-λ treatment reduces α-synuclein pathology in mice
- IFNAR1 — Interferon Alpha Receptor 1
- IFNAR2 — Interferon Alpha Receptor 2
- IFNG Gene
- IFRD1 Gene - Interferon-Related Developmental Regulator 1
- IFT172 — Intraflagellar Transport Protein 172
- IGF1 Gene
- IGF1R Gene
- IGF2 (Insulin-Like Growth Factor 2)
- IGF2BP1
- IGF2BP2
- IGHMBP2 Gene
- IHH — Indian Hedgehog
- IKBKA Gene
- IKBKB Gene
- IKBKE (IKKε)
- IKBKG Gene
- IKKBETA Gene
- IL-6/STAT3 pathway in dopaminergic neurons (2023)
- IL-8 induces MMP-9 expression in astrocytes
- IL10 — Interleukin 10
- IL11 Gene
- IL12A — Interleukin-12 Alpha
- IL12B Gene - Interleukin 12 Beta
- IL13 — Interleukin 13
- IL15 Gene
- IL16 Gene
- IL17B Gene
- IL17C Gene
- IL17D Gene
- IL17F Gene
- IL18 Gene
- IL18BP Gene
- IL19 Gene
- IL1A — Interleukin 1 Alpha
- IL1B Gene - Interleukin 1 Beta
- IL1R1 Gene
- IL1R2 Gene
- IL1RL1 Gene
- IL2 Gene
- IL21
- IL22
- IL23A Gene
- IL24 — Interleukin 24
- IL25 (Interleukin 25)
- IL26 Gene
- IL27 — Interleukin 27
- IL28A (Interleukin-28A)
- IL28B (Interleukin 28B)
- IL3 (Interleukin 3)
- IL31 (Interleukin 31)
- IL33 Gene
- IL34 Gene
- IL35 — Interleukin 35
- IL4 Gene
- IL5 Gene
- IL6 - Interleukin 6
- IL6ST - Interleukin 6 Signal Transducer (gp130)
- IL7 Gene
- IL7R Gene - Interleukin-7 Receptor Alpha Chain
- IL9 (Interleukin 9)
- IMPDH1 Gene - Inosine Monophosphate Dehydrogenase 1
- Improving vulnerable Calbindin1-positive neurons in the ventral hippocampus rescues tau-induced impairment of episodic memory
- INF2 (Inverted Formin 2)
- INPP4A Gene - Inositol Polyphosphate-4-Phosphatase Type I
- INPP4B Gene - Inositol Polyphosphate-4-Phosphatase Type II
- INPP5D Gene
- INPP5D — Inositol Polyphosphate-5-Phosphatase D (SHIP1)
- Integrative analysis reveals CHMP4A as a genetic modifier in ALS
- Ionic mechanisms of apoptosis in neurons and neuronal loss in neurodegenerative diseases
- IQCK — IQ Motif Containing Kinase
- IRAK1 Gene
- IRAK2
- IRAK4 Gene
- IREB2 — Iron Responsive Element Binding Protein 2
- IRF1 Gene - Interferon Regulatory Factor 1
- IRF3 Gene
- IRF7 Gene
- ISG15 and HERC5 in motor neuron disease
- ISG15 — Interferon-Stimulated Gene 15
- ITGAM Gene
- ITM2B — Integral Membrane Protein 2B
- ITPR1 - Inositol 1,4,5-Trisphosphate Receptor Type 1
- ITPR2 Gene
- IκBα expression following neuronal ischemia
- JAG1 — Jagged 1
- JAG2 Gene
- JAK1 — Janus Kinase 1
- JAK2 Gene - Janus Kinase 2
- JAK3 Gene
- JAM2 - Junctional Adhesion Molecule 2
- JARID2
- JNK pathway crosstalk with other neurodegenerative pathways
- JNK1 (MAPK8)
- JNK2 (MAPK9)
- JNK3 (MAPK10)
- JOIN — Junctlophilin Family Member
- JPH2 — Junctophilin 2
- JPH3 Gene
- JPH4 Gene
- JPT2 Gene - Jupiter Microtubule Stabilizing Protein 2
- JUN Gene
- JUNB Gene
- Junctional membrane complexes in neurodegenerative disease
- JUND Gene - JunD Transcription Factor
- K2P potassium channels: new functions
- KANSL1 — KAT8 Regulatory NSL Complex Subunit 1
- KARS1
- KAT2A (Lysine Acetyltransferase 2A)
- KAT2B — Lysine Acetyltransferase 2B
- KAT5 — Lysine Acetyltransferase 5
- KAT6B and KAT6A: structural and functional insights into their roles in development and disease
- KAT7 — Lysine Acetyltransferase 7 (HBO1/MYST2)
- KAT8 Gene
- KCA1A Gene
- KCNA1 Gene
- KCNA10 Gene
- KCNA2 Gene
- KCNA3 — Potassium Voltage-Gated Channel
- KCNA4 Gene
- KCNA5 Gene
- KCNA6 Gene
- KCNA7 Gene - Potassium Voltage-Gated Channel Subfamily A Member 7
- KCNAB1
- KCNAB2
- KCNAB3 — Potassium Voltage-Gated Channel Subfamily A Member Beta 3
- KCNB1 Gene
- KCNB2 Gene
- KCNC1 Gene
- KCNC2 — Potassium Voltage-Gated Channel Subfamily C Member 2
- KCNC3 Gene
- KCNC4 Gene
- KCND1 — Potassium Voltage-Gated Channel Subfamily D Member 1
- KCND2 Gene - Kv4.2 Voltage-Gated Potassium Channel
- KCND3 Gene
- KCNE1
- KCNE2
- KCNE4 (Potassium Voltage-Gated Channel Subfamily E Regulatory Subunit 4)
- KCNE5 — Potassium Voltage-Gated Channel Subfamily E Regulatory Subunit 5
- KCNF1 Gene
- KCNF2 Gene
- KCNG1 Gene
- KCNG2 Gene
- KCNG3 Gene
- KCNG4 Gene
- KCNH1 Gene
- KCNH2 — Potassium Voltage-Gated Channel Subfamily H Member 2
- KCNH3 — Potassium Voltage-Gated Channel Subfamily H Member 3
- KCNH4 Gene
- KCNH5 Gene
- KCNH7 Gene
- KCNIP2 Gene
- KCNIP3
- KCNIP4
- KCNJ1 Gene - Potassium Inwardly Rectifying Channel
- KCNJ10 Gene
- KCNJ11 Gene
- KCNJ12 Gene
- KCNJ13 Gene
- KCNJ14 Gene
- KCNJ2 — Kir2.1 Inward Rectifier Potassium Channel
- KCNJ3 Gene
- KCNJ4 — Potassium Inwardly Rectifying Channel Subfamily J Member 4
- KCNJ5 Gene
- KCNJ6 — Potassium Inwardly Rectifying Channel Subfamily J Member 6
- KCNJ8 Gene
- KCNJ9 Gene
- KCNK10 Gene
- KCNK18 — Potassium Two Pore Domain Channel Subfamily K Member 18 (TRESK)
- KCNK2 Gene
- KCNK3 Gene
- KCNK4 Gene
- KCNK5 Gene
- KCNK6 Gene
- KCNK7 Gene
- KCNK9 Gene
- KCNMB1 Gene
- KCNMB2
- KCNMB3
- KCNMB4
- KCNN1 Gene
- KCNN2 Gene
- KCNN3 — Potassium Calcium-Activated Channel Subfamily N Member 3
- KCNN4 — Potassium Calcium-Activated Channel Subfamily N Member 4
- KCNQ1 (KV7.1)
- KCNQ2 Gene
- KCNQ3 Gene
- KCNQ4 - Potassium Channel Kv7.4
- KCNQ5 - Potassium Channel Kv7.5
- KCNS1 Gene
- KCNS2 Gene
- KCNS3 variants and cognitive function in neurodevelopmental disorders
- KCNT1 Gene - Slack Channel
- KCNV1 Gene
- KCNV2 Gene
- KCTD7 Gene (CLN14)
- KDM2A Gene
- KDM2B
- KDM3A regulates neuronal stress response
- KDM3B - Lysine Specific Demethylase 3B
- KDM4A - Lysine Specific Demethylase 4A
- KDM4B (Lysine Demethylase 4B)
- KDM4C
- KDM5B (Lysine Demethylase 5B)
- KDM5C (Lysine Demethylase 5C)
- KDM6A Gene
- KDM6B (JMJD3)
- KDM7A
- KDR Gene
- KEAP1 — Kelch-Like ECH-Associated Protein 1
- Ketogenic diet effects on PDH function in neurons
- KIAA0196 (WASHC5) Gene
- KIF11 Gene
- KIF13A Gene
- KIF13B
- KIF14 Gene
- KIF15 Gene - Kinesin Family Member 15
- KIF17 — Kinesin Family Member 17
- KIF18A Gene — Kinesin Family Member 18A
- KIF18B — Kinesin Family Member 18B
- KIF19 Gene
- KIF1B — Kinesin Family Member 1B
- KIF1C
- KIF20A — Kinesin Family Member 20A
- KIF20B — Kinesin Family Member 20B
- KIF21A — Kinesin Family Member 21A
- KIF21B — Kinesin Family Member 21B
- KIF22 — Kinesin Family Member 22
- KIF24 — Kinesin Family Member 24
- KIF25 — Kinesin Family Member 25
- KIF26A — Kinesin Family Member 26A
- KIF26B — Kinesin Family Member 26B
- KIF27 — Kinesin Family Member 27
- KIF2A: a unique motor that depolymerizes microtubules
- KIF2C Gene
- KIF3A — Kinesin Family Member 3A
- KIF3B — Kinesin Family Member 3B
- KIF3C — Kinesin Family Member 3C
- KIF4A — Kinesin Family Member 4A
- KIF5A Gene
- KIF5B Gene
- KIF5C Gene
- KIF7
- KIF9 — Kinesin Family Member 9
- Kim H, et al. STX4A in lysosomal trafficking. Autophagy (2023)
- Kim J, et al. DLK2 expression in human brain and its alteration in AD. J Neuropathol Exp Neurol (2023)
- KLC1 and neuroinflammation in AD
- KLF14 Gene
- KLF4 Gene
- KLK1 Gene
- Klotho and the aging phenotype
- KMT2A — lysine methyltransferase 2A
- KMT2B — lysine methyltransferase 2B
- KMT2C — Lysine Methyltransferase 2C
- KMT2D — Lysine Methyltransferase 2D
- KMT2E Gene (Lysine Methyltransferase 2E)
- KNL1
- KPNA1
- KYAT3 Gene
- L1CAM (L1 Cell Adhesion Molecule)
- LAMA2 — Laminin Subunit Alpha 2
- LAMB2 — Laminin Subunit Beta 2
- LAMP2 Gene
- LAMP5 Gene — Lysosomal Associated Membrane Protein 5
- LAMTOR1 - Late Endosomal/Lysosomal Adaptor 1
- LAMTOR2 Gene
- LAP3 - Leucine Aminopeptidase 3
- LAPTM4A Gene
- LAPTM4B Gene
- LARS2 — Leucyl-tRNA Synthetase 2, Mitochondrial
- LAS1L Gene
- LATS1 — Large Tumor Suppressor Kinase 1, Hippo Pathway
- LATS2
- LCK — LCK Proto-Oncogene, Src Family Tyrosine Kinase
- LDLR Gene
- LEF1
- LEPR — Leptin Receptor
- LETM1 — Leucine Zipper and EF-Hand Containing Transmembrane Protein 1
- LFNG Gene - Lunatic Fringe
- LGALS1 — Galectin-1
- LGALS3 Gene
- LGI1 Gene
- LGI2 — Leucine-Rich Glioma Inactivated 2
- LGMN Gene
- LHX2 — LIM Homeobox 2
- LHX6 — LIM Homeobox 6
- LIF — Leukemia Inhibitory Factor
- LIFR - Leukemia Inhibitory Factor Receptor
- LIG1
- LIG3 Gene
- LIG4
- LILRB2 — Leukocyte Immunoglobulin-Like Receptor B2
- LIMK1 Gene
- LIMK2 Gene
- LIMP2 Gene
- LIN7A — Lin-7 Homolog A
- LIN7B — Lin-7 Homolog B
- LIN7C Gene - LIN-7 Homolog C
- LINGO1 — Leucine-Rich Repeat and Immunoglobulin-Like Domain-Containing Neurite Outgrowth Inhibitor Protein
- LINGO2 Gene
- LINGO3 Gene
- LIPA Gene
- LIS1 Gene
- LITAF — Lipopolysaccharide-Induced Tumor Necrosis Factor Factor
- LMNA Gene
- LMX1A Gene
- LONP1
- Loss of SETD1A accelerates age-related cognitive decline through mitochondrial dysfunction (2023)
- LPL — Lipoprotein Lipase
- LRFN1 — Leucine Rich Repeat and Fibronectin Type III Domain Containing 1
- LRP1 Gene
- LRP10
- LRP12 — Low Density Lipoprotein Receptor-Related Protein 12
- LRP1B — Low Density Lipoprotein Receptor-Related Protein 1B
- LRP2 — Low Density Lipoprotein Receptor-Related Protein 2 (Megalin)
- LRP3 — Low Density Lipoprotein Receptor-Related Protein 3
- LRP4 — Low Density Lipoprotein Receptor-Related Protein 4
- LRP5 — Low Density Lipoprotein Receptor-Related Protein 5
- LRP6 Gene
- LRP8 Gene
- LRPPRC — Leucine-Rich Pentatricopeptide Repeat Containing
- LRRK1 - Leucine-Rich Repeat Kinase 1
- LRRK2 as a MAP kinase scaffold: role in signaling
- LRRK2 — Leucine Rich Repeat Kinase 2
- LRRTM1 Gene
- LRRTM2 Gene
- LRRTM3 Gene
- LRRTM4 Gene
- LRSAM1 Gene
- LSD1 activity in the brain and therapeutic targeting. Trends Pharmac Sci. 2023
- LTBR Gene
- LYRM7 Gene
- Lysosomal Associated Membrane Protein 1 (LAMP1)
- Lysosomal Associated Membrane Protein 3 (LAMP3)
- Lysosomal trafficking regulators and neurodegenerative disease
- LYST regulates HOPS complex assembly for lysosomal fusion
- LZTS1 — Leucine Zipper Tumor Suppressor 1
- MACF1 in protein aggregation diseases.
- MAF - MAFA BZIP Transcription Factor
- MAFB Gene - MAF BZIP Transcription Factor B
- MAG Gene
- Mammalian amino acid transport systems
- Mammalian Rho GTPases in cell migration
- MAN2B1 Gene
- MANF Gene
- MAOA Gene
- MAOB Gene
- MAP1A Gene
- MAP1B Gene
- MAP1LC3A Gene
- MAP1LC3A Gene
- MAP1LC3B — LC3B
- MAP1LC3B2 Gene
- MAP1LC3C Gene
- MAP1S - Microtubule Associated Protein 1S
- MAP2 Gene
- MAP2K1 Gene
- MAP2K2 Gene
- MAP2K3 - Mitogen-Activated Protein Kinase Kinase 3
- MAP2K4 — Mitogen-Activated Protein Kinase Kinase 4
- MAP2K5
- MAP2K6
- MAP2K7
- MAP3K1 — Mitogen-Activated Protein Kinase Kinase Kinase 1
- MAP3K12 — Mitogen-Activated Protein Kinase Kinase Kinase 12
- MAP3K3 Gene
- MAP3K4 — Mitogen-Activated Protein Kinase Kinase Kinase 4
- MAP3K5 — Mitogen-Activated Protein Kinase Kinase Kinase 5
- MAP3K6 Gene
- MAP3K7 Gene
- MAP4 Gene
- MAP7 - Microtubule Associated Protein 7
- MAPK1 Gene
- MAPK10 Gene
- MAPK11
- MAPK12
- MAPK13 — Mitogen-Activated Protein Kinase 13
- MAPK3 Gene - ERK1
- MAPK4 Gene
- MAPK6 — Mitogen-Activated Protein Kinase 6
- MAPK7
- MAPK9 Gene
- MAPT Haplotypes (H1/H2)
- MARCH5 Gene
- MARCH7 — Membrane Associated Ring-CH Type Finger 7
- MARCHF1
- MARCHF2 — Membrane-Associated RING-CH Finger 2
- MARCKS — Myristoylated Alanine-Rich Protein Kinase C Substrate
- MARK2 Gene
- MARK4 Gene
- MARS2 — Mitochondrial Arginyl-tRNA Synthetase 2
- MAST1 Gene
- MATR3 Gene
- MAVS Gene
- MBD1 — Methyl-CpG Binding Domain Protein 1
- MBD2 Gene - Methyl-CpG Binding Domain Protein 2
- MBD3 Gene - Methyl-CpG Binding Domain Protein 3
- MBD4 Gene - Methyl-CpG Binding Domain Protein 4
- MBD5 Gene - Methyl-CpG Binding Domain Protein 5
- MBD6 Gene - Methyl-CpG Binding Domain Protein 6
- MBNL1 dysfunction in Huntington's disease
- MBNL2 Gene
- MBP - Myelin Basic Protein
- MC4R — Melanocortin 4 Receptor
- MCCC1 Gene
- MCL1 Gene - Myeloid Cell Leukemia 1
- MCOLN1 — Mucolipin-1 (TRPML1)
- MCU Gene
- MDC1 — Mediator of DNA Damage Checkpoint 1
- MDH1 — Malate Dehydrogenase 1
- MDM2 Gene
- MDM4 (MDMX)
- Mechanisms of ankyrin-B regulation in disease
- MECOM Gene
- MECP2 variants
- MEF2A
- MEF2B (Myocyte Enhancer Factor 2B)
- MEF2C ameliorates cognitive deficits in 5xFAD mouse model of Alzheimer's disease
- MELK Gene
- MERTK - MER Tyrosine Kinase
- MET - MET Proto-Oncogene, Receptor Tyrosine Kinase
- Meta-analysis of 74,046 individuals identifies 23 new susceptibility loci for Alzheimer's disease
- Methods to assess the efficacy of mitochondrial-targeted therapeutics
- MEX3B Gene
- MFF Gene
- MFN2 phosphorylation regulates mitophagy
- MFRP - Membrane Frizzled-Related Protein
- MFSD1
- MFSD2A - Major Facilitator Superfamily Domain Containing 2A
- MFSD8 — Major Facilitator Superfamily Domain Containing 8
- MGEA5 — O-GlcNAcase (OGA)
- Microglia, architects of the CNS
- MID51
- MIEF2 — Mitochondrial Elongation Factor 2 (MiD50)
- MIRO2 Gene
- Mitochondrial biogenesis in the aging brain
- Mitochondrial carrier protein import and disease
- Mitochondrial copper chaperone function in disease
- Mitochondrial cristae remodeling in neurodegenerative disease
- Mitochondrial DNA repair and neurodegeneration (2015)
- Mitochondrial DNA repair mechanisms in aging brain
- Mitochondrial dynamics in neuronal death pathways
- Mitochondrial dysfunction and neurodegeneration
- Mitochondrial dysfunction in neurodegenerative diseases
- Mitochondrial free radical signaling in neurodegeneration
- Mitochondrial quality control and disease
- Mitochondrial Supercomplexes: Physiological Organization and Dysregulation in Age-Related Neurodegenerative Disorders
- Mitofusin 1 (MFN1)
- Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation - PMID:20379270
- MLCK Gene
- MLH1 Gene
- MLKL Gene
- MLST8 Gene
- MMP1 - Matrix Metallopeptidase 1
- MMP12 - Matrix Metallopeptidase 12
- MMP14 (Matrix Metalloproteinase 14)
- MMP2 Gene
- MMP3 Gene
- MMP7 - Matrix Metallopeptidase 7
- MMP9 Gene
- MOB1A Gene
- MOG Gene
- Molecular chaperones in Alzheimer's disease
- Molecular Mechanisms of GFAP and PTPRC in Alzheimer's Disease
- Monoclonal antibodies targeting IL-20R subunits in inflammation
- MORC3 biomarker potential
- MPV17 Gene - MPV17 Mitochondrial Inner Membrane Protein
- MPZ — Myelin Protein Zero
- MRAS — Muscle RAS Oncogene
- MRC1 — Mannose Receptor C Type 1
- MRE11 Gene
- MRI biomarkers in cerebral cavernous malformation
- MS4A1 — Membrane Spanning 4-Domains A1 (CD20)
- MS4A2 Gene (FcεRIβ)
- MS4A3 Gene
- MS4A4A Gene — Membrane-Spanning 4-Domains A4A
- MS4A4E Gene - Membrane-Spanning 4-Domains A4E
- MS4A6A Gene
- MS4A6E Gene
- MS4A7 Gene — Membrane-Spanning 4-Domains A7
- MSH2 — MutS Homolog 2
- MSH3 Gene
- MSH6 — MutS Homolog 6
- MST1 Gene
- MST3 Gene
- MST4 Gene
- MSTO1 — Miosin
- MT-CO1 Gene - Mitochondrially Encoded Cytochrome C Oxidase I
- MT-ND1 Gene - Mitochondrial NADH Dehydrogenase Subunit 1
- MT1A (Metallothionein-1A)
- MT2A (Metallothionein-2A)
- MT3
- MTCH1 — Mitochondrial Carrier Homolog 1
- MTCH2 — Mitochondrial Carrier Homolog 2
- MTCL1 — Microtubule Cross-Linking Factor 1
- MTERF1 Gene - Mitochondrial Transcription Termination Factor 1
- MTOR Gene
- MTOR Gene
- mTOR Regulation and Function in Neuronal Health and Disease
- MTRR Gene
- MUL1 Gene
- Multi-omics analysis reveals GAB2 dysregulation in AD brains (2021)
- Mutations in RPL37 cause Diamond-Blackfan anemia with distinctive clinical features
- MUTYH Gene
- MXD1 Gene
- MYC Gene
- MYD88 Gene
- MYH2 Gene
- MYH7 Gene
- MYH8 (Myosin Heavy Chain 8)
- MYO15B — Myosin XVB
- MYO5A — Myosin Va
- MYO5B — Myosin Vb
- MYO6 — Myosin VI
- MYO7A — Myosin VIIa
- MYOT Gene
- MYPN Gene
- MYT1L Gene
- NADK Gene
- NAGA - Alpha-N-Acetylgalactosaminidase
- NAGLU — Alpha-N-Acetylglucosaminidase
- NAIP Gene
- NALCN - Sodium Leak Channel
- NAMPT Gene
- NAPA — NSF Attachment Protein Alpha
- NARS1 — Asparaginyl-tRNA Synthetase 1
- NARS2 Gene
- NBN Gene
- NBR1 Gene
- NBS1 (NBN)
- NCAM1 Gene
- NCAM2 genetic variants and Alzheimer's disease risk in Asian populations
- NCF1 — Neutrophil Cytosolic Factor 1
- NCF2 Gene
- NCK2 Gene
- NCL — Nucleolin
- NCOA1 Gene
- NCOA2 Gene
- NCOA4 Gene
- NCOR1 Gene - Nuclear Receptor Corepressor 1
- NCSTN Gene - Nicastrin
- NCT (Nicastrin) Gene
- NCX1 (SLC8A1) Gene
- NCX2 (SLC8A2) Gene
- NCX3 (SLC8A3) Gene
- Ndel1-dependent transport of cargo by cytoplasmic dynein in neuronal axons (2023)
- NDP52 Gene
- NDRG2 Gene
- NDUFA1 Gene
- NDUFA10 Gene
- NDUFA12 Gene
- NDUFA13 Gene
- NDUFA2 Gene
- NDUFA4 Gene
- NDUFA5 — NADH:ubiquinone Oxidoreductase Subunit A5
- NDUFA6 Gene
- NDUFA9 Gene
- NDUFAF1 — NADH:Ubiquinone Oxidoreductase Complex Assembly Factor 1
- NDUFAF2 — NADH:Ubiquinone Oxidoreductase Complex Assembly Factor 2
- NDUFAF3 Gene
- NDUFAF4 — NADH Dehydrogenase Complex Assembly Factor 4
- NDUFAF5 Gene
- NDUFAF6 Gene
- NDUFAF7 Gene
- NDUFAF8 Gene (NADH Dehydrogenase Complex Assembly Factor 8)
- NDUFB1 — NADH:ubiquinone Oxidoreductase Subunit B1
- NDUFC2 Gene
- NDUFS1 Gene
- NDUFS2 Gene
- NDUFS3 Gene - NADH:Ubiquinone Oxidoreductase Core Subunit S3
- NDUFS4 Gene
- NDUFS5 — NADH:Ubiquinone Oxidoreductase Core Subunit S5
- NDUFS6 Gene
- NDUFS7 Gene
- NDUFS8 — NADH:Ubiquinone Oxidoreductase Core Subunit S8
- NDUFV1 Gene
- NDUFV2 Gene
- NEFH Gene
- NEFH — Neurofilament Heavy Chain
- NEFL Gene
- NEFL — Neurofilament Light Chain
- NEFM — Neurofilament Medium Chain
- NEIL1 — Nei Endonuclease VIII-Like 1
- NEIL2 — Nei Endonuclease VIII-Like 2
- NEIL3 Gene
- NEK1 — NIMA Related Kinase 1
- NEK7 Gene
- Nestin and BDNF signaling (2022)
- NETO1 — Neuropilin and Tolloid Like 1
- NETO2 — Neuropilin and Tolloid Like 2
- NEU1 Gene
- NEURD1 - N-terminal EGF Like Domain Calcium Binding Protein 1
- NEUROD1 Gene
- NEUROD2 Gene
- Neurofilament in Creutzfeldt-Jakob disease
- NEUROG1 (Neurogenin-1)
- Neurogenin-1 variants and disease susceptibility
- Neuronal potassium channels as therapeutic targets in excitotoxicity
- NEXMIF Gene
- NF-κB in immune aging
- NF2 — Merlin/Neurofibromin 2
- NFASC — Neurofascin
- NFAT transcription factors in oligodendrocyte development
- NFAT1 Gene
- NFAT3 Gene
- NFAT4 — Nuclear Factor of Activated T-cells 4
- NFAT5 — Nuclear Factor of Activated T Cells 5
- NFATc1 — Nuclear Factor of Activated T Cells 1
- NFATc4 is required for the development of hippocampal long-term potentiation
- NFE2L1 Gene
- NFE2L1 — Nuclear Factor Erythroid 2-Like 1
- NFE2L2 — Nuclear Factor Erythroid 2-Related Factor 2
- NFE2L3 Gene
- NFKB1 Gene
- NFKB2 Gene
- NGF Gene
- NGFR Gene
- NGN2 (Neurogenin-2)
- NGN2 and neural stem cell differentiation
- NHEJ1 — Non-Homologous End Joining Factor 1
- NHLRC1 Gene
- NHLRC2 Gene
- NICASTRIN Gene
- NIPA1 Gene
- NIPBL - Nipped-B Like (Cohesin Loader)
- Nitric oxide synthase and BH4 in neuroinflammation
- NKX2-2 Gene
- NLGN1 Gene
- NLGN2 Gene
- NLGN3 Gene
- NLGN4X Gene
- NLGN4Y Gene
- NLR Family Member X1
- NLRC3 and neuroinflammation in neurodegenerative disease
- NLRC4 Gene
- NLRC5 — NLR Family CARD Domain Containing 5
- NLRP1 Gene
- NLRP12 — NLR Family Pyrin Domain Containing 12
- NLRP2 — NLR Family Pyrin Domain Containing 2
- NLRP6 - NLR Family Pyrin Domain Containing 6
- NLRP7 — NLR Family Pyrin Domain Containing 7
- NME1 - NME Nucleoside Diphosphate Kinase 1
- NME8 Gene
- NMNAT1 Gene
- NMNAT2 Gene
- NMNAT3 — Nicotinamide Mononucleotide Adenylyltransferase 3
- NOB1 — NIN1 Binding Protein 1
- NOD2 Gene
- NOG Gene
- NOL3
- NONO Gene
- NOP56 Gene
- NOS1 — Nitric Oxide Synthase 1
- NOS2 - Nitric Oxide Synthase 2
- NOS3 — Nitric Oxide Synthase 3
- NOSTRIN Gene
- NOTCH1 Gene
- NOTCH2 — Notch Receptor 2
- NOTCH2NLC Gene
- NOTCH3 — Notch Receptor 3
- NOTCH4 Gene - Notch Receptor 4
- NOVA1 — NOVA Alternative Splicing Regulator 1
- NOVA2 — NOVA Alternative Splicing Regulator 2
- NOX1 Gene
- NOX2 Gene
- NOX4 Gene
- NOX5 Gene
- NPAS1 - Neuronal PAS Domain Protein 1
- NPAS2 Gene
- NPAS3 Gene
- NPAS4 Gene
- NPC2 — NPC Intracellular Cholesterol Transporter 2
- NPM1 Gene
- NPR1 gene variants and cardiovascular traits
- NPRL2 Gene
- NPRL3 Gene
- NPTX1 — Neuronal Pentraxin 1
- NPTX2 — Neuronal Pentraxin 2
- NPTXR — Neuronal Pentraxin Receptor
- NPY Gene
- NPY1R Gene
- NPY2R — Neuropeptide Y Receptor Y2
- NPY5R — Neuropeptide Y Receptor Y5
- NQO1 — NAD(P)H Quinone Dehydrogenase 1
- NQO2 Gene
- NR1D1 — Nuclear Receptor Subfamily 1 Group D Member 1 (REV-ERBα)
- NR1D2 (Nuclear Receptor Subfamily 1 Group D Member 2)
- NR1H3 - Nuclear Receptor Subfamily 1 Group H Member 3
- NR4A1 Gene
- NR4A2 Gene
- NRAS Gene
- NRBP1 - Nuclear Receptor Binding Protein 1
- NRCAM Gene
- NRF1 Gene
- NRF2 Gene
- NRG1 Gene
- NRG2 - Neuregulin 2
- NRGN Gene - Neurogranin
- NRP2 Gene
- NRTN Gene
- NRXN1 Gene
- NRXN2 Gene
- NRXN3 Gene
- NSD1 (Nuclear Receptor Binding SET Domain Protein 1)
- NSD2 (Nuclear Receptor Binding SET Domain Protein 2)
- NSD3 (Nuclear Receptor Binding SET Domain Protein 3)
- NSF Gene
- NSUN2 Gene
- NT3 Gene
- NT4 Gene
- NT5C2 Gene
- NT5DC2 Gene
- NT5E Gene
- NTF3 — Neurotrophin-3
- NTF4 — Neurotrophin-4
- NTHL1 Gene
- NTN1 Gene - Netrin 1
- NTN2 Gene
- NTN3 Gene
- NTN4 Gene
- NTN4 Gene - Netrin-4
- NTNG1
- NTNG2
- NTRK1 Gene
- NTRK2 Gene
- NTRK3 Gene
- NTS — Neurotensin
- NTSR1 — Neurotensin Receptor 1
- NTSR2 Gene
- NUCKS1 Gene
- Nucleotide excision repair: from molecular mechanisms to human disease
- NUDT1 — NUDIX Hydrolase 1 (MTH1)
- NUP153 — Nucleoporin 153
- NUP214 — Nucleoporin 214
- NUP54 Gene
- NUP58 Gene
- NUP62 — Nucleoporin 62
- NUP98 — Nucleoporin 98
- NUPL2
- NURR1 Gene
- NUS1 Gene - NUS1 Homolog
- NYAP1 — Neuronal Tyrosine-Phosphorylated Adaptor
- OCLN — Occludin
- OGDH — Oxoglutarate Dehydrogenase
- OGDHL — Oxoglutarate Dehydrogenase Like
- OGG1 Gene
- OGT — O-GlcNAc Transferase
- OLIG1 Gene
- OLIG2 Gene
- OMA1 Gene
- OMGP Gene
- OPA1 — Optic Atrophy 1
- OPA3 Gene
- OPALIN — Oligodendrocyte Myelin Membrane Protein
- OPRK1 — Kappa Opioid Receptor
- OPRM1 — Mu-Opioid Receptor
- OPTN — Optineurin
- ORAI1 Gene
- Organic cation transporters in aging brain
- Organic cation transporters in cancer cell drug resistance
- OSCP1 Gene
- OSMR Gene
- OTOF (Otoferlin)
- OTUD3 — OTU Deubiquitinase 3
- OTUD4 — OTU Deubiquitinase 4
- OTULIN — OTU Deubiquitinase with Linear Linkage Specificity
- OTULIN — OTU Deubiquitinase with Linear Linkage Specificity
- OTULIN-Tau Regulation Pathway
- Oxidative stress in Alzheimer's disease
- OXPHOS mutations and neurodegeneration
- OXR1 — Oxidoreductase NRD1
- p16INK4a as biomarker for neurodegeneration (2022)
- P2RX2 Gene
- P2RX3 Gene
- P2RX4 Gene
- P2RX5 Gene
- P2RX6 — Purinergic Receptor P2X Ligand-Gated Ion Channel 6
- P2RY1 Gene
- P2RY12 Gene
- P2RY13
- P2RY14 Gene - Purinergic Receptor P2Y14
- P2X receptors in neuropathic pain and neurodegeneration
- P2Y12 receptor and neurodegeneration in Parkinson's disease
- P2Y2 agonists for neuroprotection
- p38 MAPK and amyloid-beta metabolism in Alzheimer's disease
- P75NTR Gene
- p97 inhibitors in clinical trials (2025)
- PABPN1
- PAFAH1B1 — Platelet Activating Factor Acetylhydrolase 1B Subunit 1
- PAH Gene
- PAHX
- PAK1 Gene
- PAK3 in Down syndrome and Alzheimer's disease
- PALB2 Gene
- PANK1 — Pantothenate Kinase 1
- PANK2 — Pantothenate Kinase 2
- PANK3 — Pantothenate Kinase 3
- PANK4 Gene
- PANX1 Gene
- PANX2 Gene
- PARD6A — Partitioning Defect 6 Par-6 Family Cell Polarity Protein Alpha
- PARD6B Gene
- PARD6G — Partitioning Defect 6 Par-6 Family Cell Polarity Protein Gamma
- Park et al., Therapeutic targeting of splicing
- PARK16 - Parkinson's Disease Locus 16
- PARK2 - Parkin
- PARK7 Gene - DJ-1/PARK7
- PARKIN Gene
- PARP1 Gene
- PARP2 Gene
- PARP3 Gene
- PARP4 — Poly(ADP-Ribose) Polymerase 4
- PARS10 — Parkinsonism Associated Ras-Like Protein 10
- PAX2 Gene
- PAX6 — Paired Box 6
- PBX3 — Pre-B-cell Leukemia Homeobox 3
- PCBP1 Gene
- PCBP2 post-transcriptional regulation in neurodegeneration. RNA Biol. 2021
- PCDH15 gene therapy for Usher syndrome
- PCDH19
- PCYT1B Gene
- PDCD10 Gene (Programmed Cell Death 10)
- PDE10A — Phosphodiesterase 10A
- PDE11A - Phosphodiesterase 11A
- PDE1A — Phosphodiesterase 1A
- PDE1B — Phosphodiesterase 1B
- PDE1C — Phosphodiesterase 1C
- PDE2A Gene
- PDE4A — Phosphodiesterase 4A
- PDE4B genetic variants and cognitive decline in aging
- PDE4C — Phosphodiesterase 4C
- PDE4D Gene
- PDE5A Gene
- PDE6B — Phosphodiesterase 6B
- PDE8B Gene
- PDE9A Gene
- PDGFA — Platelet-Derived Growth Factor Subunit A
- PDGFB — Platelet Derived Growth Factor Subunit B
- PDGFRA - Platelet Derived Growth Factor Receptor Alpha
- PDGFRB — Platelet Derived Growth Factor Receptor Beta
- PDHA1
- PDHX Gene
- PDIA3 - Protein Disulfide Isomerase Family A Member 3
- PDIA6 - Protein Disulfide Isomerase Family A Member 6
- PDK3 - 3-Phosphoinositide-Dependent Protein Kinase-3
- PDPK1 Gene
- PDS5A - PDS5 Cohesin Associated Factor A
- PDYN Gene
- PELI1 Gene
- PEN2 Gene
- PENK Gene
- PEO1 Gene - Twinkle Mitochondrial DNA Helicase
- PER1 Gene
- PER2 Gene
- PER3 Gene
- Peroxisomal membrane protein import
- Peroxisomal protein import in disease
- Peroxisome dynamics in mammalian cells
- PET100 — Protein PET100 Homolog (Mitochondrial)
- PET117 — Cytochrome C Oxidase Assembly Factor
- PEX1 Gene - Peroxisome Biogenesis Factor 1
- PEX10 Gene
- PEX13 Gene
- PEX2 Gene
- PEX3 Gene - Peroxisome Biogenesis Factor 3
- PEX5 Gene - Peroxisome Biogenesis Factor 5
- PEX6 Gene
- PFN1 Gene
- PFN1 — Profilin 1
- PGAP2
- PGC1A Gene
- PGK1 Gene
- Pharmacological chaperones for lysosomal disorders
- PHF23 — PHD Finger Protein 23
- PHF6 Gene
- PHF8 (PHD Finger Protein 8)
- PHOX2B Gene
- PI3K — Phosphoinositide 3-Kinase
- PICALM — Phosphatidylinositol Binding Clathrin Assembly Protein
- PICK1 - Protein Interacting With C Kinase 1
- PIEZO1 — Piezo Type Mechanosensitive Ion Channel Component 1
- PIEZO2 — Piezo Type Mechanosensitive Ion Channel Component 2
- PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)
- PIK3CA Gene
- PIK3CD Gene
- PIK3CG Gene
- PIK3R1 Gene
- PIK3R2 Gene
- PIK3R3 Gene
- PIK3R6 Gene
- PILRA Gene
- PILRB Gene
- PIN1 — Peptidyl-prolyl cis-trans Isomerase NIMA-Interacting 1
- PINK1 — PTEN Induced Kinase 1
- PINK1 — PTEN Induced Kinase 1 (PARK6)
- PITX3 Gene
- PJA1 Gene — Praja1 RING Finger E3 Ubiquitin Ligase
- PKN1 (Protein Kinase N1)
- PLA2G6 — Phospholipase A2 Group VI
- PLAA Gene
- PLAU Gene (Urokinase)
- PLCB1 Gene
- PLCB2 Gene
- PLCB3 — Phospholipase C Beta 3
- PLCB4 — Phospholipase C Beta 4
- PLCG1 - Phospholipase C Gamma 1
- PLCG2 Gene
- PLD3 Gene
- PLD4 Gene
- PLEC Gene
- PLG — Plasminogen
- PLIN1 — Perilipin 1
- PLIN2 Gene
- PLIN3 mutation and lipid storage disorders
- PLIN4 Gene
- PLIN5 — Perilipin 5
- PLK1 Gene
- PLK2 Gene
- PLK3 Gene
- PLK4 Gene
- PLN Gene
- PLOR1 Gene
- PLP1 Gene
- PLP2 overexpression induces oxidative stress and neuronal death
- PLPPR1 Gene
- PLXNA1 Gene
- PLXNA2 Gene
- PMAIP1 Gene
- PMP22 — Peripheral Myelin Protein 22
- PMS2 — DNA Mismatch Repair Protein PMS2
- PNKP - Polynucleotide Kinase 3'-Phosphatase
- PNMT Gene
- PNOC Gene
- PNP Gene
- Polarity complex in neuronal polarity disorders
- POLB Gene
- POLD1
- POLD2 — DNA Polymerase Delta Subunit 2
- POLD3 Gene
- POLD4 Gene
- POLE — DNA Polymerase Epsilon
- POLM Gene
- POLN Gene — DNA Polymerase Nu
- Polyamine transport by P5B-ATPases: a novel therapeutic angle
- POMC — Proopiomelanocortin
- POMGNT1 - Protein O-Linked Mannose N-Acetylglucosaminyltransferase 1
- POMT1 — Protein O-Mannosyltransferase 1
- POMT2
- PON1 and atherosclerosis: a protective role. Arterioscler Thromb Vasc Biol. 2009;29(1):2-8
- PON2 and lipid peroxidation in neurodegeneration
- PON3 genetic variants and disease risk
- POT1 Gene
- Potassium channels as drug targets
- POU3F2 — POU Class 3 Homeobox 2
- POU3F3 — POU Class 3 Homeobox 3 (Brn-1)
- POU5F1 (Oct4) - POU Class 5 Homeobox 1
- PP2A (PPP2R1A)
- PP2A alterations in progressive supranuclear palsy
- PPAR-alpha regulates mitochondrial function in neurons under metabolic stress
- PPARgamma-centered signaling network in neurodegeneration
- PPARGC1A Gene
- PPARGC1B Gene
- PPARGC1B — PPARG Coactivator 1 Beta
- PPID — Peptidylprolyl Isomerase D
- PPM1A Gene
- PPM1B Gene
- PPP1CB Gene
- PPP1CC Gene - Protein Phosphatase 1 Catalytic Subunit Gamma
- PPP1R15A Gene
- PPP1R15B
- PPP1R1A (DARPP-32)
- PPP1R1B Gene
- PPP1R2 Gene
- PPP1R7 — SDS22 (Protein Phosphatase 1 Regulatory Subunit 7)
- PPP1R9A Gene
- PPP1R9B — Spinophilin
- PPP2CB Gene
- PPP2R1A Gene
- PPP2R2A — Protein Phosphatase 2 Regulatory Subunit B55 Alpha
- PPP2R2B Gene
- PPP2R5A Gene
- PPP2R5B
- PPP3CA (Calcineurin Aα) — Protein Phosphatase 3 Catalytic Subunit Alpha
- PPP3CA — Protein Phosphatase 3 Catalytic Subunit Alpha
- PPP3CB Gene
- PPP3CC Gene (Calcineurin Gamma)
- PPP3R1 Gene
- PPP5C — Protein Phosphatase 5 Catalytic Subunit
- PPT1 Gene - Palmitoyl-Protein Thioesterase 1
- PPT2 Gene
- PQBP1 Gene - Polyglutamine Binding Protein 1
- PRDM1 Gene
- PRDM2 — PR/SET domain 2
- PRDM4 Gene
- PRDM9
- PRDX1 Gene
- PRDX2 — Peroxiredoxin 2
- PRDX3 — Peroxiredoxin 3
- PRDX4 — Peroxiredoxin 4
- PRDX5 — Peroxiredoxin 5
- PRDX6 and mitochondrial dysfunction in PD
- Presynaptic dysfunction in alpha-synucleinopathies
- Prevalence of Frontotemporal Dementia in Females of 5 Hispanic Families With R159H VCP Multisystem Proteinopathy
- Primary cilia dysfunction in neurodegenerative disease models
- PRIMPOL — DNA Primase/Polymerase
- PRK-mediated phosphorylation of PP2A in neuronal survival
- PRKAA1
- PRKAA2 (AMPKα2) — AMP-Activated Protein Kinase Catalytic Subunit Alpha 2
- PRKAB1 — Protein Kinase AMP-Activated Non-Catalytic Subunit Beta 1
- prkaca Gene
- PRKACB — Protein Kinase cAMP-Activated Catalytic Subunit Beta
- PRKACG — Protein Kinase A Catalytic Subunit Gamma
- PRKAR1A - Protein Kinase A Regulatory Subunit 1 Alpha
- PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta
- PRKAR2B — Protein Kinase A Regulatory Subunit 2B
- PRKCA Gene
- PRKCB — Protein Kinase C Beta
- PRKCD — Protein Kinase C Delta
- PRKCE Gene
- PRKCG — Protein Kinase C Gamma
- PRKCH
- PRKCI
- PRKCQ
- PRKCZ
- PRKDC — DNA-Dependent Protein Kinase Catalytic Subunit
- PRKG1 Gene
- PRKN — Parkin RBR E3 Ubiquitin Protein Ligase
- PRKRA Gene
- PRMT5
- PRND Gene - Prion-Like Protein Doppel
- PRNP — Prion Protein
- PROKR2 Gene - Prokineticin Receptor 2
- PROS1 — Protein S (Vitamin K-Dependent Protein S)
- PROSAP1 - Proline-Rich Synaptic-Associated Protein 1 (SHANK2)
- PRPF3 — Pre-mRNA Processing Factor 3
- PRPF31 Gene
- PRPF6 - Pre-mRNA Processing Factor 6
- PRRT2 Gene
- PSAP Gene - Prosaposin
- PSD2 Gene
- PSD3 Gene
- PSD4 Gene
- PSD93 (DLG3)
- PSEN1 — Presenilin 1
- PSEN2 — Presenilin 2
- PSENEN Gene - Presenilin Enhancer
- PSMA1 Gene
- PSMA2 Gene
- PSMA3 Gene
- PSMA4 Gene
- PSMA5 Gene
- PSMB1 Gene
- PSMB10
- PSMB2 Gene
- PSMB5 Gene
- PSMB6
- PSMB7
- PSMB8
- PSMB9
- PSMC1 (Proteasome 26S Subunit ATPase 1)
- PSP Gene - Persephin
- PSPN — Persephin
- PTBP1 Gene
- PTBP2 - Polypyrimidine Tract Binding Protein 2
- PTCH1 — Patched 1 (Hedgehog Receptor)
- PTCH2 Gene
- PTEN Gene
- PTGS2 - Prostaglandin-Endoperoxide Synthase 2
- PTK2 Gene - Focal Adhesion Kinase
- PTPRN2 — Protein Tyrosine Phosphatase Receptor Type N2
- PTPRT regulates interaction with Syntaxin-binding protein 1
- PubMed:23415642
- PUM2 — Pumilio RNA Binding Family Member 2
- PUNDC1 Gene
- Purinergic Receptor P2X 7 (P2X7)
- PVALB Gene - Parvalbumin
- PYCARD Gene
- QARS — Glutaminyl-tRNA Synthetase
- QDPR Gene
- QKI Gene
- QPCT Gene
- QRFP Gene
- QSOX1 Gene
- Rab proteins in neurodegenerative disease
- rab10 Gene
- RAB11A — Ras-Related Protein Rab-11A
- RAB11A — Ras-Related Protein Rab-11A
- RAB11B - RAB11B
- RAB11FIP5 Gene
- RAB12 Gene
- RAB15
- RAB17
- RAB18 — RAB18, Member RAS Oncogene Family
- RAB1A — Ras-Related Protein Rab-1A
- RAB22A
- RAB23 function in glial cells and neuroinflammation
- RAB25 Gene
- RAB27A Gene
- RAB27B Gene
- RAB28 Gene
- RAB29 — RAS-Related Protein Rab-29
- RAB2A Gene
- RAB30
- RAB31 — Ras-Related Protein Rab-31
- RAB32 Gene
- RAB33A
- RAB35 — Ras-Associated Protein 35
- RAB38 Gene
- RAB39B Gene
- RAB3A — Ras-Related Protein Rab-3A
- RAB3B Gene
- rab3c Gene
- RAB3D Gene
- RAB40B
- RAB43 Gene
- RAB44
- RAB45 Gene
- RAB4A Gene
- RAB4B Gene
- RAB5A Gene
- RAB5A — Ras-Related Protein Rab-5A
- RAB5B Gene
- RAB6A
- RAB6B
- RAB7 Gene
- RAB7A — RAB7A, Member RAS Oncogene Family
- RAB7L1 (RAB7 Like 1)
- RAB8A — RAB8A, Member RAS Oncogene Family
- RAB8B
- RAB9A
- RABEP1
- RAC1 Gene
- RAC2 — RAS-Related C3 Botulinum Toxin Substrate 2
- RACGAP1 — Rac GTPase Activating Protein 1
- RAD18 Gene
- RAD23A Gene
- RAD23B Gene
- RAD51
- RAD52 — DNA Repair Protein
- RAD54 Gene
- RAF1 signaling in cellular stress response
- Rag GTPases as masters of neuronal metabolism
- RAGE Gene
- RALB Gene - RAS-Related Protein Ral-B
- RAMP1
- RAMP3 — Receptor Activity Modifying Protein 3
- RANBP2 — RAN Binding Protein 2
- RANK (TNFRSF11A)
- RANKL (TNFSF11)
- Rapamycin ameliorates dopaminergic neurodegeneration via Hippo pathway
- RAPTOR Gene
- RARB
- RARS — Arginyl-tRNA Synthetase
- RASA1 — RAS p120 GTPase Activating Protein
- RASA2 — RAS GTPase-Activating Protein 2
- RASA3 — Ras GTPase-Activating Protein 3
- RASGEF1A
- RASGRF1 — Ras Protein-Specific Guanine Nucleotide-Releasing Factor 1
- RASGRF2
- RASGRP1 Gene
- RB1 — Retinoblastoma 1
- RB1CC1 Gene
- RBM10 Gene
- RBM25 (RNA Binding Motif 25)
- RBM45 Gene
- RBPJ Gene
- RBPJL — Recombination Binding Protein Lambda
- RCAN1 Gene
- RCN1 Gene (Reticulocalbin 1)
- RECQL4 — RECQ DNA Helicase Like 4
- REEP1 Gene
- REEP5 Gene
- REG3A — Regenerating Family Member 3 Alpha
- REG3G Gene
- REL Gene
- RELA (NF-κB p65)
- RELB Gene
- RELN Gene
- REST Gene
- RET Gene
- RFNG — Radical Fringe
- RGS1 — Regulator of G Protein Signaling 1
- RGS10 Gene
- RGS11 — Regulator of G Protein Signaling 11
- RGS12 Gene
- RGS14 in the medial prefrontal cortex: a cognitive enhancer?
- RGS16 in retinal ganglion cell survival and glaucoma
- RGS2 Gene - Regulator of G Protein Signaling 2
- RGS3 — Regulator of G Protein Signaling 3
- RGS4 Gene
- RGS5 — Regulator of G Protein Signaling 5
- RGS6 Gene
- RGS7 Gene
- RGS8 — Regulator of G Protein Signaling 8
- RGS9 gene therapy long-term efficacy in RP models
- RHEB Gene
- RHOT1 - Mitochondrial Rho GTPase 1
- RHOT2 Gene
- Ribosomal Protein L23a (RPL23A)
- Ribosomal protein L3 and the integrated stress response in neurons
- Ribosomal protein L34 and neural development
- Ribosomal Protein L35a (RPL35A)
- Ribosomal Protein L36a (RPL36A)
- Ribosomal protein mutation suppresses gonadal leader cell migration defects in mig-17/ADAMTS mutants in Caenorhabditis elegans
- Ribosomal protein S13 and the integrated stress response in neurons
- Ribosomal Protein S15a (RPS15A)
- Ribosomal Protein S24 (RPS24)
- Ribosomal Protein S28 (RPS28)
- Ribosomal proteins and the molecular signatures of ribosomopathies
- Ribosomal proteins: functions beyond the ribosome (2015)
- Ribosomal proteins: structure, function, and evolution
- Ribosomal stress and neurodegeneration
- Ribosome biogenesis and neurodegenerative disease
- RIC3 Gene
- RICTOR Gene
- RICTOR Gene
- RILP Gene
- RIM1 Gene
- RIM2 Gene
- RIMS1 — Regulating Synaptic Membrane Exocytosis 1
- RIMS2 Gene
- RIN3 — Rho GTPase-Activating Protein 25
- Ring Finger Protein 182
- Ring Finger Protein 186
- RIPK1 Gene
- RIPK3 Gene
- RIT2 — Ras-Like Without CAAX 2 (Rin)
- RNA Binding Fox-1 Homolog 1 (RBFOX1)
- RNA Binding Fox-1 Homolog 2 (RBFOX2)
- RNA Binding Fox-3 Homolog (NeuN) (RBFOX3)
- RNA granules and neurodegeneration
- RNA granules in dendritic compartments
- RNASEH1 — Ribonuclease H1
- RNASEH2A — Ribonuclease H2 Subunit A
- RNASEH2B — Ribonuclease H2 Subunit B
- RNASEH2C — Ribonuclease H2 Subunit C
- RNASEK — Ribonuclease Kappa
- RNC
- RNF10 — Ring Finger Protein 10
- RNF11 — RING Finger Protein 11
- RNF13 — Ring Finger Protein 13
- RNF14 — Ring Finger Protein 14
- RNF2
- RNF20
- RNF5 — RING Finger Protein 5
- RNF8 - Gene
- RNF8 Gene — Ring Finger Protein 8
- ROBO1 Gene
- ROCK1 Gene
- ROCK2 Gene
- Role of DUSP family members in neurodegeneration
- Role of mitochondrial dynamics in Alzheimer's disease pathogenesis
- Role of p40phox in host defense against pathogens
- RORA — RAR Related Orphan Receptor A
- RORB Gene
- RORC Gene
- RPA1 Gene
- RPA2 Gene
- RPA3
- RPL10 — Ribosomal Protein L10
- RPL12 — Ribosomal Protein L12
- RPL13 — Ribosomal Protein L13
- RPL13A — Ribosomal Protein L13A
- RPL14 — Ribosomal Protein L14
- RPL15
- RPL17 — Ribosomal Protein L17
- RPL18
- RPL19 — Ribosomal Protein L19
- RPL22 — Ribosomal Protein L22
- RPL23 Gene
- RPL24 — Ribosomal Protein L24
- RPL26
- RPL27A — Ribosomal Protein L27A
- RPL28 — Ribosomal Protein L28
- RPL29 — Ribosomal Protein L29
- RPL31 — Ribosomal Protein L31
- RPL32 in neuronal aging and senescence
- RPL34 — Ribosomal Protein L34
- RPL35 Gene
- RPL36
- RPL38 knockdown inhibits the inflammation and apoptosis
- RPL39
- RPL4 — Ribosomal Protein L4
- RPL5 Gene
- RPL6 — Ribosomal Protein L6
- RPL7 — Ribosomal Protein L7
- RPL7A — Ribosomal Protein L7A
- RPL8 — Ribosomal Protein L8
- RPN1 Gene
- RPN2 Gene
- RPS1 — Ribosomal Protein S1
- RPS10 Gene - Ribosomal Protein S10
- RPS11 — Ribosomal Protein S11
- RPS12 — Ribosomal Protein S12
- RPS15
- RPS16 — Ribosomal Protein S16
- RPS17
- RPS18 — Ribosomal Protein S18
- RPS19 Gene
- RPS2 — Ribosomal Protein S2
- RPS21 — Ribosomal Protein S21
- RPS23 — Ribosomal Protein S23
- RPS25 Gene
- RPS26 — Ribosomal Protein S26
- RPS27L in stress response and cellular adaptation
- RPS3A — Ribosomal Protein S3a
- RPS4X — Ribosomal Protein S4 X-linked
- RPS5 — Ribosomal Protein S5
- RPS6 Gene
- RPS6KA1 — Ribosomal Protein S6 Kinase A1
- RPS6KA2 — Ribosomal Protein S6 Kinase A2
- RPS6KB1 Gene
- RPS6KB2 - Ribosomal Protein S6 Kinase B2
- RPS7 Gene
- RPS8 Gene
- RPS9 Gene
- RPTOR — Regulatory Associated Protein of MTOR Complex 1
- RPUSD4 Gene
- RRAGA — Ras-Related GTP Binding A
- RRAS1 Gene
- RRAS2 in mitochondrial function and energy metabolism
- RRAS3 — Related RAS Virus (R-Ras) Family Member 3
- RRM2B Gene
- RTN1 Gene
- RTN2 Gene
- RTN3 Gene
- RTN4 Gene
- RUBCN Gene
- RXRA
- RXRB Gene
- RXRG Gene
- RYR1 - Ryanodine Receptor 1
- RYR2 - Ryanodine Receptor 2
- RYR3 - Ryanodine Receptor 3
- S100A1 Gene
- S100A6 Gene
- S100A8 - S100 Calcium Binding Protein A8
- S100A9 - S100 Calcium Binding Protein A9
- S100B Gene
- SACS Gene
- SAMHD1 — SAM and HD Domain Containing Metal Dependent Hydrolase 1
- SAP97 - Synapse-Associated Protein 97
- SAR1A Gene
- SARS1
- SATB2 - Special AT-Rich Sequence Binding Protein 2
- SCA7 Gene
- Scaffold proteins in neuronal homeostasis and disease
- SCAR20 Gene
- SCARA1 (Scavenger Receptor Class A Member 1)
- SCARB2 Gene
- SCD1 Gene
- SCFD1
- SCN10A Gene
- SCN11A Gene
- SCN1A Gene
- SCN1A Gene
- SCN1B Gene
- SCN2B Gene - Sodium Channel Beta Subunit
- SCN3A Gene
- SCN3B — Sodium Channel Beta 3 Subunit
- SCN4A Gene
- SCN4B Gene - Sodium Voltage-Gated Channel Beta Subunit 4
- SCN5A Gene
- SCN7A Gene
- SCN8A Gene - Nav1.6
- SCN9A Gene
- SCNN1A Gene
- SCO2 — Cytochrome c Oxidase Assembly Factor SCO2
- SCRIB Gene
- SCYL1 Gene
- SDHA Gene - Succinate Dehydrogenase Complex Subunit A
- SDHAF2 - Succinate Dehydrogenase Assembly Factor 2
- SDHB Gene
- SDHC Gene
- SEC22B Gene
- SEC61A1 - Sec61 Translocon Alpha 1
- SEC61G Gene
- SEL1L - SEL1L E3 Ubiquitin Protein Ligase
- SEM1 Gene
- SEMA3A Gene
- SEMA3F Gene
- Senataxin and transcriptional regulation
- SENP1 — SUMO Specific Peptidase 1
- SENP2 — SUMO Specific Peptidase 2
- SEPT2 — Septin 2
- SEPT7 — Septin 7
- SEPT9 — Septin 9
- Septin 4
- SEPTIN10 Gene
- SEPTIN11 Gene
- SEPTIN14 — Septin 14
- SEPTIN2 Gene
- SEPTIN5 — Septin 5
- SEPTIN6 Gene
- SEPTIN8 Gene
- SERPINA1 Gene
- SERPINA3 Gene — Alpha-1 Antichymotrypsin in Neurodegeneration
- SERPINE1 Gene
- SESN1 Gene
- SESN2 Gene
- SESN3 Gene
- SETD1B
- SETD2 — SET Domain Containing 2
- SETDB1
- SETX Gene
- Sex-specific effects of CD14 on Alzheimer's disease pathogenesis
- SFN Gene
- SFPQ Gene
- SGCE — Sarcoglycan Epsilon
- SGK1 Gene
- SGK2 Gene
- SGK3 - Serum/Glucocorticoid Regulated Kinase 3
- SGSH Gene
- SGSM1
- SGSM2
- SHANK1 — SH3 and Multiple Ankyrin Repeat Domains 3
- SHANK2 Gene
- SHANK3 - SH3 and Multiple Ankyrin Repeat Domains 3
- SHARPIN — SHANK Associated RH Domain Interactor
- SHH — Sonic Hedgehog
- SHRM3 — Shroom Family Member 3
- Siglec-dependent microglial dysfunction in neurodegenerative disease
- SIGLEC1 Gene
- SIGLEC10 — Sialic Acid Binding Ig-Like Lectin 10
- SIGLEC3 Gene (CD33)
- SIGLEC9 — Sialic Acid Binding Ig-Like Lectin 9
- SIGMA1 Gene
- SIGMAR1 Gene
- SIGMAR1 Gene
- SIL1 Gene
- Single-cell analysis of SEPT4 in substantia nigra
- Single-cell transcriptomics reveals LMX1B-expressing neurons in Parkinson's disease substantia nigra
- SIRPA Gene
- SIRT1 Gene
- SIRT2 Gene
- SIRT3 - Sirtuin 3
- SIRT4 Gene
- SIRT5 - Sirtuin 5
- SIRT6 Gene
- SIRT7 Gene
- SIVA1 — SIVA Apoptosis-Inducing Factor
- SIX1 Gene
- SLC transporters in neurological disease
- SLC11A1
- SLC11A2 Gene
- SLC12A1 Gene
- SLC12A2 — Solute Carrier Family 12 Member 2 (Na-K-2Cl Co-transporter 2)
- SLC12A5 — Solute Carrier Family 12 Member 5 (KCC2)
- SLC13A1 — Solute Carrier Family 13 Member 1 (Na+-dependent sulfate transporter)
- SLC13A2 — Solute Carrier Family 13 Member 2 (Na+-dependent citrate transporter)
- SLC15A1 — Solute Carrier Family 15 Member 1 (Peptide Transporter 1)
- SLC15A2 — Solute Carrier Family 15 Member 2 (Peptide Transporter 2)
- SLC16A1 — Solute Carrier Family 16 Member 1 (Monocarboxylate Transporter 1)
- SLC16A2 Gene (MCT8)
- SLC17A1 — Solute Carrier Family 17 Member 1 (VGLUT1)
- SLC17A5 Gene
- SLC17A6 Gene
- slc17a7 Gene
- SLC18A1 Gene
- SLC18A2 Gene
- slc1a1 Gene
- SLC1A2 — Solute Carrier Family 1 Member 2 (EAAT2)
- slc1a3 Gene
- SLC1A4 Gene
- SLC1A6 Gene
- SLC1A7 Gene
- SLC22A3 — Solute Carrier Family 22 Member 3 (OCT3)
- SLC22A4 — Solute Carrier Family 22 Member 4 (OCTN1)
- SLC22A6 — Solute Carrier Family 22 Member 6 (OAT1)
- SLC24A1 — Solute Carrier Family 2 Member 4A1 (SLC24A1)
- SLC24A2 — Solute Carrier Family 2 Member 4A2 (SLC24A2)
- SLC24A4 Gene - Solute Carrier Family 24 Member 4
- SLC25A10 Gene
- SLC25A12 Gene
- SLC25A13 Gene
- SLC25A20 mutations and metabolic disease (2011)
- SLC25A4 Gene
- SLC25A4 Gene
- SLC25A41 Gene
- SLC2A1 Gene
- SLC2A2 Gene
- SLC2A3 Gene
- SLC2A4 Gene
- SLC2A5 Gene
- SLC30A1
- SLC30A10 - Zinc Transporter 10
- SLC30A10 Gene - Manganese Efflux Transporter
- SLC30A3 — Solute Carrier Family 30 Member 3 (ZnT3)
- SLC30A4 — Zinc Transporter 4
- SLC30A5 — Solute Carrier Family 3 Member 0A5 (SLC30A5)
- SLC30A6 — Solute Carrier Family 3 Member 0A6 (SLC30A6)
- SLC30A7 — Solute Carrier Family 3 Member 0A7 (SLC30A7)
- SLC30A9 — Solute Carrier Family 3 Member 0A9 (SLC30A9)
- SLC31A1 — Solute Carrier Family 3 Member 1A1 (SLC31A1)
- SLC31A2 — Solute Carrier Family 3 Member 1A2 (SLC31A2)
- SLC33A1 — Solute Carrier Family 3 Member 3A1 (SLC33A1)
- SLC34A2 — Solute Carrier Family 3 Member 4A2 (SLC34A2)
- SLC34A3 — Sodium-Phosphate Transporter 3
- SLC39A1 — Solute Carrier Family 39 Member 1
- SLC39A10 — Solute Carrier Family 39 Member 10
- SLC39A12 — Solute Carrier Family 39 Member 12 (ZIP12)
- SLC39A13 — Solute Carrier Family 39 Member 13
- SLC39A14 — Solute Carrier Family 39 Member 14 (Zip14)
- SLC39A2 — Solute Carrier Family 39 Member 2
- SLC39A3 — Solute Carrier Family 39 Member 3
- SLC39A6 — Solute Carrier Family 39 Member 6
- SLC39A7 — Solute Carrier Family 39 Member 7
- SLC39A8
- SLC39A9 Gene
- SLC40A1 Gene
- SLC41A1 — Solute Carrier Family 41 Member 1
- SLC4A1 — Solute Carrier Family 4 Member 1 (Anion Exchanger 1)
- SLC5A1 (Sodium/Glucose Cotransporter 1)
- SLC6A1 Gene
- SLC6A12 Gene
- SLC6A14 Gene
- SLC6A2 — Norepinephrine Transporter
- SLC6A3 Gene
- SLC6A4 Gene — Serotonin Transporter
- SLC6A5 Gene
- SLC6A8 Gene
- SLC6A9 Gene
- SLC7A1 Gene
- SLC7A11 Gene - xCT Cystine/Glutamate Antiporter
- SLC7A2 — Solute Carrier Family 7 Member 2 ( cationic amino acid transporter 2)
- SLC7A3 — Cationic Amino Acid Transporter 3
- SLC9A1 — Sodium/Hydrogen Exchanger 1
- SLC9A2 — Solute Carrier Family 9 Member 2 (Na+/H+ Exchanger 2)
- SLC9A3 — Solute Carrier Family 9 Member 3 (Na+/H+ Exchanger 3)
- SLC9A7 — Solute Carrier Family 9 Member A7
- SLCO2A1 - Solute Carrier Organic Anion Transporter Family Member 2A1
- SLIT1 Gene - Slit Guidance Ligand 1
- SLIT2 — Slit Guidance Ligand 2
- SMAC Gene
- SMAD1 Gene
- SMAD2 Gene
- SMAD3 — SMAD Family Member 3
- SMAD4 — SMAD Family Member 4
- SMAD5 — SMAD Family Member 5
- SMAD6 — SMAD Family Member 6
- SMAD7 Gene
- SMAD9 — SMAD Family Member 9
- Small molecule chaperone activators for neurodegeneration
- Small molecule retromer stabilizers for neurodegenerative disease treatment
- Small molecule therapies for MPS
- SMARCA2 (BRM)
- SMARCA4
- SMARCAL1
- SMARCB1 — SWI/SNF Related Matrix Associated Actin Dependent Regulator of Chromatin Subfamily B Member 1
- SMC complexes in genome organization
- SMC1A
- SMC3 - Structural Maintenance of Chromosomes 3
- SMCR8 Gene
- SMN1 - Survival Motor Neuron 1
- SMN2 Gene
- SMNDC1 Gene
- SMO — Smoothened, Frizzled Class Receptor
- SMPD1 Gene - Acid Sphingomyelinase
- SNAP23 Gene
- SNAP25 Gene - Synaptosomal-Associated Protein 25
- SNAP29 — Synaptosomal-Associated Protein 29
- SNAP91 Gene
- SNAPIN
- SNCA — Alpha-Synuclein
- SNCAIP Gene
- SNCB Gene
- SNCB Gene
- SNCG Gene — Gamma-Synuclein
- SNPH Gene
- SNRNP200 (Small Nuclear Ribonucleoprotein 200)
- SNRNP70 Gene
- SNRPA — Small Nuclear Ribonucleoprotein Polypeptide A
- SNRPA1 — Small Nuclear Ribonucleoprotein Polypeptide A1
- SNRPB — Small Nuclear Ribonucleoprotein Polypeptide B
- SNX3 — Sorting Nexin 3
- SOBP Gene
- SOCS1 and astrocyte-mediated neuroinflammation
- SOCS3 - Suppressor of Cytokine Signaling 3
- SOCS4 — Suppressor of Cytokine Signaling 4
- SOD2 Gene
- SOD3 overexpression in AD models (2021)
- SORCS1 Gene
- SORCS2 Gene
- SORCS3 Gene
- SORL1 Gene
- SORLA Gene
- SORT1 Gene
- SOX1 Gene
- SOX10 Gene
- SOX11 — SRY-Box Transcription Factor 11
- SOX2
- SOX6 — SRY-Box Transcription Factor 6
- SOX9 Gene
- SP1 (Specificity Protein 1)
- SP3 — Specificity Protein 3
- SPART — Spartin
- SPAST
- SPATA5 Gene
- SPG11 Gene - Spastic Paraplegia 11
- SPG15 Gene - Spastic Paraplegia 15
- SPG20 Gene
- SPG21 Gene
- SPG26 Gene - Bile Acid CoA: Amino Acid N-Acyltransferase
- SPG30 Gene
- SPG35 Gene
- SPG48 (AP5Z1) Gene
- SPG7 — Spastic Paraplegia 7 (Paraplegin)
- SPHK1 — Sphingosine Kinase 1
- SPI1 Gene - PU.1
- Splicing factor dysregulation in dementia with Lewy bodies. Neurobiol Aging. 2024
- SPP1 Gene
- SPPL2A Gene
- SPR Gene
- SPTBN2 Gene
- SPTLC1 - Serine Palmitoyltransferase
- SPTLC2 Gene
- SQSTM1 — Sequestosome 1 (p62)
- SREBF1 Gene
- SREBF2 — Sterol Regulatory Element Binding Transcription Factor 2
- SRP19 - Signal Recognition Particle 19
- SRR — Serine Racemase
- SRRM2 — Serine/Arginine Repetitive Matrix 2
- SRSF1
- SRSF2 Gene
- SRSF3 Gene
- SRSF5 — Serine/Arginine Rich Splicing Factor 5
- SS18L1 (CREST) (SS18L1)
- SSBP1 Gene
- SST Gene
- STAB1 Gene
- STAM1 - Signal Transducing Adaptor Molecule 1
- STAM2 Gene - Signal Transducing Adaptor Molecule 2
- STAR — Steroidogenic Acute Regulatory Protein
- STAT1 Gene - Signal Transducer and Activator of Transcription 1
- STAT2 Gene - Signal Transducer and Activator of Transcription 2
- STAT3 Gene
- STAT4 Gene
- STAT5A Gene
- STAT5B Gene
- STAT6 — Signal Transducer and Activator of Transcription 6
- STATHMIN Gene
- STAU2 Gene
- STEX Gene
- STIM1 and synaptic plasticity in learning (2019)
- STIM2 Gene
- STING Gene
- STING1 Gene
- STIP1 Gene
- STK11 - Serine/Threonine Kinase 11
- STK24 Gene
- STK25 Gene
- STK3
- STK4 — Serine/Threonine Kinase 4
- STMN1 — Stathmin 1
- STMN2 Gene
- STRADA Gene
- STRAP — Serine Threonine Kinase Receptor Associated Protein
- STUB1 — CHIP
- STX10 — Syntaxin 10
- STX11 Gene
- STX12 - Syntaxin 12
- STX16 - Syntaxin 16
- STX17 Gene
- STX18 - Syntaxin 18
- STX1A Gene - Syntaxin-1A
- STX1B — Syntaxin-1B
- STX2 — Syntaxin 2
- STX3 Gene
- STX4 — Syntaxin-4
- STX5 Gene
- STX6 Gene
- STX7 - Syntaxin 7
- STX8 Gene
- STXBP1 — Syntaxin Binding Protein 1
- STXBP2 mutations in familial hemophagocytic lymphohistiocytosis type 2
- STXBP2 — Syntaxin Binding Protein 2
- STXBP4 Gene
- STXBP5 — Syntaxin Binding Protein 5
- SUCLA2 Gene
- SUCLG1 — Succinate-CoA Ligase GDP Forming Subunit Alpha
- SUFU — Suppressor of Fused, Hedgehog Pathway Regulator
- SUMF1 - Sulfatase Modifying Factor 1
- SUMF1 Gene
- SUMF2 — Sulfatase Modifying Factor 2
- SUMO1 — Small Ubiquitin-Like Modifier 1
- SUMO2 — Small Ubiquitin-Like Modifier 2
- Sun, Liu, Li, Li, Zhang. Revealing Causal Protein Biomarkers and Potential Therapeutic Targets for Histologic-Specific Lung Cancer.. **. 2025
- SURF2 — SURF2 Homolog
- SURF4 — SURF4 Homolog
- SURF6 — SURF6 Homolog
- SUV39H1
- SUV39H2
- SUZ12
- Suzuki M, et al. C3G and alpha-synuclein aggregation. Acta Neuropathol (2023)
- SV2A — Synaptic Vesicle Protein 2A
- SV2B Gene
- SV2C Gene
- SYK Gene
- SYN1 (Synapsin-1)
- SYN1 Gene
- SYN1 Gene — Synapsin I
- SYN2 Gene
- SYN3 — Synapsin III
- Synapsin and neurotransmitter release kinetics (2012)
- SYNAPTOGENIN — Synaptogyrin Family
- SYNE1
- SYNE2 Gene
- SYNGAP1 — Synaptic Ras GTPase Activating Protein 1
- SYNGR1 Gene
- SYNGR3 Gene
- SYNJ1 — Synaptojanin 1
- SYNJ2 Gene
- SYNPO Gene
- SYNPO2 — Synaptopodin 2
- SYNPR Gene
- SYP Gene
- SYT1 (Synaptotagmin-1)
- SYT1 — Synaptotagmin 1
- SYT11 Gene
- SYT14 - Synaptotagmin 14
- SYT2 Gene
- SYT3 Gene
- SYT4 — Synaptotagmin
- SYT5 in amyotrophic lateral sclerosis
- SYT6 (Synaptotagmin 6)
- SYT7 Gene
- SYT9 Gene
- TAAR1 — Trace Amine-Associated Receptor 1
- TAAR5 — Trace Amine-Associated Receptor 5
- TAAR6 Gene
- TAB1 — TAK1-Binding Protein 1
- TAB2 Gene
- TAB3 Gene
- TAC1 Gene
- TACI Gene (TNFRSF13B)
- TACR1 — Tachykinin Receptor 1
- TAF15 Gene
- TAK1 Gene
- TALDO1 Gene
- TAOK1 Gene
- TAOK2 Gene
- TARDBP mutations in ALS
- TARDBP — TAR DNA Binding Protein 43
- Targeting astrocyte-neuron metabolic coupling in neurodegenerative diseases
- Targeting calcineurin signaling in Alzheimer's disease therapy
- Targeting DNA repair for neurodegeneration
- Targeting eIF4E in neurodegenerative disease
- Targeting ERRgamma for neurodegenerative disease therapy
- Targeting FIH-1 in neurodegenerative disease
- Targeting histone acetylation for the treatment of neurodegenerative diseases: novel insights and therapeutic potential
- Targeting histone demethylases in neurodegenerative diseases
- Targeting HSPB2 for neurodegenerative disease therapy
- Targeting IKK/NF-κB axis in neurodegenerative diseases
- Targeting KCNH6 for treating gastric emptying disorders
- Targeting NOXA for neuroprotection in AD and PD
- Targeting NRP1 for neurodegenerative disease therapy: current status and future directions
- Targeting PDK4 in neurodegenerative models
- Targeting peroxisomes for neurodegenerative disease therapy
- Targeting PI3K signaling in Alzheimer's disease
- Targeting PP1 for Alzheimer's disease treatment: opportunities and challenges
- Targeting ribosomal dysfunction in neurodegenerative diseases
- Targeting Slack channels in neurodegenerative disease
- Targeting β3-AR as a therapeutic strategy for neurodegenerative diseases
- TARS1 — Threonyl-tRNA Synthetase 1
- TAX1BP1 Gene
- TBC1D24 Gene
- TBK1 Gene
- TBK1 — TANK Binding Kinase 1
- TBL2 Gene
- TBP - TATA-Box Binding Protein
- TBX1 haploinsufficiency and neurocognitive phenotype
- TBX2 — T-Box Transcription Factor 2
- TBX3 Gene
- TCF3
- TCF4 Gene
- TCF4 Gene
- TCF7L2 (Transcription Factor 7-Like 2)
- TDP-43 pathology in ALS and its implications for therapeutic strategies
- TDP1 Gene
- TDP2 — Tyrosyl-DNA Phosphodiesterase 2
- TEAD1 — TEA Domain Transcription Factor 1
- Tectonin Beta-Propeller Repeat Containing 2
- TERC Gene
- TERT Gene
- TERT Gene
- TET1 Gene
- TET2 Gene
- TET3 Gene
- Tetrahydrobiopterin metabolism in aging brain
- TF
- TFAM Gene
- TFAP4 — Transcription Factor AP-4
- TFB1M — Mitochondrial Transcription Factor B1
- TFB2M — Mitochondrial Transcription Factor B2
- TFE3 Gene
- TFEB
- TFG Gene
- TFIIH in neuronal function and disease
- TFR1 Gene
- TFRC
- TGFB1 — Transforming Growth Factor Beta 1
- TGFB2 Gene
- TGFB3 Gene
- TGFBI
- TGFBR1 — TGF-beta Receptor 1
- TGFBR1 — Transforming Growth Factor Beta Receptor 1
- TGFBR2 (Transforming Growth Factor Beta Receptor 2)
- TGFBR2 — Transforming Growth Factor Beta Receptor 2
- TGM2 — Transglutaminase 2
- TGM6 Gene
- TH Gene
- THAP1 Gene
- THBS4 Gene
- The distribution of dopamine receptors in the primate brain
- The eIF2α/ATF4 pathway is essential for stress-induced translation regulation
- The influence of dopamine receptor D4 gene polymorphism on cognitive function in early Parkinson's disease
- The neuroprotective effect of CGRP in Alzheimer's disease models is mediated via RAMP1/RAMP2 signaling
- The role of DNAJB proteins in protein homeostasis
- The role of Nrf2 in antioxidant response in neurodegeneration
- The role of P2X7 in Alzheimer's disease: from pathogenesis to therapeutic targeting
- The role of ROBO3 in neural crest cell development
- Therapeutic approaches for SCA6
- Therapeutic approaches to neurodegeneration
- Therapeutic targeting of delta glutamate receptors
- Therapeutic targeting of MAP3K2 in neurodegeneration
- Therapeutic targeting of selenoprotein pathways (2024)
- TIA1 - TIA1 Cytotoxic Granule Associated RNA Binding Protein
- TIA1L (TIA1 Cytotoxic Granule-Associated RNA Binding Protein-Like)
- TIAL1 — TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1
- TIC1 Gene
- TID1 Gene
- TIGAR - TP53-Induced Glycolysis and Apoptosis Regulator
- TIGAR Gene — TP53-Induced Glycolysis and Apoptosis Regulator
- TIGD2 Gene
- TIMD4 Gene (T Cell Immunoglobulin and Mucin Domain Containing 4)
- TIMM10 — Mitochondrial Import Inner Membrane Translocase Subunit Tim10
- TIMM10B (Translocase of Inner Mitochondrial Membrane 10 Homolog B)
- TIMM13 Gene
- TIMM23 — Translocase of Inner Mitochondrial Membrane 23
- TIMM50 Gene - Mitochondrial Import Protein
- TIMM8B Gene - Mitochondrial Import Protein
- TIMM9
- TIMMDC1 — Translocase of Inner Mitochondrial Membrane Domain Containing 1
- TIMP1 Gene
- TINF2 Gene
- TIRAP — TIR Domain-Containing Adaptor Protein
- TK2 Gene
- TKT Gene
- TLR1 Gene
- TLR10 Gene
- TLR2 — Toll-Like Receptor 2
- TLR3 — Toll-Like Receptor 3
- TLR4 Gene
- TLR5 Gene
- TLR6 Gene
- TLR7 Gene
- TLR8 Gene
- TLR9 — Toll-Like Receptor 9
- TMBIM6 Gene
- TMEM106B — Transmembrane Protein 106B
- TMEM119 — Transmembrane Protein 119
- TMEM135 Gene
- TMEM16 family in apoptotic cell clearance
- TMEM163 Gene
- TMEM163 — Transmembrane Protein 163
- TMEM173 (STING)
- TMEM175 Gene
- TMEM199 Gene
- TMEM229B Gene
- TMEM237 — Transmembrane Protein 237
- TMEM43
- TMEM57 Gene
- TMEM59 Gene
- TMEM65 Gene
- TMEM71 — Transmembrane Protein 71
- TNC Gene
- TNF - Tumor Necrosis Factor
- TNF Gene
- TNFAIP1 — TNF Alpha Induced Protein 1
- TNFAIP6 — TNF Alpha Induced Protein 6
- TNFAIP8 — TNF Alpha Induced Protein 8
- TNFAIP8L1 — TNF Alpha Induced Protein 8 Like 1
- TNFRSF1A Gene
- TNFRSF1A Gene
- TNFRSF1B Gene
- TNFRSF1B Gene
- TNFRSF21 Gene
- TNFSF12 Gene (TWEAK)
- TNKS Gene
- TNKS2 Gene
- TNN Gene
- TNR Gene — Tenascin R
- TOLLIP — Toll-Interacting Protein
- TOMM20 — Translocase of Outer Mitochondrial Membrane 20
- TOMM40 Gene
- TOMM40L — Translocase of Outer Mitochondrial Membrane 40 Like
- TOMM70
- TOR1A Gene
- TP53 Gene
- TPH2 — Tryptophan Hydroxylase 2
- TPM1 — Tropomyosin 1
- TPM3 Gene
- TPP1 Gene - Tripeptidyl Peptidase 1
- TPPP Gene
- TPR — Translocated Promoter Region
- TPX2
- TRA2B — Transformer 2 Beta Homolog
- TRADD Gene
- TRAF2 Gene
- TRAF3
- TRAF6 Gene
- TRAIL Gene (TNFSF10)
- Transdiagnostic Proteomic Changes in Neurodegeneration
- Translation dysregulation in AD
- TREH — Trehalase
- TREM1 — Triggering Receptor Expressed on Myeloid Cells 1
- TREM2 — Triggering Receptor Expressed on Myeloid Cells 2
- TREML2 — Triggering Receptor Expressed on Myeloid Cells-Like 2
- TREX1 — Three Prime Repair Exonuclease 1
- Triggering Receptor Expressed on Myeloid Cells 3 (TREM3)
- TRIM11 Gene
- TRIM16 — Tripartite Motif-Containing Protein 16
- TRIM17 Gene
- TRIM20 Gene
- TRIM24 — Tripartite Motif Containing 24
- TRIM25 Gene (Tripartite Motif Containing 25)
- TRIM3
- TRIM32 Gene
- TRIM32 Gene
- TRIM37 — Tripartite Motif Containing 37
- TRIM46 Gene
- TRIM55 Gene
- TRIM63 Gene
- TRIM9 Gene
- TRKA Gene
- TRKB Gene
- TRKC Gene
- TRMU Gene
- Tropomyosin in neuronal survival
- TRPA1 Gene
- TRPC1 Gene
- TRPC3 Gene
- TRPC4
- TRPC5
- TRPC6 Gene
- TRPC7
- TRPM1 Gene
- TRPM2 - Transient Receptor Potential Melastatin 2
- TRPM3 Gene - Transient Receptor Potential Channel
- TRPM4 Gene
- TRPM5 — Transient Receptor Potential Cation Channel Subfamily M Member 5
- TRPM6 — Transient Receptor Potential Cation Channel Subfamily M Member 6
- TRPM7 Gene
- TRPM8 — Transient Receptor Potential Cation Channel Subfamily M Member 8
- TRPV1 Gene
- TRPV3 Gene
- TRPV4 Gene
- TRPV5
- TRPV6
- TSC1 — Tuberous Sclerosis Complex 1
- TSC2 — Tuberous Sclerosis Complex 2
- TTBK2 Gene
- TTR — Transthyretin
- TUBA1A — Tubulin Alpha 1A
- TUBB — Tubulin Beta Class I
- TUBB1 — Tubulin Beta 1
- TUBB2A — Tubulin Beta 2A Class IIa
- TUBB2B — Tubulin Beta 2B Class IIb
- TUBB3 Gene
- TUBB4A — Tubulin Beta 4A Class IVa
- TUBB4B - Tubulin Beta 4B Class IIa
- TUBB6 Gene
- TUBG1 — Tubulin Gamma 1
- TUFM and cellular stress responses
- TWNK Gene
- TWNK Gene
- TXN — Thioredoxin
- TXN2 — Thioredoxin 2
- TXNDC5 — Thioredoxin Domain Containing 5
- TXNIP inhibition for diabetes
- TXNRD1 — Thioredoxin Reductase 1
- TYDP1 — Tyrosyl-DNA Phosphodiesterase 1
- TYK2 — Tyrosine Kinase 2
- TYMP Gene
- TYNDASE — Tyndall
- TYRO3 - TYRO3 Receptor Tyrosine Kinase
- TYROBP — TYRO Binding Protein (DAP12)
- TYW5 Gene
- UBA1 Gene
- UBB — Ubiquitin B
- UBC
- UBE2A Gene
- UBE2B - Gene
- UBE2B Gene — Ubiquitin-Conjugating Enzyme E2 B
- UBE2D1
- UBE2I — SUMO-Conjugating Enzyme
- UBE2K Gene
- UBE2N
- UBE2V1 Gene (UEV-1)
- UBE2V2
- UBE3A Gene
- Ubiquitin-proteasome system in neurodegeneration
- UBQLN3 — Ubiquilin 3
- UBQLN4 Gene
- UBR4 — Ubiquitin Protein Ligase E3 Component N-Recognin 4
- UBR5 - Ubiquitin-Protein Ligase E3 Component N-Recognin 5
- UBX proteins: from mechanism to therapy (2025)
- UBXD1 Gene
- UBXD3
- UBXD4
- UCHL1 Gene
- UCHL3 Gene
- UCHL5 - Ubiquitin C-Terminal Hydrolase L5
- UCP2 — Uncoupling Protein 2
- UCP3 Gene
- UCP4 Gene
- UFM1 — Ubiquitin-like Modifier 1
- UGCG Gene
- UGDH — UDP-Glucose 6-Dehydrogenase
- UHRF1 Gene
- ULF1 Gene
- ULK1 — UNC-51 Like Kinase 1
- ULK2 Gene
- ULK3 Gene
- ULK4 Gene
- ULK4 Gene - Unc-51 Like Kinase 4
- ULKL1 (ULK5) Gene
- UNC13B — UNC13 Homolog B (Munc13-2)
- UNC5A — UNC-5 Netrin Receptor A
- UNC5B Gene
- UNC5B — Netrin-1 Receptor
- UNC5C — Unc-5 Netrin Receptor C
- UNC5D methylation in neuropsychiatric disease (2024)
- UNG Gene
- UniProt Q8N4L2 — Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase
- UQCRB
- UQCRFS1 Gene
- UQCRQ
- UROCORTIN Gene
- USF1 — Upstream Transcription Factor 1
- USF2 — Upstream Transcription Factor 2
- USH1C Gene
- USH2A Gene
- USP14 Gene
- USP24 Gene
- USP30 — Ubiquitin Specific Peptidase 30
- USP34
- USP7 Gene
- UVRAG Gene
- VAMP1 Gene
- VAMP2 Gene - Synaptobrevin-2
- VAMP3 Gene
- VAMP4 Gene
- VAMP6 Gene
- VAMP7 Gene
- VAMP8 — Vesicle Associated Membrane Protein 8
- VAPB (VAMP-Associated Protein B)
- VASP (Vasodilator-Stimulated Phosphoprotein)
- VCP — Valosin-Containing Protein
- VCX Gene
- VDAC1 — Voltage Dependent Anion Channel 1
- VDAC2 — Voltage-Dependent Anion Channel 2
- VEGF (Vascular Endothelial Growth Factor)
- VEGFA — Vascular Endothelial Growth Factor A
- VEGFB Gene
- VFRM Gene
- VGF — VGF Nerve Growth Factor Inducible
- VGLUT1 Gene
- VGLUT2 Gene
- VGLUT3 Gene
- VHL Gene
- VIM Gene
- Vitamin D supplementation and motor outcomes in Parkinson's disease: a meta-analysis
- VKORC1L1 Gene - Vitamin K Epoxide Reductase Complex Subunit 1-Like 1
- VMAT2 Gene
- VPS11 — Vacuolar Protein Sorting 11
- VPS13A
- VPS13C Gene
- VPS13C Gene - Vacuolar Protein Sorting 13 Homolog C
- VPS13D Gene
- VPS16 Gene
- VPS18 Gene
- VPS29 Gene
- VPS33A Gene
- VPS33B Gene
- VPS35 — Vacuolar Protein Sorting 35 Homolog
- VPS37B Gene
- VPS37C Gene
- VPS41 Gene
- VPS45 — Vacuolar Protein Sorting 45 Homolog
- VPS4A — Vacuolar Protein Sorting 4 Homolog A
- VPS51 Gene
- VPS53
- VPS54 Gene
- VPS8 Gene
- VRK1 — Vaccinia-Related Kinase 1
- VTI1A Gene
- VTI1A — Vesicle Transport through Interaction with Tethering Factor 1A
- WARS1
- WASHC1 — WASH Complex Subunit 1
- WDFY3 Gene
- WDPCP (WD Repeat Containing Polypeptide)
- WDR41 Gene
- WDR43 Gene
- WDR45 - WD Repeat Domain 45
- WDR45B — WD Repeat Domain 45B
- WDR45L Gene
- WDR7 — WD Repeat Domain 7
- WDR73 Gene
- WDR81 — WD Repeat Domain 81
- WEE1 Gene
- WFS1 — Wolfram Syndrome 1
- WHRN Gene
- WIF1 Gene - Wnt Inhibitory Factor
- WIPI1 Gene
- WIPI2 - WD Repeat Domain, Phosphoinositide Interacting 2
- WIPI3 Gene
- WIPI4 Gene
- Wnt signaling in the vertebrate central nervous system
- WNT1 Gene
- WNT10A Gene
- WNT10B Gene
- WNT11 Gene
- WNT16 Gene
- WNT2 Gene
- WNT2B Gene - Wnt Family Member 2B
- WNT3 Gene
- WNT3A Gene
- WNT4 Gene
- WNT5A Gene
- WNT5B Gene
- WNT6 — Wnt Family Member 6
- WNT7A Gene
- WNT7B Gene - Wnt Family Member 7B
- WNT8A Gene
- WNT8B Gene
- WNT9A — Wnt Family Member 9A
- WNT9B Gene
- WRN — Werner Syndrome RecQ Like Helicase
- WWOX and autophagy in neurodegeneration
- WWTR1 (TAZ) — WW Domain Containing Transcription Regulator 1, Hippo Effector
- X-linked SBMA
- XCL1 — X-C Motif Chemokine Ligand 1
- XIAP
- XK Gene
- XLF
- XPA Gene
- XPC — Xeroderma Pigmentosum Complementation Group C
- XPF Gene
- XPO1 Gene
- XRCC1 Gene
- XRCC2 — X-Ray Repair Cross-Complementing 2
- XRCC3
- XRCC4
- XRCC5 Gene
- XRCC6 Gene
- XRCC7 (DNA-PKcs) - DNA-Dependent Protein Kinase Catalytic Subunit
- YAP1 — Yes-Associated Protein 1
- YARS2 — Tyrosyl-tRNA Synthetase 2, Mitochondrial
- YBX1 Gene
- YES1 — YES Proto-Oncogene 1, Src Family Tyrosine Kinase
- YME1L1 Gene
- YWHAB Gene
- YWHAE Gene
- YWHAG Gene
- YWHAH Gene — 14-3-3 Eta (η) Protein
- YWHAZ Gene
- YY1 — Yin Yang 1
- ZAP70 — Zeta Chain T-Cell Receptor Associated Protein Kinase 70
- ZBP1 (Z-DNA Binding Protein 1)
- ZC3HAV1 Gene
- ZCCHC10 — Zinc Finger CCHC-Type Containing 10
- ZCCHC17 — Zinc Finger CCHC-Type Containing 17
- ZCWPW1 — Zinc Finger CW-Type and PWWP Domain
- ZDHHC12 (Zinc Finger DHHC-Type Containing 12)
- ZDHHC13 variants in autism spectrum disorder
- ZDHHC14 — Zinc Finger DHHC-Type Containing 14
- ZDHHC8 — Zinc Finger DHHC-Type Palmitoyltransferase 8
- ZDHHC9 Gene (Zinc Finger DHHC-Type Containing 9)
- ZFP36L2 — Zinc Finger Protein L2
- ZFP57 — Zinc Finger Protein 57
- ZFYVE19 — Zinc Finger FYVE Domain Containing 19
- ZFYVE26 Gene
- Zinc in synaptic plasticity and memory
- Zinc supplementation and cognition (2011)
- ZIP11 and cellular zinc metabolism
- ZIP5 in embryonic development
- ZNF512B Gene
- ZNF655 Gene - Zinc Finger Protein 655
- ZNF7 - Zinc Finger Protein 7
- ZNF746 Gene
- ZNRNP1 — Zinc Finger, RNGTT Type 1
- ZPR1 Gene
- ZRANB3 — Zinc Finger RanBP2-Type Containing 3
- ''- Beta-Secretase 1 (BACE1/proteins/bace1-protein''
- ''Lysosomal calcium dysregulation in neurodegeneration (2023)''
- ''PMID:4444^5: - "Mitochondrial''
- '- excitotoxicity — Can trigger calpain-mediated p25 generatio'
- '- Homer1 in synaptic organization and neurological disorders'
- '- Veli proteins in neurological diseases'
- 'AlzForum: PSEN2 Mutations'
- 'ALZFORUM: QRL-201'
- 'Brain penetrant PHD inhibitors'
- 'Genetic mutations in Parkinson's disease: screening of a selected population from North-Eastern Italy'
- 'GNAS mutations and disease'
- 'GRP94: function and disease relevance (2012)'
- (2011). Akt-mediated effects of BDNF on GABAergic synapses in Huntington's disease. Neurobiology of Aging, 32(12), 2136-2144. DOI:10.1016/j.neurobiolaging.2010.06.012
- (2021). ATG16L1 deficiency in microglia induces neuroinflammation and neuronal dysfunction. Proc Natl Acad Sci USA 118(34):e2107827118. PMID:34446695
- (2021). Discovery of brain-penetrant protein tyrosine phosphatase 1B inhibitors for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry, 213, 113267. DOI:10.1016/j.ejmech.2021.113267
- (2024) AMBRA1 phosphorylation status as biomarker for neurodegenerative disease progression
- 10.1016/j.cell.2015.06.044
- 10.1016/j.kint.2017.06.014
- 10.7554/eLife.00498
- 14-3-3 Proteins — Adapter and Scaffold Proteins
- 26S Proteasome
- 3-Phosphoinositide Dependent Protein Kinase 1
- 3R-Tau Protein
- 4E-BP1 Protein
- 4R-Tau Protein
- 5-HT1A Receptor Protein
- 5-HT1B Receptor Protein
- 5-HT1E Receptor Protein
- 5-HT2A Receptor
- 5-HT2A Receptor Protein
- 5-HT2C Receptor
- 5-HT2C Receptor Protein
- 5-HT4 Receptor Protein
- 5-HT5A receptor genetic variants and neuropsychiatric disorders
- 5-Hydroxytryptamine Receptor 1F (5-HT1F)
- <a href=" G protein-coupled receptor kinases (1998)
- A-Raf Protein
- A2A Adenosine Receptor Protein
- A2M Protein
- ABCA1 and cholesterol efflux in neurons
- ABCA1 Protein
- ABCA2 Protein
- ABCA4 mutations and retinal degeneration: mechanisms and therapies
- ABCA7 Protein
- ABCB1 Protein (P-glycoprotein)
- ABCD1 mutations and genotype-phenotype correlation
- ABCD2 Protein
- ABCD3 Protein
- ABCG1 Protein
- ABCG2 Protein
- ABCG4 Protein
- ABHD12 Protein - Alpha/Beta Hydrolase Domain Containing 12
- ABI3 Protein
- ABIN1 Protein
- ABL1 Protein (ABL1 Tyrosine Kinase)
- ACAD9 Protein
- ACE Protein
- Acid Alpha-Mannosidase Protein
- Acid Sphingomyelinase (ASM) Protein
- ACSL1 Protein — Acyl-CoA Synthetase Long Chain Family Member 1
- ACSL4 Protein
- ACTB Protein
- Actinin Alpha 2 (ACTN2 Protein)
- Activating Transcription Factor 4 (ATF4)
- Activation of Wnt signaling and cognitive decline in Alzheimer's disease
- ACTN1 Protein
- ADAM10 Protein
- ADAM12 Protein
- ADAM15 Protein
- ADAM17 Protein
- ADAM19 Protein
- ADAM22 Protein
- ADAM23 Protein
- ADAM8 Protein
- ADAM9 Protein — Disintegrin and Metalloproteinase Domain 9
- ADAMTS-4 Protein
- ADAR Protein
- ADAR2 Protein
- ADARB1 Protein (Adenosine Deaminase Acting on RNA 1)
- ADCY1 Protein
- ADCY2 Protein — Adenylate Cyclase 2
- ADCY3 Protein — Adenylate Cyclase 3
- ADCY5 Protein — Adenylate Cyclase 5
- ADCY7 Protein — Adenylate Cyclase 7
- ADCY8 Protein
- ADCY9 Protein — Adenylate Cyclase 9
- Adenosine A1 Receptor Protein
- Adenosine A2a Receptor Protein
- Adenylate Cyclase 1 Protein
- Adenylate Cyclase 5 Protein
- Adenylate Cyclase 6 Protein
- ADGRV1 Protein (GPR98)
- ADH1C Protein
- ADNP Protein
- ADORA2B Protein
- adra2b Protein
- ADRB3 Protein — Adrenoceptor Beta 3
- AF-6/Afadin Protein
- AFG3L2 Protein
- AGER/RAGE Protein
- AGO2 Protein
- AHSA1 Protein
- AIF Protein
- AIFM1 Protein — Apoptosis-Inducing Factor
- AIM2 Protein
- AIM2 Protein — Absent in Melanoma 2
- AKT1 Protein
- AKT1 Protein (Protein Kinase B Alpha)
- AKT2 Protein
- AKT3 Protein
- ALDH1A1 Protein (Aldehyde Dehydrogenase 1A1)
- ALDH1A2 Protein
- ALDH1A3 Protein
- ALDH1L1 Protein
- ALDH2 Protein — Aldehyde Dehydrogenase 2
- ALK Protein
- ALKBH5 Protein (AlkB Homolog 5)
- ALOX15 Protein
- Alpha-1 Antitrypsin (SERPINA1)
- Alpha-1A Adrenergic Receptor
- Alpha-1A Adrenergic Receptor Protein
- Alpha-1D Adrenergic Receptor
- Alpha-1D Adrenergic Receptor Protein
- Alpha-2A Adrenergic Receptor Protein
- Alpha-2C Adrenergic Receptor Protein
- Alpha-2C Adrenergic Receptor Protein
- Alpha-Catenin Protein
- Alpha-Galactosidase A (GLA Protein)
- Alpha-Galactosidase A Protein
- Alpha-Internexin (INA)
- Alpha-Ketoglutarate Dehydrogenase Protein
- Alpha-L-iduronidase Protein
- alpha-SNAP Protein (NSF Attachment Protein Alpha)
- Alpha2-adrenergic modulation of microglial activation
- ALS2 Protein (Alsin)
- ALS2 regulates mitochondrial dynamics through Miro1 trafficking.
- ALS4 Protein (Alsin)
- ALS4 Protein (Alsine)
- Alsin Protein
- Alsin Protein (ALS2)
- ALSINC Protein - ALS IncRNA
- ALZFORUM Protein
- AMPA Receptor Protein
- AMPA Receptor Protein
- AMPA Receptor Protein
- AMPD2 Protein — Adenosine Monophosphate Deaminase 2
- Amphiphysin Protein
- AMPK Alpha
- AMPK Protein
- Amyloid-Beta (Aβ)
- Amyloid-beta Protein
- Androgen Receptor Protein
- ANG Protein
- ANG Protein (Angiogenin)
- ANG Protein (Angiogenin)
- Angiogenin Protein
- ANKRD1 Protein
- ANKRD11 Protein
- ANKRD11 Protein — Ankyrin Repeat Domain 11
- ANKRD16 Protein
- Ankyrin B Protein
- Ankyrin-1 Protein
- ANKZF1 Protein
- Annexin A11 Protein
- ANO3 and hyperexcitability in neurological disorders
- ANT1 Protein
- ANT2 Protein
- ANT3 Protein
- Anterior Pharynx Defective 1 (APH-1) Protein
- ANXA1 Protein — Annexin A1
- ANXA11 Protein — Annexin A11
- ANXA2 Protein — Annexin A2
- AP-2 Alpha-1 Protein
- AP-2 Beta-1 Protein
- AP2A1 Protein (Adaptor-Related Protein Complex 2 Alpha 1)
- AP2A2 Protein
- APAF-1 Protein
- APBB1 Protein
- APBB2 Protein
- APC Protein
- APC Protein
- APE2 Protein
- APEX1 Protein
- APEX2 Protein
- APH1A Protein
- APH1A Protein - Gamma-Secretase Subunit
- APH1B Protein - Anterior Pharynx Defective 1 Homolog B
- APLP1 Protein
- APLP2 Protein
- APOA1 Protein
- APOA2 Protein
- APOB Protein
- APOC2 Protein
- APOC3 Protein
- ApoE (Apolipoprotein E)
- ApoER2 Protein
- Apolipoprotein C-I
- Apolipoprotein C-II Protein
- Apolipoprotein C-III Protein
- Apolipoprotein D (ApoD) Protein
- Apolipoprotein E (ApoE)
- Apoptotic Protease Activating Factor 1 Protein
- APP Protein
- APPBP2 Protein
- AQP1 Protein
- AQP4 Protein
- AQP4 Protein — Aquaporin 4
- Aquaporin-4 Protein
- AR Protein
- ARC Protein
- ARF1 Protein
- ARG1 Protein
- Arginine Vasopressin (AVP)
- ARHGAP26 Protein
- ARHGEF2 Protein (LARG)
- ARHGEF6 Protein
- ARHGEF9 Protein
- ARID1A Protein
- ARPC1B Protein
- ARRB1 Protein — Arrestin Beta 1
- ARRB2 Protein — Arrestin Beta 2
- Artemin Protein
- Artemis Protein
- ARTN Protein — Artemin
- Arylsulfatase A Protein
- Arylsulfatase B Protein
- ASAH1 Protein
- ASCL1 Protein
- ASCT2 Protein (Alanine-Serine-Cysteine Transporter 2)
- ASO therapy neurodegenerative (2012)
- ASPM Protein
- ASTN1 Protein
- Astrocyte HO-1 in Alzheimer's disease
- ASXL1 Protein
- ASXL2 Protein
- Ataxin-1
- Ataxin-1 (ATXN1)
- Ataxin-1 Protein
- Ataxin-1 Protein
- Ataxin-1 Protein (ATXN1)
- Ataxin-10 Protein
- Ataxin-2
- Ataxin-2 (ATXN2)
- Ataxin-2 Protein
- Ataxin-2 Protein (ATXN2)
- Ataxin-3 (ATXN3)
- Ataxin-3 (Josephin)
- Ataxin-3 Protein
- Ataxin-3 Protein
- Ataxin-7
- Ataxin-7 (ATXN7)
- Ataxin-7 Protein
- Ataxin-7 Protein
- Ataxin-8 Protein
- ATF2 Protein — Activating Transcription Factor 2
- ATF3 Protein
- ATF4 Protein
- ATF6 Protein
- ATF6 Protein
- ATG10 Protein
- ATG101 Protein
- ATG12 Protein
- ATG12 Protein (Autophagy-related Protein 12)
- ATG13 Protein
- ATG14 Protein
- ATG14 Protein
- ATG16L1 Protein
- ATG2A Protein
- ATG2B Protein
- ATG3 Protein
- ATG4A Protein
- ATG4B Protein — Autophagy Related 4B
- ATG4C Protein
- ATG4D Protein
- ATG5 Protein
- ATG5 — ATG5 Protein
- ATG7 Protein
- ATG9A Protein
- ATG9A Protein
- ATG9B Protein
- Atlastin-1 Protein
- Atlastin-1 Protein
- ATN1 Protein
- ATOX1 Protein
- ATP10B Protein
- ATP13A2 and autophagy in PD pathogenesis
- ATP13A2 Protein (PARK9)
- ATP13A3 Protein
- ATP13A9 Protein - ATPase 13A9
- ATP1A1 Protein
- ATP1A2 Protein
- ATP1A3 Protein - Sodium-Potassium ATPase Alpha 3
- ATP1B1 Protein
- ATP1B2 Protein
- ATP2A2 Protein (SERCA2)
- ATP2B1 Protein
- ATP5A1 Protein
- ATP5B Protein
- ATP5F1 Protein — ATP Synthase F1 Subunit Beta
- ATP6AP2 (Renin Receptor) Protein
- ATP7A Protein - Copper-transporting ATPase 1
- ATP7B Protein - Copper-transporting ATPase 2
- ATR Protein
- Atrophin1 (ATN1) Protein
- ATRX Protein
- ATXN10 Protein
- ATXN2 Protein (Ataxin-2)
- ATXN3 clinical trials (2024)
- AURKA Protein
- Autophagy and autophagy-dependent diseases: a new frontier in molecular medicine
- Auxilin Protein
- AXIN1 Protein
- AXIN1 Protein
- AXIN2 Protein
- AXIN2 Protein
- Axl Protein
- B-Raf Protein
- BACE1 activity as biomarker in cerebrospinal fluid
- BACE1 Protein
- BACE2 Protein
- BACH1 Protein — Transcriptional Repressor
- BAFFR (B Cell Activating Factor Receptor) Protein
- BAG-4 Protein
- BAG1 Protein
- BAG2 Protein
- BAG3 Protein
- BAG5 Protein
- BAG6 Protein
- BAI1 Protein
- BAK1 Protein
- Bassoon Protein
- BAX Inhibitor 1 Protein
- BAX Protein
- BAX Protein
- Bcl-XL Protein
- BCL2 (B-Cell Lymphoma 2)
- BCL2 Protein
- BCL2A1 Protein
- BCL2L1 Protein — BCL-XL
- BCL2L11 Protein — BIM
- BDNF Protein
- Beclin 1 (BECN1)
- Beclin-1
- Beclin-1 Protein
- Beclin-1 Protein
- BECN1 Protein
- BECN1 Protein (Beclin-1)
- BECN2 Protein
- Beta-1 Adrenergic Receptor Protein
- Beta-2 Adrenergic Receptor Protein
- Beta-Actin Protein
- Beta-amyloid Peptide
- Beta-Galactosidase Protein
- Beta-Glucuronidase Protein
- Beta-Synuclein Protein
- Beta-Synuclein Protein
- Bicaudal D1 (BICD1)
- BICD2 and disease: connecting basic mechanisms to clinical phenotypes
- BID Protein
- BIM Protein
- BIN1 Protein
- BiP (GRP78)
- BiP - Binding Immunoglobulin Protein (GRP78)
- BK channel activators in models of stroke
- BK Channel Alpha Protein
- BMAL1 Protein
- BMF Protein
- BMP2 Protein
- BMP4 Protein
- BMPR1A (ALK3) Protein
- BMPR2 Protein
- BNIP3 Protein
- BNIP3L Protein
- Brain-Derived Neurotrophic Factor (BDNF)
- BRCA1 Protein
- BRCA2 Protein
- BRG1 Protein
- BRIP1 Protein
- BSCL2 Protein - Seipin
- BST1 Protein
- BTK Protein
- Butyrylcholinesterase (BuChE) Protein
- c-Fos Protein
- c-Jun Protein
- c-Raf Protein (RAF1)
- c-Rel Protein
- c-Src — Proto-Oncogene Tyrosine-Protein Kinase Src
- C19orf12 Protein
- C1Q Protein (Complement Component 1q)
- C1qA Protein
- C1QB Protein — Complement Component 1 Q
- C1QC Protein
- C2 Protein
- C3 Protein (Complement Component 3)
- C4A Protein (Complement Component 4A)
- C4B Protein
- C5 Protein
- C6 Protein
- C9orf72 Dipeptide Repeat Proteins
- C9orf72 Dipeptide Repeat Proteins (DPRs)
- C9orf72 DPR Protein
- C9orf72 Protein
- CABP1 Protein
- CACNA1B Protein
- CACNA1D Protein
- CACNA1E Protein (Cav2.3 R-type Calcium Channel)
- CACNA1F Protein - Cav1.4 Calcium Channel
- CACNA1G Protein - Cav3.1 T-type Calcium Channel
- CACNA1H Protein (Cav3.2 T-type Calcium Channel)
- CACNA1I Protein - Cav3.3 T-Type Calcium Channel
- CACNA1S Protein - Cav1.1 Calcium Channel
- CACNA2D2 Protein (Alpha2delta-2 Subunit)
- CACNB1 Protein - Calcium Channel Beta-1 Subunit
- CACNB2 Protein (CaB2)
- CACNB3 Protein
- CACNB4 Protein (CaB4)
- CACNG1 Protein - Calcium Channel Gamma-1 Subunit
- CACNG2 Protein - Stargazin Calcium Channel Gamma-2
- Calbindin - Calbindin D-28k
- Calbindin Protein
- CALCA Protein — Calcitonin Gene-Related Peptide
- Calcineurin (PPP3CA)
- Calcineurin A Alpha Protein
- Calcineurin A Protein
- Calcineurin B Protein
- Calcineurin B Protein
- Calcineurin Protein
- Calcineurin Protein (PPP3CA)
- Calcitonin Receptor Protein
- Calcium-Sensing Receptor Protein
- CALCML1 Gene
- Calmodulin (CALM) Protein
- Calmodulin 2 (CALM2)
- Calmodulin-1 (CaM)
- Calmodulin-1 Protein
- Calmodulin-2 Protein
- Calmodulin-3 Protein
- Calpain-1 Protein
- Calreticulin Protein
- Calretinin - Calretinin
- CaMK1 Protein
- CaMK1A Protein
- CaMK1D Protein
- CaMK4 Protein
- CaMKII Alpha Protein
- CaMKII Beta Protein
- CaMKII Protein (CaMK2A)
- CaMKII Protein — Calcium/Calmodulin-Dependent Protein Kinase II
- CAMKK2 Protein
- CAML Protein
- CAMSAP1 Protein
- CAPN1 Protein
- CAPRIN1 Protein
- CAPS1 Protein
- CAPSN1 Protein
- CAPZB Protein
- CARD14 Protein
- CASK — Calcium/Calmodulin-Dependent Serine Protein Kinase
- CASP12 (Caspase-12)
- CASP3 Protein — Caspase-3
- CASP4 Protein
- Caspase 2 (CASP2)
- Caspase-1 (CASP1)
- Caspase-1 Protein
- Caspase-1 Protein
- Caspase-1 Protein
- Caspase-3 (CASP3)
- Caspase-3 (CASP3)
- Caspase-3 Protein
- Caspase-6
- Caspase-7 Protein
- Caspase-8
- Caspase-8 (CASP8)
- Caspase-9
- Caspase-9 Protein
- CASS4 Protein
- Catalase Protein
- Catalase Protein
- Catenin Alpha-2 Protein
- Cathepsin A Protein
- Cathepsin B Protein
- Cathepsin B Protein (CTSB)
- Cathepsin D (CTSD)
- Cathepsin E Protein
- Cathepsin K
- Cathepsin L (CTSL) Protein
- Cathepsin L Protein
- Cathepsin S - CTSS Protein
- Cathepsin S Protein
- Cathepsin Z Protein
- CAV1 Protein
- Cav1.2 - Voltage-Gated L-Type Calcium Channel (CACNA1C)
- Cav1.2 Protein
- Cav1.2 Protein (L-type Calcium Channel Alpha-1C)
- CAV2 Protein
- Cav2.1 P/Q-Type Calcium Channel
- Cav2.1 Protein (P/Q-type Calcium Channel Alpha-1A)
- Cav2.3 Protein
- Cav2.3 Protein (R-type Calcium Channel Alpha-1E)
- CAV3 Protein
- Cav3.1 Protein
- Cav3.2 Protein
- Cav3.2 Protein (T-type Calcium Channel Alpha-1H)
- Caveolin-1
- CAVEOLIN-1 Protein (CAV1)
- Caveolin-3
- CBL Protein (Casitas B-lineage Lymphoma)
- CBX7 Protein
- CCAAT/Enhancer Binding Protein Alpha Protein
- CCAAT/Enhancer Binding Protein Beta Protein
- CCAAT/Enhancer Binding Protein Delta Protein
- CCDC114 Protein
- CCDC88C Protein
- CCER2 Protein
- CCL2 Protein
- CCL2 Protein
- CCL2/MCP-1 Protein
- CCL3 Protein
- CCL4 Protein
- CCL5 Protein
- CCM2 Protein
- CCND1 Protein (Cyclin D1)
- CCNF Protein
- CCNF Protein (Cyclin F)
- CCR5 Protein
- CCR5 Protein
- CCS Protein
- CD200 Protein
- CD200R1 in vascular dementia and cerebrovascular disease
- CD2AP Protein
- CD300A Protein
- CD33 (Siglec-3)
- CD33 Protein — Cluster of Differentiation 33 (Siglec-3)
- CD36 Protein (Cluster of Differentiation 36)
- CD4 Protein
- CD40 Protein - Cluster of Differentiation 40
- CD44 Protein
- CD47 Protein
- CD59 Protein
- CD68 Protein (Macrosialin)
- CD69 Protein
- CD8 Protein
- CDC25C Protein
- CDC37 (Cell Division Cycle 37) Protein
- CDK1 Protein
- CDK11 Protein
- CDK12 Protein
- CDK2 Protein
- CDK4 Protein
- CDK5 Protein
- CDK5 Protein (Cyclin-Dependent Kinase 5)
- CDK5R1 (p35/p25, CDK5 Activator 1)
- CDK5R2 Protein
- Cdk5RAP2 Protein
- CDK6 Protein
- CDK9 Protein
- CDKAL1 Protein
- CDKN2A Protein
- CDR1 Protein
- CDR2 Protein
- CELF1 Protein
- CELF2 Protein
- Cell Division Cycle 42 (Cdc42)
- CENPJ Protein
- Centrin Protein
- Cerebellin-1 Protein
- Cerebellin-2 Protein
- Cerebral Dopamine Neurotrophic Factor
- CERNUNNOS Protein
- CERNUNNOS Protein
- CernunnosX1 Protein
- CERS1 Protein
- CERS2 Protein (Ceramide Synthase 2)
- CERS6 Protein
- Ceruloplasmin (CP)
- Ceruloplasmin Protein
- CFB Protein — Complement Factor B
- CFL1 Protein
- CFLAR Protein
- CFTR Protein
- cGAS Protein
- CHARGE syndrome: update on the clinical features and molecular pathogenesis (2009)
- CHAT Protein
- CHAT Protein
- CHCHD10 in cellular stress response and protein aggregation
- CHCHD10 Protein
- CHCHD10 Protein (Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 10)
- CHCHD2 Protein
- CHCHD3 Protein
- CHCHD5 Protein
- CHCHD6 Protein
- CHD1 Protein
- CHD2 Protein
- CHD4 Protein
- CHD5 Protein
- CHEK1 Protein
- CHEK2 Protein
- CHEK2 Protein
- Chemokine signaling in neuronal development
- CHI3L1 Protein (YKL-40)
- CHIP Protein (STUB1)
- CHL1 Protein
- CHMP2B
- CHMP2B Protein
- CHOP Protein
- CHOP Protein
- CHOP Protein (DDIT3)
- CHRNA1 Protein
- CHRNA2 Protein
- CHRNA3 Protein
- CHRNA5 Protein
- CHRNB2 Protein — Nicotinic Receptor Beta 2 Subunit
- Chromogranin A Protein
- CHST14 Protein - Dermatan 4-O-Sulfotransferase 1
- CIITA Protein
- Citrate Synthase Protein
- CK2 Protein (Casein Kinase 2)
- Clarin 1
- Clathrin Protein
- Claudin-5 Protein
- ClC-3 Chloride Channel
- ClC-4 Chloride Channel
- ClC-5 Chloride Channel
- ClC-6 Chloride Channel
- ClC-7 Chloride Channel
- CLEC16A Protein
- CLEC7A / Dectin-1 Protein
- CLIP1 Protein
- CLN3 Protein (Battenin)
- CLN5 Protein
- CLN6 Protein
- CLN8 Protein
- CLOCK Protein
- CLPP Protein
- CLRN1 (Clarin 1)
- Clusterin (CLU / Apolipoprotein J)
- Clusterin Protein
- Clusterin Protein
- CNR1 Protein
- CNTF Protein
- CNTFR Protein
- CNTN1 Protein
- CNTN2 Protein
- COA6 Protein (Cytochrome C Oxidase Assembly Factor 6)
- COA7 Protein
- Cofilin-1 Protein
- Cofilin-1 Protein
- Cofilin-1 — Actin-Depolymerizing Factor
- COL4A1 Protein
- Collagen IV Alpha-2 Chain Protein
- Complement C1q Subunit A Protein
- Complexin Protein
- COMPLEXIN-1 Protein
- Complexin-1 Protein
- COMPLEXIN-1 Protein (CPLX1)
- Complexin-1 regulates autophagy in neurodegenerative diseases
- Complexin-2 Protein
- Complexin-2 Protein
- Complexin-3 (CPLX3)
- Complexin1 Protein
- COMT Protein
- Connexin 26 (Gap Junction Beta-2) (GJB2)
- Contactin 2 Protein
- Contactin Associated Protein 2 (CNTNAP2 Protein)
- COPA Protein
- COQ2 Protein
- COQ4 Protein
- COQ5 Protein
- COQ6 Protein
- COQ7 Protein
- COQ8A Protein (ADCK3)
- COQ8B Protein
- COQ9 Protein
- Cortactin — CTTN Protein
- Corticotropin Releasing Hormone (CRH)
- COX10 Protein
- COX15 Protein
- COX20 Protein (Cytochrome C Oxidase Assembly Factor)
- COX4I1 Protein — Cytochrome C Oxidase Subunit 4I1
- COX5A Protein
- COX6B1 Protein (Cytochrome C Oxidase Subunit 6B1)
- CPLX4 Protein
- CR1 Protein
- Creatine Kinase Brain Protein
- CREB Protein
- CREB1 Protein
- CREB5 Protein — cAMP Responsive Element Binding Protein 5
- CREBBP Protein
- CRKL Protein
- CRMP2 Protein
- CRMP2 Protein
- CRMP2 Protein
- CRY1 Protein
- CRY2 Protein
- CSF1 Protein
- CSF1R Protein (Colony Stimulating Factor 1 Receptor)
- CSNK1D Protein (Casein Kinase 1 Delta)
- CSNK1E Protein
- CST3 (Cystatin C) Protein
- CTCF Protein
- CTNNB1 Protein
- CTSB Protein
- CTSD (Cathepsin D)
- CTSD Protein - Cathepsin D
- CTSF Protein (Cathepsin F)
- CUL4A Protein
- Cullin-3 — Protein
- CX3CL1 (Fractalkine) Protein
- CX3CR1 Protein (Fractalkine Receptor)
- CXCL12/SDF-1 Protein
- CXCL2 Protein
- CXCL8 Protein
- CXCR3 Protein
- CXCR4 Protein
- Cyclin E2 (CCNE2) Protein
- Cyclin F Protein
- CYFIP2
- CYLD Protein — Lysine-Specific Deubiquitinase in Neurodegeneration
- CYP11A1 Protein (Cholesterol Side-Chain Cleavage Enzyme)
- CYP27A1 Protein
- CYP2U1 Protein — Cytochrome P450 2U1
- CYP46A1 and brain cholesterol in aging and neurodegeneration
- CYP7B1 Protein - Oxysterol 7-alpha-hydroxylase
- Cystathionine Beta Synthase (CBS)
- Cystatin B Protein
- Cystatin C (CST3)
- Cystatin C Protein (CST3)
- Cysteine String Protein (CSP)
- Cystinosin (CTNS Protein)
- Cytochrome c Protein
- Cytochrome c Protein
- Cytoplasmic Dynein 1 Intermediate Chain 1 (DYNC1I1)
- D1 Dopamine Receptor
- D3 Dopamine Receptor Protein
- D5 Dopamine Receptor Protein
- DAB1 Protein
- DAO Protein (D-Amino Acid Oxidase)
- DAOA Protein
- DAP12 Protein
- DAPK1 Protein
- DARPP-32 Protein
- DARS2 Protein
- DAT Protein
- DAT1 (Dopamine Transporter) Protein
- DBH Protein
- DBH Protein
- DBL Protein
- DCC Netrin 1 Receptor Protein
- DCPS Protein (Decapping Scavenger)
- DCTN1 Protein
- DCTN1 Protein (Dynactin Subunit 1)
- DCTN2 Protein - Dynactin Subunit 2
- DCTN3 Protein
- DCTN4 Protein
- DCTN5 Protein
- DCTN6 Protein
- DDC Protein
- DDC Protein
- DDX1 Protein
- DDX17 Protein (p72)
- DDX20 Protein
- DDX3X Protein
- DDX41 Protein
- DDX46 Protein
- DDX5 Protein
- DDX50 Protein
- DDX55 Protein
- DDX6 Protein
- Dedicator of Cytokinesis 1 Protein
- Delta-Opioid Receptor Protein
- DEPDC5 Protein
- DERLIN-1 Protein
- DES Protein
- DGAT1 Protein
- DGUOK Protein
- DHCR24 Protein
- DIABLO Protein
- Diacylglycerol Lipase Alpha (DAGLα)
- Diacylglycerol Lipase Beta (DAGLβ)
- DIAPH3 Protein
- DISC1 Protein
- Discs Large Homolog 2 (PSD-93)
- Discs Large Homolog 3 (PSD-93)
- Dishevelled 1 Protein
- Dishevelled 2 Protein
- Dishevelled 3 Protein
- DJ-1 Protein
- DJ-1 Protein (PARK7)
- DLG Associated Protein 1 (SAPAP1) (DLGAP1 Protein)
- DLG1 — Discs Large Homolog 1 Protein (MAGUK Scaffold)
- DLG4 Protein
- DLG5 Protein - Discs Large Homolog 5
- DLGAP3 Protein
- DLGAP4 Protein
- DLGAP5 Protein
- DLK Protein
- DLL1 Protein
- DLL4 Protein
- DLX2 Protein
- DLX5 Protein
- DLX6 Protein
- DMT1 (Divalent Metal Transporter 1)
- DMT1 Protein
- DNA Ligase III Protein
- DNA Ligase IV Protein
- DNA-PKcs (PRKDC) Protein
- DNAJA1/Hsp40 Protein
- DNAJA3 Protein
- DNAJB1 Protein
- DNAJB2 Protein
- DNAJB6 Protein
- DNAJB7 Protein
- DNAJB8 Protein
- DNAJB9 Protein
- DNAJC10 Protein (ERdj5)
- DNAJC11 Protein
- DNAJC12 Protein
- DNAJC13 Protein (RME-8)
- DNAJC16 Protein
- DNAJC19 Protein
- DNAJC2 Protein - DnaJ Heat Shock Protein Family Member C2
- DNAJC3 Protein
- DNAJC5 Protein
- DNAJC6 Protein (Auxilin)
- DNAJC7 Protein
- DNAJC8 Protein
- DNAJC9 Protein
- DNM2 Protein
- DNMT1 Protein
- DNMT3A Protein (DNA Methyltransferase 3A)
- DNMT3B Protein
- DOCK3 Protein - Dedicator of Cytokinesis 3
- Dopamine Receptor D1 (DRD1)
- Dopamine Receptor D2 (DRD2)
- DOT1L Protein
- Doublecortin (DCX) Protein
- DRAM1 Protein
- drd3 Protein
- drd4 Protein
- DRD5 Protein (D5 Dopamine Receptor)
- Drebrin Protein
- DRP1 (Dynamin-Related Protein 1)
- DRP1 Protein
- DRP1 Protein (Dynamin-1-like Protein)
- DSCAM Protein
- DUSP1 Protein
- DVL1 Protein
- Dynactin Protein
- Dynactin Protein
- Dynamin-1 Protein
- Dynamin-1 Protein
- Dynamin-1 Protein (DNM1)
- Dynamin-2 Protein
- Dynamin-3 Protein
- DYNC1H1 Protein
- DYNC1I2 Protein
- DYNC1LI1 Protein
- DYNC1LI2 Protein
- Dynein Light Chain Tctex-1 Protein
- Dynein Light Chain Tctex-3 Protein
- Dynein — Cytoplasmic Dynein 1
- DYRK1A Protein
- DYRK1A Protein (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A)
- DYRK1B Protein
- Dystroglycan Protein
- Dystrophin Protein
- E-Cadherin (CDH1) Protein
- E2 - Dihydrolipoamide S-Acetyltransferase
- E2F Transcription Factor 2
- E2F1 Protein
- EAAT2 Protein
- EAAT4 Protein (Excitatory Amino Acid Transporter 4)
- EAAT5 Protein (Excitatory Amino Acid Transporter 5)
- EBF3 Protein
- ECSIT Protein
- eEF1A in protein aggregation diseases
- eEF1B2 Protein
- eEF2 Protein
- EFEMP1 Protein
- EFNA1 Protein
- EGF Protein
- EGFR Protein
- EGR1 Protein
- EGR3 Protein (Early Growth Response 3)
- eIF2 Alpha
- eIF2A Protein
- EIF2AK3 Protein (PERK)
- eIF2B is a target of GCN2 during amino acid starvation
- eIF2B Protein
- eIF2B1 Protein
- eIF2B2 Protein
- eIF2B3 Protein
- eIF2B4 Protein
- EIF4E Protein
- EIF4EBP1 Protein (4E-BP1)
- eIF4G1 Protein
- EIF4G1 Protein
- ELAVL3 Protein
- ELAVL4 Protein
- ELKS Protein
- ELMO1 Protein - Engulfment and Cell Motility 1
- ELOAL (ELOA Like Protein)
- Elongator Complex Subunit 1 (IKBKAP) Protein
- ELOVL4 Protein
- ELOVL7 Protein
- EMAP Protein
- ENaC Alpha Protein
- ENDOG Protein (Endonuclease G)
- Endonuclease G Protein
- Endophilin Protein
- Endothelial Nitric Oxide Synthase (NOS3)
- ENO1 Protein
- EP300 Protein (p300)
- EPG5 Protein
- EPHA1 Protein
- EphA4 Protein
- EphrinA2 (EFNA2) Protein
- EPM2A Protein (Laforin)
- EPN1 Protein
- Epsilon-Sarcoglycan (SGCE)
- ERBB3 (HER3) Protein
- ERCC2 Protein (XPD) - DNA Repair Helicase
- ERK1 Protein
- ERK1 Protein
- ERK1 Protein
- ERK2 Protein
- ERK2 Protein
- ERLIN1 Protein (Erlin-1)
- ERLIN2 Protein
- ERN1/IRE1 Protein — ER Stress Sensor
- ERP29 Protein
- ERP57 Protein
- ERS1 Protein
- EWSR1 Protein
- EWSR1 Protein
- EZH2 Protein
- F-box Protein 31 (FBXO31) Protein
- F-Box/WD Repeat-Containing Protein 1 (β-TrCP1) Protein
- F11R Protein
- FA2H Protein
- FADD Protein
- FAM126A Protein — Hyccin
- FAM172A Protein
- FAN1 Protein
- FANCA Protein
- FANCB Protein
- FANCC Protein
- FANCD2 Protein
- FANCE Protein
- FANCF Protein
- FANCG Protein
- FANCL Protein
- FANCM Protein
- FANCN Protein
- FAS Protein
- FASLG Protein - Fas Ligand
- FASN Protein
- FBXO3 Protein
- FBXO38 Protein
- FBXO7 Protein
- FBXO7 Protein (PARK15)
- FC Gamma Receptor IIIA
- FCGR1A Protein - Fc Gamma Receptor IA
- FE65 Protein
- FEN1 Protein
- FEN1 Protein
- Fermitin-2 (FERMT2 / Kindlin-2)
- Fermitin-2 Protein (Kindlin-2)
- FERMT2 Protein
- FERMT2 Protein
- Ferritin Heavy Chain (FTH1)
- Ferritin Light Chain (FTL)
- Ferritin Light Chain (FTL)
- Ferritin Mitochondrial (FTMT)
- Ferroportin
- Ferroportin (SLC40A1)
- FGF-2 Protein (bFGF)
- FGF1 Protein
- FGF17 Protein
- FGF20 Protein
- FGF7 Protein
- FGF9 Protein
- FGFR-1 Protein
- FGFR-2 Protein
- FGFR3 Protein
- FGFR4 Protein
- FHL1 Protein
- FIG4 Protein
- FIG4 Protein
- FIGN Protein
- Filamin A (FLNA)
- FIS1 Protein
- Fission 1 (FIS1)
- FKBP4 Protein
- FLNC Protein
- FLOT1 Protein (Flotillin-1)
- Flotillin-1
- Flotillin-1 Protein
- Flotillin-2
- Flotillin-2 Protein
- FLT1 Protein (VEGF Receptor 1)
- FLT3 Protein
- FLVCR1 Protein
- FMR1 Protein (Fragile X Messenger Ribonucleoprotein 1)
- FMRP Protein
- FN1 Protein (Fibronectin)
- FNIP1 Protein
- Folliculin Protein
- Formin 2 Protein
- FOS Protein
- FosB in stress response and adaptation
- FOXA2 Protein
- FOXM1 Protein
- FOXO1 Protein
- FOXO3 Protein
- FOXO3 Protein (Forkhead Box O3)
- FOXP1 Protein
- FOXP2 Protein
- FOXP4 Protein
- FSP1 Protein - Ferroptosis Suppressor Protein 1
- FSP1/AIFM2 (Ferroptosis Suppressor Protein 1)
- FTH1 Protein
- FTH1 Protein — Ferritin Heavy Chain
- FTL Protein
- FTL Protein — Ferritin Light Chain
- FTO Protein (Fat Mass and Obesity-Associated Protein)
- Fumarate Hydratase Protein
- FUNDC1 Protein
- FUS (Fused in Sarcoma) Protein
- FUS Protein
- Fused in Sarcoma (FUS) Protein
- FXN Protein (Frataxin)
- FXN Protein — Frataxin
- FXR Protein (Farnesoid X Receptor)
- FYCO1 Protein — FYVE and Coiled-Coil Domain Containing 1
- FYN Protein (Fyn Tyrosine Kinase)
- Fyn — Proto-Oncogene Tyrosine-Protein Kinase Fyn
- FZD1 Protein
- FZD10 Protein
- FZD3 Protein
- FZD4 Protein
- FZD5 Protein
- FZD7 Protein
- FZD8 Protein
- FZD9 Protein
- G Protein-Activated Inward Rectifier Potassium Channel 1 (GIRK1/KCNJ3)
- G Protein-Coupled Receptor 37 Like 1 Protein
- G3BP1 Protein — Ras-GTPase-Activating Protein-Binding Protein 1
- G3BP2 Protein - Ras-GTPase-Activating Protein-Binding Protein 2
- G9a/GLP Histone H3K9 Methyltransferase (EHMT1)
- GAB2 Protein
- GABA and glycine in neurodegenerative diseases
- GABA-A Alpha-4 Protein — GABA-A Receptor Alpha 4 Subunit
- GABA-A Alpha-5 Protein — GABA-A Receptor Alpha 5 Subunit
- GABA-A Receptor Alpha 1 Protein
- GABA-A Receptor Beta 1 Subunit
- GABA-A Receptor Beta2 Protein
- GABA-A Receptor Epsilon Protein
- GABA-A Receptor Theta (GABRQ) Protein
- GABA-B Receptor Protein
- GABA-B Receptor Subunit 1 — Protein
- GABA-B Receptor Subunit 2 — Protein
- GABAA Receptor
- GABARAP Protein
- GABARAPL1 Protein
- GABARAPL2 Protein
- GABPB1 Protein
- GABRA1 Protein
- GABRA2 Protein
- GABRA3 Protein
- GABRA6 Protein
- GABRB2 Protein
- GABRB3 Protein - GABA-A Receptor Beta 3 Subunit
- GABRD Protein — GABA-A Receptor Delta Subunit
- GABRE Protein (GABA-A Receptor Subunit Epsilon)
- GABRF Protein (GABA-A Receptor Subunit F)
- GABRG2 Protein — GABA-A Receptor Gamma2 Subunit
- GADD34 Protein
- GADD45A Protein
- GADD45B Protein
- GAIN Protein (GABARAPL2) - GABA-A Receptor Associated Protein Like 2
- GAK Protein
- GAL3ST1 Protein
- Galanin
- GALC Protein
- Galectin-3 in prion diseases and proteinopathies
- Galectin-3 Protein
- Galectin-3 Protein
- Gamma-Actin Protein
- Gamma-Synuclein Protein
- GAN Protein
- GAP43 Protein
- GAPDH Protein
- Gasdermin D Protein
- Gasdermin E Protein
- GBA1 (Glucocerebrosidase) Protein
- GBA1 Protein (Glucocerebrosidase)
- GBA2 Protein - Non-lysosomal Glucosylceramidase
- GBM Protein — Glioblastoma Multiforme
- GCH1 Protein
- GCLC (Glutamate-Cysteine Ligase Catalytic Subunit)
- GCLC Protein
- GCLM (Glutamate-Cysteine Ligase Modifier Subunit)
- GDAP1 Protein
- GDI1 Protein
- GDI2 Protein
- GDNF Protein
- Gelsolin Protein
- Gemin-1 Protein (GEMIN1)
- Gemin-2 Protein
- Gemin-4 Protein
- Gemin-5 Protein
- Gemin-6 Protein
- Gemin-7 Protein
- Gemin-8 Protein
- Gene therapy approaches for MATRIN3-ALS
- Gene therapy approaches for TDP-43 proteinopathy, Gene Ther (2020)
- Gephyrin Protein
- GET4 Protein (Guided Entry of Tail-anchored protein 4)
- GFAP (Glial Fibrillary Acidic Protein)
- GFAP Protein
- GFRAL Protein - GDNF Receptor Alpha Like
- GFRα1 Protein
- GFRα2 Protein - GDNF Family Receptor Alpha 2
- GFRα3 Protein - GDNF Family Receptor Alpha 3
- GFRα4 Protein - GDNF Family Receptor Alpha 4
- GID4 Protein
- Gigaxonin (GAN) Protein
- GIGYF1 Protein
- GIGYF2 Protein
- GIGYF2 Protein (GRB10-Interacting GYF Protein 2)
- GIRK1 Protein
- GIRK2/Kir2.2 — G Protein-Activated Inward Rectifier Potassium Channel 2
- GJA1 Protein
- GJB1 Protein — Connexin 32
- GJC2 Protein
- GLE1 Protein
- GLE1 Protein
- Glial Cell Derived Neurotrophic Factor (GDNF)
- GLO1 Protein
- GLP-1 Receptor
- GLRA1 Protein
- GLRA1 Protein (Glycine Receptor Alpha-1 Subunit)
- GLRB Protein
- GLT8D1 Protein
- Glucocerebrosidase (GCase)
- GluK2 Protein
- GluK2 Protein
- GLUL Protein (Glutamine Synthetase)
- GluR4 Protein (AMPA)
- GluR5 Protein
- GluR6 Protein
- GluR7 Protein
- GluR8 Protein
- GluRδ1 (GRID1) Protein
- GLUT1 Protein
- GLUT1 Protein (Glucose Transporter 1)
- GLUT3 (Glucose Transporter 3) Protein
- Glutamate Receptor Interacting Protein 1 (GRIP1 Protein)
- Glutamine Synthetase Protein
- Glutathione Synthetase (GSS)
- Glycogen Branching Enzyme
- Glycosylation, galectins and innate immunity in tumor metastasis and neuroinflammation
- Glypican-1 Protein (GPC1)
- Glypican-4 Protein (GPC4)
- GM-CSF Receptor Alpha Chain
- GM-CSF Receptor Common Beta Chain
- GM2A Protein - GM2 Activator Protein
- GNA14 (G Protein Alpha 14)
- GNA15 (G Protein Alpha 15)
- gnai1 Protein
- GNAI3 (G Protein Alpha i3)
- gnao1 Protein
- GNAT1 (G Protein Alpha Transducin 1)
- GNB2 Protein
- GNB4 Protein — G Protein Subunit Beta 4
- GNB5 (G Protein Subunit Beta 5)
- GNG2 Protein
- GNG3 Protein
- GNG5 Protein — G Protein Subunit Gamma 5
- GNS Protein - N-Acetylglucosamine-6-Sulfatase
- gp130 Protein - IL-6 Signal Transducer
- GPCR signaling in neurodegeneration (2005)](/proteins/gng4-protein)
- GPM6B Protein
- GPNMB Protein
- GPR37 Protein
- GPX1 Protein
- GPX4 (Glutathione Peroxidase 4)
- GPX4 Protein - Glutathione Peroxidase 4
- [GPX4** is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Redirecting to GPX4 (Glutathione Peroxidase 4)
- GRAMD1A Protein
- GRAMD1B Protein - GRAM Domain Containing 1B
- GRIA2 Protein (AMPA Receptor 2)
- GRIA3 Protein
- GRIA4 Gene
- GRIA4 Protein - Glutamate Receptor AMPA Type Subunit 4
- GRID2 Protein
- GRIK1 Gene
- GRIK1 Protein - Glutamate Receptor Kainate Type Subunit 5
- GRIK3 Gene
- GRIK3 Protein - Glutamate Receptor Kainate Type Subunit 7
- GRIK4 Gene
- GRIK4 Protein - Glutamate Receptor Kainate Type Subunit 8
- GRIK5 Protein - Glutamate Receptor Kainate Type Subunit
- GRIK6 Protein - GluK6 Kainate Receptor
- GRIN1 Protein
- GRIN2A Protein
- GRIN2A Protein (NMDA Receptor Subunit 2A)
- GRIN2B variants in neurodevelopmental disorders: a systematic review
- GRIN2C Gene
- GRIN2C Protein - NR2C NMDA Receptor Subunit
- GRIN2D Protein
- GRIP2 Protein - Glutamate Receptor Interacting Protein 2
- GRK2 Protein — G Protein-Coupled Receptor Kinase 2
- GRK5 Protein — G Protein-Coupled Receptor Kinase 5
- GRK6 Protein — G Protein-Coupled Receptor Kinase 6
- grm1 Protein
- GRP78 — Glucose-Regulated Protein 78
- GRP94 (Glucose-Regulated Protein 94)
- GRPR Protein
- GSDMD Protein
- GSDME Protein — Gasdermin E
- GSK-3β
- GSK-3β Protein
- GSK3 in dopaminergic neuron survival
- GSK3-beta Protein
- GSK3A Protein
- GSK3B (Glycogen Synthase Kinase 3 Beta)
- GSK3B Protein (Glycogen Synthase Kinase 3 Beta)
- [GSK3B Protein** is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Redirecting to GSK3B Protein (Glycogen Synthase Kinase 3 Beta)
- GSTM1 Protein (Glutathione S-Transferase Mu 1)
- GSTP1 Protein (Glutathione S-Transferase Pi 1)
- GTF2H1 Protein
- GTF2H2 Protein
- GTF2H3 Protein
- GUCY2F (Retinal Guanylate Cyclase 2F)
- Gα11 Protein
- Gα12 Protein
- Gα13 Protein
- Gαi2 Protein
- Gαq Protein
- Gβ1 Protein - G Protein Subunit Beta 1
- HAP40 Protein
- HAPLN1 Protein
- HCN channel modulators for CNS disorders
- HCN1 Protein
- HCN2 Protein - Hyperpolarization-activated Cyclic Nucleotide-gated Channel 2
- HCN3 Protein
- HCN4 Protein — HCN Channel 4
- HDAC1 Protein
- HDAC10 Protein
- HDAC11 Protein
- HDAC2 Protein — Histone Deacetylase 2
- HDAC3 Protein
- HDAC4 Protein
- HDAC4 Protein
- HDAC5 (Histone Deacetylase 5) Protein
- HDAC5 Protein
- HDAC6 Protein
- HDAC6 Protein
- HDAC7 Protein
- HDAC7 Protein (Histone Deacetylase 7)
- HDAC8 Protein
- HDAC9 Protein
- Heat Shock Protein 70 (HSPA1A)
- Heat Shock Proteins
- HEATR1 Protein
- HECTD1 Protein
- Heme Oxygenase 2
- Heme Oxygenase-1 (HO-1)
- Heme Oxygenase-1 (HO-1/HMOX1)
- Hepatocyte Nuclear Factor 4 Alpha
- Hepcidin
- Hepsin Protein
- HERC2 — HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 2
- hERG Protein
- HERPUD1 Protein
- HES1 (Hairy and Enhancer of Split 1) Protein
- HEXDC3
- Hexosaminidase A (Hex A) Protein
- Hexosaminidase B (Hex B) Protein
- HFE Protein - Homeostatic Iron Regulator
- HGF ameliorates tau pathology through MET/AKT signaling pathway.
- HGF clinical applications (2015)
- HGSNAT Protein - Heparan-Alpha-Glucosaminide N-Acetyltransferase
- HIF-1α (Hypoxia-Inducible Factor 1-Alpha)
- HIF-1α Protein - Hypoxia Inducible Factor 1-alpha
- HIP1 Protein
- HIP2 (Huntingtin Interacting Protein 2)
- HIPK2 Protein
- HK2 Protein — Hexokinase 2
- HLA-DRB1 Protein
- HLA-DRB1 Protein
- HMGB1 Protein
- HMGCR Protein — HMG-CoA Reductase
- HMOX1 Protein — Heme Oxygenase 1
- hnRNP D-Like Protein
- hnRNP L Protein
- HNRNP-A2B1 Protein
- HNRNPA1 Protein
- HNRNPA1 Protein
- HNRNPA1 Protein
- HNRNPA2B1 Protein
- HNRNPA2B1 Protein
- HNRNPC Protein
- HNRNPD Protein
- HNRNPF Protein
- HNRNPG Protein
- HNRNPK Protein
- HNRNPL Protein
- HNRNPM Protein
- HNRNPQ Protein
- HNRNPR Protein
- HNRNPU Protein
- HNRNPUL1 Protein
- HNRNPUL2 Protein
- HNRPM — HNRPM Protein
- HNRPU — HNRPU Protein
- Homeobox A1 Protein (HOXA1)
- HOMER2 Protein
- HRK Protein
- Hsc70 Protein
- HSF1 Protein - Heat Shock Factor 1
- Hsp10 Protein
- Hsp105 Protein
- Hsp110 Protein
- Hsp22 Protein
- Hsp27 Protein
- Hsp40 Protein
- HSP60 (Heat Shock Protein 60)
- Hsp60 Protein
- HSP70 (Heat Shock Protein 70 / HSPA1A)
- HSP70 Protein
- Hsp70 Protein Family
- HSP90 Protein (Heat Shock Protein 90)
- HSP90 — Heat Shock Protein 90
- HSP90AA1 Protein
- HSP90AB1 Protein
- HSPA13 Protein
- HSPA14 Protein
- HSPA1A Protein
- HSPA1B Protein
- HSPA1L Protein
- HSPA2 Protein
- HSPA5/BiP Protein
- HSPA9 Protein
- HSPB1 Protein
- HSPB2 Protein
- HSPB5 Protein — Alpha B-Crystallin
- HSPB6 Protein — Hsp20
- HSPB7 Protein
- HSPB8 Protein
- HSPD2 Protein
- HSPE1 Protein
- HSPH1 Protein
- htr1b Protein
- htr1d Protein
- HTR1E Protein — 5-Hydroxytryptamine Receptor 1E
- htr2a Protein
- htr2c Protein
- htr6 Protein
- htr7 Protein
- HTRA1 genetic variants influence brain atrophy patterns in Alzheimer's disease
- HTRA2 Protein
- https://www.ncbi.nlm.nih.gov/gene/4780
- Huntingtin (HTT)
- Huntingtin (HTT) Protein
- Huntingtin Protein
- Huntingtin Protein (HTT)
- HUWE1 Protein
- IBA1 Protein
- IBA57 Protein
- ICAM1 Protein
- IDH1 Protein - Isocitrate Dehydrogenase 1
- IDO1 Protein
- Iduronate Sulfatase Protein
- IFI16 Protein
- IFIH1 (MDA5) Protein
- IFN-γ Protein
- IFNAR1 Protein — Interferon Alpha Receptor 1
- IFNAR2 Protein — Interferon Alpha Receptor 2
- IFRD1 Protein - Interferon-Related Developmental Regulator 1
- IGF2 Protein (Insulin-like Growth Factor 2)
- IGF2BP1 Protein
- IGF2BP2 Protein
- IGF2R Protein
- IGHMBP2 Protein
- IKBKB Protein
- IKBKG Protein
- IKK Alpha Protein
- IKK Gamma (NEMO) Protein
- IKK Protein
- IKKα Protein
- IKKβ Protein
- IKKε (IKBKE) Protein
- IL-1 Beta Protein
- IL-10 Protein
- IL-12 Protein
- IL-18 Protein
- IL-18BP Protein
- IL-1α Protein
- IL-1β Protein
- IL-1β Protein - Interleukin-1 Beta
- IL-34 Protein
- IL-6 Protein
- IL-6 Protein - Interleukin 6
- IL-6R Protein
- IL-6R Protein
- IL-8 Protein
- IL1B — Interleukin-1 Beta
- IL1R2 Protein
- IL1RL1 Protein (ST2)
- IL33 Protein
- IL34 Protein
- IL4 Protein
- IL6 Signal Transducer (gp130/IL6ST) Protein
- IMPDH1 Protein
- IMPDH2 Protein
- INS Protein (Insulin)
- Insulin Receptor (INSR) Protein
- Insulin-Degrading Enzyme (IDE)
- Insulin-Like Growth Factor 1 Protein
- Insulin-Like Growth Factor 1 Receptor Protein
- Integrin Beta-1 (ITGB1) Protein
- Intercellular Adhesion Molecule-5 Protein
- Intercellular Adhesion Molecule-5 Protein
- Interleukin-1 beta (IL-1β)
- Interleukin-1 Receptor Accessory Protein
- Interleukin-1 Receptor Type 1 Protein
- Interleukin-18 Protein
- Internexin (INA) Protein
- Intersectin Protein
- Inverted Formin 2 (INF2)
- Investigation of C9orf72 in ALS and FTD cohorts
- IP3 Receptor 1 Protein
- IP₃ Receptor Protein
- IRAK1 Protein
- IRAK4 Protein
- IRE1/ERN1 (Inositol-Requiring Enzyme 1)
- IREB2 Protein
- IRF1 Protein - Interferon Regulatory Factor 1
- IRF3 Protein
- IRF7 Protein
- Irisin — Exercise-Induced Myokine
- Iron-sulfur cluster biogenesis and human disease
- Is alpha-synuclein neurotoxic in multiple system atrophy?
- ISG15 Protein — Interferon-Stimulated Gene 15
- ISL2 Protein
- ITCH Protein
- ITGAM Protein
- ITGB3 Protein (Integrin Beta-3)
- ITPR1 Gene
- ITPR1 Protein (IP3 Receptor Type 1)
- ITPR2 Protein
- ITPR2 Protein — Inositol 1,4,5-Trisphosphate Receptor Type 2
- IκBα Protein
- IκBα Protein (NFKBIA)
- IκBβ Protein
- IκBε Protein
- Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov. 2006;5(3):247-264. DOI:10.1038/nrd1983
- JAG1 Protein
- JAK1 Protein — Janus Kinase 1
- JAK2 Protein
- Janus Kinase 3
- JNK (c-Jun N-terminal Kinase) Protein
- JNK1 Protein
- JNK2 Protein
- JNK3 Protein
- JNK3 Protein (c-Jun N-terminal Kinase 3)
- JPH3 Protein
- JUN Protein
- JunB Protein
- Junctophilin-3 Protein
- JUP Protein
- KANSL1 Protein
- Kappa-Opioid Receptor Protein
- KAT2B Protein — Lysine Acetyltransferase 2B (PCAF)
- KAT5 Protein — Lysine Acetyltransferase 5 (TIP60)
- KAT6A Protein
- KAT6B Protein
- KAT8 Protein
- KCa3.1 Protein — Potassium Calcium-Activated Channel Subfamily M Member 2
- KCNA10 Protein - Kv1.10 Potassium Channel
- KCNA2 Protein
- KCNA3 Protein
- KCNA6 Protein (Potassium Voltage-Gated Channel Subfamily A Member 6)
- KCNA7 Protein - Kv1.7 Potassium Channel
- KCNAB1 Protein
- KCNAB2 Protein
- KCNB2 Protein (Potassium Voltage-Gated Channel Subfamily B Member 2)
- KCNC1 Gene
- KCNC4 Protein (Potassium Voltage-Gated Channel Subfamily C Member 4)
- KCND1 Protein — Potassium Voltage-Gated Channel Subfamily D Member 1
- KCND2 Protein (Kv4.2 Potassium Channel)
- KCNE1 Protein
- KCNE2 Protein
- KCNE3 Protein
- KCNE4 Protein
- KCNE5 Protein
- KCNG1 Protein (Potassium Voltage-Gated Channel Modifier Subunit 1)
- KCNG4 Protein (Potassium Voltage-Gated Channel Modifier Subunit 4)
- KCNH2 Protein — Potassium Voltage-Gated Channel
- KCNH3 Protein — Neuronal Potassium Channel
- KCNH6 Protein (ERG2 Potassium Channel)
- KCNIP1 Protein
- KCNJ1 Protein (ROMK Potassium Channel)
- KCNJ13 Protein (Kir7.1 Potassium Channel)
- KCNJ15 Protein (Kir4.2 Potassium Channel)
- KCNJ3 Protein
- KCNJ4 Protein (Kir2.3 Potassium Channel)
- KCNJ6 Protein (Kir3.2 Potassium Channel)
- KCNJ8 Protein
- KCNJ9 Protein (Kir3.3 Potassium Channel)
- KCNK10 Protein
- KCNK12 Protein
- KCNK13 Protein
- KCNK14 Protein
- KCNK15 Protein
- KCNK16 Protein
- KCNK17 Protein
- KCNK18 Protein - Potassium Two Pore Domain Channel Subfamily K Member 18
- KCNK2 Protein (TASK-1 Potassium Channel)
- KCNK3 Protein (TASK-1 Potassium Channel)
- KCNK4 Protein (TRAAK Potassium Channel)
- KCNK5 Protein
- KCNK6 Protein
- KCNK7 Protein (KCNK Potassium Channel 7)
- KCNK9 Protein
- KCNMA1 Protein (BK Channel)
- KCNN3 Protein (Small Conductance Calcium-Activated Potassium Channel 3)
- KCNN4 Protein (Small Conductance Calcium-Activated Potassium Channel 4)
- KCNQ1 Protein (KV7.1)
- KCNQ2 Protein (Kv7.2)
- KCNQ3 Protein
- KCNQ3 Protein
- KCNQ4 Protein - Potassium Channel Kv7.4
- KCNQ5 Protein - Potassium Channel Kv7.5
- KCTD7 Protein
- KDM1A Protein (Lysine Specific Demethylase 1A (LSD1))
- KDM2A Protein
- KDM3A Protein
- KDM3B Protein (Lysine Specific Demethylase 3B (JHDM2B))
- KDM4A Protein (Lysine Specific Demethylase 4A (JMJD2A))
- KDM5A Protein (Lysine Specific Demethylase 5A (JARID1A))
- KDM5D Protein
- KDM6A Protein (Lysine Specific Demethylase 6A (UTX))
- KEAP1 - Kelch-like ECH-Associated Protein 1
- KEAP1 Protein
- KIF13A Protein
- KIF13B Protein
- KIF18A Protein
- KIF1B Protein
- KIF1C Protein
- KIF20A Protein (Kinesin Family Member 20A)
- KIF21A Protein
- KIF21B Protein (Kinesin Family Member 21B)
- KIF3C Protein
- KIF5A Protein
- KIF5C Protein
- KIF7 Protein
- Kinesin Family Member 2A (KIF2A)
- Kinesin-1 Heavy Chain
- Kinesin-1 Heavy Chain Protein
- Kinesin-1 Heavy Chain Protein
- Kinesin-3 Family Member KIF1A
- Kir2.1 Protein
- Kir2.1 Protein
- Kir2.2 Potassium Channel
- Kir2.3 — Inward Rectifier Potassium Channel 2.3
- Kir4.1 Potassium Channel (KCNJ10)
- KL Protein
- KLK1 Protein
- KLK6 Protein
- KPNA1 Protein
- Ku70 Protein
- Ku80 Protein
- Kv1.1 (KCNA1) Protein
- Kv1.1 Protein
- Kv2.1 Potassium Channel
- Kv3.1 Protein
- Kv3.1 Protein
- Kv3.3 Potassium Channel
- Kv3.3 Protein
- Kv3.4 Protein
- Kv4.3 Potassium Channel Protein
- Kv7.2 (KCNQ2) Protein
- Kv7.2 Potassium Channel
- Kv7.3 Potassium Channel
- KYAT3 Protein
- L-type Calcium Channel
- L-type Calcium Channel Protein
- L1CAM Protein
- LAG3 Protein (CD223)
- LAMA5 Protein (Laminin Subunit Alpha-5)
- LAMP1 Protein
- LAMP1 Protein
- LAMP2 Protein
- LAMP2 Protein
- LAMP2A and the autophagy-lysosomal pathway in neuronal cells
- LAMP2A Protein
- LAMP3 Protein
- LAMP4 Protein
- LAMP5 Protein
- LAMTOR2 Protein
- LAPTM4A Protein — Lysosomal-Associated Transmembrane Protein 4 Alpha
- LAPTM4B Protein
- LAS1L (LAS1 Like Ribosome Biogenesis Factor)
- LC3 (Microtubule-Associated Protein 1 Light Chain 3)
- LC3 Protein
- LC3B Protein
- LC3C Protein
- LCK Protein (Lymphocyte-Specific Protein Tyrosine Kinase)
- Lck — Proto-Oncogene Tyrosine-Protein Kinase Lck
- LDL Receptor Protein
- LDLR Protein (Low-Density Lipoprotein Receptor)
- LDLRAD3 (LDLR Adapter Protein 1) Protein
- LETM1 Protein
- LGALS1 Protein — Galectin-1
- LGI1 Protein
- LIF Protein — Leukemia Inhibitory Factor
- LIF Receptor Protein - Leukemia Inhibitory Factor Receptor
- LIG3 Protein — DNA Ligase III
- LIM Kinase 1 (LIMK1)
- LIM Kinase 2 (LIMK2)
- LIMP-2 Protein
- LIMP-2: structure and function of the lysosomal membrane protein
- LINGO1 Protein
- Liprin Protein
- LIS1 Protein
- LITAF Protein
- LKB1 and aging
- LMNA Protein
- LPL Protein — Lipoprotein Lipase
- LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1)
- LRP1 Protein
- LRP10 Protein
- LRP12 Protein
- LRP1B Protein
- LRP1B Protein - LDL Receptor-Related Protein 1B
- LRP2 Protein (Megalin)
- LRP2 Protein - Megalin
- LRP3 Protein
- LRP4 Protein
- LRP4 Protein - LDL Receptor-Related Protein 4
- LRP5 Protein
- LRP5 Protein - LDL Receptor-Related Protein 5
- LRP6 Protein
- LRP8 (ApoER2) Protein
- LRPPRC Protein
- LRRK1 Protein - Leucine-Rich Repeat Kinase 1
- LRRK2 (Leucine-Rich Repeat Kinase 2)
- LRRTM1 Protein
- LRRTM2 Protein
- LRRTM3 Protein
- LRRTM4 Protein
- LRSAM1 Protein
- LSM1 Protein
- LTBR Protein
- LXR Protein (Liver X Receptor)
- LXR-alpha Protein
- Lyn — Proto-Oncogene Tyrosine-Protein Kinase Lyn
- Lysosomal Acid Lipase (LIPA) Protein
- MADD Protein
- MAFB Protein - MAF BZIP Transcription Factor B
- MANF Protein
- Mannose-Binding Lectin 2 Protein
- MAO-A (Monoamine Oxidase A) Protein
- MAO-B inhibitors and neuroinflammation in Parkinson's disease
- MAOA Protein
- MAOB Protein
- MAP Kinase Phosphatase 1 (MKP1/DUSP1)
- MAP Kinase Phosphatase 3 (DUSP6/MKP3)
- MAP1B Protein
- MAP1B Protein
- MAP1LC3A Protein
- MAP1LC3B Protein (LC3B)
- MAP1LC3B2 Protein
- MAP1S Protein
- MAP2 Protein
- MAP2 Protein — Microtubule-Associated Protein 2
- MAP2K1/MEK1 Protein
- MAP2K2/MEK2 Protein
- MAP2K3 Protein (MEK3)
- MAP3K12 Protein — DLK (Dual-Leucine Zipper Kinase)
- MAP3K6 Protein (MEKK6)
- MAP4 Protein
- MAP6 Protein — Microtubule-Associated Protein 6
- MAP7 Protein
- MAPK1 Protein (ERK2)
- MAPK10 Protein (JNK3)
- MAPK11 Protein (p38β)
- MAPK14 Protein
- MAPK3 Protein (ERK1)
- MAPK8 Protein (JNK1)
- MAPK9 Protein (JNK2)
- MAPT Protein
- MARCH5 Protein
- MARCH7 Protein
- MARCHF2 Protein
- MARK2 Protein
- MARK4 Protein (Microtubule Affinity Regulating Kinase 4)
- MATR3 Protein
- Matrin-3 Protein
- MATRIN3 Protein
- MAX Protein (MAX)
- MBD1 Protein — Methyl-CpG Binding Domain Protein 1
- MBD2 Protein - Methyl-CpG Binding Domain Protein 2
- MBD3 Protein - Methyl-CpG Binding Domain Protein 3
- MBD4 Protein - Methyl-CpG Binding Domain Protein 4
- MBD5 Protein - Methyl-CpG Binding Domain Protein 5
- MBD6 Protein - Methyl-CpG Binding Domain Protein 6
- MBP Protein
- MCL1 Protein
- MCPH1 Protein
- MCU Protein
- MDA5 Protein
- MDM2 Protein
- MECOM Gene — MDS1 and EVI1 Complex
- MeCP2 Protein
- MECP2 Protein
- MEF2A Protein
- MEF2C Protein
- MEF2D Protein - Myocyte Enhancer Factor 2D
- MEK1 Protein
- MEK2 Protein
- MEKK1 Protein
- MEKK2 Protein
- MEKK3 Protein
- MELK Protein
- Merlin Protein
- Merlin Protein
- MERTK Protein - MER Tyrosine Kinase
- MET Protein
- Metallothioneins
- METTL14 Protein (m6A Methyltransferase Subunit)
- METTL3 Protein (m6A Methyltransferase)
- MFN1 Protein
- MFN2 Protein (Mitofusin 2)
- MFSD1 Protein
- MFSD8 Protein (CLN7)
- mGluR1 Protein
- mGluR2 Protein
- mGluR2 Protein
- mGluR2 Protein
- mGluR2 Protein — Glutamate Metabotropic Receptor 2
- mGluR3 Protein
- mGluR3 Protein
- mGluR3 Protein — Glutamate Metabotropic Receptor 3
- mGluR4 Protein
- mGluR4 Protein
- mGluR4 Protein
- mGluR4 Protein — Glutamate Metabotropic Receptor 4
- mGluR5 (Metabotropic Glutamate Receptor 5)
- mGluR5 Protein
- mGluR5 Protein
- mGluR5 Protein — Glutamate Metabotropic Receptor 5
- mGluR6 Protein
- mGluR6 Protein
- mGluR6 Protein (Metabotropic Glutamate Receptor 6)
- mGluR7 Protein
- mGluR7 Protein
- mGluR7 Protein (Metabotropic Glutamate Receptor 7)
- mGluR8 Protein
- mGluR8 Protein
- mGluR8 Protein (Metabotropic Glutamate Receptor 8)
- Microtubule Associated Protein 1A Protein
- MiD49 Protein
- MiD50 Protein
- Miro1 Protein
- MIRO2 Protein
- Mitochondrial Aspartyl-tRNA Synthetase
- Mitochondrial Carrier ATA-1 Protein
- Mitochondrial Carrier Family
- Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications, Curr Neurovasc Res 2020
- Mitofusin 1 (MFN1)
- Mitofusin 2 (MFN2)
- Mitofusin-1 Protein
- Mitofusin-2 Protein
- MLK3 (MAP3K12) Protein
- MLKL Protein
- MLL1 Histone H3K4 Methyltransferase (KMT2A)
- MLL2/MLL4 Histone H3K4 Methyltransferase (KMT2B)
- MLST8 Protein
- MME Protein (Neprilysin/CD10)
- MMP2 Protein
- MMP9 Protein
- MMP9 Protein
- MOG Protein
- Molecular cloning and expression of a human kainate receptor
- Molecular genetics of Leber congenital amaurosis
- MORC3 Protein
- MPV17 Protein
- MPZ Protein — Myelin Protein Zero
- MRE11 Protein
- MRE11A Protein
- MS4A1 Protein
- MS4A2 Protein
- MS4A3 Protein
- MS4A4A Protein
- MS4A6A Protein
- MS4A6E Protein
- MSH2 Protein - MutS Homolog 2
- MSH6 Protein - MutS Homolog 6
- MST1 Protein
- MST3 Protein
- MT-ATP6 Protein (ATP Synthase Subunit 6)
- MT-CO1 Protein (Cytochrome c Oxidase I)
- MT-CYB Protein (Cytochrome b)
- MT-ND5 Protein (NADH Dehydrogenase 5)
- MTCH1 Protein
- MTCH2 Protein
- MTOR Protein
- MTOR Protein
- mTORC1 Protein — Mechanistic Target of Rapamycin Complex 1
- Mu-Opioid Receptor Protein
- Mucolipin-1 (TRPML1) Protein
- MUL1 Protein
- MULE Protein
- Munc13-1
- MUNC13-1 Protein
- Munc13-2 - Unc-13 Homolog B
- Munc18-1 Protein
- Munc18-1 Protein
- Munc18-1 Protein
- Munc18-1 Protein (STXBP1)
- Muscarinic Acetylcholine Receptor M1 (CHRM1)
- Muscarinic Acetylcholine Receptor M2 (CHRM2)
- MUTYH Protein
- MyD88 expression in human brain: correlation with neuropathology and clinical dementia
- MyD88 Protein
- MYO5A Protein
- MYT1L Protein
- N- Cadherin Protein
- N-Cadherin (CDH2) Protein
- N-WASP Protein
- NADK in cell signaling (2018)
- NADPH Oxidase 2
- NAGA Protein - Alpha-N-Acetylgalactosaminidase
- NAGLU Protein (Alpha-N-Acetylglucosaminidase)
- NAMPT Protein
- Nav1.1 Sodium Channel
- Nav1.1 Sodium Channel Protein
- Nav1.2 Protein
- Nav1.2 Sodium Channel (SCN2A)
- Nav1.3 Protein
- Nav1.4 Sodium Channel
- Nav1.5 Sodium Channel
- Nav1.6 Protein (SCN8A)
- Nav1.9 Sodium Channel
- Na⁺/Ca²⁺ Exchanger (NCX) Protein
- NBR1 Protein
- NBS1 Protein
- NCAM1 Protein
- NCOA4 Protein
- NCSTN Protein
- NDP52 Protein
- NDUFA9 Protein
- NDUFAF1 Protein
- NDUFAF1 Protein
- NDUFAF2 Protein
- NDUFAF6 Protein
- NDUFS1 Protein
- NDUFS2 Protein
- NDUFS4 Protein
- NDUFS7 Protein
- NEAT1 (Nuclear Enriched Abundant Transcript 1)
- NEFH Protein
- NEIL1 Protein — Nei Endonuclease VIII-Like 1
- NEIL2 Protein
- NEIL3 Protein
- NEK1 Protein
- NEK7 Protein
- NELL2 Protein
- NEMO/IKKγ Protein
- Neprilysin (NEP / CD10 / MME)
- Nerve Growth Factor (NGF)
- NES Protein
- Nestin Protein
- Nestin Protein
- Netrin 2 Protein
- Netrin 4 Protein
- Netrin-1 Protein
- Neurabin-1 (PPP1R18)
- Neurabin-1 Protein
- Neurexin-1 Protein
- Neurexin-1 Protein (NRXN1)
- Neuritin Protein
- NEUROD1 Protein
- Neurofibromin regulates amyloid precursor protein processing
- Neurofilament Heavy Chain (NF-H)
- Neurofilament Heavy Chain (NFH)
- [Neurofilament Heavy Chain** is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Redirecting to Neurofilament Heavy Chain (NF-H)
- Neurofilament Light Chain (NF-L)
- Neurofilament Light Chain (NFL)
- Neurofilament Light Chain Protein
- Neurofilament Light Chain Protein
- Neurofilament Medium (NFM) Protein
- Neurofilament Medium Chain (NEFM) Protein
- Neurofilament Medium Chain (NF-M)
- Neurofilament-Light Chain (NEFL) Protein
- Neurogranin (RC3)
- Neuroligin 1 (NLGN1)
- Neuroligin-1 Protein
- Neuroligin-1 Protein
- Neuronal Nitric Oxide Synthase
- Neuropeptide Y (NPY)
- Neuropilin-1 (NRP1) Protein
- Neuroplastin Protein
- Neurotrophin-3 (NT-3)
- Neurotrophin-4 (NT-4)
- Neurturin Protein
- Neurturin Protein
- NEXMIF Protein
- NF-kappaB
- NF-kB Signaling Pathway in Neurodegeneration
- NF-κB p100/p52 Protein
- NF-κB p105 Protein
- NF-κB p105/p50 Protein
- NF-κB p50 Protein
- NF-κB p65 Protein
- NFASC Protein
- NFAT1 Protein
- NFAT2 Protein
- NFAT3 Protein
- NFAT5 Protein — Nuclear Factor of Activated T Cells 5
- NFE2L1 expression in post-mortem Alzheimer brain correlates with disease severity
- NFE2L3 Protein
- NFKB2 Protein
- NGB Protein
- NGF Protein
- NGFR (p75NTR) Protein
- NGN2 Protein
- NHLRC1 Protein
- NHLRC2 Protein — NHL Repeat Containing 2
- Nibrin Protein
- Nicastrin (NCSTN Protein)
- Nicastrin (NCT) Protein
- Nicastrin Protein
- Nicastrin Protein - Gamma-Secretase Component
- Nicotinic Acetylcholine Receptor Alpha 4 Subunit
- Nicotinic Receptor Alpha 7 Protein
- Nicotinic Receptor Alpha9 Subunit (CHRNA9)
- NKX2-2 Protein
- NLGN2 Protein
- NLGN3 Protein
- NLGN4X Protein
- NLRC3 Protein
- NLRC4 Protein
- NLRC5 Protein — NLR Family CARD Domain Containing 5
- NLRP1 Protein
- NLRP12 Protein — NLR Family Pyrin Domain Containing 12
- NLRP2 Protein — NLR Family Pyrin Domain Containing 2
- NLRP3 (NLR Family Pyrin Domain Containing 3)
- NLRP3 Protein
- NLRP4 Protein
- NLRP6 Protein (NACHT, LRR and PYD Domains-Containing Protein 6)
- NLRP6 Protein - Inflammasome Component
- NLRP7 Protein — NLR Family Pyrin Domain Containing 7
- NLRX1 Protein
- NMDA Receptor
- NMDA receptor hypofunction in Parkinson's disease
- NMDA Receptor NR2A Protein
- NMDA Receptor Protein
- NMDA Receptor Subunit NR1 (GRIN1)
- NMDA Receptor Subunit NR2B (GRIN2B)
- NME1 Protein - Nucleoside Diphosphate Kinase 1
- NME8/NDPK8 Protein
- NMNAT1 Protein
- NMNAT2 Protein
- NMNAT3 Protein
- NNMT Protein
- NOB1 Protein
- Nogo-A in the basal ganglia and its role in the pathogenesis of Parkinson's disease
- NONO Protein
- Nop56 Protein
- NOS2 Protein (Inducible Nitric Oxide Synthase)
- NOSTRIN Protein
- Notch1 Protein
- Notch1 Protein
- Notch2 Protein
- Notch2 Protein
- NOTCH3 Protein
- NOTCH3 Protein
- NOX2/CYBB (NADPH Oxidase 2)
- NOXA Protein
- NOXA1 Protein
- NOXO1 Protein
- NPAS2 Protein
- NPAS3 Protein
- NPAS4 Protein
- NPC1 Protein
- NPC2 Protein — Niemann-Pick C2 Protein
- NPEP Protein
- NPL4 Protein
- NPRL2 Protein
- NPRL3 Protein
- NPTX1 Protein
- NPTX2 Protein
- NPTXR Protein
- NPY Protein
- NQO1 Protein (NAD(P)H Quinone Dehydrogenase 1)
- NQO1 Protein — NAD(P)H Quinone Dehydrogenase 1
- NQO2 (NAD(P)H Quinone Dehydrogenase 2)
- NR2B (GluN2B) NMDA Receptor Subunit
- NR2D subunits in memory and cognitive disorders
- NR3A (NMDA Receptor Subunit)
- NR3B (NMDA Receptor Subunit)
- NRAMP1 Protein
- NRAS Protein
- NRCAM Protein
- NRG1 Protein
- NRG2 Protein
- NRG3 (Neuregulin-3) Protein
- NRG4 Protein
- NRP2 Protein
- NRSF Protein
- NRXN1 Protein
- NRXN2 Protein
- NRXN3 Protein
- NSF Protein
- NT5C2 Protein
- NT5E Protein
- NTF3 Protein
- NTF4 Protein
- NTF5 (Neurotrophin-5) Protein
- NTN3 Protein
- NTRK1 Protein
- NTRK3 Protein
- NUCKS1 Protein
- Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)
- Nuclear Receptor Nurr1 Protein
- Nuclear Receptor Related 1 (NURR1)
- Nuclear Respiratory Factor 1 (NRF1)
- Nucleolin Protein
- Nucleoporin 54
- Nucleoporin 58
- Nudel Protein
- NUDT1 Protein — NUDIX Hydrolase 1 (MTH1)
- NUP62 Protein
- NUP98 Protein
- NUPL2 Protein
- Nur77 Protein
- NUS1 Protein - Nogo-B Receptor
- NYAP1 Protein
- Occludin Protein
- OGG1 Protein
- OGT Protein — O-GlcNAc Transferase
- Olig1 Protein — Oligodendrocyte Transcription Factor 1
- Olig2 Protein — Oligodendrocyte Transcription Factor 2
- OMA1 Protein
- OMGP Protein
- OPA1 Protein
- OPA1 Protein
- OPA3 Protein
- Opalin Protein
- Optineurin
- OPTN Protein (Optineurin)
- OPTN Protein (Optineurin)
- OPTN Protein (Optineurin)
- OSMR Protein
- Osteopontin (SPP1)
- Otoferlin Protein
- OTX2 Protein
- OXR1 Protein (Oxidoreductase NRD1)
- P-glycoprotein (ABCB1)
- p21-Activated Kinase 3 (PAK3) Protein
- P2RX6 Protein — Purinergic Receptor P2X Subunit 6
- P2RX7 Protein
- P2RY13 Protein
- P2X1 Receptor Protein
- P2X2 Receptor Protein
- P2X3 Receptor Protein
- P2X4 Receptor Protein
- P2X5 Receptor Protein
- P2X7 Protein
- P2X7 Receptor Protein
- P2X7 receptor regulates autophagy in neurodegenerative diseases (2021)
- P2Y12 Protein
- P2Y12 Receptor Protein
- p35 Protein
- p38 Alpha Protein (MAPK14)
- p38 MAPK Protein
- p38 MAPK Protein (p38 Alpha)
- P49768
- P4ATP5 (ATP10A) Protein
- P4HB Protein
- p62 - Sequestosome 1 (SQSTM1)
- p62 Protein (Sequestosome-1)
- p62/SQSTM1
- p62/SQSTM1 Protein
- p67phox Protein
- p70S6K (RPS6KB1) Protein
- p75NTR Protein
- p75NTR Protein
- PABPN1 Protein
- PACS1 Protein
- PAH Protein
- PAK1 Protein
- PAK2 Protein (p21-Activated Kinase 2)
- PALB2 Protein - Partner and Localizer of BRCA2
- PANK1 Protein
- PANK2 Protein (Pantothenate Kinase 2)
- PANX1 Protein
- Paraoxonase 1 (PON1) Protein
- Paraoxonase 2 (PON2)
- Paraoxonase 3 (PON3) Protein
- PARK16 Protein - PARK16
- PARK2 Protein
- PARK2 Protein - Parkin
- PARK7 (DJ-1) Protein
- PARK7 Protein (DJ-1)
- PARK7 — Parkinsonism Associated Deglycase (DJ-1)
- Parkin
- Parkin Protein
- PARL Protein
- PARP1 (Poly(ADP-Ribose) Polymerase 1)
- PARP1 Protein
- PARP2 Protein
- PARP3 Protein
- Parvalbumin (PVALB) Protein
- PAX6 Protein
- PBX3 Protein
- PCBP1 Protein
- PCBP2 Protein
- PCNA Protein (Proliferating Cell Nuclear Antigen)
- PDE10A Protein — Dual-Specificity Phosphodiesterase 10A
- PDE1A Protein — Calcium/Calmodulin-Dependent Phosphodiesterase 1A
- PDE1B Protein — Phosphodiesterase 1B
- PDE1C Protein — Phosphodiesterase 1C
- PDE4A Protein — cAMP-Specific Phosphodiesterase 4A
- PDE4B Protein — Phosphodiesterase 4B
- PDE4C Protein — Phosphodiesterase 4C
- PDE4D Protein
- PDGF-A Protein
- PDGF-B Protein
- PDGFR-Beta Protein
- PDGFRA — Platelet-Derived Growth Factor Receptor Alpha
- PDHA1 Protein — Pyruvate Dehydrogenase E1 Alpha 1
- PDHA2 Protein
- PDHX Protein
- PDIA1 Protein
- PDIA6 Protein
- PDP1 Protein
- PDYN Protein
- PECAM1 Protein
- PELI1 Protein
- PEN-2 Protein - Gamma-Secretase Subunit
- PEN2 Protein
- PEN2 Protein
- PER1 Protein
- PER2 Protein
- PER3 Protein
- Peripherin Protein
- Peripherin Protein
- PERK (Protein Kinase R-like ER Kinase)
- Peroxiredoxin 5 (PRDX5)
- Peroxiredoxin-2 Protein
- PET100 Protein
- PEX1 Protein - Peroxisome Biogenesis Factor 1
- PEX10 Protein
- PEX12 Protein
- PEX13 Protein
- PEX2 Protein - Peroxisome Biogenesis Factor 2
- PEX3 Protein - Peroxisome Biogenesis Factor 3
- PEX5 Protein - Peroxisome Biogenesis Factor 5
- PEX6 Protein - Peroxisome Biogenesis Factor 6
- PFBN1 Protein
- PFKFB3 Protein
- PFKL Protein
- PFN1 Protein
- PGAP2 Protein
- PGC-1 Alpha
- PGC-1α (PPARGC1A)
- PGC-1α Protein
- PGC-1α Protein
- PGC-1β Protein
- PGC1A Protein
- PGK1 Protein
- PGRMC1 Protein
- Phenylalanine Hydroxylase (PAH)
- PHF6 Protein
- Phospholamban Protein
- Phospholipase C gamma 1
- Phospholipase C Gamma 1 Protein
- Phosphorylated Tau at Threonine 181 (p-tau181)
- Phosphorylated Tau at Threonine 217 (p-tau217)
- Phosphorylated Tau at Threonine 231 (p-tau231)
- Phosphorylated Tau Protein
- PI3K p110α Protein
- PI3K Protein
- PICALM Protein
- Piccolo Protein
- PICK1 Protein
- PIEZO2 Protein
- PIK3C3 (VPS34) Protein
- PIK3C3 Protein
- PIK3R1 Protein (p85α)
- PILRA Protein
- PILRB Protein
- PIM1 Protein (Proviral Integration Site for Moloney Murine Leukemia Virus 1)
- PIN1 Protein
- PINK1
- PINK1 Protein
- PITX3 Protein
- PKA C-alpha Protein
- PKA RIIβ Protein (Protein Kinase A Regulatory Subunit 2B)
- PKM Zeta
- PKM2 Protein
- PKR (Protein Kinase R)
- PKR Protein (Protein Kinase R)
- PLA2G6 Protein
- PLA2G6 Protein (iPLA2-VI)
- PLAA Protein (Phospholipase A2 Activating Protein)
- PLAU Protein
- PLC Beta 1 Protein
- PLCG2 Protein
- PLD3 Protein — Phospholipase D3
- PLEKHG5 Protein
- Plexin A2 Protein
- Plexin A3 Protein
- Plexin A4 Protein
- PLIN2 Protein
- PLK1 Protein
- PLK2 Protein
- PLK3 Protein
- PLK4 Protein
- PLP1 Protein
- PLP2 Protein
- PM20D1 Protein
- PMCA1 Protein — Plasma Membrane Calcium ATPase 1
- PMP22 Protein — Peripheral Myelin Protein 22
- PNKP Protein - Polynucleotide Kinase 3'-Phosphatase
- PNMT Protein
- PNMT Protein
- PNN Protein (Pinin)
- PNOC Protein
- PNP Protein
- POLB Protein
- POLD1 Protein
- POLD1 Protein
- POLD1 Protein
- POLD2 Protein
- POLD3 Protein
- POLD4 Protein
- POLE Protein - DNA Polymerase Epsilon Catalytic Subunit
- POLG Protein
- POLG2 structure at high resolution
- POLM Protein
- POLN Protein
- POMGNT1 Protein - Protein O-Mannose Beta-1,2-N-Acetylglucosaminyltransferase
- POMT1 Protein
- POMT2 Protein
- Potassium Voltage-Gated Channel Subfamily C Member 2 (Kv3.2)
- PP1 Protein
- PP2A B55β Regulatory Subunit
- PP2A Protein
- PP2A Protein (Protein Phosphatase 2A)
- PP2A Protein (Protein Phosphatase 2A)
- PP2B Protein (Calcineurin)
- PPAR (Peroxisome Proliferator-Activated Receptor)
- PPAR-alpha Protein
- PPM1A Protein
- PPM1H Protein
- PPP1CA Protein (Protein Phosphatase 1 Alpha)
- PPP1R15A Protein (GADD34)
- PPP3CB Protein
- PPP5C Protein
- PPT1 Protein (Palmitoyl-Protein Thioesterase 1)
- PPT2 Protein
- PRDM2 Histone Methyltransferase (PRDM2)
- PRDX1 (Peroxiredoxin 1)
- PRDX1 Protein (Peroxiredoxin 1)
- PRDX2 (Peroxiredoxin 2)
- PRDX3 Protein
- Presenilin Enhancer 2 (PEN-2) Protein
- Presenilin Protein
- Presenilin-1 (PSEN1)
- Presenilin-2 (PSEN2)
- Prion Protein
- Prion Protein (PRNP)
- Prion Protein (PrP)
- Prion Protein (PrP)
- prkaca Protein
- PRKACB Protein
- PRKCA Protein (Protein Kinase C Alpha)
- PRKCG Protein (PKCγ)
- PRKRA Protein
- PRND Protein - Prion-Like Protein Doppel
- Profilin-1 Protein
- Progranulin (PGRN)
- Progranulin Protein
- Progranulin Protein
- Progranulin Protein
- Progranulin Protein (PGRN)
- Protein Drug Targets
- Protein Families & Clusters
- Protein Kinase C beta
- Protein Kinase C delta
- Protein Kinase C epsilon
- Protein Rankings
- Proteins
- Proteins Overview
- Protocadherin 15
- Protocadherin 15 Protein
- PRPF3 Protein (Pre-mRNA Processing Factor 3)
- PRPF31 Protein
- PRPH Protein
- PSAP Protein
- PSD-93 Protein
- PSD-95 Protein
- PSD-95 Protein (DLG4)
- PSEN1 Protein (Presenilin-1)
- PSEN2 Protein (Presenilin-2)
- PSMA1 Protein
- PSMA2 Protein
- PSMA3 Protein
- PSMA4 Protein
- PSMA5 Protein
- PSMA6 Protein
- PSMB1 Protein
- PSMB10 Protein
- PSMB2 Protein
- PSMB5 Protein
- PSMB6 Protein
- PSMB7 Protein
- PSMB8 Protein
- PSMB9 Protein
- PSPN Protein — Persephin
- PTBP1 Protein — Polypyrimidine Tract Binding Protein 1
- PTEN Protein
- PTEN Protein
- PTEN Protein (Phosphatase and Tensin Homolog)
- PTGS2/COX-2 Protein - Cyclooxygenase-2
- PTK2 Protein - FAK
- PTK2B/PYK2 Protein
- PTPRB Protein (VE-PTP)
- PTPRC Protein - Protein Tyrosine Phosphatase Receptor Type C
- PTPRD Protein
- PTPRF Protein
- PTPRG Protein
- PTPRN2 Protein
- PTPRT Protein
- PTX3 Protein (Pentraxin 3)
- PU.1 Protein (SPI1)
- PUM2 Protein
- PUMA Protein
- PUNDC1 Protein
- PYCARD/ASC Protein
- QDPR Protein
- QKI Protein
- QPCT Protein
- QRFPR Protein
- QRFPR Protein
- QSOX1 Protein
- Rab Interacting Lysosomal Protein Protein
- rab10 Protein
- RAB11A Protein (Ras-Related Protein Rab-11A)
- RAB11B Protein
- RAB12 Protein
- RAB25 Protein
- RAB27A Protein (Ras-Related Protein Rab-27A)
- RAB27B Protein
- RAB28 Protein
- RAB29 Protein
- RAB32 Protein
- RAB38 Protein
- RAB39B Protein
- RAB3A Protein
- RAB3A Protein
- RAB3B Protein
- RAB3B Protein
- rab3c Protein
- RAB4A Protein
- Rab5 Protein
- RAB5A Protein
- RAB5B Protein
- RAB5C Protein
- RAB7 Protein
- RAB7 Protein (Ras-related protein Rab-7a)
- RAB7A Protein
- RAB7L1 Protein
- RAB8A — RAB8A Protein (Ras-Related Protein)
- RABEP1 Protein
- RAC1 Protein
- RAC2 Protein
- RAD18 Protein — DNA Damage Repair and Translesion Synthesis
- RAD23A Protein
- RAD23B Protein
- RAD50 Protein
- RAD51 Protein
- RAG1 Protein
- RAG2 Protein
- RAGE (Receptor for Advanced Glycation End Products)
- RALB Protein - RAS-Related Protein Ral-B
- RAMP1 (Receptor Activity Modifying Protein 1) Protein
- RAMP2 Protein
- RAMP3 expression in tauopathy and amyloid pathology
- RAN GTPase Protein
- RANBP2 Protein
- RAPGEF1 Protein (C3G)
- Raptor Protein
- RASGEF1A Protein
- RASGRF1 Protein — Ras-GRF1
- RASGRF2 (Ras-GRF2) Protein
- RB1 Protein (Retinoblastoma Protein)
- RB1CC1 Protein
- RBFOX1 Protein (A2BP1)
- RBFOX2 Protein
- RBFOX3/NeuN Protein
- RBM10 Protein
- RBM17 Protein (SPF45)
- RBM25 Protein
- RBM38 Protein (RNPC1)
- RBM39 Protein (CAPER)
- RBM45 Protein
- RBPJ Protein
- RCAN1 Protein
- RECQL4 Protein
- Reelin Protein
- Reelin Protein
- REEP1 Protein
- REG3A Protein
- REG3G Protein
- RELA (p65) Protein
- RELB (NF-κB Subunit RelB) Protein
- RELB Protein
- REST Protein — RE1-Silencing Transcription Factor
- RET Protein
- Retinoic Acid Receptor Beta
- Retromer Protein
- REV-ERBα Protein
- REV-ERBβ Protein
- RGS12 Protein
- RGS14 Protein
- RGS2 Protein - Regulator of G Protein Signaling 2
- RGS3 Protein
- RGS4 Protein
- RGS6 Protein
- RGS7 Protein
- RHBDF2 (iRhom2) Protein
- RHEB Protein
- RhoA Protein
- RHOT1 Protein - MIRO1 - Mitochondrial Rho GTPase 1
- RHOT2 Protein
- Ribonuclease Kappa (RNK) — Circular RNA Clearance Mechanism
- Ribophorin I Protein
- Ribophorin II Protein
- Ribosomal Protein L11
- Ribosomal Protein L23
- Ribosomal Protein L23a
- Ribosomal Protein L36a
- Ribosomal Protein L9
- Ribosomal Protein S14
- Ribosomal Protein S20
- Ribosomal Protein S3a
- Ribosomal Protein S6
- RIC3 Protein — Acetylcholine Receptor Chaperone
- RICTOR Protein
- RICTOR Protein
- RIG-I Protein
- RIM1 Protein
- RIM2 Protein
- RIMS1 Protein
- RIMS2 Protein
- RIPK1 (Receptor-Interacting Kinase 1)
- RIPK1 Protein
- RIPK2 Protein
- RIPK3 Protein
- RIPK3 Protein
- RIPOR1 Protein (Rho Family Interacting Protein 1)
- RNF115 Protein
- RNF149 Protein
- RNF182 Protein
- RNF186 Protein
- ROCK1 Protein
- ROCK2 Protein
- Role of cathepsin D in APP processing and Aβ generation
- ROR1 (Receptor Tyrosine Kinase-like Orphan Receptor 1) Protein
- ROR2 (Receptor Tyrosine Kinase-like Orphan Receptor 2) Protein
- RORα Protein
- RORγ Protein
- Roundabout 1 Protein
- Roundabout 2 Protein
- Roundabout 3 Protein
- RPA1 Protein
- RPA2 Protein
- RPL31 Protein
- RPL38 Protein
- RPL39 Protein
- RPL5 Protein
- RPS12 Protein — Ribosomal Protein S12
- RPS15 Protein (Ribosomal Protein S15)
- RPS19 Protein
- RPS24 Protein
- RPS25 Protein
- RPS26 Protein
- RPS3 Protein
- RPS7 Protein
- RPTOR Protein
- RRM2B Protein
- RTN1 Protein (Reticulon-1)
- RTN2 Protein (Nogo)
- RTN3 Protein (Reticulon-3)
- RTN4 Protein (Nogo)
- Rubicon Protein
- RXRA Protein
- Ryanodine Receptor 1 (RyR1 Protein)
- Ryanodine Receptor 1 Protein
- Ryanodine Receptor 2 (RyR2 Protein)
- Ryanodine Receptor 2 Protein
- Ryanodine Receptor 3 (RyR3 Protein)
- Ryanodine Receptor 3 Protein
- S100A1 Protein
- S100A10 Protein
- S100A8 Protein - Calgranulin A
- S100A9 Protein - Calgranulin B
- S100B Protein
- S1PR1 (Sphingosine-1-Phosphate Receptor 1) Protein
- S6K1 Protein
- Sacsin (SACS Protein)
- SALL1 Protein
- SAM50 Protein
- SAP102 Protein — Synapse-Associated Protein 102
- SARM1 Protein
- SCARA1 Protein
- SCARB1 Protein (Scavenger Receptor Class B Type 1)
- SCD1 Protein
- SCFD1 Protein
- SCN10A Protein (Nav1.8)
- SCN11A Protein (Sodium Voltage-Gated Channel Alpha Subunit 11)
- SCN1B Protein
- SCN2B Protein (Sodium Voltage-Gated Channel Beta Subunit 2)
- SCN3A Protein (Sodium Voltage-Gated Channel Alpha Subunit 3)
- SCN3B Protein (Sodium Voltage-Gated Channel Beta Subunit 3)
- SCN4A Protein (Nav1.4)
- SCN4B Protein - Sodium Channel Beta-4 Subunit
- SCN7A Protein (Sodium Voltage-Gated Channel Alpha Subunit 7)
- SCN8A Protein (Sodium Voltage-Gated Channel Alpha Subunit 8)
- SCN9A Protein (Nav1.7)
- SDHA Protein - Succinate Dehydrogenase Complex Subunit A
- SDHB Protein
- SDHC Protein
- Sec61 Translocon Subunit Gamma
- SEC61A1 Protein - Sec61 Translocon Alpha 1
- SEL1L Protein
- Selective blocking of KCNN4 suppresses autoimmune disease
- Selectivity of Aurora kinase inhibitors
- Selectivity of Aurora kinase inhibitors
- SEMA3A Protein
- SENP1 Protein - SUMO Specific Peptidase 1
- SENP2 Protein - SUMO Specific Peptidase 2
- SENP3 Protein
- Separin (SEPSECS) Protein
- Sepiapterin Reductase (SPR)
- Septin-7 Protein
- SEPTIN2 Protein
- SEPTIN4 Protein
- Septin5 Protein
- Sequestosome-1 (p62) Protein
- SERCA (Sarco/Endoplasmic Reticulum Ca²⁺-ATPase)
- SERCA Protein
- SERCA1 Protein — Sarco/Endoplasmic Reticulum Calcium ATPase 1
- Serine Palmitoyltransferase 1 Protein
- Serine Palmitoyltransferase Protein
- Serotonin Receptor 2B Protein
- Serotonin Receptor 3A Protein
- Serpin Neuroprotection in Neurodegeneration
- SESN1 Protein
- SESN2 Protein
- SESN3 Protein
- SETDB1 (SET Domain Bifurcated 1) Protein
- SETX Protein
- SF3B1 Protein
- SFPQ Protein
- SGK1 Protein
- Shank1 Protein
- SHANK1 — Shank1 Protein (Postsynaptic Scaffold)
- SHANK2 Gene — SH3 and Multiple Ankyrin Repeat Domains 2
- SHANK3 Protein - SH3 and Multiple Ankyrin Repeat Domains 3
- SHIP1 (INPP5D) Protein
- SHP2 Protein
- SIGLEC1 Protein
- SIGLEC9 Protein
- Sigma-1 Receptor (Sigmar1)
- Sigma-1 Receptor Protein
- Sigma1R Protein
- SIGMAR1 Protein
- Signal Transducer and Activator of Transcription 4
- SIL1 Protein
- SIN3A Protein
- SIRPA Protein
- SIRT1 Protein
- SIRT2 Protein
- SIRT3 Protein - Mitochondrial Sirtuin
- SIRT4 Protein
- SIRT5 Protein - Mitochondrial Desuccinylase
- SIRT6 Protein
- SIRT7 Protein
- SK1 Protein
- SK2 Protein
- SK3 Protein (KCNN3)
- Slack Channel Protein
- Slack Channel Protein
- Slack Channel Protein (KCNT1)
- SLC17A5 Protein
- slc17a6 Protein
- slc17a7 Protein
- SLC18A2 Protein
- slc1a1 Protein
- SLC1A2 Protein — EAAT2/GLT-1
- slc1a3 Protein
- SLC25A12 Protein
- SLC25A13 Protein
- SLC25A4 Protein
- SLC2A4RG Protein (SLC2A4 Regulator)
- SLC30A10 Protein
- SLC39A14 Protein
- SLC39A8 Protein
- SLC6A1 Protein — GABA Transporter 1
- SLC6A3 Protein
- slc6a4 Protein
- Slick Channel Protein
- Slit 1 Protein
- Slit 2 Protein
- SMAC/DIABLO Protein
- SMAD Family Member 3
- SMAD Family Member 6
- SMAD Family Member 7
- SMAD Family Member 9
- SMAD1 Protein
- SMAD2 Protein
- SMAD4 Protein
- SMAD5 (SMAD Family Member 5) Protein
- Small molecule MAPK inhibitors for neuroprotection
- SMARCA2 Protein (BAF155)
- SMN Protein
- SMN1 Protein
- SMN2 Protein
- SMURF1 Protein
- SNAP-25
- SNAP-25 Protein
- SNAP23 Protein
- SNAP25 (Synaptosomal-Associated Protein 25)
- SNAP29 Protein
- SNAP47 Protein
- SNAPIN Protein
- SNARE Complex
- SNCAIP Protein
- SNCB Protein
- SNCG Protein (Gamma-Synuclein)
- SNRNP200 Protein
- SNRNP70 Protein
- SNX1 Protein
- SNX2 Protein
- SNX3 Protein — Sorting Nexin 3 in Neurodegeneration
- SOD1 (Cu/Zn Superoxide Dismutase)
- SOD1 Protein
- SOD1 Protein
- SOD2 Protein
- SOD3 Protein (Extracellular Superoxide Dismutase)
- Sodium Channel Nav1.1 (SCN1A) Protein
- Somatostatin (SST)
- SORCS1 Protein
- SORCS3 Protein
- SORL1 Protein
- SORL1 Protein
- SORL1 Protein
- SORT1 Protein (Sortilin 1)
- Sortilin 1 Protein
- Sortilin Protein
- SOX10 Protein
- SOX2 Protein
- Sp1 Protein
- SPARC Protein
- SPART Protein — Spartin
- Spastin Protein
- Spastin Protein
- SPATA18 Protein
- SPATA5 Protein
- Spatacsin Protein (SPG11)
- Spectrin Alpha Protein
- SPG11 Cytoskeletal Protein
- SPG11 Protein
- SPG15 Protein - ZFYVE26
- SPG20 Protein
- SPG7 Protein — Paraplegin
- SPHK1 Protein
- Spinophilin (PPP1R9B)
- SPTLC1 Protein (Serine Palmitoyltransferase 1)
- SPTLC2 Protein
- SQSTM1 Protein (p62/Sequestosome-1)
- SQSTM1/p62 Protein
- SRC Protein (SRC Proto-Oncogene)
- SREBF2 Protein — Sterol Regulatory Element Binding Factor 2 (SREBP-2)
- SREBP1 Protein
- SREBP1 Protein (Sterol Regulatory Element-Binding Protein 1)
- SRP19 Protein - Signal Recognition Particle 19
- SRR Protein — Serine Racemase
- SRSF1 Protein
- SRSF2 Protein
- SRSF3 Protein
- SRSF9 Protein
- SRXN1 Protein
- SSBP1 Protein
- SST Protein — Somatostatin
- St6galnac5 (ST6 N-acetylneuraminic acid alpha-2,6-sialyltransferase)
- STAT1 Protein
- STAT2 Protein
- STAT3 Protein
- Stathmin 1 Protein
- Stathmin 2 (SCG10) Protein
- Stathmin Protein
- Stathmin-1 Protein
- Stathmin-1 Protein
- Stathmin-2 Protein
- Stathmin-2 Protein
- [Stathmin-2** is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Redirecting to Stathmin-2 (SCG10)
- Staufen2 Protein
- STIM1 Protein
- STING Protein
- STING Protein
- STIP1 Protein
- STK11 Protein - LKB1 - Serine/Threonine Kinase 11
- STK24 Protein
- STK25 Protein
- Structural basis for DNAJC14 function. Nat Commun. 2023;14(1):2947
- Strumpellin (KIAA0196/WASHC5 Protein)
- STUB1/CHIP Protein
- STX1 — Syntaxin-1
- STX17 Protein
- STXBP1 Protein
- STXBP2 Protein (Munc18-2)
- Succinyl-CoA Ligase ADP-Forming Subunit Beta Protein
- Succinyl-CoA Ligase GDP-Forming Subunit Alpha Protein
- SUMF1 Protein - Sulfatase Modifying Factor 1
- SUMO1 Protein - Small Ubiquitin-Like Modifier 1
- SUMO2 Protein - Small Ubiquitin-Like Modifier 2
- Survival Motor Neuron (SMN)
- SV2A Protein
- SV2C Protein
- SYF2 Protein
- SYK Protein
- SYN2 Protein
- SYN3 Protein
- Synaphin Protein
- Synapse-Associated Protein 97
- Synapsin I Protein
- Synapsin I Protein
- Synapsin II Protein
- Synapsin-1 Protein
- Synapsin-1 Protein (SYN1)
- Synapsin-2 Protein
- Synapsin1 Protein
- Synaptic calcium-permeable AMPA receptors in neurodegeneration
- Synaptic Vesicle Glycoprotein 2B Protein
- Synaptic vesicle proteins and neuronal activity
- SYNAPTOBREVIN-2 Protein (VAMP2)
- Synaptogyrin 1 Protein
- Synaptojanin 1 Protein
- Synaptojanin 2 Protein
- Synaptojanin-1 Protein
- Synaptophysin Protein
- Synaptophysin Protein (SYP)
- Synaptophysin Test
- Synaptopodin (SYNPO Protein)
- Synaptotagmin-1
- Synaptotagmin-1 Protein
- Synaptotagmin-1 Protein
- Synaptotagmin-1 Protein (SYT1)
- Synaptotagmin-2 Protein
- Synaptotagmin-2 Protein
- Synaptotagmin-2 Protein
- Synaptotagmin-3 Protein
- Synaptotagmin-7
- Synaptotagmin-7 Protein
- Syndecan-3 Protein (SDC3)
- Syndecan-4 Protein (SDC4)
- SYNE1 Protein
- SynGAP Protein
- SYNJ1 Protein
- Synphilin-1 Protein
- SYNPR Protein
- Syntaxin 6 Protein
- Syntaxin-1A Protein
- Syntaxin-1A Protein
- Syntaxin-1A Protein
- Syntaxin-1B (STX1B)
- Syntaxin-binding protein 5
- SYT11 Protein
- TAB1 Protein (TAK1-Binding Protein 1)
- TAB2 Protein
- TAB2 Protein (TAK1-Binding Protein 2)
- TAB3 Protein
- TAB3 Protein — TAK1-Binding Protein 3
- TAC1 (Tachykinin Precursor 1) Protein
- TACI Protein (Transmembrane Activator and Calcium Modulator)
- TAF15 Protein
- TAK1 Protein
- TAK1 Protein
- TALDO1 Protein
- Tankyrase (TNKS) Protein
- TAOK1 Protein
- TAOK2 Protein
- TAR DNA-Binding Protein 43 (TDP-43)
- TARDBP/TDP-43 Protein
- Targeting caspase-8 for neuroprotection
- Targeting complement in neuroinflammatory diseases
- Targeting Frizzled-6 in cancer: therapeutic potential and challenges
- Targeting microglia in neurodegenerative disease
- Targeting mitochondrial ATP synthase in neurodegenerative disease
- Targeting Nav1.8 for chronic pain
- Targeting RNA-binding proteins in cancer therapy
- Targeting splicing factors for cancer and neurodegeneration
- Tau Protein
- TBC1D24 Protein
- TBCK Protein
- TBK1 Protein
- TBK1 Protein (TANK-Binding Kinase 1)
- TBP Protein - TATA-Box Binding Protein
- TCF4 Protein
- TCTP Protein
- TDP-43 Protein
- TDP-43 Protein
- TDP-43 Protein
- TDP-43 Protein
- TDP2 Protein
- Tenascin C Protein
- Tenascin-C Protein (Tenascin-C, TNC)
- Terazosin and doxazosin in Parkinson disease (Mov Disord, 2018)
- TERT Protein
- Tet Methylcytosine Dioxygenase 1 Protein
- Tet Methylcytosine Dioxygenase 2 Protein
- Tet Methylcytosine Dioxygenase 3 Protein
- TFAM Protein
- TFAP4 Protein
- TFE3 Protein
- TFEB Protein
- TFEB Protein (Transcription Factor EB)
- TFG Protein (TRK-Fused Gene)
- TFIIH and nucleotide excision repair in neurons. DNA Repair (Amst). 2018;66:27-37
- TFRC Protein
- TGF-beta Receptor 1 (TGFβR1) Protein
- TGF-beta1 Protein
- TGF-β Receptor 1 (TGFBR1) Protein
- TGF-β Receptor 2 (TGFBR2) Protein
- TGF-β1 Protein
- TGFB2 Protein
- TGFB3 Protein
- TGFBR2 Protein — Transforming Growth Factor Beta Receptor 2
- TGM2 Protein
- TH Protein — Tyrosine Hydroxylase
- The DNAJ family in aging and longevity
- The dual role of Aurora kinases in protein aggregation diseases. Prog Neurobiol. 2023;227:102376
- The Nrf2/ARE signaling pathway and peroxiredoxin
- Therapeutic modulation of vesicular GABA transport
- Therapeutic potential of DLGAP2 modulation in synaptic disorders
- Thymidine Kinase 2 Protein
- Thymidine Phosphorylase Protein
- TIA1 Protein
- TIA1 Protein
- TIA1L Protein
- TIAL1 Protein (TIA1 Cytotoxic Granule-Associated RNA Binding Protein)
- TIC1 Protein
- TIGAR Protein — TP53-Induced Glycolysis and Apoptosis Regulator
- TIGD1 Protein
- TIGD2 Protein
- TIM23 Protein (Translocase of Inner Mitochondrial Membrane 23)
- TIMM10 Protein — Mitochondrial Import Inner Membrane Translocase Subunit Tim10
- TIMM13 Protein
- TIMM22 Protein
- TIMM23 Protein — Translocase of Inner Mitochondrial Membrane 23
- TIMM50 Protein - Mitochondrial Import Protein
- TIMM8A Protein
- TIMM8B Protein - Mitochondrial Import Protein
- TK2 Protein
- TKT Protein
- TLP (TROVE1) Protein
- TLR1 Protein
- TLR2 Protein — Toll-Like Receptor 2
- TLR3 Protein — Toll-Like Receptor 3
- TLR4 Protein
- TLR5 Protein
- TLR6 Protein
- TLR7 Protein
- TLR8 Protein
- TLR9 Protein — Toll-Like Receptor 9
- TMEM106B
- TMEM106B Protein (Transmembrane Protein 106B)
- TMEM119 Protein
- TMEM135 Protein
- TMEM163 Protein (Transmembrane Protein 163)
- TMEM175 Protein
- TMEM175 Protein
- TMEM199 Protein — Transmembrane Protein 199
- TMEM229B Protein
- TMEM230 Protein
- TMEM266 Protein
- TMEM57 Protein
- TMEM9 Protein
- TMX2 Protein
- TNF Alpha Protein
- TNF-alpha Protein - Tumor Necrosis Factor
- TNFAIP3 Protein
- TNFR1 Protein
- TNFR1 Protein
- TNFR2 (TNFRSF1B Protein)
- TNK2/ACK1 Protein
- TNKS Protein
- TNKS2 Protein
- TNN Protein
- Toll-Like Receptor 4 (TLR4)
- TOLLIP Protein
- TOMM20 Protein
- TOMM22 — Translocase of Outer Mitochondrial Membrane 22
- TOMM40 Protein
- TOMM70 Protein
- TOR1A Protein
- TP53 Protein (p53)
- TPM1 Protein — Tropomyosin 1
- TPM2 Protein — Tropomyosin 2
- TPM3 Protein — Tropomyosin 3
- TPP1 Protein (Tripeptidyl Peptidase 1)
- TPPP/p25alpha Protein
- TPPP3 Protein
- TRA2B Protein - Transformer-2 Beta
- TRADD Protein
- TRAF2 Protein
- TRAF6 Protein
- TRAF6 Protein
- TRAIL (TNFSF10) Protein
- TRAIL Protein
- Transferrin Protein
- Transferrin Protein
- Transferrin Receptor 1 (TFRC)
- Transferrin Receptor 2
- Transglutaminase 6 Protein
- TRAP1 Protein
- TREK-1 Protein
- TREM2 Protein
- TREM2 Protein — Triggering Receptor Expressed on Myeloid Cells 2
- TREML2 Protein (TREM-like transcript 2)
- TRESK Protein
- TREX1 Protein
- TRIM16 Protein
- TRIM2 Protein
- TRIM28 (KAP1) Protein
- TRIM32 Protein
- TRIM32 Protein
- TrkA (Tropomyosin Receptor Kinase A) (NTRK1)
- TrkA Protein — Tropomyosin Receptor Kinase A
- TrkB Protein
- TrkB Protein
- TrkB Protein
- TrkC (Tropomyosin Receptor Kinase C) (NTRK3)
- TrkC Protein
- TRPA1 Protein
- TRPA1 Protein
- TRPC1 Protein
- TRPM1 Protein (Melastatin)
- TRPM2 (Transient Receptor Potential Melastatin 2)
- TRPM2 Protein - Transient Receptor Potential Melastatin 2
- TRPM3 Protein
- TRPM4 Protein
- TRPM5 Protein
- TRPM6 Protein
- TRPM8 — TRPM8 Protein
- TRPV1 Protein
- TRPV2 Protein
- TRPV4 Protein
- TSC1 Protein — Hamartin
- TTR (Transthyretin) Protein
- TTR Protein (Transthyretin)
- TUBA1A Protein
- TUBA4A Protein
- TUBB2A Protein
- TUBB2B Protein
- TUBB3 mutations and neuropathy
- TUBB3 Protein
- TUBB4B Protein
- TUBB6 Protein
- Tuberin Protein
- TUBG1 Protein
- Tubulin Beta-4A Protein
- Tubulin Protein
- Tumor Protein P53
- TWEAK Protein
- TWIK-2 Protein
- Twinkle (Mitochondrial DNA Helicase)
- TWNK Protein
- TXNRD1 Protein
- TYK2 Protein — Tyrosine Kinase 2
- Tyro3 Protein
- TYROBP Protein (DAP12)
- TYROBP/DAP12 Protein
- Tyrosyl-DNA Phosphodiesterase 1
- U2AF1 Protein
- U2AF2 Protein
- UBA1 Protein (E1 Ubiquitin-Activating Enzyme)
- UBC Protein
- UBC9 Protein
- UBE2A Protein
- UBE2B Protein
- UBE2C Protein
- UBE2I Protein
- UBE2K Protein
- UBE2L3 Protein
- UBE2N Protein
- UBE2V2 Protein
- UBE3A Protein
- Ubiquilin Protein
- Ubiquilin-2 (UBQLN2)
- Ubiquilin-4 Protein
- Ubiquitin
- Ubiquitin B (UBB) Protein
- Ubiquitin Protein
- Ubiquitin-B Protein
- Ubiquitin-C Protein
- UBQLN1 Protein — Ubiquilin 1
- UBQLN2
- UBQLN2 Protein
- UBQLN2 Protein
- UBSLN Protein (Ubisolin)
- UBXD1 Protein
- UCHL1 Protein
- UFD1 Protein
- UFL1 Protein (UFM1-Specific Protease 1)
- UGCG Protein (UDP-Glucose Ceramide Glucosyltransferase)
- UGDH in the context of synaptic plasticity and memory formation
- UHRF1 polymorphisms and neurodegenerative disease risk
- ULK1 Protein
- ULK1 — ULK1 Protein
- ULK2 Protein
- ULK3 Protein
- ULK4 Protein
- UNC-5A Protein
- UNC-5B Protein
- UNC-5D Protein
- UNC13A Protein
- UNC13A Protein
- UNC5C Protein (Unc-5 Netrin Receptor C)
- Uncoupling Protein 2 (UCP2)
- Uncoupling Protein 3 (UCP3)
- UNG Protein
- UniProt
- Update TDP-43 protein page with comprehensive content
- UPF3B Protein (Up-frameshift Protein 3B)
- USF1 Protein
- USF2 Protein
- USH1G Protein
- USH2A Protein
- USHER Syndrome 1G Protein
- USP10 Protein
- USP14 Protein
- USP15 Protein
- USP19 Protein
- USP24 Protein
- USP30 Protein
- USP7 Protein (HAUSP Deubiquitinase)
- VAChT Protein
- Vacuolar protein sorting-associated protein 26A
- Vacuolar protein sorting-associated protein 29
- Valosin-Containing Protein (VCP)
- VAMP1 Protein
- VAMP2 Protein
- VAMP2 Protein
- VAMP2 — Synaptobrevin-2
- VAMP3 Protein (Cellubrevin)
- VAPB Protein
- Vascular Endothelial Growth Factor (VEGF)
- Vasopressin Protein (Arginine Vasopressin)
- VCAM1 Protein
- VCP (Valosin-Containing Protein)
- VCP Gene
- VCP Protein
- VCP Protein (p97)
- VDAC1 Protein
- VDAC2 — Voltage-Dependent Anion Channel 2 Protein
- VDAC3 Protein
- VEGFA Protein - Vascular Endothelial Growth Factor A
- VEGFB Protein
- VEGFR1 (FLT1) Protein
- VEGFR2 (KDR) Protein
- Vesicular GABA Transporter
- VGAT Protein
- VGF Nerve Growth Factor
- VGF Protein — VGF Nerve Growth Factor Inducible
- VGLUT1 Protein
- VGLUT1 Protein (SLC17A7)
- VGLUT2 Protein
- VGLUT3 Protein
- VHL Protein
- VIM Protein
- Vimentin mutations cause giant axonal neuropathy
- Vimentin Protein
- Vimentin Protein
- Vipr1 Protein
- VLDL Receptor
- VMAT1 Protein
- VMAT1 Protein
- VMAT2 Protein
- VPS13 proteins: lipid transporters at membrane contact sites. J Cell Sci
- VPS13A Protein
- VPS13C Protein
- VPS13D Protein
- VPS13D Protein
- VPS16 Protein
- VPS33A Protein
- VPS33B Protein
- VPS34 Protein
- VPS35 Protein
- VPS35 Protein
- VPS4 Protein
- VPS4A Protein — Vacuolar Protein Sorting 4 Homolog A
- VPS51 Protein
- VPS53 Protein
- VPS54 Protein
- VRK1 Protein — Vaccinia-Related Kinase 1
- VTI1A Protein
- VTI1A Protein (Vesicle Transport Through Interaction with TIA-1 1A)
- VTI1B Protein (Vesicle Transport through Interaction with t-SNAREs 1B)
- VTN Protein (Vitronectin)
- WAS Protein
- WASF2 Protein
- WASHC2 Protein
- WAVE1 Protein
- WDR43 Protein
- WDR45 Protein (WIPR1)
- WDR45B Protein
- WDR62 Protein
- WDR7 Protein
- WDR7 Protein (WD Repeat Domain 7)
- WDR81 Protein
- WEE1 Protein
- WFS1 Protein - Wolframmin
- WIF1 Protein - Wnt Inhibitory Factor
- WIPI1 Protein
- WIPI1 Protein
- WIPI2 Protein
- WIPI2 Protein - Autophagy Protein
- WIPI3 Protein
- WIPI4 Protein
- Wnt/beta-catenin activation promotes alpha-synuclein clearance in Parkinson's disease models
- WNT1 Protein
- WNT2 Protein
- WNT3A Protein
- WNT5A Protein
- WRN Protein - Werner Syndrome RecQ Like Helicase
- WTAP Protein (Wilms' Tumor 1-Associated Protein)
- WWTR1 Protein
- X-linked Inhibitor of Apoptosis Protein (XIAP)
- XBP1 - X-Box Binding Protein 1
- XBP1 Protein
- xCT Protein - SLC7A11 Cystine/Glutamate Antiporter
- XK Protein
- XPO1/CRM1 Protein
- XRCC1 Protein
- XRCC2 Protein - DNA Repair Protein
- XRCC3 Protein
- XRCC4 Protein
- XRCC5 (Ku80) Protein
- XRCC7 Protein (DNA-PKcs)
- YAP1 Protein
- YBX1 Protein
- Yes1 — Proto-Oncogene Tyrosine-Protein Kinase Yes1
- YKL-40 Protein
- YME1L1 Protein
- YOD1 Protein
- YWHAB Protein
- YWHAE Protein
- YWHAG Protein
- YWHAH Protein (14-3-3 Eta)
- YWHAQ Protein
- ZBP1 Protein
- ZC3HAV1 Protein
- ZCWPW1 Protein
- ZFYVE19 Protein
- ZFYVE26 Protein
- ZNF746 Protein
- ZPR1 Protein
- α-Syn phosphorylation in disease
- α2δ-1 Calcium Channel Subunit
- α2δ-4 Protein
- αB-Crystallin (CRYAB)
- βIII-Spectrin
- "Nav channel distribution in AIS." J Neurosci
- "Sleep and autonomic dysfunction in Parkinson's disease." Journal of Neurology, Neurosurgery & Psychiatry. 2006
- ''Coyle JT, Price DL, DeLong MR. Alzheimer''s disease: a disorder of cortical cholinergic innervation. Science. 1983;219(4589):1184-1190. PMID:2954786''
- ''Trace amine-associated receptor 1: A promising target for neuroprotective therapy in Parkinson''s disease. Ageing Research Reviews. 2023;85:101865. DOI:10.1016/j.arr.2023.101865''
- ''Vanhoesen J, Schapira AHV. The gut-brain axis in Parkinson''s disease: new insights from pathogenesis to therapy. Nat Rev Neurol. 2019;15(12):707-709. DOI''
- 'Aguggia M, et al. Serotonin receptor modulation and neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109882.'
- 'Dentate nucleus physiology and dysfunction'
- 'Kisspeptin therapy in Alzheimer's disease: Preclinical evidence. Ann Neurol. 2024'
- 'Onuf''s nucleus: a morphological and functional study. Surg Radiol Anat. 2007'
- 'Processing of sound in the auditory cortex'
- 'Thalamic relay functions and their modulation by behavioral state'
- (2007) Hippocampal formation. Oxford University Press. PMID:18670917
- (2020)
- (2020) Cholinergic modulation of hippocampal circuits. Neuron. PMID:32078796
- (2023) Layer 2/3 connectivity in neurodegeneration. Cell Rep. PMID:37068023
- -nucleus-neCuneate Nucleus Neurons
- 3D Bioprinted Neurons
- 5-HT1A Neurons
- 5-HT2A Neurons
- 5-HT2C Neurons
- 5-HT3A Neurons
- A1 Noradrenergic Neurons
- A1 Reactive Astrocytes
- A2 Noradrenergic Neurons
- A5 Noradrenergic Neurons
- A7 Noradrenergic Neurons
- AADC Neurons
- Abducens Internuclear Neurons
- Abducens Nucleus
- Abducens Nucleus (ABD) Neurons
- Abducens Nucleus (CN VI) Neurons
- Abducens Nucleus Cholinergic Neurons
- Abducens Nucleus Motor Neurons
- Abducens Nucleus Neurons
- Accessory Cervical Nucleus
- Accessory Cuneate Nucleus
- Accessory Cuneate Nucleus
- Accessory Cuneate Nucleus in Vestibular Processing
- Accessory Cuneate Nucleus Neurons
- Accessory Nerve Nucleus
- Accessory Nucleus
- Accessory Nucleus in Head Movement
- Accessory Nucleus Neurons (Edinger-Westphal Nucleus)
- Accessory Oculomotor Nucleus Neurons
- Accessory Olfactory Bulb (AOB)
- Accessory Olfactory Bulb Neurons
- Accessory Olivary Neurons
- Accessory Olivary Nuclei in Motor Learning
- Accessory Olivary Nucleus
- Accessory Olive (AO) Neurons
- Accessory Olive (Expanded)
- Accessory Optic System (AOS) Neurons
- Accessory Optic System (AOS) Neurons
- Accessory Optic System (AOS) Neurons
- Accumbens Core in Behavioral Flexibility
- Adenosine A2A Receptor Neurons
- Adenosine A2B Receptor Neurons
- Adenosine A3 Receptor Neurons
- Adenosine Receptor (A1/A2A) Neurons
- Adiponectin-Responsive Neurons
- Adrenal Chromaffin Cells
- Adrenal Chromaffin Cells in Neurodegeneration
- Aggression Cells
- Aging Microglia
- Aging Oligodendrocytes
- Aging-Associated Astrocytes
- Agranular Insular Cortex Neurons
- AgRP (Agouti-Related Protein) Neurons
- AgRP/NPY Neurons
- AII Amacrine Cells
- AKT (Protein Kinase B) Neurons
- ALDH1A1+ Dopamine Neurons
- Allen Brain Map. Cell type taxonomy. Allen Brain Atlas
- Alpha Locus Coeruleus Neurons
- Alpha Motor Neurons
- Alpha Motor Neurons
- Alpha-1 Adrenergic Neurons
- Alpha-1 Adrenergic Receptor Neurons
- Alpha-2 Adrenergic Neurons
- Alpha-2 Adrenergic Receptor Neurons
- Alpha-Melanocyte-Stimulating Hormone (α-MSH) Neurons
- Alpha-Synuclein Aggregation in Dopaminergic Neurons
- Alpha-Synuclein Expressing Neurons
- Alpha-Synuclein Overexpressing Neurons
- Alpha-Synuclein-Exposed Neurons
- Alpha-Synucleinopathy-Associated Neurons
- ALS-FTD Overlap Neurons
- Alzheimer's disease: a disorder of cortical cholinergic innervation
- Amacrine Cells (Retina)
- Amacrine Cells in Motion Detection
- Ambiguus Nucleus
- Ambra1 Neurons
- AMPA Receptor Neurons
- Amygdala Central Nucleus GABA Output Neurons
- Amygdala Central Nucleus in Fear and Stress Responses
- Amygdala Central Nucleus in Neurodegeneration
- Amygdala Central Nucleus Neurons
- Amygdala CRH Neurons
- Amygdala Granular Neurons
- Amygdala in Fear Memory
- Amygdala Neurons
- Amygdala Neurons in Parkinson's Disease
- Amyloid-Beta Accumulating Neurons
- Amyloid-Beta Metabolism in Cortical Neurons
- Amyloid-Beta-Exposed Neurons
- Amyloid-Beta-Exposed Neurons
- Angular Gyrus
- Angular Gyrus Neurons
- Antagonism of central melanin-concentrating hormone 1 receptors reduces food intake and body weight. Endocrinology. 2021;162(5):bqab038. DOI:10.1210/endocr/bqab038
- Anterior Cingulate Cortex (ACC) Neurons
- Anterior Cingulate Cortex (ACC) Pyramidal Neurons
- Anterior Cingulate Cortex Neurons
- Anterior Cingulate Cortex Neurons in Alzheimer's Disease
- Anterior Cingulate Cortex Pyramidal Neurons
- Anterior Commissure Fibers
- Anterior Hypothalamic Area Neurons
- Anterior Hypothalamic Nucleus Neurons
- Anterior Olfactory Nucleus (AON) Neurons
- Anterior Olivary Complex
- Anterior Pretectal Nucleus (APT) Neurons
- Anterior Thalamic Nuclei
- Anterior Thalamic Nucleus (ATN) Neurons
- Anterodorsal Thalamic Nucleus (AD) Neurons
- Anteroventral Cochlear Nucleus
- Anteroventral Periventricular Nucleus Neurons
- Anteroventral Thalamic Nucleus (AV) Neurons
- Anteroventral Thalamic Nucleus Neurons
- Anti-AMPAR Encephalitis-Affected Neurons
- Anti-CASPR2 Encephalitis-Affected Neurons
- Anti-GABA-B Receptor Encephalitis-Affected Neurons
- Anti-LGI1 Encephalitis-Affected Neurons
- Anti-NMDA Receptor Encephalitis-Affected Neurons
- APOE-Expressing Astrocytes
- APOE4 Homozygous Astrocytes
- APP-Overexpressing Neurons
- Arachnoid Membrane Cells
- Arcuate NPY Neurons in Neurodegeneration
- Arcuate NPY/AgRP in Appetite
- Arcuate NPY/AgRP Neurons
- Arcuate Nucleus (ARC) Expanded
- Arcuate Nucleus (ARC) Neurons
- Arcuate Nucleus Dopamine Neurons
- Arcuate Nucleus Dopamine Neurons
- Arcuate Nucleus Expanded v2
- Arcuate Nucleus in Neuroendocrine Control
- Arcuate Nucleus Neurons
- Arcuate Nucleus Neurons
- Arcuate Nucleus NPY Neurons
- Arcuate Nucleus NPY/AgRP Neurons
- Arcuate Nucleus NPY/AgRP Neurons
- Arcuate Nucleus of Medulla
- Arcuate Nucleus POMC in Energy Balance
- Arcuate Nucleus POMC Neurons
- Arcuate Nucleus POMC Neurons
- Arcuate Nucleus POMC Neurons
- Arcuate Nucleus POMC Neurons
- Arcuate Nucleus POMC Neurons
- Arcuate Nucleus POMC Neurons - Expanded
- Arcuate Nucleus TH Neurons
- Arcuate POMC Neurons
- Area Postrema Expanded
- Area Postrema Neurons
- Area Postrema Neurons
- Area Postrema Neurons in Chemotherapy-Induced Nausea
- Argyrophilic Grain Disease (AGD) Neurons
- Arx Neurons
- Astroblasts
- Astrocyte Precursor Cells
- Astrocytes
- Astrocytes in ALS
- Astrocytes in Amyotrophic Lateral Sclerosis
- Astrocytes in Argyrophilic Grain Disease
- Astrocytes in Brain Homeostasis
- Astrocytes in Dementia with Lewy Bodies
- Astrocytes in Hepatic Encephalopathy
- Astrocytes in Neurodegeneration
- Astrocytes in Neurodegeneration
- Astrocytes in Parkinson's Disease Neurodegeneration
- Astrocytes in Parkinson's Disease Neurodegeneration
- Astrocytes in Wilson Disease
- Astroglia (Astrocytes)
- ATP P2X3 Receptor Neurons
- Atrophic Neurons
- Auditory pathway in neurodegeneration
- Auditory plasticity in the brainstem
- Autonomic Ganglion Neurons in Neurodegeneration
- Autonomic Neurons
- Autonomic Neurons in Multiple System Atrophy
- Autonomic Neurons in Multiple System Atrophy
- Autophagy-Deficient Neurons
- Autophagy-Deficient Neurons in Neurodegeneration
- Autophagy-Impaired Neurons
- Autophagy-Lysosomal Dysfunction Neurons
- AVP (Arginine Vasopressin) Neurons
- Axo-Axonic Cells
- Axo-Axonic Cells (Chandelier Cells)
- Axon Initial Segment (AIS) Neurons
- Axon Initial Segment (AIS) Neurons
- Axon Initial Segments
- Axonal Degeneration-Prone Neurons
- B Cells (B Lymphocytes)
- B-Lymphocytes (CNS)
- Baroreceptor Neurons
- Barrington's Nucleus (Pontine Micturition Center) Neurons
- Barrington's Nucleus in Micturition
- Barthel's Ganglion
- Basal Forebrain Cholinergic in Lewy Body Disease
- Basal Forebrain Cholinergic in Memory
- Basal Forebrain Cholinergic Neurons
- Basal Forebrain Cholinergic Neurons
- Basal Forebrain Cholinergic Neurons (BFCN) Expanded
- Basal Forebrain Cholinergic Neurons in Alzheimer's Disease
- Basal Forebrain Cholinergic Neurons in Alzheimer's Disease
- Basal Forebrain Cholinergic Neurons in Alzheimer's Disease
- Basal Forebrain Cholinergic Neurons in Down Syndrome
- Basal Forebrain Cholinergic Projection Neurons
- Basal Forebrain GABAergic Neurons
- Basal Ganglia Direct and Indirect Pathway Neurons
- Basal Ganglia Output Neurons
- Basal Nucleus of Meynert (Expanded)
- Basal Nucleus of Meynert Neurons
- Basal Radial Glia
- Basilar Pontine Nuclei Neurons
- Basket Cells
- Basket Cells (Fast-Spiking PV+)
- Basket Neurons
- Basolateral Amygdala (BLA) Neurons
- Basolateral Amygdala Expanded v2
- Basolateral Amygdala in Emotional Memory
- Basolateral Amygdala Neurons
- Basolateral Amygdala Pyramidal Neurons
- BDNF and melatonin in neurodegenerative diseases
- BDNF Neurons
- BDNF Neurons
- Beclin-1 (BECN1) Neurons
- Bed Nucleus of Stria Terminalis Expanded v2
- Bed Nucleus of Stria Terminalis in Anxiety
- Bed Nucleus of Stria Terminalis in Stress
- Bed Nucleus of the Acoustic Stria
- Bed Nucleus of the Stria Terminalis (BNST) Neurons
- Bed Nucleus of the Stria Terminalis (BNST) Neurons
- Bed Nucleus of the Stria Terminalis Dorsal Neurons
- Bed Nucleus of the Stria Terminalis Dorsal Neurons
- Bed Nucleus of the Stria Terminalis in Anxiety
- Bed Nucleus of the Stria Terminalis Neurons
- Bed Nucleus of the Stria Terminalis Neurons in Neurodegeneration
- Bergmann Glia
- Beta Tanycytes
- Beta-1 Adrenergic Receptor Neurons
- Beta-2 Adrenergic Receptor Neurons
- Beta-3 Adrenergic Receptor Neurons
- Beta-Endorphin Neurons
- Betz Cells
- Betz Cells (Primary Motor Cortex)
- Betz Cells in Amyotrophic Lateral Sclerosis
- Betz Cells in Hereditary Spastic Paraplegia
- Biomarker Neuron Entities
- Bipolar Cells in Visual Processing
- Bipolar Neurons in Neurodegeneration
- Bistratified Cells
- Bistratified Interneurons
- Blood-Brain Barrier
- Blood-brain barrier repair after stroke
- Blood-Brain Barrier Transport Cells
- BNST Anterior Division
- BNST Posterior Division
- BNST Vasopressin Neurons
- Border Cells
- Botzinger Complex Neurons
- Brain Capillary Endothelial Cells
- Brain Endothelial Cells
- Brain Endothelial Cells
- Brain Endothelial Cells in Neurodegeneration
- Brain Ependymal Cells
- Brain Organoid Neurons
- Brain Pericytes
- Brain Pericytes in Neurodegeneration
- Brain Pericytes in Neurodegeneration
- Brain Pericytes in Neurodegeneration
- Brain resting-state abnormalities in chronic pain
- Brain Vascular Endothelial Cells
- Brain Venous Endothelial Cells
- Brainstem Dorsal Raphe Serotonin Neurons
- Brainstem Laterodorsal Tegmental Nucleus
- Brainstem Nuclei in Multiple System Atrophy
- Brainstem Nucleus Ambiguus Motoneurons
- Brainstem Pre-Botzinger Complex Neurons
- Brainstem Reticular Neurons
- Brainstem Serotonergic Neurons
- Brainstem Serotonergic Neurons in Parkinson Disease
- Brainstem Serotonergic Raphe Neurons
- Brocas Area
- Bushy Cells (Auditory Brainstem)
- Bötzinger Complex
- Bötzinger Complex Neurons
- C9orf72 iPSC-Derived Neurons
- C9orf72 Motor Neurons
- C9orf72-Deficient Neurons
- Ca1 Pyramidal Neurons
- CA2 Pyramidal Neurons
- CA3 Mossy Cells
- CA3 Pyramidal Cells
- CA3 Pyramidal Neurons
- CA3 Pyramidal Neurons
- CADASIL Vascular Cells
- Cajal-Retzius Cells
- Cajal-Retzius Neurons
- Calbindin Neurons
- Calbindin-Positive Neurons in Alzheimer's Disease
- Calcitonin Gene-Related Peptide (CGRP) Neurons
- Calcium channels in ALS excitotoxicity
- Calcium Dysregulation-Vulnerable Neurons
- Calcium Homeostasis in Neurons
- Calcium-Binding Protein Neurons
- Calcium-Dysregulated Neurons
- Calcium/Calmodulin-Dependent Protein Kinase (CaMK) Neurons
- Calretinin (CR+) Interneurons
- Calretinin Interneurons
- Calretinin Neurons
- Calretinin Positive Interneurons
- Calretinin-Positive Neurons in Alzheimer's Disease
- Cannabinoid CB1 Receptor Neurons
- Cannabinoid Receptor Neurons
- Cardiac Intrinsic Neurons
- Cardiovagal Neurons in the Nucleus of the Solitary Tract
- Carotid Body Chemoreceptor Cells
- CART Neurons
- CART Peptide Neurons
- CART Receptor Neurons
- Catecholaminergic Neurons
- Caudal Ventrolateral Medulla in Baroreflex
- Caudal Ventrolateral Medulla Neurons
- Caudal Ventrolateral Medulla Neurons
- Caudate Head in Habit Formation
- Caudate Nucleus
- Caudate Nucleus Neurons
- Caudate Nucleus Projection Neurons
- CB1 Cannabinoid Receptor Neurons
- CCK Interneurons (Hippocampus)
- Cck Positive Interneurons
- CCK-A (CCKAR) Neurons
- CCK-B (CCKBR) Neurons
- CCR5 Neurons
- CD33-Positive Microglia
- Celiac Ganglion Neurons
- Cell Atlas Coverage
- Cell Atlas Markers
- Cell biology of spinocerebellar ataxias
- Cell Type Atlas
- Cell Type Rankings
- Cell Type Vulnerability Rankings
- Cell Types
- Cell Types Overview
- Cellular Senescence in Neurodegeneration
- Central Amygdala
- Central Amygdala CRF Neurons
- Central Amygdala in Fear Learning
- Central Amygdala Interneurons
- Central Amygdala Neurons
- Central Canal Neurons
- Central Cerebellar Nucleus (CeN) Neurons
- Central Chemoreceptor Neurons
- Central Gray Matter Neurons
- Central Lateral Thalamic Nucleus
- Central Medial Thalamic Nucleus
- Central Nervous System Vascular Unit
- Central Nucleus Amygdala Neurons
- Central Oxytocin Neurons
- Central Vasopressin Neurons
- Centrolateral Thalamic Nucleus
- Centromedian Thalamic Nucleus (CM) Neurons
- Centromedian Thalamic Nucleus in Arousal
- Centromedian Thalamic Nucleus in Arousal
- Centromedian Thalamic Nucleus Neurons
- Centromedian Thalamic Nucleus Neurons
- Centromedian Thalamus Neurons
- Centromedian-Parafascicular Complex (CM-Pf) Neurons
- Cerebellar Basket Cells
- Cerebellar Basket Cells
- Cerebellar Basket Cells in Neurodegeneration
- Cerebellar Basket Cells in Neurodegeneration
- Cerebellar Circuit Neurons
- Cerebellar Deep Nuclei in Essential Tremor
- Cerebellar Deep Nuclei in Motor Execution
- Cerebellar Deep Nuclei in Motor Output
- Cerebellar Deep Nuclei Neurons
- Cerebellar Flocculus Neurons
- Cerebellar Golgi Cells
- Cerebellar Golgi Cells in Autism Spectrum Disorder
- Cerebellar Golgi Cells in Autism Spectrum Disorder
- Cerebellar Golgi Cells in Neurodegeneration
- Cerebellar Granule Cell Layer
- Cerebellar Granule Cell Progenitors
- Cerebellar Granule Cell Progenitors in Neurodegeneration
- Cerebellar Granule Cells
- Cerebellar Granule Cells (Alternative)
- Cerebellar Granule Cells (Expanded)
- Cerebellar Granule Cells In Alzheimers Disease
- Cerebellar Granule Cells in Ataxia
- Cerebellar Granule Cells in Ataxia-Telangiectasia
- Cerebellar Granule Cells in Friedreich Ataxia
- Cerebellar Granule Cells in Motor Coordination
- Cerebellar Granule Cells in Multiple System Atrophy
- Cerebellar Granule Cells in Neurodegeneration
- Cerebellar Granule Cells in Neurodegeneration
- Cerebellar Granule Cells in Neurodegenerative Disease
- Cerebellar Granule Cells in Refsum Disease
- Cerebellar Granule Cells in Refsum Disease
- Cerebellar Granule Cells in Sensory Integration
- Cerebellar Granule Neurons
- Cerebellar Granule Neurons in Neurodegeneration
- Cerebellar Hemisphere Neurons
- Cerebellar Interneurons
- Cerebellar Interneurons in Neurodegeneration
- Cerebellar Interposed Nucleus
- Cerebellar Interposed Nucleus in Neurodegeneration
- Cerebellar Lugaro Cells
- Cerebellar Lugaro Cells
- Cerebellar Molecular Layer
- Cerebellar Molecular Layer Interneurons
- Cerebellar Molecular Layer Interneurons
- Cerebellar Molecular Layer Interneurons
- Cerebellar Molecular Layer Interneurons
- Cerebellar Molecular Layer Interneurons in Neurodegeneration
- Cerebellar Neurons in Creutzfeldt-Jakob Disease
- Cerebellar Neurons in Multiple System Atrophy
- Cerebellar Nodulus Neurons
- Cerebellar Nuclei Neurons
- Cerebellar Parallel Fibers
- Cerebellar Purkinje Cell Layer
- Cerebellar Purkinje Cells
- Cerebellar Purkinje Cells
- Cerebellar Purkinje Cells (Expanded)
- Cerebellar Purkinje Cells Expanded
- Cerebellar Purkinje Cells in Ataxia
- Cerebellar Purkinje Cells in Ataxia-Telangiectasia
- Cerebellar Purkinje Cells in Autism Spectrum Disorder
- Cerebellar Purkinje Cells in Motor Coordination
- Cerebellar Purkinje Cells in Motor Coordination
- Cerebellar Purkinje Cells in Neurodegeneration
- Cerebellar Purkinje Cells in Neurodegeneration
- Cerebellar Purkinje Cells in SCA
- Cerebellar Purkinje Cells in Spinocerebellar Ataxia
- Cerebellar Purkinje Cells in Spinocerebellar Ataxia
- Cerebellar Purkinje Cells in Spinocerebellar Ataxia
- Cerebellar Purkinje Cells in Spinocerebellar Ataxia
- Cerebellar Purkinje Cells in Spinocerebellar Ataxia Type 1
- Cerebellar Purkinje Neurons
- Cerebellar Stellate Cells
- Cerebellar Stellate Cells
- Cerebellar Stellate Cells
- Cerebellar Stellate Cells
- Cerebellar Unipolar Brush Cells
- Cerebellar Unipolar Brush Cells in Episodic Ataxia
- Cerebellar Vermis Neurons
- Cerebral Amyloid Angiopathy Vascular Cells
- Cerebral Endothelial Cells
- Cerebral Endothelial Cells in Neurodegeneration
- Cerebral Endothelial Cells in Neurodegeneration
- Cerebral Organoid Neurons
- Cerebral Vascular Smooth Muscle Cells
- Cerebral Vascular Smooth Muscle Cells
- Cerulospinal Neurons
- Cervical Spinal Cord Interneurons in Breathing
- CGRP Calcitonin Gene-Related Peptide Neurons
- CGRP Neurons
- Chandelier Cells
- Chandelier Neurons
- Chemogenetically Modified Neurons
- Chemosensitive Nucleus Tractus Solitarius Neurons
- Chief Sensory Trigeminal Nucleus
- Chief Sensory Trigeminal Nucleus
- Chloride (ClC) Channel Neurons
- Cholecystokinin (CCK) Neurons
- Cholecystokinin Interneurons
- Cholecystokinin-Expressing Interneurons (CCK Interneurons)
- Choline Acetyltransferase (ChAT) Neurons
- Choline Acetyltransferase Neurons
- Cholinergic Basal Forebrain Neurons
- Cholinergic Basal Forebrain Neurons in Alzheimer's Disease
- Cholinergic Basal Forebrain Neurons in Alzheimer's Disease
- Cholinergic Basal Forebrain Neurons in Alzheimer's Disease
- Cholinergic Basal Forebrain Neurons in Down Syndrome
- Cholinergic Efferent (CHAT) Neurons
- Cholinergic Interneurons in Huntington Disease
- Cholinergic Neurod Pathology
- Cholinergic Neurons
- Cholinergic Neurons (Basal Forebrain)
- Cholinergic Neurons (Brain)
- Cholinergic Neurons in Adult Polyglucosan Body Disease
- Cholinergic Neurons in Cognitive Decline
- Cholinergic Neurons in Dementia with Lewy Bodies
- Cholinergic Neurons in Neurodegeneration
- Cholinergic Pedunculopontine Neurons
- Choroid Plexus
- Choroid Plexus Epithelial Cells
- Choroid Plexus Epithelial Cells
- Choroid Plexus Epithelial Cells - Expanded
- Choroid Plexus Epithelial Cells in Neurodegeneration
- Choroid Plexus Epithelial Cells in Neurodegeneration
- Choroid Plexus Epithelium
- Chromaffin Cells
- Chronic Traumatic Encephalopathy (CTE) Neurons
- Ciliary Ganglion Neurons
- Cingulate Bundle Axons
- Cingulate Cortex Neurons
- Circadian Clock Neurons
- Circadian Rhythm Neurons
- Circadian Rhythm Neurons in Neurodegeneration
- Circular Nucleus
- Circular Nucleus (Circ) Neurons
- Circumventricular Organs
- Circumventricular Organs Tanycytes
- Clarke Column Neurons
- Clathrin Coat Neurons
- Claudius Cells
- Claustrum in Multisensory Integration
- Claustrum Neurons
- Claustrum Neurons
- Claustrum Neurons in Consciousness
- Claustrum Neurons in Neurodegeneration
- Claustrum Neurons in Neurodegeneration
- Climbing Fiber Inputs
- Climbing Fiber Inputs
- Climbing Fiber Neurons
- Climbing Fiber Synapses
- CNS Border-Associated Macrophages (BAMs)
- Cocaine- and Amphetamine-Regulated Transcript (CART) Neurons
- Cochlear Hair Cells in Age-Related Hearing Loss
- Cochlear Hair Cells in Aging
- Cochlear Hair Cells in Auditory Neuropathy Spectrum Disorder
- Cochlear Nerve Root Entry Zone Neurons
- Cochlear Neurons
- Cochlear Nuclei in Auditory Processing
- Cochlear Nuclei Neurons
- Cochlear Nucleus Bushy Cells
- Cochlear Nucleus Multipolar Cells
- Cochlear Nucleus Neurons
- Cochlear Nucleus Neurons
- Coeruleospinal Neurons
- Coeruleus-Subcoeruleus Complex
- Columns of the Fornix Neurons
- Commissural Fornix
- Commissural Nucleus Neurons
- Commissural Nucleus Neurons
- Commissural Nucleus of Probst
- Commissural Nucleus of the Arcuate
- Commissural Nucleus of the Forel (CF) Neurons
- Commissural Nucleus of the Habenula
- Commissural Superior Colliculus
- Compact Nucleus Ambiguus (cNA) Neurons
- Compact Triangular Nucleus (Triangularis) Neurons
- Comparative anatomy of zona incerta across mammals
- Concept Cells
- Cone Bipolar Cells (Retina)
- Cone Photoreceptors
- Corpus Callosum Fibers
- Corpus Callosum Projection Neurons
- Cortical Amygdala (CoA) Neurons
- Cortical Basket Cells (Parvalbumin-Positive)
- Cortical Basket Cells (Pyramidal-Targeting)
- Cortical Bipolar Cells
- Cortical Bipolar GABAergic Interneurons
- Cortical Border Cells
- Cortical Chandelier Cells
- Cortical Columns in Neurodegeneration
- Cortical Episodic Memory Cells
- Cortical Fear Memory Cells
- Cortical GABAergic Interneurons in Amyotrophic Lateral Sclerosis
- Cortical Glutamatergic Pyramidal Neurons
- Cortical Head Direction Cells
- Cortical Hem Neurons
- Cortical Interneuron Degeneration in Alzheimer's Disease
- Cortical Interneurons
- Cortical Interneurons (Calretinin-Positive)
- Cortical Interneurons in Alzheimer's Disease
- Cortical Interneurons in Neurodegeneration
- Cortical Ivy Cells
- Cortical Lattice Cells
- Cortical Layer 1 Interneurons
- Cortical Layer 1 Neurons
- Cortical Layer 1 Neurons
- Cortical Layer 2/3 IT Neurons
- Cortical Layer 2/3 Pyramidal Neurons
- Cortical Layer 3 Pyramidal Neurons
- Cortical Layer 4 Granule Neurons
- Cortical Layer 4 Spiny Neurons
- Cortical Layer 4 Spiny Stellate Cells
- Cortical Layer 4 Spiny Stellate Neurons
- Cortical Layer 5 Neurons
- Cortical Layer 5 PT Neurons
- Cortical Layer 5 Pyramidal Neurons
- Cortical Layer 5 Pyramidal Neurons in Alzheimer's Disease
- Cortical Layer 6 Corticothalamic Neurons
- Cortical Layer 6 Neurons
- Cortical Layer 6b Neurons
- Cortical Layer-Specific Astrocytes
- Cortical LTP Neurons in Neurodegeneration
- Cortical Martinotti Cells
- Cortical Neurogliaform Cells
- Cortical Neurons
- Cortical Neurons Hub
- Cortical Neurons in Alzheimer's Disease
- Cortical Neurons in Alzheimer's Disease
- Cortical Neurons in Corticobasal Degeneration
- Cortical Neurons in Dementia with Lewy Bodies
- Cortical Neurons in Dementia with Lewy Bodies
- Cortical Neurons in Frontotemporal Dementia
- Cortical Neurons in Huntington's Disease
- Cortical Neurons in Menkes Disease
- Cortical NPY Neurons
- Cortical Object Vector Cells
- Cortical PV Fast-Spiking Interneurons
- Cortical Pyramidal Neurons
- Cortical Pyramidal Neurons (Layer 5)
- Cortical Pyramidal Neurons (Layers 2/3)
- Cortical Pyramidal Neurons (Layers 2/3)
- Cortical Pyramidal Neurons in Corticobasal Degeneration
- Cortical Reward Prediction Error Cells
- Cortical Somatostatin Interneurons
- Cortical Speed Cells
- Cortical SST Detector Cells
- Cortical Stellate Cells
- Cortical Time Cells
- Cortical Vasoactive Intestinal Peptide (VIP) Neurons
- Cortical VIP Disinhibitory Neurons
- Cortico-Basal Degeneration Neurons
- Corticobasal Syndrome Neurons
- Corticobulbar Tract Fibers
- Corticofugal Projection Neurons
- Corticopontine Projection Neurons
- Corticospinal Neurons
- Corticospinal Tract Fibers
- Corticostriatal Neurons
- Corticostriatal Projection Neurons in Habit Formation
- Corticothalamic Projection Neurons
- Corticothalamic Pyramidal Neurons
- Corticotrophs
- Corticotropin-Releasing Factor Neurons in Stress
- Corticotropin-Releasing Factor Receptor Neurons
- Corticotropin-Releasing Hormone (CRH) Neurons
- Corticotropin-Releasing Hormone Neurons - Hypothalamic
- Cottrell et al. Sigma-2 receptor: a novel therapeutic target for Alzheimer's disease. Ageing Res Rev (2021)
- Coup-TF1 (Nr2f1) Neurons
- Cranial Nerve Motor Neurons
- CREB Neurons
- CRF (Corticotropin-Releasing Factor) Neurons
- CRF Corticotropin Releasing Factor Neurons
- CRF Neurons in Paraventricular Nucleus
- CRF Receptor 1 Neurons
- CRF Receptor 2 Neurons
- CRH Neurons
- CRH Neurons - Expanded
- CRH-Positive Hippocampal Neurons
- CRISPR gene editing for glaucoma
- Crus I Neurons
- Crus II Neurons
- CRX-Positive Photoreceptor Neurons
- CSF1R-Inhibited Microglia
- CTIP2-Positive (BCL11B) Neurons
- Cuneate Fasciculus Fibers
- Cuneate Nucleus (Cune) Neurons
- Cuneate Nucleus in Neurodegeneration
- Cuneate Nucleus in Tactile Sensation
- Cuneate Nucleus in Tactile Sensation
- Cuneate Nucleus Neurons
- Cuneate Nucleus Neurons
- Cuneiform Nucleus (CnF)
- Cuneiform Nucleus Neurons
- Cuneocerebellar Nucleus
- Cuneocerebellar Tract Fibers
- CX3CR1-Expressing Neurons
- CXCR4 Neurons
- D1 Dopamine Receptor MSNs
- D1 Striatal Medium Spiny Neurons in Huntington's Disease
- D1-Like Dopamine Receptor Neurons
- D2 Dopamine Receptor MSNs
- D2 Striatal Medium Spiny Neurons in Parkinson's Disease
- D2-Like Dopamine Receptor Neurons
- D3 Dopamine Neurons
- D4 Dopamine Neurons
- D5 Dopamine Neurons
- Darkschewitsch Nucleus
- Deep Brain Stimulation-Affected Neurons
- Deep Cerebellar Nuclear Neurons
- Deep Cerebellar Nuclei in Motor Learning
- Deep Cerebellar Nuclei Neurons
- Deep Cerebellar Nuclei Neurons
- Deep Cerebellar Nuclei Neurons (Expanded)
- Deep Cerebellar Nuclei Neurons in Neurodegeneration
- Deep Cerebellar Nucleus Neurons
- Deep Layer Superior Colliculus (dlSC) Neurons
- Deep Layer Superior Colliculus Neurons
- Deep Layer Superior Colliculus Neurons
- Deep Mesencephalic Nucleus (DpMe) Neurons
- Deep Mesencephalic Nucleus (Expanded)
- Deep Superior Colliculus (dSC) Neurons
- Deep White Layer Superior Colliculus Neurons
- Deiters' Cells
- Delta Opioid Receptor (DOR) Neurons
- Dendritic Cells (CNS)
- Dendritic Spine Degeneration in Neurodegeneration
- Dendritic Spine-Deficient Neurons
- Dendritic Spines
- Dendritic Spines
- Dendritic Spines in Neurodegeneration
- Dentate Cerebellar Nucleus (DCN) Neurons
- Dentate Granule Cells in Temporal Lobe Epilepsy
- Dentate Gyrus Granule Cells
- Dentate Gyrus Granule Cells
- Dentate Gyrus Granule Cells Expanded
- Dentate Gyrus Granule Cells in Alzheimer's Disease
- Dentate Gyrus Granule Cells in Alzheimer's Disease
- Dentate Gyrus Granule Cells in Alzheimer's Disease
- Dentate Gyrus Granule Cells in Lafora Disease
- Dentate Gyrus Granule Cells in Temporal Lobe Epilepsy
- Dentate Gyrus Granule Cells in Temporal Lobe Epilepsy
- Dentate Gyrus Granule Cells in Temporal Lobe Epilepsy
- Dentate Gyrus Granule Cells in Temporal Lobe Epilepsy
- Dentate Gyrus Granule Neurons
- Dentate Gyrus Hilar Interneurons
- Dentate Gyrus Hilar Mosaic (iPSC-Derived)
- Dentate Gyrus Hilar Mosaic Neurons
- Dentate Gyrus Hilar Neurons
- Dentate Gyrus Hilar Neurons in Neurodegeneration
- Dentate Gyrus Hilar Neurons in Neurodegeneration
- Dentate Gyrus Hilus Interneurons
- Dentate Gyrus Hilus Neurons
- Dentate Gyrus Hilus Neurons in Neurodegeneration
- Dentate Gyrus Molecular Layer Interneurons
- Dentate Gyrus Mossy Cells
- Dentate Gyrus Mossy Cells in Alzheimer's Disease
- Dentate Gyrus Neural Stem Cells in Hippocampal Neurogenesis
- Dentate Gyrus Neural Stem Cells in Temporal Lobe Epilepsy
- Dentate Gyrus Neurons in Temporal Lobe Epilepsy
- Dentate Gyrus Polymorphic Layer Neurons
- Dentate Hilar Mossy Cells in Hippocampal Sclerosis
- Dentate Hilus Neurons
- Dentate Mossy Fiber to CA3 Synaptic Neurons
- Dentate Nucleus Neurons
- Descending serotonergic circuits in chronic pain states
- Designer Receptors Exclusively Activated by Designer Drugs (DREADD) Neurons
- Diagonal Band in Memory
- Diagonal Band of Broca
- Diagonal Band of Broca Complex
- Diagonal Band of Broca Neurons
- Diagonal Band of Broca Vertical Limb Neurons
- Dichotomous anatomical properties of mouse striatal medium spiny neurons
- Diffuse Amyloid Deposits in Alzheimer's Disease
- Disease-Associated Astrocytes (A1/A2)
- Disease-Associated Astrocytes (DAA)
- Disease-Associated Microglia
- Disease-Associated Microglia (DAM)
- Disease-Associated Microglia (DAM)
- Disease-Associated Microglia in Alzheimer's Disease
- Disease-Associated Microglia Type 2 (DAM2)
- Disease-Associated Oligodendrocytes
- Disease-Associated Oligodendrocytes
- Dlx1 Neurons
- Dlx2 Neurons
- DNA Damage and Repair in Neurons
- DNA Damage-Accumulating Neurons in Neurodegeneration
- Dopamine Beta-Hydroxylase (DBH) Neurons
- Dopamine D2 Receptor Neurons
- Dopamine D3 Receptor Neurons
- Dopamine D4 Receptor Neurons
- Dopamine D5 Receptor Neurons
- Dopamine Neurons in Attention Deficit Hyperactivity Disorder
- Dopamine Neurons in Dopamine-Responsive Dystonia
- Dopamine Neurons in FXTAS
- Dopamine Neurons in Multiple System Atrophy
- Dopamine Neurons in Reward Learning
- Dopamine Neurons in Ventral Tegmental Area
- Dopamine Receptor Neurons
- Dopamine Transporter (DAT) Neurons
- Dopamine Transporter Neurons
- Dopamine Transporters in Parkinson's Disease
- Dopaminergic Neurons (SNpc)
- Dopaminergic Neurons Hub
- Dopaminergic Neurons in Parkinson's Disease
- Dopaminergic Substantia Nigra Neurons in Parkinson's Disease
- Dopaminergic Ventral Tegmental Area Neurons
- Dopaminergic VTA Neurons in Parkinson's Disease
- Dorsal Accessory Olive Neurons
- Dorsal Acoustic Stria (Stria of Held) Neurons
- Dorsal Cochlear Nucleus Fusiform Cells
- Dorsal Cochlear Nucleus Neurons
- Dorsal Cochlear Nucleus Neurons
- Dorsal Column Nuclei
- Dorsal Column Nuclei Neurons
- Dorsal Horn Neurons in Pain Transmission
- Dorsal Motor Nucleus of the Vagus
- Dorsal Motor Nucleus of the Vagus
- Dorsal Motor Nucleus of the Vagus in Parkinson's Disease
- Dorsal Motor Nucleus of the Vagus Neurons
- Dorsal Motor Nucleus of Vagus
- Dorsal Motor Nucleus of Vagus in Multiple System Atrophy
- Dorsal Motor Nucleus of Vagus in Parkinson Disease
- Dorsal Raphe GABAergic Interneurons
- Dorsal Raphe in Parkinson's Disease
- Dorsal Raphe Nucleus
- Dorsal Raphe Nucleus
- Dorsal Raphe Nucleus (DRN) Expanded
- Dorsal Raphe Nucleus (DRN) Neurons
- Dorsal Raphe Nucleus (DRN) Serotonergic Neurons
- Dorsal Raphe Nucleus (DRN) Serotonin Neurons
- Dorsal Raphe Nucleus - Median Division
- Dorsal Raphe Nucleus Expanded (DRN)
- Dorsal Raphe Nucleus GABAergic Neurons
- Dorsal Raphe Nucleus in Mood and Neurodegeneration
- Dorsal Raphe Nucleus Serotonergic
- Dorsal Raphe Nucleus Serotonergic Projection Neurons
- Dorsal Raphe Nucleus Serotonin Neurons (Expanded)
- Dorsal Raphe Serotonergic Neurons
- Dorsal Raphe Serotonergic Neurons
- Dorsal Raphe Serotonergic Neurons (Expanded)
- Dorsal Raphe Serotonergic Neurons in Lewy Body Disease
- Dorsal Raphe Serotonergic Neurons in Neurodegeneration
- Dorsal Raphe Serotonergic Neurons in Neurodegeneration
- Dorsal Raphe Serotonergic Neurons in Parkinson's Disease
- Dorsal Raphe Serotonergic Projection Neurons
- Dorsal Raphe Serotonergic Projection Neurons
- Dorsal Raphe Serotonergic Projection Neurons
- Dorsal Raphe Serotonin in Depression
- Dorsal Raphe Serotonin Neurons in Neurodegeneration
- Dorsal Raphé Nucleus Serotonergic Neurons
- Dorsal Respiratory Group (DRG) Neurons
- Dorsal Root Ganglion Neurons
- Dorsal Root Ganglion Neurons in Chemotherapy-Induced Neuropathy
- Dorsal Root Ganglion Neurons in Chronic Neuropathic Pain
- Dorsal Root Ganglion Neurons in Neurodegeneration
- Dorsal Root Ganglion Neurons in Neuropathic Pain
- Dorsal Root Ganglion Neurons in Neuropathy
- Dorsal Root Ganglion Neurons in Peripheral Neuropathy
- Dorsal Tegmental Nucleus (DTN) Neurons
- Dorsal Tegmental Nucleus in Neurodegeneration
- Dorsal Tegmental Nucleus Neurons
- Dorsal Terminal Nucleus (DTN)
- Dorsal Terminal Nucleus Neurons
- Dorsolateral Prefrontal Cortex
- Dorsolateral Prefrontal Cortex (DLPFC) Pyramidal Neurons
- Dorsomedial Hypothalamic Neurons
- Dorsomedial Hypothalamic Nucleus (DMH) Neurons
- Dorsomedial Hypothalamic Nucleus Neurons
- Dorsomedial Hypothalamus in Arousal
- Dorsomedial Hypothalamus Neurons
- Dorsomedial Hypothalamus Neurons
- Double Bouquet Cells
- Down Syndrome (Trisomy 21) Neurons
- Drouin-Ouellet et al. 5-HT1B receptor expression in multiple system atrophy. Mov Disord (2019)
- Dura Mater Fibroblasts
- Dynorphin Neurons
- Dysfunctional Oligodendrocytes
- Dysgranular Insular Cortex Neurons
- Dysregulated Neurons
- Early-Stage PD Dopaminergic Neurons
- Ectorhinal Cortex
- Ectorhinal Cortex Neurons
- Edinger-Westphal Nucleus
- Edinger-Westphal Nucleus
- Edinger-Westphal Nucleus Cholinergic Neurons
- Edinger-Westphal Nucleus in Pupillary Reflex
- Edinger-Westphal Nucleus Neurons
- Edinger-Westphal Nucleus Neurons
- Edinger-Westphal Preganglionic Neurons
- Emboliform Cerebellar Nucleus
- Emboliform Nucleus Neurons
- Endocannabinoid CB2 Receptor Neurons
- Endopeduncular Nucleus Neurons
- Endophilin Neurons
- Endopiriform Neurons
- Endopiriform Nucleus (EpN) Neurons
- Endopiriform Nucleus Deep Layer Neurons
- Endopiriform Nucleus Neurons
- Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegeneration
- Endothelial Cells
- Engineered Neuronal Cells
- Enkephalin Neurons
- Enteric Glial Cells
- Enteric Glial Cells
- Enteric Glial Cells
- Enteric Glial Cells in Neurodegeneration
- Enteric Glial Cells in Parkinson Disease
- Enteric Glial Cells in Parkinson's Disease
- Enteric Nervous System in Neurodegeneration
- Enteric Nervous System Neurons
- Enteric Nervous System Neurons in Multiple System Atrophy
- Enteric Nervous System Neurons in Parkinson's Disease
- Enteric Neurons
- Enteric Neurons in Alzheimer's Disease
- Enteric Neurons in Gut-Brain Axis
- Enteric Neurons in Multiple System Atrophy
- Enteric Neurons in Neurodegeneration
- Enteric Neurons in Parkinson's Disease
- Enteric Neurons in Parkinson's Disease
- Enteric Neurons in Parkinson's Disease
- Enteric Neurons in Parkinson's Disease
- Enteric Neurons in PD Progression
- Enteric Neurons with Alpha-Synuclein Pathology
- Enteric Neurons with Alpha-Synuclein Pathology
- Enterochromaffin Cells
- Enterochromaffin Cells
- Enterochromaffin Cells in Irritable Bowel Syndrome
- Enteroendocrine Cells
- Enteroendocrine Neurons in Neurodegeneration
- Entopeduncular Nucleus Neurons
- Entorhinal Cortex Layer 2 Neurons
- Entorhinal Cortex Layer 3 Neurons
- Entorhinal Cortex Layer 3 Neurons
- Entorhinal Cortex Layer 5 Neurons
- Entorhinal Cortex Layer II
- Entorhinal Cortex Layer II Neurons
- Entorhinal Cortex Layer II Neurons
- Entorhinal Cortex Layer II Neurons in Alzheimer's Disease
- Entorhinal Cortex Layer II Neurons in Alzheimer's Disease
- Entorhinal Cortex Layer II Neurons in Alzheimer's Disease
- Entorhinal Cortex Layer II Neurons in Alzheimer's Disease
- Entorhinal Cortex Layer III
- Entorhinal Cortex Layer III Neurons
- Entorhinal Cortex Layer III Pyramidal Neurons
- Entorhinal Cortex Neurons
- Entorhinal Cortex Stellate Cells (Layer II)
- Entorhinal Layer 2 Neurons
- Entorhinal Layer II Grid Cells
- Entorhinal Layer II Star Neurons
- Ependymal Cells
- Ependymal Cells - Expanded
- Ependymal Cells in Normal Pressure Hydrocephalus
- Ependymal Cells in Normal Pressure Hydrocephalus
- Ependymal Cells in Normal Pressure Hydrocephalus
- Episodic Memory Cells
- Epithalamus Neurons
- ER Stress Neurons
- ER Stress Neurons
- Escape Memory Cells
- Estrogen Receptor Alpha Neurons
- Estrogen Receptor Beta Neurons
- Excitotoxic Neurons
- Excitotoxicity-Vulnerable Neurons
- Exosome-Secreting Neurons
- Exosome-Secreting Neurons
- Expand CRF neurons page: fix DOI hyperlinks
- External Cuneate Nucleus in Motor Control
- External Cuneate Nucleus Neurons
- External Cuneate Nucleus Neurons
- External Globus Pallidus (GPe) Neurons
- Facial Nerve Nucleus
- Facial Nucleus
- Facial Nucleus (CN VII) Motor Neurons
- Facial Nucleus (FAC) Neurons
- Facial Nucleus Expanded v2
- Facial Nucleus in Facial Expression
- Fasciculus Retroflexus (Habenulopeduncular Tract) Neurons
- Fast-Spiking Interneurons
- Fast-Spiking Parvalbumin Interneurons
- Fastigial Nucleus (Fastigial Cerebellar Nucleus) Neurons
- Fastigial Nucleus Neurons
- Fatal Familial Insomnia Neurons
- Fear Memory Cells
- Ferroptosis-Sensitive Neurons
- Ferroptotic Neurons
- Fibrillary Astrocytes
- Fibrous Astrocytes
- Field of Cajal Neurons
- Field of Forel Neurons
- Fimbria of the Fornix
- Flocculonodular Lobe Neurons
- Flocculus Neurons
- Flocculus Neurons
- Focused Ultrasound-Affected Neurons
- Fork Cells
- Formatio Reticularis
- Fornix Axons
- Fornix Fibers
- Fornix Neurons
- Foxg1 Neurons
- Foxp1 Neurons
- FoxP2-Expressing Neurons
- Fragile X Syndrome Neurons
- Free Nerve Endings
- Frontal Cortex Layer 2 Neurons in Frontotemporal Dementia
- Frontal Cortex Neurons in Alzheimer's Disease
- Frontal Cortex Neurons in Frontotemporal Dementia
- Frontal Cortex Neurons in Frontotemporal Dementia
- Frontal Cortex Neurons in Huntington Disease
- Frontotemporal Lobar Degeneration Neurons
- FUS Proteinopathy Neurons
- FUS-Mutant Motor Neurons
- Fusiform Gyrus Neurons
- GABA Receptors in Neuronal Inhibition
- GABA Receptors in Neuronal Inhibition
- GABA Transporter (GAT) Neurons
- GABA Transporter Neurons in Inhibitory Transmission
- GABA-A Alpha1 Neurons
- GABA-A Alpha2 Neurons
- GABA-A Beta3 Neurons
- GABA-A Gamma2 Neurons
- GABA-A Receptor Neurons
- GABA-B Receptor Neurons
- GABA-C Receptor Neurons
- Gabaa Receptor Neurons
- GABAergic circuits in the dentate gyrus and epileptogenesis
- GABAergic Neuron Vulnerability
- GABAergic Neurons
- GABAergic Neurons in Neurodegeneration
- GABAergic Neurons in Substantia Nigra Reticularis
- GABAergic Neurons — Cell Type Hierarchy
- GABAergic Preoptic Area Neurons
- GABAergic Preoptic Area Neurons
- GABAergic Striatal Interneurons in Huntington's Disease
- Galanin Neurons
- Galanin Neurons (Hypothalamus)
- Galanin Receptor 1 Neurons
- Galanin Receptor 2 Neurons
- Galanin Receptor Neurons
- Gamma Motor Neurons
- Gamma Motor Neurons
- Gamma Motor Neurons
- Gastrin-Releasing Peptide (GRP) Neurons
- GBA-N370S Heterozygous Neurons
- GBA1 Mutant Neurons
- GDNF (Glial Cell Line-Derived Neurotrophic Factor) Neurons
- GDNF Neurons
- Gelatinosa Nucleus Neurons
- Gene therapy targeting Muller glia
- Gene-Edited Neurons
- Genetic therapies for spinal muscular atrophy
- Geniculate Ganglion Neurons
- Geniculostriate Pathway
- Gephyrin Neurons
- Gerstmann-Straussler-Scheinker Disease Neurons
- Ghrelin Neurons
- Ghrelin Receptor (GHSR) Neurons
- Ghrelin-Responsive Neurons
- Ghrelin-Responsive Neurons
- Giant Dopamine Neurons
- Gigantocellular Nucleus (Gi) Neurons
- Gigantocellular Nucleus Expanded v2
- Gigantocellular Reticular Formation in Arousal
- Gigantocellular Reticular Neurons
- Gigantocellular Reticular Nucleus
- Gigantocellular Reticular Nucleus
- Gigantocellular Reticular Nucleus (Gi) Neurons
- Gigantocellular Reticular Nucleus Alpha
- Gigantocellular Reticular Nucleus Neurons
- Gigantocellular Reticular Nucleus Neurons
- Gigantocellular Reticular Nucleus Neurons
- Glial Cells
- Glial Cells Hub
- Glial Cells — Cell Type Hierarchy
- Glial Scar Astrocytes
- Globose Cerebellar Nucleus
- Globose Nucleus Neurons
- Globus Pallidus externa (GPe) Neurons
- Globus Pallidus External Segment (GPe) Neurons
- Globus Pallidus External Segment (GPe) Neurons
- Globus Pallidus External Segment GABA Neurons
- Globus Pallidus External Segment Neurons
- Globus Pallidus Externus (GPe) Neurons
- Globus Pallidus Externus Arkypallidal Neurons
- Globus Pallidus Externus Expanded
- Globus Pallidus Externus GABA Neurons
- Globus Pallidus Externus GABAergic in Neurodegeneration
- Globus Pallidus Externus GABAergic Neurons
- Globus Pallidus Externus in Movement Regulation
- Globus Pallidus Externus Neurons
- Globus Pallidus interna (GPi) Neurons
- Globus Pallidus Interna in Movement Output
- Globus Pallidus Internal Segment (GPi) GABAergic Neurons
- Globus Pallidus Internal Segment (GPi) Neurons
- Globus Pallidus Internal Segment GABA Neurons
- Globus Pallidus Internus (GPi) Neurons
- Globus Pallidus Internus GABA Neurons
- Globus Pallidus Internus GABAergic
- Globus Pallidus Internus in Parkinsons Disease
- Globus Pallidus Internus Neurons
- Globus Pallidus Neurons
- Globus Pallidus Neurons in Corticobasal Degeneration
- Globus Pallidus Neurons in Corticobasal Degeneration
- Globus Pallidus Neurons in Progressive Supranuclear Palsy
- Globus Pallidus Pkan
- GluA1 (AMPA1) Neurons
- GluA2 (AMPA2) Neurons
- GluA3 (AMPA3) Neurons
- GluA4 (AMPA4) Neurons
- Glucose Metabolism-Vulnerable Neurons
- Glucose-Sensing Neurons
- GluK1 (KAR1) Neurons
- GluK1 Kainate Receptor Neurons
- GluK2 (KAR2) Neurons
- GluK2 Kainate Receptor Neurons
- GluK3 (KAR3) Neurons
- GluK4 (KAR4) Neurons
- GluK5 (KAR5) Neurons
- Glutamate Decarboxylase (GAD) Neurons
- Glutamate Receptor Neurons
- Glutamate Transporter Neurons
- Glutamatergic Neurons
- Glutamatergic Neurons in Subthalamic Nucleus
- Glutamatergic Neurons — Cell Type Hierarchy
- Glycine Receptor Neurons
- Glycine Transporter (GlyT) Neurons
- Glymphatic Dysfunction Astrocytes
- Goblet Cells
- Golgi Cells
- Golgi Tendon Organs
- Gonadal Axis Neurons in Gonadotropin-Secreting Adenoma
- Gonadotrophs
- Gonadotropin-Releasing Hormone (GnRH) Neurons
- Gonadotropin-Releasing Hormone (GnRH) Neurons
- Gonadotropin-Releasing Hormone Neurons
- GPER (G-Protein Coupled Estrogen Receptor) Neurons
- GPR17 Neurons
- GPR3 Neurons
- GPR37 (PARK7) Neurons
- GPR39 Neurons
- Gracile Fasciculus Fibers
- Gracile Nucleus (Grac) Neurons
- Gracile Nucleus in Proprioception
- Gracile Nucleus Neurons
- Gracile Nucleus Neurons
- Granular Insular Cortex Neurons
- Granule Cells
- Grid Cells
- GRN-Mutant Neurons
- GSK3β (Glycogen Synthase Kinase 3 Beta) Neurons
- Gustatory Nucleus Neurons
- Habcnular Commissure Fibers
- Habennular Nucleus Neurons
- Habenula in Reward Prediction
- Habenula Neurons
- Habenula Neurons in Depression
- Habenula Neurons in Mood and Reward
- Habenula Neurons in Neurodegeneration
- Habenular Nuclei
- Habenuolopeduncular Nucleus (Nucleus of the Retroflex) Neurons
- Hartman's Pigmented Nucleus Neurons
- HCN (Hyperpolarization-Activated Cyclic Nucleotide-Gated) Channel Neurons
- HCN1 Neurons
- Head Direction Cells
- HEK293 Cell Line
- Hensen's Cells
- Hexanucleotide Repeat Expansion Motor Neurons
- Hilar HAA8+ Neurons
- Hilar Mossy Cells
- Hilar Neurons (Dentate Gyrus)
- HIPP Cells
- Hippocampal Astrocytes
- Hippocampal Axo-Axonic Cells
- Hippocampal Basket Cells
- Hippocampal Basket Cells
- Hippocampal Basket Cells in Neurodegeneration
- Hippocampal Bistratified (BC/AS) Interneurons
- Hippocampal Bistratified Cells
- Hippocampal CA1 Interneurons
- Hippocampal CA1 Pyramidal Cells in Memory
- Hippocampal CA1 Pyramidal Neurons
- Hippocampal CA1 Pyramidal Neurons
- Hippocampal CA1 Pyramidal Neurons
- Hippocampal CA1 Pyramidal Neurons
- Hippocampal CA1 Pyramidal Neurons
- Hippocampal CA1 Pyramidal Neurons (Expanded)
- Hippocampal CA1 Pyramidal Neurons in Aging-Related Tauopathy
- Hippocampal CA1 Pyramidal Neurons in Alzheimer's Disease
- Hippocampal CA1 Pyramidal Neurons in Alzheimer's Disease
- Hippocampal CA2 Neurons in Alzheimer Disease
- Hippocampal CA2 Neurons in Alzheimer's Disease
- Hippocampal CA2 Pyramidal Neurons
- Hippocampal CA2 Pyramidal Neurons
- Hippocampal CA3 Mossy Cells
- Hippocampal CA3 Neurons
- Hippocampal CA3 Neurons in Temporal Lobe Epilepsy
- Hippocampal CA3 Pyramidal Cells
- Hippocampal CA3 Pyramidal Neurons
- Hippocampal CA3 Pyramidal Neurons
- Hippocampal CA3 Pyramidal Neurons (Expanded)
- Hippocampal CA3 Pyramidal Neurons in Alzheimer's Disease
- Hippocampal CA3 Pyramidal Neurons in Alzheimer's Disease
- Hippocampal CA3 Pyramidal Neurons in Epilepsy
- Hippocampal CA3 Pyramidal Neurons in Memory
- Hippocampal CA3 Pyramidal Neurons in Neurodegeneration
- Hippocampal CA3 Pyramidal Neurons in Parkinson's Disease
- Hippocampal CA3 Stratified Interneurons
- Hippocampal CA4 Neurons
- Hippocampal CA4 Pyramidal Neurons
- Hippocampal Cajal Retzius Cells Neurodegeneration
- Hippocampal Cajal-Retzius Cells
- Hippocampal Cajal-Retzius Cells
- Hippocampal Cajal-Retzius Cells
- Hippocampal Cajal-Retzius Cells
- Hippocampal Cajal-Retzius Cells in Neurodegeneration
- Hippocampal Cajal-Retzius Cells in Neurodegeneration
- Hippocampal Cajal-Retzius Cells in Neurodegeneration
- Hippocampal Dentate Gyrus Granule Cells
- Hippocampal Dentate Gyrus Mossy Cells
- Hippocampal Dentate Gyrus Mossy Cells V2
- Hippocampal Fork Cells
- Hippocampal Granule Cells in Neurodegeneration
- Hippocampal Granule Neurons
- Hippocampal Hilus
- Hippocampal HIPP Cells
- Hippocampal HIPP Interneurons
- Hippocampal Interneurons
- Hippocampal Ivy Cells
- Hippocampal Martinotti Cells
- Hippocampal MOPP Cells
- Hippocampal Mossy Cells
- Hippocampal Neural Stem Cells
- Hippocampal Neurons
- Hippocampal Neurons Hub
- Hippocampal O-LM Cells
- Hippocampal O-LM Cells
- Hippocampal O-LM Cells
- Hippocampal O-LM Interneurons
- Hippocampal O-LM Interneurons in Neurodegeneration
- Hippocampal Theta-Firing Neurons
- Histamine H1 Receptor Neurons
- Histamine H2 Receptor Neurons
- Histamine H3 Autoreceptor Neurons
- Histamine H3 Receptor Neurons
- Histamine H4 Receptor Neurons
- Histamine Neurons
- Histaminergic System in Neurodegeneration
- Histaminergic Tuberomammillary Neurons
- Histaminergic Tuberomammillary Neurons
- Homer isoforms differentially regulate synaptic plasticity
- Horizontal Cells (Retina)
- Horizontal Cells in Alzheimer's Disease
- Horizontal Cells in Lateral Inhibition
- Horizontal Cells of Cajal
- Horizontal Cells of the Striatum
- Horizontal Diagonal Band Cholinergic Neurons
- Horizontal Diagonal Band GABAergic Neurons
- Horizontal Diagonal Band Neurons
- Horizontal Diagonal Band Nucleus Neurons
- Horizontal Limb of Diagonal Band
- Horizontal Limb of Diagonal Band (HDB) Neurons
- Horizontal Limb of Diagonal Band Cholinergic
- Horizontal Limb of Diagonal Band Cholinergic Neurons
- Horizontal Limb of Diagonal Band in Olfaction
- Horizontal Limb of Diagonal Band Neurons
- Horizontal Limb of the Diagonal Band (HDB)
- Horizontal Limb of the Diagonal Band (HDB)
- HPA Axis Neurons in Neurodegeneration
- HT22 Cell Line
- Huntingtin Mutant Neurons
- Huntingtin Protein and Striatal Neuron Degeneration
- Huntington's Disease Medium Spiny Neurons
- Huntington's disease: Molecular basis and therapeutic approaches
- Hyperactive Neurons
- Hypoactive Neurons
- Hypocretin/Orexin Neurons
- Hypocretin/Orexin Neurons
- Hypocretin/Orexin Neurons (Expanded)
- Hypoglossal Nucleus
- Hypoglossal Nucleus (CN XII) Motor Neurons
- Hypoglossal Nucleus (HYP) Neurons
- Hypoglossal Nucleus in Tongue Movement
- Hypoglossal Nucleus Neurons
- Hypothalamic AgRP/NPY Neurons
- Hypothalamic AgRP/NPY Neurons in Neurodegeneration
- Hypothalamic Arcuate Galanin Neurons
- Hypothalamic Arcuate NPY Neurons
- Hypothalamic Arcuate POMC Neurons
- Hypothalamic CRH Neurons
- Hypothalamic CRH Neurons in Stress-Related Disorders
- Hypothalamic Dopamine Neurons
- Hypothalamic Dopamine Neurons in Neurodegeneration
- Hypothalamic MCH Neurons
- Hypothalamic MCH Sleep-Promoting Neurons
- Hypothalamic Melanocortin Neurons
- Hypothalamic Nesfatin-1 Neurons
- Hypothalamic Neurons
- Hypothalamic Neurons in Empty Sella Syndrome
- Hypothalamic Neurons in Growth Hormone Excess
- Hypothalamic Neurons in Langerhans Cell Histiocytosis
- Hypothalamic Neurons in Neurosarcoidosis
- Hypothalamic Neurons in Pituitary Apoplexy
- Hypothalamic Neurons in Prolactinoma
- Hypothalamic Neurotensin Neurons
- Hypothalamic NPY Neurons
- Hypothalamic NPY/AgRP Neurons
- Hypothalamic Orexin (Hypocretin) Energizing Neurons
- Hypothalamic Orexin Neurons
- Hypothalamic Orexin Neurons in Alzheimer's Disease
- Hypothalamic Orexin Neurons in Narcolepsy
- Hypothalamic Orexin Neurons in Narcolepsy
- Hypothalamic Orexin Neurons in Narcolepsy
- Hypothalamic Orexin Neurons in Neurodegeneration
- Hypothalamic Orexin Neurons in Neurodegeneration
- Hypothalamic Oxytocin and Vasopressin Neurons
- Hypothalamic POMC Neurons
- Hypothalamic POMC Neurons in Prader-Willi Syndrome
- Hypothalamic POMC Neurons in Prader-Willi Syndrome
- Hypothalamic Preoptic Area Sleep-Active Neurons
- Hypothalamic Preoptic Thermoregulatory Neurons
- Hypothalamic Sleep-Wake Circuit Neurons
- Hypothalamic Somatostatin Neurons
- Hypothalamic Supraoptic Nucleus Vasopressin Neurons
- Hypothalamic Tanycytes
- Hypothalamic Tanycytes
- Hypothalamic TRH Neurons
- Hypothalamic TRH Neurons in Central Hypothyroidism
- Hypothalamic-Pituitary Axis Neurons
- Hypothalamic-Pituitary-Adrenal Axis Neurons in Cushing Disease
- Hypoxia-Sensitive Dopaminergic Neurons
- Hypoxia-Sensitive Neurons
- Ia Inhibitory Interneurons
- Ia Inhibitory Interneurons
- Ib Inhibitory Interneurons
- IGF-1 Receptor Neurons
- Incertohypothalamic Area
- Incertohypothalamic Dopamine Neurons
- Incertohypothalamic Dopamine Neurons
- Incus Nucleus (Posterior Thalamic Nucleus)
- Induced Pluripotent Stem Cell-Derived Neurons
- Indusium Griseum (IG) Neurons
- Inferior Colliculus Commissural
- Inferior Colliculus Commissural Neurons
- Inferior Colliculus Core
- Inferior Colliculus Cortical Layer Neurons
- Inferior Colliculus in Sound Localization
- Inferior Colliculus Neurons
- Inferior Colliculus Neurons
- Inferior Colliculus Neurons in Auditory Processing
- Inferior Colliculus Neurons in Hearing Loss
- Inferior Olivary Complex
- Inferior Olivary Complex Neurons
- Inferior Olivary Neurons
- Inferior Olivary Nucleus
- Inferior Olivary Nucleus Neurons
- Inferior Olivary Nucleus Neurons
- Inferior Olive / Olivary Nucleus
- Inferior Olive Climbing Fibers in Motor Learning
- Inferior Olive Neurons in Neurodegeneration
- Inferior Temporal Cortex Neurons
- Inferior Temporal Cortex Neurons in Prosopagnosia
- Inferotemporal Cortex
- Inflammatory Astrocytes
- Inflammatory Astrocytes in ALS
- Infralimbic Cortex Expanded
- Infralimbic Cortex Neurons
- Infralimbic Cortex Pyramidal Neurons
- Inhibitors of AADC in Parkinson's disease: past, present and future
- Inner Hair Cells
- Inner Plexiform Layer Interneurons
- Insular Cortex Neurons
- Insular Cortex Neurons
- Insular Cortex Neurons
- Insular Cortex Neurons in Alzheimer's Disease
- Insular Cortex Neurons in Pain Perception
- Insulin Receptor (INSR) Neurons
- Insulin-Responsive Neurons
- Interanterodorsal Nucleus
- Interanterodorsal Thalamic Nucleus (IAD) Neurons
- Intercalated Amygdala Nuclei in Fear Memory
- Intercalated Amygdala Nucleus
- Intercalated Amygdala Nucleus Neurons
- Intercalated Nucleus of the Amygdala (ITCN) Neurons
- Intercalated Nucleus of the Medulla
- Intercalated Striatum Neurons
- Intercollicular Nucleus (IC) Neurons
- Intercollicular Nucleus (IC) Neurons
- Interfascicular Nucleus (IF) Neurons
- Intermediate Gray Layer Superior Colliculus Neurons
- Intermediate Nucleus of the Lateral Lemniscus
- Intermediate Progenitor Cells
- Intermediate Tuberal Nucleus
- Intermediate Tuberal Nucleus (ITN) Neurons
- Intermediodorsal Thalamic Nucleus Neurons
- Intermediolateral Cell Column (IML) Neurons
- Intermediolateral Cell Column Neurons
- Intermediolateral Nucleus (IML) Neurons
- Internal Globus Pallidus (GPi) Neurons
- Interneurons
- Interneurons — Cell Type Hierarchy
- Internuclear Neurons (FF Neurons)
- Internuclear Ophthalmalmic Neurons
- Interoceptive Nucleus Neurons
- Interoceptors
- Interpeduncular Neurons
- Interpeduncular Nucleus
- Interpeduncular Nucleus (IPN) Neurons
- Interpeduncular Nucleus (IPN) Neurons
- Interpeduncular Nucleus (IPN) Neurons
- Interpeduncular Nucleus Cholinergic Neurons
- Interpeduncular Nucleus Cholinergic Neurons in Parkinson's Disease
- Interpeduncular Nucleus GABAergic Neurons
- Interpeduncular Nucleus in Nicotine
- Interpeduncular Nucleus in Parkinson's Disease
- Interpolar Spinal Trigeminal Nucleus
- Interposed Cerebellar Nucleus (IntN) Neurons
- Interposed Nucleus (Interposed Cerebellar Nucleus) Neurons
- Interposed Nucleus Neurons
- Interstitial Nucleus of Cajal
- Interstitial Nucleus of Cajal
- Interstitial Nucleus of Cajal
- Interstitial Nucleus of Cajal (INC) Neurons
- Interstitial Nucleus of Cajal Neurons
- Interstitial Nucleus of the Anterior Commissure
- Interstitial Nucleus of the Caudal Medulla Ventral Neurons
- Interstitial Nucleus of the Medial Longitudinal Fasciculus
- Interstitial Nucleus of the Vestibulospinal Tract (INV) Neurons
- Interstitiospinal Neurons
- Intertrigeminal Nucleus (ITN) Neurons
- Intestinal Enteric Neurons in Neurodegeneration
- Intestinal Tuft Cells
- Intracardiac Neurons
- Intralaminar Thalamic Neurons
- Intralaminar Thalamic Nuclei (ILN) Neurons
- Intralaminar Thalamic Nuclei Neurons
- Intrinsic Cardiac Neurons
- Intrinsically Photosensitive Retinal Ganglion Cells
- Intrinsically Photosensitive Retinal Ganglion Cells (ipRGCs)
- iPSC-Derived Astrocytes
- iPSC-Derived Cholinergic Neurons
- iPSC-Derived Cortical Neurons
- iPSC-Derived Dopamine Neurons
- iPSC-Derived Dopamine Neurons
- iPSC-Derived Dopaminergic Neurons
- iPSC-Derived Dopaminergic Neurons (LRRK2 G2019S)
- iPSC-Derived GABAergic Neurons
- iPSC-Derived Hippocampal Neurons
- iPSC-Derived LRRK2 G2019S Dopaminergic Neurons
- iPSC-Derived Microglia
- iPSC-Derived Microglia
- iPSC-Derived Motor Neurons
- iPSC-Derived Neurons
- iPSC-Derived Noradrenergic Neurons
- iPSC-Derived Oligodendrocytes
- iPSC-Derived Serotonergic Neurons
- iPSC-Derived Striatal Neurons
- Iron in oligodendrocytes and myelination
- Iron-Laden Microglia
- Islands of Calleja (Ic) Neurons
- Islands of Calleja Neurons
- Jugular Ganglion Neurons
- Juvenile-Onset Huntington Disease Neurons
- Juxtacapsular Nucleus Neurons
- Juxtapositional Cortex (J) Neurons
- Kainate GluK1 Receptor Neurons
- Kainate Receptor Neurons
- Kaiser, R. H., et al. (2018). "VTA and depression." American Journal of Psychiatry
- Kappa Opioid Receptor (KOR) Neurons
- Kenyon Cells
- Kisspeptin Neurons
- Kisspeptin Neurons (Expanded)
- Kitara Cells
- Knockout Cells
- Kolliker-Fuse Nucleus (KFn) Neurons
- Koniocellular Thalamic Neurons
- Krause End Bulbs
- Kupffer Cells
- Kölliker-Fuse Lateral Subnucleus
- Kölliker-Fuse Nucleus
- Kölliker-Fuse Nucleus
- Kölliker-Fuse Nucleus (KF) Neurons
- Kölliker-Fuse Nucleus Expanded v2
- Kölliker-Fuse Nucleus Neurons
- Kölliker-Fuse Nucleus Neurons
- Kölliker-Fuse Subnucleus
- L23 Interneurons Schizophrenia
- Lactotrophs
- Lamina I Neurons
- Lamina I Nociceptive Neurons
- Lamina I Projection Neurons
- Lamina I Spinothalamic Neurons
- Lamina I Spinothalamic Neurons
- Lamina II Interneurons
- Lamina IX Neurons (Spinal Motor Pools)
- Lamina VII Preganglionic Neurons
- LAMP5+ Interneurons
- Lanceolate Endings
- Large Basket Cells
- Late-Stage Parkinson Dopaminergic Neurons
- Lateral Amygdala Neurons
- Lateral Cerebellar Nucleus
- Lateral Dorsal Tegmental Nucleus
- Lateral Dorsal Thalamic Nucleus Neurons
- Lateral Geniculate Nucleus
- Lateral Geniculate Nucleus
- Lateral Geniculate Nucleus (LGN) Neurons
- Lateral Habenula Dopamine Neurons
- Lateral Habenula in Depression
- Lateral Habenula in Parkinson's Disease
- Lateral Habenula Neurons
- Lateral Habenula Neurons
- Lateral Habenula Neurons
- Lateral Hypothalamic Area (LHA) Neurons
- Lateral Hypothalamic Area Neurons
- Lateral Hypothalamic MCH Neurons
- Lateral Hypothalamic Orexin Neurons
- Lateral Hypothalamic Orexin Neurons - Expanded
- Lateral Hypothalamic Orexin Neurons in Narcolepsy
- Lateral Hypothalamic Orexin/Hypocretin Neurons
- Lateral Hypothalamus
- Lateral Hypothalamus Expanded
- Lateral Hypothalamus in Arousal and Reward
- Lateral Hypothalamus MCH Neurons
- Lateral Hypothalamus MCH Neurons
- Lateral Hypothalamus MCH Neurons
- Lateral Hypothalamus Neurons
- Lateral Hypothalamus Orexin Neurons
- Lateral Hypothalamus Orexin/Hypocretin Neurons
- Lateral Hypothalamus Orexin/Hypocretin Neurons
- Lateral Hypothalamus Orexin/Hypocretin Neurons
- Lateral Lemniscus Neurons
- Lateral Parabrachial Nucleus
- Lateral Periaqueductal Gray (lPAG) Neurons
- Lateral Pericentral Nucleus of Inferior Colliculus Neurons
- Lateral Posterior Thalamic Nucleus (LP) Neurons
- Lateral Prefrontal Cortex
- Lateral Preoptic Area (LPOA) Neurons
- Lateral Preoptic Area (LPOA) Neurons
- Lateral Preoptic Area Neurons
- Lateral Reticular Nucleus Neurons
- Lateral Septal Neurons
- Lateral Septal Nucleus
- Lateral Septal Nucleus (LS) Neurons
- Lateral Septal Nucleus Neurons
- Lateral Septal Nucleus Neurons
- Lateral Septum in Social Behavior
- Lateral Septum Neurons
- Lateral Spinothalamic Tract Neurons
- Lateral Superior Olive (LSO) Neurons
- Lateral Superior Olive Neurons
- Lateral Terminal Nucleus (LTN) Neurons
- Lateral Ventricle Neural Stem Cells
- Lateral Vestibular Nucleus (Deiters' Neurons)
- Lateral Vestibular Nucleus (Deiters' Nucleus) Neurons
- Lateral Vestibular Nucleus (LVN) Expanded
- Lateral Vestibular Nucleus Neurons
- Laterodorsal Tegmental (LDT) Cholinergic Neurons
- Laterodorsal Tegmental Cholinergic Neurons
- Laterodorsal Tegmental Neurons
- Laterodorsal Tegmental Neurons
- Laterodorsal Tegmental Neurons in Addiction
- Laterodorsal Tegmental Nucleus
- Laterodorsal Tegmental Nucleus
- Laterodorsal Tegmental Nucleus
- Laterodorsal Tegmental Nucleus (LDT) Cholinergic Neurons
- Laterodorsal Tegmental Nucleus Cholinergic Neurons
- Laterodorsal Tegmental Nucleus Cholinergic Neurons in Parkinson's Disease
- Laterodorsal Tegmental Nucleus Cholinergic Neurons in Parkinson's Disease
- Laterodorsal Tegmental Nucleus GABAergic Neurons
- Laterodorsal Tegmental Nucleus in Arousal
- Laterodorsal Tegmental Nucleus Neurons
- Laterodorsal Tegmental Nucleus Neurons
- Lateropontine Nucleus Neurons
- Lattice Cells
- Layer 1 Cortical Interneurons
- Layer 1 Cortical Interneurons
- Layer 1 Cortical Interneurons
- Layer 2 Cortical Neurons
- Layer 2 Entorhinal Cortex Neurons
- Layer 2 Entorhinal Cortex Neurons in Alzheimer Disease
- Layer 2 Entorhinal Cortex Neurons in Early Alzheimer's Disease
- Layer 2/3 Intratelencephalic Neurons
- Layer 2/3 Intratelencephalic Neurons
- Layer 2/3 Intratelencephalic Neurons in Fragile X Syndrome
- Layer 3 pyramidal neuron integration in cortical columns
- Layer 4 Cortical Neurons
- Layer 4 Granule Cells
- Layer 4 Spiny Stellate Cells
- Layer 4 Spiny Stellate Cells
- Layer 5 Cortical Neurons
- Layer 5 Pyramidal Neurons in Frontal Cortex Neurodegeneration
- Layer 5 Pyramidal Tract Neurons
- Layer 5 Pyramidal Tract Neurons
- Layer 5 Pyramidal Tract Neurons
- Layer 6 Cortical Neurons
- Layer 6 Corticothalamic Neurons
- Layer 6 Corticothalamic Neurons
- Layer 6 Corticothalamic Neurons
- Layer 6b Cortical Neurons
- LC3 (MAP1LC3) Neurons
- Leptin Receptor (LEPR) Neurons
- Leptin-Responsive Neurons
- LeX/ssea-1 is expressed by adult neural stem cells
- LHX6-Positive Neurons
- Limbic Encephalitis Recovery and Residual Neuronal Changes
- Limbic Thalamic Nucleus
- Limbic Thalamus Neurons
- Limitans Suprageniculate Complex
- Linear Nucleus of Raphe Neurons
- Linear Nucleus of the Midbrain
- Linear Nucleus of the Raphe (R Li) Neurons
- Linear Raphe Nucleus
- Lingual Cortex Neurons
- Lipid Droplet-Accumulating Neurons
- Lipid-Loaded Microglia (Foam Cells)
- Locus Coeruleus
- Locus Coeruleus (LC) Noradrenergic Neurons
- Locus Coeruleus Alpha Adrenergic Neurons
- Locus Coeruleus Alpha Neurons
- Locus Coeruleus Alpha Neurons
- Locus Coeruleus Alpha-2 Adrenergic Neurons
- Locus Coeruleus Alpha-2 Adrenergic Neurons
- Locus Coeruleus Alpha-2 Adrenergic Neurons
- Locus Coeruleus Astrocytes
- Locus Coeruleus Autonomic Neurons
- Locus Coeruleus Cholinergic Interneurons
- Locus Coeruleus GABAergic Neurons
- Locus Coeruleus in Arousal
- Locus Coeruleus in Major Depressive Disorder
- Locus Coeruleus in Stress Response
- Locus Coeruleus Neurons (Expanded)
- Locus Coeruleus Neurons in Alzheimer's Disease
- Locus Coeruleus Neurons in Dementia with Lewy Bodies
- Locus Coeruleus Noradrenaline Neurons
- Locus Coeruleus Noradrenergic in Progressive Supranuclear Palsy
- Locus Coeruleus Noradrenergic Neurons
- Locus Coeruleus Noradrenergic Neurons
- Locus Coeruleus Noradrenergic Neurons (Expanded)
- Locus Coeruleus Noradrenergic Neurons in Alzheimer's Disease
- Locus Coeruleus Noradrenergic Neurons in Alzheimer's Disease
- Locus Coeruleus Noradrenergic Neurons in Alzheimer's Disease
- Locus Coeruleus Noradrenergic Projection Neurons
- Locus Coeruleus Noradrenergic Projection Neurons
- Locus Coeruleus Noradrenergic System
- Locus Coeruleus Noradrenergic System
- Locus Coeruleus Norepinephrine
- Locus Coeruleus Norepinephrine in AD
- Locus Coeruleus Norepinephrine Neurons
- Locus Coeruleus Norepinephrine Neurons in Neurodegeneration
- Low-Threshold Spiking Interneurons
- Lower Motor Neurons (Spinal)
- Lower Motor Neurons in ALS with C9orf72
- LRRK2 G2019S Dopaminergic Neurons
- LRRK2 Mutant Dopamine Neurons
- LRRK2-Associated Dopamine Neurons
- LRRK2-R1441C Dopaminergic Neurons
- Lymphocytic Hypophysitis Neurons
- Lysosomal Autophagy Neuron
- Lysosomal System in Neurons
- Lysosomal-Impaired Neurons
- M-Current Expressing (KCNQ2/3) Neurons
- M1 Polarized Microglia
- Magnocellular Neurosecretory Cells
- Magnocellular Nucleus Neurons
- Magnocellular Preoptic Nucleus
- Magnocellular Preoptic Nucleus
- Magnocellular Preoptic Nucleus Neurons
- Magnocellular Red Nucleus (RNm) Neurons
- Main Olfactory Bulb (MOB) Neurons
- Main Trigeminal Sensory Nucleus
- Mamillary Bodies in Memory
- Mammillary Bodies Neurons
- Mammillary Bodies Neurons (Expanded)
- Mammillary Body Neurons
- Mammillary Body Neurons
- Mammillotegmental Tract Neurons
- Mammillothalamic Tract Fibers
- Mammillothalamic Tract Neurons
- Mammotegmental Tract Fibers
- MAPT-Mutant Neurons
- Martinotti Cells
- Martinotti Neurons
- Mast Cells
- Math1 (Atoh1) Neurons
- MCH Melanin Concentrating Hormone Neurons
- MCH Neurons
- Mechanisms of TMS-induced plasticity
- Mechanoreceptors
- Medial Accessory Olive Neurons
- Medial Amygdala (MeA) Neurons
- Medial Amygdala in Social Behavior
- Medial Amygdala Neurons
- Medial Dorsal Thalamic Nucleus Neurons
- Medial Eminence
- Medial Forebrain Bundle (MFB) Expanded
- Medial Forebrain Bundle Cholinergic Projection Neurons
- Medial Forebrain Bundle Expanded v2
- Medial Forebrain Bundle Fibers
- Medial Forebrain Bundle in Neurodegeneration
- Medial Forebrain Bundle Neurons
- Medial Forebrain Bundle Neurons
- Medial Forebrain Bundle Projecting Neurons
- Medial Geniculate Body
- Medial Geniculate Body in Auditory Relay
- Medial Geniculate Body Neurons
- Medial Geniculate Body Neurons
- Medial Geniculate Nucleus (Expanded)
- Medial Geniculate Nucleus (MGN) Neurons
- Medial Geniculate Nucleus Neurons
- Medial Habenula in Addiction
- Medial Habenula Neurons
- Medial Habenula Neurons
- Medial Habenula Neurons
- Medial Hypothalamus
- Medial Nucleus of the Trapezoid Body (MNTB) Neurons
- Medial Prefrontal Cortex
- Medial Prefrontal Cortex Pyramidal Neurons
- Medial Preoptic Area (MPOA) Neurons
- Medial Preoptic Area (MPOA) Neurons
- Medial Preoptic Area Expanded
- Medial Preoptic Area Gonadotropin-Releasing Hormone Neurons
- Medial Preoptic Area Neurons
- Medial Preoptic Nucleus (MPO) Neurons
- Medial Preoptic Nucleus Neurons
- Medial Pretectal Nucleus (MPT)
- Medial Pretectal Nucleus (MPT) - Expanded
- Medial Septal (MS) Cholinergic Neurons
- Medial Septal Cholinergic in Memory Disorders
- Medial Septal Cholinergic Neurons
- Medial Septal Cholinergic Neurons
- Medial Septal Cholinergic Neurons
- Medial Septal Cholinergic Neurons and Memory Circuits
- Medial Septal Cholinergic Projection
- Medial Septal Nucleus
- Medial Septal Nucleus
- Medial Septal Nucleus in Memory
- Medial Septal Nucleus Neurons
- Medial Septo-Hippocampal Cholinergic Neurons
- Medial Septo-Hippocampal Cholinergic Neurons
- Medial Septo-Hippocampal Cholinergic Neurons in Neurodegeneration
- Medial Septo-Hippocampal Cholinergic Projection Neurons
- Medial Septo-Hippocampal GABAergic Neurons
- Medial Septum Cholinergic Neurons
- Medial Septum Diagonal Band Complex
- Medial Septum GABAergic Neurons
- Medial Septum in Spatial Memory
- Medial Septum Neurons
- Medial Septum Neurons
- Medial Superior Olive (MSO) Neurons
- Medial Temporal Lobe Circuit Neurons
- Medial Terminal Nucleus (MTN)
- Medial Terminal Nucleus Neurons
- Medial Terminal Nucleus of Accessory Optic System
- Medial Vestibular Nucleus Expanded
- Medial Vestibular Nucleus Neurons
- Medial Vestibular Nucleus Neurons
- Median Eminence
- Median Eminence Beta Tanycytes
- Median Eminence in Neurodegeneration
- Median Eminence Neuroendocrine Endings
- Median Eminence Neurons
- Median Eminence Tanycytes
- Median Eminence Tanycytes
- Median Forebrain Bundle (MFB) Neurons
- Median Preoptic Nucleus (MnPO) Neurons
- Median Preoptic Nucleus in Sleep Pressure
- Median Preoptic Nucleus in Thermoregulation
- Median Preoptic Nucleus Neurons
- Median Raphe Expanded
- Median Raphe Neurons
- Median Raphe Nucleus
- Median Raphe Nucleus
- Median Raphe Nucleus
- Median Raphe Nucleus (MRN) Neurons
- Median Raphe Nucleus Expanded (MRN)
- Median Raphe Serotonergic Neurons
- Median Raphe Serotonergic Neurons
- Median Raphe Serotonergic Neurons
- Mediodorsal Nucleus in Executive Function
- Mediodorsal Thalamic Nucleus (MD) Neurons
- Mediodorsal Thalamic Nucleus Neurons
- Mediodorsal Thalamic Nucleus Neurons
- Medium Spiny Neurons (MSNs)
- Medium Spiny Neurons in Bipolar Disorder
- Medullary Kidney-Shaped Neurons
- Medullary Raphespinal Neurons
- Medullary Reticular Formation
- Medullary Reticular Neurons
- Medullary Reticular Nucleus in Breathing
- Meissner Corpuscle Cells
- Meissner Corpuscles
- Melanin-Concentrating Hormone (MCH) Neurons
- Melanin-Concentrating Hormone (MCH) Neurons
- Melanin-Concentrating Hormone Neurons
- Melanin-Concentrating Hormone Neurons
- Melanocytes in Parkinson Disease
- Melanocytes in Parkinson's Disease
- Melanopsin-Containing Retinal Ganglion Cells (ipRGCs)
- Melanotrophs
- Meningeal Cells
- Meningeal Cells
- Meningeal Fibroblasts
- Meningeal Lymphatic Endothelial Cells
- Meningeal Neurons
- Merkel Cells
- Merkel Disc (Merkel Cells)
- Mesencephalic Dopaminergic Neurons
- Mesencephalic Locomotor Region (MLR) Neurons
- Mesencephalic Nucleus of Trigeminal Nerve
- Mesencephalic Reticular Formation (Expanded)
- Mesencephalic Reticular Formation Neurons
- Mesencephalic Trigeminal Nucleus
- Mesencephalic Trigeminal Nucleus (MesV) Expanded
- Mesencephalic Trigeminal Nucleus (MesV) Neurons
- Mesencephalic Trigeminal Nucleus Neurons
- Mesencephalic Trigeminal Nucleus Neurons
- Mesencephalic Trigeminal Nucleus Neurons
- Mesencephalic V Nucleus in Proprioception
- Mesenchymal Stem Cells
- Mesenchymal Stem Cells in Neurodegenerative Disease Therapy
- Mesenteric Plexus Neurons
- Mesocortical Dopamine Neurons
- Mesocortical Dopamine Neurons
- Mesocortical Dopaminergic Circuit
- Mesodiencephalic Junction (MDJ) Neurons
- Mesolimbic Dopamine Neurons
- Mesolimbic Dopamine Neurons
- Mesolimbic Dopamine Pathway Neurons in Parkinson's Disease
- Mesolimbic Dopaminergic Circuit
- Mesopontine Cholinergic Neurons
- Mesopontine Cholinergic Tegmental Neurons
- Mesopontine Cholinergic Tegmental Neurons
- Mesopontine Cholinergic Tegmental Neurons
- Mesopontine Reticular Formation
- Metabolically Impaired Neurons
- Metabotropic Glutamate (mGluR) Receptor Neurons
- Metabotropic Glutamate Receptor 1 (mGluR1) Neurons
- Metabotropic Glutamate Receptor 2 (mGluR2) Neurons
- Metabotropic Glutamate Receptor 3 (mGluR3) Neurons
- Metabotropic Glutamate Receptor 4 (mGluR4) Neurons
- Metabotropic Glutamate Receptor 7 (mGluR7) Neurons
- Metabotropic Glutamate Receptor 8 (mGluR8) Neurons
- mGluR1 (GRM1) Neurons
- mGluR2 (GRM2) Neurons
- mGluR3 (GRM3) Neurons
- mGluR4 (GRM4) Neurons
- mGluR5 (GRM5) Neurons
- mGluR5 Metabotropic Glutamate Neurons
- Microglia
- Microglia in Alzheimer's Disease
- Microglia in Alzheimer's Disease Neurodegeneration
- Microglia in Alzheimer's Disease Neurodegeneration
- Microglia in Alzheimer's disease: From pathology to therapeutic targeting
- Microglia in Batten Disease
- Microglia in Chronic Neuroinflammation
- Microglia in Huntington's Disease
- Microglia in Nasu-Hakola Disease
- Microglia in Neuroinflammation
- Microglia in Parkinson Disease
- Microglia in Parkinson's Disease Substantia Nigra
- Microglia in Rasmussen Encephalitis
- Microglia in Synapse Pruning
- Microglia State Index
- Microglial Cells — Cell Type Hierarchy
- Midbrain Neurotensin Neurons
- Midbrain Organoid Dopaminergic Neurons
- Midget Bipolar Cells
- Midline Thalamic Neurons
- Midline Thalamic Nuclei
- Mirror Neurons
- Mitochondrial Dynamics Dysregulation in Neurodegeneration
- Mitochondrial Dysfunction Dopaminergic Neurons
- Mitochondrial Dysfunction in Dopaminergic Neurons
- Mitochondrial Dysfunction Neurons
- Mitochondrial Quality Control in Neurons
- Mitochondrially Impaired Neurons
- Mitochondrially-Dysfunctional Neurons
- Mitofusin (MFN1/2) Neurons
- Mitral Cells
- MOPP Cells
- Morphologically Altered Astrocytes
- Mossy Cells Dentate Gyrus
- Mossy Cells in Hippocampal Sclerosis
- Mossy Fiber Terminals
- Motor Cortex in Amyotrophic Lateral Sclerosis
- Motor Cortex Neurons in Frontotemporal Dementia
- Motor Cortex Pyramidal Neurons
- Motor Cortex Stimulation-Affected Neurons
- Motor Neuron Disease (MND) Neurons
- Motor Neurons
- Motor Neurons in ALS and Frontotemporal Dementia
- Motor Neurons in Amyotrophic Lateral Sclerosis
- Motor Neurons in Amyotrophic Lateral Sclerosis
- Motor Neurons in C9orf72-Linked ALS/FTD
- Motor Neurons in Kennedy Disease
- Motor Neurons in Spinal Muscular Atrophy
- Motor Neurons in Wilson Disease
- Motor Nucleus of Trigeminal Nerve
- Motor Nucleus of Trigeminal Neurons
- Motor Nucleus of Vagus
- Motor Trigeminal Nucleus
- MPTP-Induced Dopaminergic Neurons
- MT1 (MTNR1A) Receptor Neurons
- MT1B (MTNR1B) Receptor Neurons
- mTOR (Mammalian Target of Rapamycin) Neurons
- Mu Opioid Receptor (MOR) Neurons
- Muller Glia in Retinal Degeneration
- Multiple System Atrophy Neurons
- Multipolar Neurons in Neurodegeneration
- Muscarinic M1 Acetylcholine Receptor Neurons
- Muscarinic M2 Acetylcholine Receptor Neurons
- Muscarinic M3 Acetylcholine Receptor Neurons
- Muscarinic M4 Acetylcholine Receptor Neurons
- Muscarinic M5 Acetylcholine Receptor Neurons
- Muscle Spindles
- Mutant Synuclein Prion-Like Neurons
- Myelinating Oligodendrocytes
- Myelinating Schwann Cells
- Myenteric Plexus (Auerbach) Neurons
- Myenteric Plexus Neurons (Auerbach's Plexus)
- Müller Glia (Retina)
- Müller Glia in Retinal Support
- Müller Glial Cells
- Narrow-Field Amacrine Cells
- Natural Killer (NK) Cells
- Necroptotic Neurons
- Nerve Growth Factor (NGF) Responsive Neurons
- Nesfatin-1 Neurons
- Nesfatin-1 Neurons
- Nesfatin-1 Nucleobindin Neurons
- Neural Crest-Derived Glia
- Neural Progenitor Cells in Neurodegeneration
- NeuroD1 Neurons
- NeuroD2 Neurons
- Neurodegeneration-Associated Microglia (NAM)
- Neuroepithelial Cells
- Neurogenesis
- Neurogliaform Cells
- Neuroimmune Interface: CNS-Immune Interactions
- Neuroinflammation and VTA neuron survival
- Neuroinflammation Microglia
- Neuroinflammation-Responsive Neurons
- Neuroinflammation-Sensitive Neurons
- Neurokinin A (NK2) Receptor Neurons
- Neurokinin B (NK3) Receptor Neurons
- Neuromedin B (NmB) Neurons
- Neuromedin S Neurons
- Neuromedin U (NmU) Neurons
- Neuromelanin-Containing Neurons
- Neuronal Ceroid Lipofuscinosis Cell Pathology
- Neuronal Intermediate Filament Inclusion Bodies in Neurodegeneration
- Neuronal Loss Patterns in Huntington's Disease Grade C
- Neuronal Nitric Oxide Synthase Neurons
- Neuronal Precursor Cells
- Neuronal Spheroids
- Neuronatin Neurons
- Neurons
- Neurons in Dentatorubral-Pallidoluysian Atrophy
- Neurons in Lysosomal Storage Disorders with Neurodegeneration
- Neurons in Normal Pressure Hydrocephalus
- Neurons in Prion Disease
- Neurons in Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)
- Neurons in Wilson Disease
- Neurons Susceptible to Viral Infection
- Neurons — Cell Type Hierarchy
- Neuropathology of amygdala in Lewy body disease (2011)
- Neuropathology of Parkinson's disease
- Neuropeptide Y (NPY) Neurons
- Neuropeptide Y (NPY) Neurons
- Neuropeptide Y (NPY) Neurons (Arcuate)
- Neuropeptide Y Neurons in Feeding Behavior
- Neuropeptide Y/AgRP Neurons
- Neuroprotective (A2) Reactive Astrocytes
- Neuroprotective Astrocytes
- Neuroprotective Microglia
- Neurotensin Neurons
- Neurotensin Receptor 1 Neurons
- Neurotensin Receptor 2 Neurons
- Neurotensin-mediated anti-excitotoxic effects in neurons
- Neurotoxic (A1) Reactive Astrocytes
- Neurotoxic Astrocytes
- Neurovascular Unit Cells
- Newly Formed Oligodendrocytes (NFOLs)
- NFT-Bearing Neurons
- NG2 Cells
- NG2 Glia (Oligodendrocyte Precursor Cells)
- NG2 Glia (Polydendrocytes)
- NGF Neurons
- Nicotinic Acetylcholine Alpha-4/Beta-2 Receptor Neurons
- Nicotinic Acetylcholine Alpha-6/Beta-2 Receptor Neurons
- Nicotinic Acetylcholine Alpha-7 Receptor Neurons
- Nicotinic Acetylcholine Alpha-9/Alpha-10 Receptor Neurons
- Nicotinic α4β2 Receptor Neurons
- Nigral Astrocytes
- Nigral Astrocytes in Parkinson's Disease
- Nigral Dopamine Burst-Firing Neurons
- Nigral Dopamine Neurons in Dementia with Lewy Bodies
- Nigral Dopaminergic Neurons
- Nigral Dopaminergic Neurons in Dementia with Lewy Bodies
- Nigral GABAergic Neurons
- Nigral Glia in Parkinson's Disease
- Nigral Microglia in Parkinson's Disease
- Nigral Microglia in Progressive Supranuclear Palsy
- Nigrostriatal Dopamine Neurons
- Nigrostriatal Dopamine Neurons
- Nigrostriatal Dopamine Terminals in Parkinson Disease
- Nigrostriatal Dopamine Terminals in Parkinson's Disease
- Nigrostriatal Dopamine Terminals in Parkinson's Disease
- Nigrostriatal Dopaminergic Circuit
- Nigrostriatal Pathway Dopaminergic Neurons
- Nigrostriatal Pathway Dopaminergic Neurons
- Nigrostriatal Projection Neurons
- Nitrergic Neurons
- Nitric Oxide Producing Neurons
- Nkx2.1 Neurons
- NLRP3 as therapeutic target in neurodegenerative disease
- NLRP3 Inflammasome-Activated Microglia
- NMDA Receptor Neurons
- nNOS Neurons
- Nociceptin Orphanin FQ Neurons
- Nociceptin Receptor (NOP) Neurons
- Nociceptin/Orphanin FQ (N/OFQ) Neurons
- Nociceptors
- Nodes of Ranvier
- Nodes of Ranvier
- Nodes of Ranvier in Neurodegeneration
- Nodose Ganglion Neurons
- Nodose Ganglion Visceral Sensory Neurons
- Nodulus Neurons
- Nodulus Neurons
- Non-Myelinating Schwann Cells
- Noradrenergic Locus Coeruleus in Major Depressive Disorder
- Noradrenergic Locus Coeruleus Neurons in Alzheimer's Disease
- Noradrenergic Neurons
- Noradrenergic Neurons (Locus Coeruleus)
- Noradrenergic Neurons (Locus Coeruleus)
- Noradrenergic Neurons in Neurodegeneration
- Noradrenergic System in Neurodegeneration
- Norepinephrine Neurons
- Norepinephrine Transporter (NET) Neurons
- NPFF Neurons
- NPY Neurons - Expanded
- NPY Neuropeptide Y Neurons
- Npy Y1 Receptor Neurons
- NPY-Positive Hippocampal Interneurons
- NPY-Y1 Receptor Neurons
- NPY-Y2 Receptor Neurons
- NPY-Y5 Receptor Neurons
- NPY/AgRP Neurons in Hypothalamus
- NR2A (GRIN2A) Neurons
- NR2B (GRIN2B) Neurons
- NREM-Specific Neurons
- NT-3 (Neurotrophin-3) Neurons
- Nucleus Accumbens Core (NAc Core) Medium Spiny Neurons
- Nucleus Accumbens Core (NAcCore) Expanded
- Nucleus Accumbens Core in Instrumental Learning
- Nucleus Accumbens Core Neurons
- Nucleus Accumbens Core Neurons
- Nucleus Accumbens D1 Medium Spiny Neurons (Expanded)
- Nucleus Accumbens D2 Medium Spiny Neurons (Expanded)
- Nucleus Accumbens in Parkinson's Disease
- Nucleus Accumbens in Reward Learning
- Nucleus Accumbens Medium Spiny Neurons
- Nucleus Accumbens Medium Spiny Neurons
- Nucleus Accumbens Neurons
- Nucleus Accumbens Neurons in Anhedonia
- Nucleus Accumbens Shell (NAc Shell) Medium Spiny Neurons
- Nucleus Accumbens Shell (NAcShell) Expanded
- Nucleus Accumbens Shell GABAergic Neurons
- Nucleus Accumbens Shell in Reward Seeking
- Nucleus Accumbens Shell Median Neurons
- Nucleus Accumbens Shell Neurons
- Nucleus Accumbens Shell Neurons
- Nucleus Ambiguus (NA) Neurons
- Nucleus Ambiguus (NA) Neurons
- Nucleus Ambiguus Compacta (cNA)
- Nucleus Ambiguus Expanded
- Nucleus Ambiguus in Cardiac Control
- Nucleus Ambiguus Neurons
- Nucleus Basalis Cholinergic
- Nucleus Basalis Cholinergic in Alzheimer Disease
- Nucleus Basalis Cholinergic Neurons in Alzheimer's Disease
- Nucleus Basalis Cholinergic Neurons in Neurodegeneration
- Nucleus Basalis in Cortical Activation
- Nucleus Basalis Meynert Cholinergic Neurons
- Nucleus Basalis Meynert in Dementia
- Nucleus Basalis Neurons
- Nucleus Basalis of Meynert (NBM) Cholinergic Neurons
- Nucleus Basalis of Meynert Cholinergic
- Nucleus Basalis of Meynert Cholinergic Neurons
- Nucleus Basalis of Meynert Cholinergic Neurons (Expanded)
- Nucleus Basalis of Meynert Cholinergic Neurons in Alzheimer's Disease
- Nucleus Basalis of Meynert Cholinergic Neurons in Alzheimer's Disease
- Nucleus Basalis of Meynert Cortical Projection Neurons
- Nucleus Basalis of Meynert Expanded v2
- Nucleus Basalis of Meynert in Alzheimer's Disease
- Nucleus Basalis of Meynert in Memory
- Nucleus Basalis of Meynert Neurons
- Nucleus Basalis of Meynert Neurons
- Nucleus Basalis of Meynert Neurons
- Nucleus Basalis of Meynert Neurons in Lewy Body Disease
- Nucleus Caeruleus Subdivision (LC-sub)
- Nucleus Circularis Neurons
- Nucleus Cuneatus Neurons
- Nucleus Cuneatus Neurons
- Nucleus Darkschewitsch
- Nucleus Ellipticus
- Nucleus Fimbrialis
- Nucleus Gigantocellularis Alpha (GiA)
- Nucleus Gracilis Neurons
- Nucleus Gracilis Neurons
- Nucleus Incertus (NI)
- Nucleus Incertus (NI) Neurons
- Nucleus Incertus Neurons
- Nucleus Intercalatus Stamurae (InC)
- Nucleus Limitans Neurons
- Nucleus of Belzear
- Nucleus of Darkschewitsch
- Nucleus of Darkschewitsch
- Nucleus of Darkschewitsch (ND) Neurons
- Nucleus of Diagonal Band Neurons
- Nucleus of Diagonal Broca (NDB) Cholinergic Neurons
- Nucleus of Koelliker-Fuse (KF) Neurons
- Nucleus of Meynert Cholinergic Neurons
- Nucleus of Meynert Cholinergic Neurons
- Nucleus of Meynert Neurons
- Nucleus of the Ansa Lenticularis Neurons
- Nucleus of the Basal Optic Root Neurons
- Nucleus of the Brachium of the Inferior Colliculus
- Nucleus of the Brachium of the Superior Colliculus
- Nucleus of the Diagonal Band (NDB) Expanded
- Nucleus of the Diagonal Band (NDB) Neurons
- Nucleus of the Diagonal Band - Vertical Limb
- Nucleus of the Diagonal Band Cholinergic Neurons
- Nucleus of the Diagonal Band in Neurodegeneration
- Nucleus of the Diagonal Band Neurons
- Nucleus of the Facial Nerve (Facial Nucleus) Neurons
- Nucleus of the Field of Forel (FF) Neurons
- Nucleus of the Fields of Forel (FF) Neurons
- Nucleus of the Lateral Lemniscus (LLL) Neurons
- Nucleus of the Lateral Olfactory Tract
- Nucleus of the Lateral Olfactory Tract (NLOT) Neurons
- Nucleus of the Optic Tract (NOT)
- Nucleus of the Optic Tract (NOT) Neurons
- Nucleus of the Posterior Commissure
- Nucleus of the Posterior Commissure Neurons
- Nucleus of the Solitary Tract
- Nucleus of the Solitary Tract (NST) Neurons
- Nucleus of the Solitary Tract (NTS) Expanded
- Nucleus of the Solitary Tract (NTS) Neurons
- Nucleus of the Solitary Tract (NTS) Neurons
- Nucleus of the solitary tract in autonomic control
- Nucleus of the Solitary Tract in Neurodegeneration
- Nucleus of the Solitary Tract in Visceral Sensation
- Nucleus of the Solitary Tract Neurons
- Nucleus of the Solitary Tract Neurons
- Nucleus of the Solitary Tract Neurons
- Nucleus of the Solitary Tract Neurons (Expanded)
- Nucleus of the Vertical Limb (Diagonal Band of Broca)
- Nucleus of the Vertical Limb Neurons
- Nucleus of the Vertical Limb of the Diagonal Band (VDB) Neurons
- Nucleus Opticus Basalis (NOB) Neurons
- Nucleus Ovalis Neurons
- Nucleus Ovalis Neurons
- Nucleus Ovoidalis Neurons
- Nucleus Ovoidalis Neurons
- Nucleus Parabrachialis Lateralis (PBL)
- Nucleus Parabrachialis Medialis (PBM)
- Nucleus Paragigantocellularis Lateralis Neurons
- Nucleus Pars Cavernosa Neurons
- Nucleus Pars Cochlearis Neurons
- Nucleus Prepositus
- Nucleus Prepositus Hypoglossi (NPH) Neurons
- Nucleus Prepositus Hypoglossi (NPH) Neurons
- Nucleus Prepositus Hypoglossi Expanded
- Nucleus Prepositus Hypoglossi Expanded (NPH)
- Nucleus Pretectal Olivary Neurons
- Nucleus Pretectalis
- Nucleus Raphe Magnus
- Nucleus Raphe Magnus Pain Modulation Neurons
- Nucleus Raphe Magnus Pain Modulation Neurons
- Nucleus Raphe Magnus Serotonergic Neurons
- Nucleus Raphe Obscurus
- Nucleus Raphe Obscurus Expanded v2
- Nucleus Raphe Pallidus
- Nucleus Raphe Pallidus Expanded
- Nucleus Raphes Magnus
- Nucleus Raphes Magnus Expanded (NRM)
- Nucleus Raphes Obscurus
- Nucleus Raphes Pallidus
- Nucleus Raphespiralis Neurons
- Nucleus Raphé Pallidus Serotonergic Neurons
- Nucleus Reticularis Thalami
- Nucleus Reticularis Thalami
- Nucleus Retroambiguus Neurons
- Nucleus Retroventralis (RVM)
- Nucleus Reuniens
- Nucleus Reuniens in Memory
- Nucleus Reuniens Neurons
- Nucleus Rhomboid
- Nucleus Robustus Arcuati (ARC) Dopaminergic Neurons
- Nucleus Ruber (Red Nucleus) Neurons
- Nucleus Sagulum (Sagulum) Neurons
- Nucleus Tractus Solitarii Neurons
- Nucleus Tractus Solitarius Cardiovagal Neurons
- Nucleus Tractus Solitarius in Autonomic Regulation
- Nucleus Tractus Solitarius in Neurodegeneration
- Nucleus Tractus Solitarius Neurons
- Nucleus Tractus Solitarius Neurons
- Nucleus Tractus Solitarius Neurons in Neurodegeneration
- Nucleus Tractus Spinalis (Spinal Trigeminal Nucleus) Neurons
- Nucleus Tractus Spinalis Nervi Trigemini
- Nucleus Tractus Spinalis V Neurons
- Nucleus Vestibularis Superior Expanded (SuVe)
- Nucleus Y (Accessory Optic System) Neurons
- Nucleus Z
- O-LM Cells
- Object Vector Cells
- Occipital Cortex (V1) Neurons
- Occipital Cortex Neurons
- Occipital Cortex Neurons in Posterior Cortical Atrophy
- Octopus Cells (Auditory Brainstem)
- Oculomotor Neurons in Amyotrophic Lateral Sclerosis
- Oculomotor Nucleus
- Oculomotor Nucleus (CN III) Neurons
- Oculomotor Nucleus (CN III) Neurons
- Oculomotor Nucleus (Detailed)
- Oculomotor Nucleus (OCU) Neurons
- Oculomotor Nucleus Cholinergic Neurons
- Oculomotor Nucleus Expanded v2
- Oculomotor Nucleus in Eye Movements
- Oculomotor Nucleus Interneurons
- Oculomotor Nucleus Neurons
- OFF-Bipolar Neurons
- Olfactory Bulb Granule Cells
- Olfactory Bulb Mitral Cells
- Olfactory Bulb Neurons
- Olfactory Bulb Neurons in Neurodegeneration
- Olfactory Bulb Neurons in Neurodegeneration
- Olfactory Bulb Neurons in Parkinson's Disease
- Olfactory Bulb Short-Axon Cells
- Olfactory Bulb Tufted Cells
- Olfactory Ensheathing Cells
- Olfactory Ensheathing Cells in Parkinson's Disease
- Olfactory Receptor Neurons
- Olfactory Tubercle in Odor-Driven Behavior
- Olfactory Tubercle Neurons
- Olig2 Neurons
- Oligodendrocyte Lineage in Alzheimer's Disease
- Oligodendrocyte Lineage in Multiple System Atrophy
- Oligodendrocyte Precursor Cells
- Oligodendrocyte Precursor Cells (OPCs)
- Oligodendrocyte Precursor Cells in Demyelinating Disease
- Oligodendrocyte Precursor Cells in Periventricular Leukomalacia
- Oligodendrocyte Progenitor Cells (OPCs) - Expanded
- Oligodendrocytes
- Oligodendrocytes in Adrenoleukodystrophy
- Oligodendrocytes in CNS Myelination
- Oligodendrocytes in Multiple System Atrophy
- Oligodendrocytes in Multiple System Atrophy
- Oligodendrocytes in Multiple System Atrophy
- Oligodendrocytes in Neurodegeneration
- Oligodendrocytes Myelinating
- Olivary Complex
- Olivary Complex in Motor Learning
- Olivary Complex Inferior Olive Neurons
- Olivary Complex Neurons
- Olivary Nuclei (Inferior Olive) Neurons
- Olivary Pretectal Nucleus
- Olivary Pretectal Nucleus Neurons
- Olivocochlear Neurons
- Olivocochlear Neurons in Age-Related Hearing Loss
- OLM Cells
- ON-Bipolar Neurons
- ON-OFF Amacrine Cells
- Onuf's Nucleus
- Onuf's Nucleus in Neurodegeneration
- OPA1 (Optic Atrophy 1) Neurons
- Opsoclonus-Myoclonus Ataxia Syndrome Neurons
- Optogenetically-Modified Neurons in Neurodegeneration Research
- Oral Spinal Trigeminal Nucleus
- Oral Trigeminal Nucleus (Vo) Neurons
- Orbital Cortex Neurons
- Orbital Frontal Cortex Neurons
- Orbital Frontal Cortex Pyramidal Neurons
- Orbital Frontal Cortex Pyramidal Neurons
- Orbitofrontal Cortex (OFC) Neurons
- Orbitofrontal Cortex Neurons
- Orbitofrontal Cortex Neurons
- Orbitofrontal Cortex Neurons in Alzheimer's Disease
- Orbitofrontal Cortex Pyramidal Neurons
- Orbitofrontal Cortical Neurons in Neurodegeneration
- Orexin Neurons
- Orexin Neurons in Narcolepsy with Cataplexy
- Orexin Receptor Neurons
- Orexin-1 Receptor Neurons
- Orexin-1 Receptor Neurons
- Orexin-2 Receptor Neurons
- Orexin-A (Hypocretin-1) Neurons
- Orexin/Hypocretin Neurons
- Orexin/Hypocretin Neurons
- Orexin/Hypocretin Neurons in Wakefulness
- Organum Vasculosum Lamina Terminalis Neurons
- Organum Vasculosum Lamina Terminalis Neurons
- Organum Vasculosum Neurons
- Organum Vasculosum of the Lamina Terminalis (OVLT)
- Organum Vasculosum of the Lamina Terminalis (OVLT) Neurons
- Organum Vasculosum of the Lamina Terminalis Neurons
- Osmoreceptor Neurons
- Otic Ganglion Neurons
- Outer Hair Cells
- Outer Radial Glia
- Oxidative Stress Vulnerable Neurons
- Oxidative Stress-Exposed Cortical Neurons
- Oxidative Stress-Responsive Neurons
- Oxidative Stress-Vulnerable Neurons
- Oxidatively Damaged Neurons
- Oxytocin (OXT) Neurons
- Oxytocin Neurons (Expanded)
- Oxytocin Neurons in Social Bonding
- Oxytocin Receptor Neurons
- P2X Purinergic Receptor Neurons
- P2Y Purinergic Receptor Neurons
- P2Y12 Neurons
- P2Y2 Neurons
- p62 (SQSTM1) Neurons
- PAC1 (ADCYAP1R1) Receptor Neurons
- PACAP Neurons
- PACAP/VPAC Receptor Neurons
- Pacinian Corpuscle Cells
- Pacinian Corpuscles
- Pancreatic Plexus Neurons
- Paneth Cells
- Papez Circuit Neurons
- Parabigeminal Nucleus Neurons
- Parabrachial Complex
- Parabrachial Neurons
- Parabrachial Nucleus
- Parabrachial Nucleus (Expanded)
- Parabrachial Nucleus (PBN) Neurons
- Parabrachial Nucleus (PBN) Neurons
- Parabrachial Nucleus Cholinergic Neurons
- Parabrachial Nucleus in Autism Spectrum Disorder
- Parabrachial Nucleus in Autonomic Control
- Parabrachial Nucleus in Neurodegeneration
- Parabrachial Nucleus Neurons
- Parabrachial Nucleus Taste Neurons
- Parabrachial Taste Neurons
- Parabrachialis Posterior Nucleus
- Paracentral Thalamic Nucleus
- Parafascicular Thalamic Nucleus
- Parafascicular Thalamic Nucleus in Movement
- Parafascicular Thalamic Nucleus Neurons
- Paragigantocellular Neurons
- Paragigantocellular Nucleus Neurons
- Paragigantocellular Reticular Nucleus
- Paragigantocellular Reticular Nucleus
- Paragigantocellular Reticular Nucleus (ParGi) Neurons
- Paragigantocellular Reticular Nucleus in Panic
- Parahippocampal Cortex Neurons
- Parahippocampal Cortex Neurons in Alzheimer's Disease
- Parainsular Cortex Neurons
- Parainterfascicular Nucleus
- Parainterfascicular Nucleus (PIF) Neurons
- Paralemniscal Nucleus
- Paralemniscal Nucleus Neurons
- Parallel Fiber Synapses
- Paramedian Lobule Neurons
- Paramedian Pontine Reticular Formation
- Paramedian Pontine Reticular Formation (PPRF) Neurons
- Paramedian Pontine Reticular Formation (PPRF) Neurons
- Paramedian Reticular Formation
- Paramedian Reticular Nucleus Neurons
- Paraneoplastic Cerebellar Degeneration Neurons
- Paranigral Nucleus (PN) Neurons
- Paranigral Nucleus (PN) Neurons
- Parasolitary Nucleus (PSol) Neurons
- Parastrial Nucleus (PS) Neurons
- Parasubicular Neurons
- Parasubiculum
- Parasubiculum Neurons
- Parasubthalamic Nucleus (PSTN) Neurons
- Parasubthalamic Nucleus Neurons
- Parasympathetic Neurons
- Parasympathetic Preganglionic Neurons
- Parataenial Thalamic Nucleus (PT) Neurons
- Parataenial Thalamic Nucleus Neurons
- Paratenial Nucleus (PT) Neurons
- Paratenial Thalamic Nucleus (PT)
- Paratrigeminal Nucleus
- Paratrigeminal Nucleus Expanded
- Paratrigeminal Nucleus Neurons
- Paraventricular Hypothalamic CRH Neurons
- Paraventricular Hypothalamic Neurons in Neurodegeneration
- Paraventricular Hypothalamic Nucleus (PVN) Neurons
- Paraventricular Hypothalamic Nucleus Expanded v2
- Paraventricular Hypothalamic Nucleus in Stress
- Paraventricular Hypothalamic Nucleus Neurons
- Paraventricular Hypothalamus Neurons
- Paraventricular Nucleus (PVN) CRH Neurons
- Paraventricular Nucleus (PVN) Neurons
- Paraventricular Nucleus Autonomic Neurons
- Paraventricular nucleus connectivity alterations in Alzheimer's disease
- Paraventricular Nucleus CRH Neurons
- Paraventricular Nucleus CRH Neurons
- Paraventricular Nucleus in Stress Response
- Paraventricular Nucleus Neuroendocrine Neurons
- Paraventricular Nucleus Neurons
- Paraventricular Nucleus of Thalamus
- Paraventricular Thalamic Nucleus (PVT) Neurons
- Paraventricular Thalamus Neurons
- Parietal Association Cortex
- Parietal Cortex Neurons
- Parietal Cortex Neurons
- Parkin (PRKN) Neurons
- Parkin-Deficient Dopaminergic Neurons
- Parkinsonism-Dementia Complex of Guam (PDC) Neurons
- Parkinsonism-Dementia Complex of Guam Neurons
- Pars Reticularis Nigral Neurons
- Parvalbumin (PV) Neurons
- Parvalbumin Expressing Interneurons
- Parvalbumin Interneurons in Schizophrenia
- Parvalbumin Neurons (PV+)
- Parvalbumin-Positive (PV+) Interneurons
- Parvalbumin-Positive (PV+) Interneurons
- Parvalbumin-Positive Interneurons
- Parvalbumin-Positive Interneurons in Alzheimer's Disease
- Parvicellular Neurosecretory Neurons
- Parvicellular Reticular Formation Neurons
- Parvicellular Reticular Neurons
- Parvicellular Reticular Nucleus
- Parvicellular Reticular Nucleus Neurons
- Parvocellular Neurosecretory Neurons
- Parvocellular Reticular Neurons
- Pax6 Neurons
- PBM effects on neuroinflammation
- PC12 Cell Line
- PC12 Cell Line
- Peduncular Ponto-Tegmental Nucleus Neurons
- Pedunculopontine Cholinergic Neurons
- Pedunculopontine Cholinergic Neurons in Neurodegeneration
- Pedunculopontine Neurons
- Pedunculopontine Nucleus (PPN) Cholinergic Neurons
- Pedunculopontine Nucleus (PPN) Cholinergic Neurons
- Pedunculopontine Nucleus (PPN) Cholinergic Neurons
- Pedunculopontine Nucleus (PPN) Neurons
- Pedunculopontine Nucleus (PPN) Neurons - Expanded
- Pedunculopontine Nucleus Cholinergic in Progressive Supranuclear Palsy
- Pedunculopontine Nucleus Cholinergic Neurons
- Pedunculopontine Nucleus Cholinergic Neurons (PPN)
- Pedunculopontine Nucleus Cholinergic Neurons in Lewy Body Disease
- Pedunculopontine Nucleus Cholinergic Neurons in Neurodegeneration
- Pedunculopontine Nucleus Cholinergic Neurons in Neurodegeneration
- Pedunculopontine Nucleus Cholinergic Neurons in Parkinson's Disease
- Pedunculopontine Nucleus Cholinergic Projection Neurons
- Pedunculopontine Nucleus Cholinergic Projection Neurons
- Pedunculopontine Nucleus GABAergic Neurons
- Pedunculopontine Nucleus GABAergic Neurons
- Pedunculopontine Nucleus in Gait and Arousal
- Pedunculopontine Nucleus in Parkinson's Disease
- Pedunculopontine Nucleus in REM Sleep
- Pedunculopontine Nucleus Neurons
- Pedunculopontine Nucleus Neurons in Lewy Body Disease
- Pedunculopontine Tegmental Nucleus
- Pedunculopontine Tegmental Nucleus Neurons
- Pelvic Plexus Neurons
- Penfield Homunculus Neurons
- Peptidergic Neurons
- Periaqueductal Gray (PAG) Neurons
- Periaqueductal Gray in Analgesia
- Periaqueductal Gray in Pain and Defensive Behavior
- Periaqueductal Gray Neurons
- Pericytes
- Pericytes in Diabetic Encephalopathy
- Perifornical Nucleus (PeF) Neurons
- Perifornical Nucleus Neurons
- Perifornical Orexin Neurons
- Periglomerular Cells
- Perihypoglossal Nuclei Complex Neurons
- Perihypoglossal Nucleus Neurons
- Perineuronal net digestion with chondroitinase ABC is equivalent to light deprivation in promoting memory formation
- Perineuronal Net-Associated Neurons
- Periolivary Nucleus
- Periolivary Nucleus Neurons
- Peripeduncular Nucleus (PPN) Neurons
- Peripheral Nerve Stimulation-Affected Neurons
- Peripheral Sensory Neurons in Chemotherapy-Induced Neuropathy
- Perirhinal Cortex
- Perirhinal Cortex Layer 2/3 Neurons
- Perirhinal Cortex Neurons
- Perirhinal Cortex Neurons
- Perivascular Astrocytes
- Perivascular Macrophages
- Periventricular Hypothalamic Nucleus Expanded
- Periventricular Nucleus
- Periventricular Nucleus (PVN) Neurons
- Periventricular Nucleus Hypothalamus
- Periventricular Nucleus in Stress
- Petrosal Ganglion Neurons
- Photoreceptor Cells
- Photoreceptor Cells (Retina)
- Photoreceptor Cells in Parkinson's Disease
- Photoreceptor-Input Neurons
- Photoreceptors in Inherited Retinal Dystrophies
- Photoreceptors in Light Detection
- Photoreceptors in Neurodegeneration
- Photoreceptors in Vision
- PHOX2B Neurons
- Phrenic Nucleus in Diaphragm Control
- Phrenic Nucleus Motor Neurons
- Physiology and pathology of choroid plexus
- Pia Mater Fibroblasts
- Pial Cells
- Pinceau Axons in Cerebellar Synaptic Inhibition
- Pineal Gland Photoreceptor-like Cells
- Pinealocytes
- Pinealocytes in Circadian Rhythm Disorders
- Pink1 Neurons
- PINK1-Deficient Dopamine Neurons
- PINK1-Deficient Dopamine Neurons
- PINK1-Deficient Dopaminergic Neurons
- Piriform Cortex Neurons
- Piriform Cortex Neurons
- Piriform Cortex Pyramidal Neurons
- Piriform Cortex Pyramidal Neurons
- Pituicytes
- Pituicytes - Expanded
- Pituitary Intermedia Cells
- Pituitary Somatotrophs Neurodegeneration
- Place Cells
- Plexiform Layer Interneurons
- PNMT Phenylethanolamine N-methyltransferase Neurons
- Polydendrocytes (NG2 Glia)
- POMC (Proopiomelanocortin) Neurons
- POMC Neurons - Expanded
- POMC Neurons in Hypothalamus
- Pontine Nuclei
- Pontine nuclei functional connectivity changes in early AD
- Pontine Nuclei in Cerebellar Input
- Pontine Nuclei in Cerebello-Cortical Communication
- Pontine Nuclei Neurons
- Pontine Raphe in Serotonergic Modulation
- Pontine Raphe Magnus Serotonergic Neurons
- Pontine Raphe Nucleus (PRn) Neurons
- Pontine Raphe Nucleus Serotonergic
- Pontine Reticular Formation
- Pontine Reticular Formation
- Pontine Reticular Formation Neurons
- Pontine Reticular Nucleus (Oral Part)
- Posterior Cingulate Cortex (PCC) Neurons
- Posterior Cingulate Cortex (PCC) Pyramidal Neurons
- Posterior Cingulate Cortex Neurons
- Posterior Cingulate Cortex Neurons in Alzheimer's Disease
- Posterior Column-Medial Lemniscus Pathway Fibers
- Posterior cortical atrophy
- Posterior Hypothalamic Area Neurons
- Posterior Hypothalamic Nucleus
- Posterior Hypothalamic Nucleus (PHN) Neurons
- Posterior Hypothalamic Nucleus Neurons
- Posterior Olivary Complex
- Posterior Parietal Cortex Neurons
- Posterior Parietal Cortex Neurons
- Posterior Parietal Cortex Pyramidal Neurons
- Posterior Parietal Cortex Pyramidal Neurons
- Posterior Pretectal Nucleus (PPT) Neurons
- Posterior Thalamic Nuclear Group Sensory Neurons
- Posterior Thalamic Nucleus (VPL/VPM) Neurons
- Posterodorsal Tegmental Nucleus (PDTg) Neurons
- Posterodorsal Tegmental Nucleus GABAergic Neurons
- Posterodorsal Tegmental Nucleus Neurons
- Posteromedial Thalamic Nucleus (PM) Neurons
- Postinspiratory Complex (PiCo) Neurons
- Postinspiratory Complex Neurons
- Postsynaptic Densities
- PPN GABAergic Neurons
- Pre-Botzinger Complex in Respiratory Control
- Pre-Botzinger Complex in Respiratory Rhythm
- Pre-Bötzinger Complex
- Pre-Bötzinger Complex (Expanded)
- Pre-Bötzinger Complex - Expanded
- Pre-Bötzinger Complex Expanded v2
- Pre-Bötzinger Complex Neurons
- Pre-Bötzinger Complex Neurons
- Pre-Bötzinger Complex Neurons
- Pre-Bötzinger Complex Neurons
- Precommissural Nucleus (PrC) Neurons
- Precuneus Cortical Neurons
- Precuneus Neurons in Alzheimer's Disease
- Prefrontal Cortex in Executive Function
- Prefrontal Cortex Layer 3 Neurons
- Prefrontal Cortex Layer 5 Pyramidal Neurons
- Prefrontal Cortex Layer 5 Pyramidal Neurons
- Prefrontal Cortex Layer 5 Pyramidal Neurons
- Prefrontal Cortex Neurons in Alzheimer's Disease
- Prefrontal Cortex Pyramidal Neurons
- Prefrontal Cortex Pyramidal Neurons in Executive Function
- Prefrontal Cortex Pyramidal Neurons in Neurodegeneration
- Prefrontal Cortical Pyramidal Neurons
- Preganglionic Autonomic Neurons
- Prelimbic Cortex Neurons
- Premammillary Nucleus
- Premammillary Nucleus Expanded v2
- Premammillary Nucleus Neurons
- Premotor Cortex
- Preolivary Nucleus
- Preoptic Anterior Hypothalamus
- Preoptic Area (POA) Neurons
- Preoptic Area Expanded
- Preoptic Area GABAergic Neurons
- Preoptic Area GABAergic Neurons
- Preoptic Area GABAergic Neurons
- Preoptic Area in Thermoregulation
- Preoptic Area Neurons
- Preoptic Area Sleep Neurons
- Preoptic Area Sleep-Active Neurons
- Preoptic Area Sleep-Active Neurons
- Preoptic Area Sleep-Active Neurons
- Preoptic Area Sleep-Active Neurons
- Preoptic Sleep-Active Neurons
- Prepositus Hypoglossi Nucleus (PHN) Neurons
- Prepositus Nucleus
- Presubicular Neurons
- Presubiculum
- Presubiculum Neurons
- Presubiculum Neurons (Expanded)
- Presynaptic Terminals in Neurodegeneration
- Pretectal Nuclei
- Pretectal Nucleus Complex
- Pretectal Nucleus Neurons
- Pretectal Nucleus Neurons
- Pretectal Olivary Neurons
- Pretectal Olivary Nucleus
- Pretectal Olivary Nucleus (PON) Neurons
- Primary Age-Related Tauopathy (PART) Neurons
- Primary Auditory Cortex Neurons
- Primary Motor Cortex
- Primary Somatosensory Cortex
- Primary Somatosensory Cortex Neurons
- Primary Visual Cortex
- Primary Visual Cortex Neurons
- Primed Microglia
- Primed Microglia
- Principal Olive Neurons
- Principal Pars Compacta
- Principal Sensory Nucleus in Face Touch
- Principal Sensory Nucleus of Trigeminal Nerve
- Principal Sensory Trigeminal Nucleus
- Principal Sensory Trigeminal Nucleus (Pr5) Neurons
- Principal Sensory Trigeminal Nucleus Neurons
- Principal Trigeminal Nucleus Sensory Neurons
- Prion Protein Expressing Neurons
- Prion-Infected Neurons
- Prion-Like Spreading Neurons
- Profound impairment in social recognition and reduction in anxiety in vasopressin V1a receptor knockout mice. Neuropsychopharmacology. 2021;46(4):726-736. DOI:10.1038/s41386-020-00926-4
- Progranulin-Deficient Microglia
- Progressive Supranuclear Palsy Neurons
- Prolactin-Producing Neurons
- Proopiomelanocortin (POMC) Neurons
- Proopiomelanocortin Neurons
- Proopiomelanocortin Neurons in Appetite Control
- Proprioceptors
- Proteasomal Dysfunction-Associated Neurons
- Protein Aggregate-Bearing Neurons
- Protein Kinase A (PKA) Neurons
- Protoplasmic Astrocytes
- Psd95 Neurons
- PSEN1-Mutant Neurons
- PSEN2-Mutant Neurons
- Pseudounipolar Neurons
- Pterygopalatine Ganglion (PPG) Neurons
- Pterygopalatine Ganglion Neurons
- Pulmonary Neurons
- Pulvinar
- Pulvinar Expanded v2
- Pulvinar in Visual Attention
- Pulvinar Neurons
- Pulvinar Nucleus
- Pulvinar Thalamic Nucleus
- Pulvinar Thalamic Nucleus Neurons
- Purkinje Cell Axonal Terminals
- Purkinje Cells
- Putamen
- Putamen in Motor Learning
- Putamen Neurons
- Putamen Projection Neurons
- PV Interneurons (Hippocampus)
- Pyramidal Neurons
- Pyramidal Tract Neurons
- Pyriform Cortex Pyramidal Cells
- Radial Glia
- Radial Glia in Neurodegeneration
- Radial Glia Neural Progenitors
- Radial Glia Neurons
- Radial Glial Cells
- Raphe Dorsalis Neurons
- Raphe Magnus Expanded
- Raphe Magnus Neurons
- Raphe Magnus Neurons
- Raphe Magnus Pain Modulation Neurons
- Raphe Magnus Pain Modulation Neurons
- Raphe Magnus Pain Modulation Neurons
- Raphe Magnus Pain Modulation Neurons in Neurodegeneration
- Raphe Magnus Serotonergic Neurons
- Raphe Nuclei
- Raphe Nuclei in Mood Regulation and Neurodegeneration
- Raphe Nuclei Neurons
- Raphe Nuclei Serotonergic Neurons
- Raphe Nuclei Serotonergic System
- Raphe Nucleus Serotonergic Neurons in Parkinson's Disease
- Raphe Obscurus (ROb) Neurons
- Raphe Obscurus Expanded
- Raphe Obscurus Neurons
- Raphe Pallidus (RPa) Neurons
- Raphe Pallidus in Thermoregulation
- Raphe Pallidus Neurons
- Raphe Serotonergic Neurons
- Raphe Serotonergic Neurons in Depression and Neurodegeneration
- Raphe Serotonergic Neurons in Migraine
- Raphe Serotonergic Neurons in Neurodegeneration
- Raphe Spinal Neurons
- Raphespinal Neurons
- Raphé Interpositus Neurons
- Raphé Magnus Serotonergic Projection Neurons
- Ras/Rap1 Signaling Neurons
- Reactive Astrocytes (A2 Phenotype)
- Reactive Astrocytes A1 Phenotype in Neurodegeneration
- Reactive Astrocytes in Neurodegeneration
- Reactive Astrocytes in Neuroinflammation
- Reactive Astrocytes Overview
- Recovering Neurons in Autoimmune Encephalitis
- Red Nucleus (Expanded)
- Red Nucleus in Motor Control
- Red Nucleus Neurons
- Red Nucleus Neurons
- Red Nucleus Neurons
- Red Nucleus Neurons
- Red Nucleus Neurons in Motor Control
- Red Nucleus Neurons in Neurodegeneration
- Red Nucleus Neurons in Neurodegeneration
- Red Nucleus Psp
- Reelin-Expressing Neurons
- Regenerating Oligodendrocytes
- Regular Spiking Basket Cells
- REM-Off Neurons
- REM-On Neurons
- Remak Cells
- Renshaw Cells
- Renshaw Cells in Recurrent Inhibition
- Research methods for enteric glia studies
- Resilient Neurons in Alzheimer's Disease
- Resilient Neurons in Parkinson's Disease
- Resilient Ventral Tegmental Area Dopamine Neurons
- Resistin-Responsive Neurons
- Responsive Neurostimulation System-Affected Neurons
- Reticular Formation Arousal
- Reticular Formation Giant Neurons
- Reticular Formation Neurons
- Reticular Formation Neurons
- Reticular Thalamic Nucleus (RTN) Neurons
- Reticular Thalamic Nucleus Expanded v2
- Reticular Thalamic Nucleus GABAergic Neurons
- Reticular Thalamic Nucleus in Sleep Spindles
- Reticular Thalamic Nucleus Neurons
- Reticularis Pontis Oralis Neurons
- Reticulospinal Neurons
- Reticulospinal Projection Neurons
- Reticulospinal Tract Fibers
- Reticulotegmental Nucleus (RtTg)
- Reticulotegmental Nucleus (RtTg)
- Retinal AII Amacrine Cells
- Retinal Amacrine Cells
- Retinal Amacrine Cells
- Retinal Bipolar Cells
- Retinal Bipolar Cells
- Retinal Bipolar Cells in Alzheimer's Disease
- Retinal Cone Photoreceptors
- Retinal Direction-Selective Ganglion Cells
- Retinal Ganglion Cells
- Retinal Ganglion Cells (RGCs)
- Retinal Ganglion Cells in Alzheimer's Disease
- Retinal Ganglion Cells in Alzheimer's Disease
- Retinal Ganglion Cells in Glaucoma
- Retinal Ganglion Cells in Glaucoma
- Retinal Ganglion Cells in Leber Hereditary Optic Neuropathy
- Retinal Ganglion Cells in Leber Hereditary Optic Neuropathy
- Retinal Ganglion Cells in Neurodegeneration
- Retinal Ganglion Cells in Neurodegeneration
- Retinal Ganglion Cells in Visual Transmission
- Retinal Ganglion Cells with Tauopathy
- Retinal Horizontal Cells
- Retinal Horizontal Cells
- Retinal Midget Bipolar Cells
- Retinal Organoid Photoreceptors
- Retinal Photoreceptor Inner Segments
- Retinal Pigment Epithelium
- Retinal Pigment Epithelium (RPE) - Expanded
- Retinal Rod Photoreceptors
- Retinal Rod Photoreceptors Neurodegeneration
- Retinal spectral-domain OCT in Parkinson's disease with dementia
- Retroambiguus Nucleus (RA) Neurons
- Retrochiasmatic Area (Retro) Neurons
- Retrochiasmatic Area Neurons
- Retromammillary Nucleus Neurons
- Retromer Complex Neurons
- Retrorubral Field (A8) Dopaminergic Neurons
- Retrosplenial Cortex
- Retrosplenial Cortex (RSC) Neurons
- Retrosplenial Cortex Neurons
- Retrosplenial Cortex Neurons in Alzheimer's Disease
- Retrotrapezoid Nucleus (RTN) Neurons
- Rett Syndrome Neurons
- Reuniens Nucleus (Re) Neurons
- Reuniens Thalamic Neurons
- Reuniens Thalamic Nucleus
- Reuniens Thalamic Nucleus in Memory
- Reuniens Thalamic Nucleus Neurons
- Reward Prediction Error Cells
- RFRP Neurons (RFamide-Related Peptide)
- Rhomboid Nucleus Neurons
- Rhomboid Thalamic Nucleus
- Rhomboid Thalamic Nucleus (Rh) Neurons
- Ripple-Associated Interneurons (Hippocampus)
- Ristral Spinal Interneurons
- Rod Bipolar Cells (Retina)
- Rod Photoreceptors
- Rohde Cells (Spinal)
- Role of adenylyl cyclase 8 in modulating anxiety-related behaviors
- Role of histamine in Alzheimer's disease pathophysiology
- Role of serotonin in Parkinson's disease progression
- Rosehip Neurons
- Rostral Interstitial Nucleus of MLF
- Rostral Interstitial Nucleus of MLF
- Rostral Interstitial Nucleus of MLF (riMLF) Neurons
- Rostral Interstitial Nucleus of MLF Neurons
- Rostral Migratory Stream Neural Progenitors
- Rostral Migratory Stream Neuroblasts
- Rostral Ventral Respiratory Group (rVRG) Neurons
- Rostral Ventral Respiratory Group (rVRG) Neurons
- Rostral Ventrolateral Medulla in Blood Pressure
- Rostral Ventrolateral Medulla Sympathetic Neurons
- Rostral Ventrolateral Medulla Sympathetic Neurons
- Rostral Ventrolateral Medulla Sympathetic Premotor Neurons
- Rostral Ventromedial Medulla Neurons
- Rostromedial Tegmental Nucleus
- Rostromedial Tegmental Nucleus in Neurodegeneration
- Rostromedial Tegmental Nucleus Neurons
- Rotenone-Exposed Dopaminergic Neurons
- Rprml Neurons
- Rubrospinal Neurons
- Rubrospinal Projection Neurons
- Rubrospinal Tract Fibers
- Ruffini Endings
- RVLM Sympathetic Neurons
- Sacral Parasympathetic Nucleus in Pelvic Function
- Sagulum Nucleus (Nucleus Sagulum) Neurons
- SATB2-Positive Neurons
- Satellite Glial Cells
- Satellite Glial Cells (PNS)
- Satellite Glial Cells - Expanded
- Satellite Glial Cells in Trigeminal Neuralgia
- Satellite Glial Cells in Trigeminal Neuralgia
- Scarpa's (Vestibular) Ganglion Neurons
- Schwann Cell Precursors
- Schwann Cells
- Schwann Cells
- Schwann Cells (Peripheral Nervous System)
- Schwann Cells in Charcot-Marie-Tooth Disease
- Schwann Cells in Charcot-Marie-Tooth Disease
- Schwann Cells in Peripheral Myelination
- Schwann Cells in Peripheral Neuropathy
- SCN Arcuate Projecting Neurons
- Secondary Visual Cortex
- Secretagogin Neurons
- Segmental Dorsal Horn Neurons
- Senescent Astrocytes
- Senescent Neurons
- Sensory Neurons
- Septal and Diagonal Band Neurons
- Septal Cholinergic Neurons
- Septal Cholinergic Neurons
- Septal Cholinergic Neurons in Memory
- Septal Diagonal Band Complex
- Septal GABAergic Neurons
- Septal Neurons
- Septal Nuclei Cholinergic Neurons
- Septal Nuclei in Memory and Social Behavior
- Septal Nuclei Neurons
- Septal Nuclei Neurons
- Septal Nucleus Cholinergic Neurons
- Septal Nucleus Cholinergic Neurons
- Septofimbrial Nucleus (SFN) Neurons
- Serotonergic Dorsal Raphe Neurons in Depression and Neurodegeneration
- Serotonergic Dorsal Raphe Nucleus Neurons
- Serotonergic function and 5-HT1E receptor binding in platelets from patients with major depressive disorder
- Serotonergic Neurons
- Serotonergic Neurons (Raphe Nuclei)
- Serotonergic Raphe Neurons in Depression and Neurodegeneration
- Serotonergic Raphe Neurons in Migraine
- Serotonergic System in Neurodegeneration
- Serotonin 5-HT1A Receptor Neurons
- Serotonin 5-HT1A Receptor Neurons
- Serotonin 5-HT1D Receptor Neurons
- Serotonin 5-HT2A Receptor Neurons
- Serotonin 5-HT2A Receptor Neurons
- Serotonin 5-HT2C Receptor Neurons
- Serotonin 5-HT3 Receptor Neurons
- Serotonin 5-HT4 Receptor Neurons
- Serotonin 5-HT5 Receptor Neurons
- Serotonin 5-HT6 Receptor Neurons
- Serotonin 5-HT7 Receptor Neurons
- Serotonin in Alzheimer's disease: therapeutic implications
- Serotonin Neurons
- Serotonin Neurons in Mood Regulation
- Serotonin Receptor Neurons
- Serotonin Spinal Projection Neurons
- Serotonin Transporter (SERT) Neurons
- Serotonin Transporter (SERT) Neurons
- SH-SY5Y Cell Line
- Shank Protein Neurons
- Shank Scaffold Protein Neurons
- Silence of the Purkinje cells
- Simplex Lobule Neurons
- SK-N-SH Cell Line
- Skeletal Muscle Cells
- Sleep-Wake Switch Neurons
- SNARE Complex Neurons
- SNCA-A53T Alpha-Synuclein Neurons
- SNCA-Overexpressing Dopaminergic Neurons
- SNr GABAergic Output Neurons
- Social Identity Cells
- SOD1 Mutant Motor Neurons
- SOD1 Mutant Motor Neurons
- Solitary Nucleus Neurons
- Solitary Nucleus Neurons
- Solitary Tract Fibers
- Somatostatin Expressing Interneurons
- Somatostatin Interneurons (Hippocampus)
- Somatostatin Neurons
- Somatostatin Receptor 1 Neurons
- Somatostatin Receptor 2 Neurons
- Somatostatin Receptor 3 Neurons
- Somatostatin Receptor 4 Neurons
- Somatostatin Receptor 5 Neurons
- Somatostatin Receptor Neurons
- Somatostatin-Expressing (SOM) Cortical Interneurons
- Somatostatin-Positive (SST+) Interneurons
- Somatostatin-Positive Cortical Interneurons
- Somatotrophs
- Sox10 Neurons
- Sox2 Neurons
- Spatially-Resolved Neuron Populations
- Speed Cells
- Sphenopalatine Ganglion (SPG) Neurons
- Spinal Cord Astrocytes
- Spinal Cord Astrocytes in ALS
- Spinal Cord Astrocytes in Neurodegeneration
- Spinal Cord Astrocytes in Neurodegeneration
- Spinal Cord Dorsal Horn Neurons
- Spinal Cord Dorsal Horn Neurons in Neurodegeneration
- Spinal Cord Intermediolateral Cell Column Neurons
- Spinal Cord Interneurons in Chronic Neuropathic Pain
- Spinal Cord Interneurons in Motor Neuron Disease
- Spinal Cord Lamina I Neurons
- Spinal Cord Lamina I Neurons
- Spinal Cord Lamina I Neurons in Pain
- Spinal Cord Lamina I Pain Neurons
- Spinal Cord Lamina I Projection Neurons
- Spinal Cord Lamina I Projection Neurons
- Spinal Cord Lamina II (Substantia Gelatinosa) Neurons
- Spinal Cord Lamina II Interneurons
- Spinal Cord Lamina II Interneurons
- Spinal Cord Lamina VII
- Spinal Cord Lamina VII Neurons in Autonomic
- Spinal Cord Lamina X
- Spinal Cord Lamina X Neurons
- Spinal Cord Microglia
- Spinal Cord Microglia in Chronic Neurodegenerative Pain
- Spinal Cord Motor Neurons
- Spinal Cord Motor Neurons
- Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis
- Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis
- Spinal Cord Neurons in Amyotrophic Lateral Sclerosis
- Spinal Cord Oligodendrocyte Precursor Cells in Neurodegeneration
- Spinal Cord Oligodendrocytes
- Spinal Cord Organoid Motor Neurons
- Spinal Cord Preganglionic Neurons
- Spinal Cord Propriospinal Neurons
- Spinal Cord Renshaw Cells
- Spinal Cord Stimulation-Affected Neurons
- Spinal Cord V2a Interneurons in ALS
- Spinal Cord Ventral Horn Motor Neurons
- Spinal Dorsal Horn (Expanded)
- Spinal Dorsal Horn Interneurons
- Spinal Dorsal Horn Lamina I Projection Neurons
- Spinal Dorsal Horn Lamina II (Substantia Gelatinosa) Neurons
- Spinal Dorsal Horn Neurons
- Spinal Gamma Motor Neurons
- Spinal Interneurons
- Spinal Interneurons in Locomotion
- Spinal Interneurons in Motor Control
- Spinal Lamina I Neurons
- Spinal Lamina I Projection Neurons
- Spinal Lamina I Projection Neurons
- Spinal Lamina II Inner Neurons
- Spinal Lamina II Neurons
- Spinal Lamina III Neurons
- Spinal Lamina III-IV Neurons
- Spinal Lamina IV Neurons
- Spinal Lamina V Neurons
- Spinal Lamina VI Neurons
- Spinal Lamina VII Neurons
- Spinal Lamina VIII Neurons
- Spinal Lamina X Neurons
- Spinal Motor Neurons
- Spinal Motor Neurons
- Spinal Motor Neurons in Krabbe Disease
- Spinal Motor Neurons in Neurodegeneration
- Spinal Motor Neurons in Spinal Muscular Atrophy
- Spinal Motor Neurons in Spinal Muscular Atrophy
- Spinal Muscular Atrophy Neurons
- Spinal Nerve Piriform Plexus
- Spinal Nucleus of Trigeminal Nerve
- Spinal Nucleus of Trigeminal Nerve Caudalis Neurons
- Spinal Nucleus of Trigeminus
- Spinal Nucleus of V Interneurons
- Spinal Preganglionic Neurons
- Spinal RAI Interneurons
- Spinal Respiratory Neurons
- Spinal Reticular Neurons
- Spinal Reticular Nucleus
- Spinal Reticulospinal Neurons
- Spinal Rubrospinal Neurons
- Spinal Trigeminal Nucleus (Sp5) Neurons
- Spinal Trigeminal Nucleus (SpV)
- Spinal Trigeminal Nucleus Caudalis
- Spinal Trigeminal Nucleus Caudalis Neurons
- Spinal Trigeminal Nucleus in Neurodegeneration
- Spinal Trigeminal Nucleus in Pain
- Spinal Trigeminal Nucleus Interneurons
- Spinal Trigeminal Nucleus Interpolaris
- Spinal Trigeminal Nucleus Interpolaris Neurons
- Spinal Trigeminal Nucleus Interpolated Part
- Spinal Trigeminal Nucleus Neurons
- Spinal Trigeminal Nucleus Oral Part
- Spinal Ventral Horn Motor Neurons
- Spinal Ventral Horn Motor Neurons
- Spinal Ventral Horn Neurons
- Spinal Vestibular Nucleus (SpVN) Expanded
- Spinal Vestibular Nucleus (SpVN) Neurons
- Spinal Vestibular Nucleus (SpVN) Neurons
- Spinal Vestibular Nucleus Neurons
- Spinal Vestibular Nucleus Neurons
- Spinal Vestibulospinal Neurons
- Spinal Visceral Motor Neurons
- Spino-Olivary Neurons
- Spinocerebellar Ataxia Type 2 Neurons
- Spinocerebellar Neurons
- Spinocerebellar Neurons in Ataxia
- Spinocerebellar Tract Fibers
- Spinocerebellum in Limb Coordination
- Spinocervical Tract Neurons
- Spinocervicothalamic Pathway Fibers
- Spinoreticular Tract Fibers
- Spinothalamic Neurons
- Spinothalamic Tract (STT) Expanded
- Spinothalamic Tract Fibers
- Spinothalamic Tract Neurons
- Spinothalamic Tract Neurons in Pain
- Spiny Stellate Cells
- Spiral Ganglion Neurons
- Spiral Ganglion Type I Neurons
- Spiral Ganglion Type I Neurons
- Spiral Ganglion Type II Neurons
- Spiral Ganglion Type II Neurons
- Starburst Amacrine Cells
- Stellate Ganglion Neurons
- Stiff-Person Syndrome-Affected Neurons
- Stratum Lacunosum-Moleculare Neurons
- Stratum Radiatum Neurons
- Stress Granule Formation in Neurodegeneration
- Stress Granule-Associated Neurons
- Stress Granules and RNP Granules
- Stressed Neurons
- Stria Terminalis
- Stria Terminalis Fibers
- Striatal Aspiny Neurons in Huntington's Disease
- Striatal Cholinergic Interneurons
- Striatal Cholinergic Interneurons
- Striatal Cholinergic Interneurons in Huntington's Disease
- Striatal Cholinergic Interneurons in Parkinson's Disease
- Striatal D1-Medium Spiny Neurons
- Striatal D2-Medium Spiny Neurons
- Striatal Direct Pathway Medium Spiny Neurons (D1-MSNs)
- Striatal Fast-Spiking Interneurons
- Striatal Indirect Pathway Medium Spiny Neurons (D2-MSNs)
- Striatal Interneuron Vulnerability in Huntington's Disease
- Striatal Interneurons
- Striatal Interneurons in Corticobasal Degeneration
- Striatal Interneurons in Huntington's Disease
- Striatal Low-Threshold Spiking Interneurons
- Striatal Low-Threshold Spiking Interneurons
- Striatal Medium Spiny Neurons
- Striatal Medium Spiny Neurons
- Striatal Medium Spiny Neurons in Huntington's Disease
- Striatal Medium Spiny Neurons in Huntington's Disease
- Striatal Medium Spiny Neurons in Huntington's Disease
- Striatal Medium Spiny Neurons in Huntington's Disease
- Striatal Medium Spiny Neurons in Neurodegenerative Disease
- Striatal Neurons in Corticobasal Degeneration
- Striatal Neurons in Multiple System Atrophy
- Striatal Neurons in Tardive Dyskinesia
- Striatal NPY Interneurons
- Striatal Parvalbumin Interneurons
- Striatal Tonic Dopamine Neurons
- Striatal Tonically Active Interneurons
- Striatal Tonically Active Neurons
- Striatum in Procedural Memory
- Subcoeruleus Neurons
- Subcoeruleus Nucleus
- Subcoeruleus Nucleus
- Subcoeruleus Nucleus (SubC) - Expanded
- Subcoeruleus Nucleus (SubC) Neurons
- Subcoeruleus Nucleus Neurons
- Subcoeruleus Nucleus Neurons
- Subcommissural Organ
- Subcuneiform Nucleus Neurons
- Subfornical Organ Neurons
- Subfornical Organ Neurons
- Subiculum Neurons
- Subiculum Pyramidal Neurons
- Sublaterodorsal Nucleus (SLD) Neurons
- Sublaterodorsal Nucleus Neurons
- Submedial Thalamic Nucleus (SMT)
- Submucosal Plexus (Meissner) Neurons
- Submucosal Plexus Neurons
- Submucous Plexus Neurons (Meissner's Plexus)
- Subplate Neurons
- Subplate Neurons
- Substance P (NK1) Receptor Neurons
- Substance P Neurons
- Substantia Gelatinosa Neurons
- Substantia Gelatinosa Neurons
- Substantia Innominata Neurons
- Substantia Innominata Neurons
- Substantia Nigra Dopamine in Corticobasal Degeneration
- Substantia Nigra Dopamine Neurons in Aceruloplasminemia
- Substantia Nigra Dopaminergic Neurons
- Substantia Nigra Neurons
- Substantia Nigra Neurons in Corticobasal Degeneration
- Substantia Nigra Neurons in Progressive Supranuclear Palsy
- Substantia Nigra Pars Compacta (SNc)
- Substantia Nigra Pars Compacta (SNc) Dopamine Neurons
- Substantia Nigra Pars Compacta (SNc) Dopaminergic Neurons
- Substantia Nigra Pars Compacta Dopamine Neurons
- Substantia Nigra Pars Compacta Dopamine Neurons
- Substantia Nigra Pars Compacta Dopamine Neurons
- Substantia Nigra Pars Compacta Dopamine Neurons
- Substantia Nigra Pars Compacta Dopamine Neurons
- Substantia Nigra Pars Compacta Dopamine Neurons (Expanded)
- Substantia Nigra Pars Compacta Dopamine Neurons in Parkinson's Disease
- Substantia Nigra Pars Compacta Dopamine Neurons in Parkinson's Disease
- Substantia Nigra Pars Compacta Dopaminergic Neurons
- Substantia Nigra Pars Compacta Dopaminergic Neurons
- Substantia Nigra Pars Compacta in Motor Control
- Substantia Nigra Pars Compacta in Parkinson's Disease
- Substantia Nigra Pars Compacta Neurons
- Substantia Nigra Pars Reticularis in Motor Output
- Substantia Nigra Pars Reticulata
- Substantia Nigra Pars Reticulata (SNr) Expanded
- Substantia Nigra pars Reticulata (SNr) GABA Neurons
- Substantia Nigra Pars Reticulata (SNr) Neurons
- Substantia Nigra Pars Reticulata Expanded
- Substantia Nigra Pars Reticulata GABA Neurons
- Substantia Nigra Pars Reticulata GABA Neurons
- Substantia Nigra Pars Reticulata GABA Output Neurons
- Substantia Nigra Pars Reticulata GABAergic Output Neurons
- Substantia Nigra Pars Reticulata GABAergic Output Neurons
- Substantia Nigra Pars Reticulata GABAergic Output Neurons
- Substantia Nigra Pars Reticulata Neurons
- Substantia Nigra Pars Reticulata Neurons in Parkinson Disease
- Substantia Nigra Pars Reticulata Neurons in Parkinson's Disease
- Subthalamic Nucleus (STN) Neurons
- Subthalamic Nucleus Excitatory Projection Neurons
- Subthalamic Nucleus Expanded
- Subthalamic Nucleus Glutamate Neurons
- Subthalamic Nucleus Glutamatergic Neurons
- Subthalamic Nucleus in Movement
- Subthalamic Nucleus in Parkinson's Disease
- Subthalamic Nucleus Neurons
- Subthalamic Nucleus Neurons in Progressive Supranuclear Palsy
- Subventricular Zone (SVZ) Neural Progenitors
- Subventricular Zone Neural Stem Cells
- Subventricular Zone Progenitors
- Superior Central Nucleus Neurons
- Superior Central Raphe Nucleus
- Superior Cervical Ganglion Neurons
- Superior Colliculus (SC) Neurons
- Superior Colliculus Deep Layer Neurons
- Superior Colliculus Deep Layers
- Superior Colliculus in Orientation
- Superior Colliculus Intermediate Layer Neurons
- Superior Colliculus Neurons
- Superior Olivary Complex (SOC) Neurons
- Superior Olivary Complex in Sound Localization
- Superior Olivary Complex Neurons
- Superior Periolivary Nucleus (SPON) Neurons
- Superior Temporal Gyrus
- Superior Temporal Gyrus Neurons
- Superior Vestibular Nucleus (SVN) Neurons
- Supplementary Motor Area
- Suprachiasmatic Nucleus (SCN) Neurons - Expanded
- Suprachiasmatic Nucleus AVP Neurons
- Suprachiasmatic Nucleus Circadian Neurons in Neurodegeneration
- Suprachiasmatic Nucleus in Circadian Rhythm
- Suprachiasmatic Nucleus Neurons
- Suprachiasmatic Nucleus Neurons
- Suprachiasmatic Nucleus Neurons
- Suprachiasmatic Nucleus Neurons in Circadian Disorders
- Suprachiasmatic Nucleus Neurons in Neurodegeneration
- Suprachiasmatic Nucleus Neurons in Shift Work Disorder
- Suprachiasmatic Nucleus VIP Neurons
- Suprachiasmatic Nucleus VIP Neurons
- Supramammillary Neurons
- Supramammillary Nucleus (SuM) Neurons
- Supramammillary Nucleus (SuM) Neurons
- Supramammillary Nucleus in Neurodegeneration
- Supramammillary Nucleus Neurons
- Supramarginal Gyrus Neurons
- Supraoptic Nucleus (SON) Neurons
- Supraoptic Nucleus (SON) Neurons
- Supraoptic Nucleus Expanded v2
- Supraoptic Nucleus Neurons
- Supraoptic Nucleus Oxytocin Neurons
- Supraoptic Nucleus Oxytocin Neurons
- Supraoptic Nucleus Oxytocin Neurons
- Supraoptic Nucleus Oxytocin Neurons
- Supraoptic Nucleus Vasopressin Neurons
- Supraoptic Nucleus Vasopressin Neurons
- Supraoptic Nucleus Vasopressin Neurons
- Supraoptic Nucleus Vasopressin Neurons
- Supraoptic Vasopressin Neurons Neurodegeneration
- Surveying Microglia
- SVZ Neural Stem Cells
- Sympathetic Chain Ganglion Neurons
- Sympathetic Neurons
- Sympathetic Preganglionic Neurons
- Synapsin Neurons
- Synaptic Astrocytes
- Synaptic Boutons
- Synaptic density and subicular integrity in early AD: a PET study with [11C]UCB-J
- Synaptic Loss in Neurodegeneration
- Synaptic Pruning Microglia
- Synaptic Vesicle Cycle
- Synaptic Vulnerability Neurons
- Synaptically Strengthened Neurons
- Synaptically Weakened Neurons
- Synaptojanin Neurons
- Synaptophysin Neurons
- Synaptotagmin Neurons
- Synucleinopathy Neurons
- T-Lymphocytes (CNS)
- Tachykinin Neurons
- Tachykinin NK1 Receptor Neurons
- Taenia Tecta Neurons
- Tail of the Ventral Tegmental Area Neurons
- Tanycytes
- Tanycytes
- Tanycytes Enhanced
- Tanycytes in Alpers Syndrome
- Tanycytes in Energy Balance and Neurodegeneration
- Tanycytes in Energy Balance and Neurodegeneration
- Taste Receptor Cells
- Taste Receptor Cells in Neurodegeneration
- Tau Pathology Astrocytes (TPA)
- Tau Pathology Cortical Neurons
- Tau Pathology in Pyramidal Neurons
- Tau Protein Expressing Neurons
- Tau-Associated Neurons
- Tau-Associated Neurons
- Tau-Hyperphosphorylated Neurons
- Tauopathy Neurons
- Tauopathy Neurons in PSP
- Tauopathy-Associated Neurons
- Tauopathy-Associated Neurons in Frontotemporal Dementia
- TDP-43 Aggregate Neurons
- TDP-43 Proteinopathy Neurons
- TDP-43 Proteinopathy Neurons
- TDP-43 Proteinopathy Neurons in Frontotemporal Dementia
- Tectospinal Projection Neurons
- Telencephalon Development
- Telomere Dysfunction-Associated Neurons
- Temporal Association Cortex
- Temporal Cortex Layer 2 Neurons
- Temporal Cortex Layer 5 Pyramidal Neurons in Semantic Dementia
- Temporal Cortex Neurons
- Temporal Cortex Neurons in Alzheimer's Disease
- Temporal Cortex Neurons in Frontotemporal Dementia
- Temporal Cortex Pyramidal Neurons
- Temporal Polar Cortex Neurons
- Temporal Pole Neurons
- Terminal Nucleus Neurons
- Thalamic Centromedian Nucleus
- Thalamic Neurons
- Thalamic Neurons in Fatal Familial Insomnia
- Thalamic Neurons in Huntington Disease
- Thalamic Parafascicular Nucleus
- Thalamic Relay Neurons
- Thalamic Relay Neurons
- Thalamic Reticular Neurons in Attention
- Thalamic Reticular Nucleus (TRN) Neurons
- Thalamic Reticular Nucleus GABAergic
- Thalamic Reticular Nucleus in Epilepsy
- Thalamic Reticular Nucleus in Epilepsy
- Thalamic Reticular Nucleus Neurons
- Thalamic Ventrobasal Neurons
- Thalamocortical Relay Neurons
- The pontine REM sleep switch
- The role of the claustrum in the default mode network
- Thermoreceptors
- Thermoregulatory Neurons
- Theta Pacemaker Neurons (Hippocampus)
- Theta-Firing Dopamine Neurons
- Theta-Firing Dopamine Neurons in Parkinson's Disease
- Thyroid Axis Neurons in TSH-Secreting Adenoma
- Thyroid Follicular Cells
- Thyroid-Stimulating Hormone Neurons
- Thyrotrophs
- Thyrotropin-Releasing Hormone (TRH) Neurons
- TIDA Tuberoinfundibular Dopamine Neurons
- Time Cells
- Tle4 Neurons
- Trace Amine-Associated Receptor (TAAR) Neurons
- Transcranial Direct Current Stimulation-Affected Neurons
- Transcriptional changes in dorsal horn neurons in chronic pain
- Transentorhinal Cortex Neurons
- Translotitudinal Cells
- Trapezoid Body Complex
- Trapezoid Body Neurons
- Trapezoid Body Nucleus Neurons
- TREK1 Neurons
- TREM2-Deficient Microglia
- TREM2-Expressing Microglia
- Triangular Nucleus of Septum
- Triangular Nucleus of the Septum (Tria) Neurons
- Triangular Septal Nucleus (TSN) Neurons
- Triangular Septal Nucleus Neurons
- Trigeminal Ganglion Neurons
- Trigeminal Mesencephalic Nucleus
- Trigeminal Mesencephalic Nucleus Neurons
- Trigeminal Motor Nucleus (MoV) Neurons
- Trigeminal Motor Nucleus in Mastication
- Trigeminal Sensory Neurons in Neuropathic Pain
- Trigeminothalamic Pathway Fibers
- Trilaminar Cells
- Trilaminar Cells
- Trochlear Nerve Motor Neurons
- Trochlear Nucleus
- Trochlear Nucleus (CN IV) Neurons
- Trochlear Nucleus (TRO) Neurons
- Trochlear Nucleus Cholinergic Neurons
- Trochlear Nucleus Motor Neurons
- Trochlear Nucleus Neurons
- TRPV1 Sensory Neurons
- Tryptophan Hydroxylase (TPH) Neurons
- Tryptophan Hydroxylase Neurons
- Tuber Cinereum Neurons
- Tuberal Hypothalamic Neurons
- Tuberal Nucleus Neurons
- Tuberoinfundibular Dopamine (TIDA) Neurons
- Tuberoinfundibular Dopamine Neurons
- Tuberoinfundibular Dopamine Neurons
- Tuberoinfundibular Dopamine Neurons in Parkinson's Disease
- Tuberoinfundibular Dopaminergic Pathway
- Tuberomammillary Histaminergic Neurons
- Tuberomammillary Nucleus Expanded
- Tuberomammillary Nucleus Expanded v2
- Tuberomammillary Nucleus GABA Neurons
- Tuberomammillary Nucleus Histamine in Sleep
- Tuberomammillary Nucleus Histamine Neurons
- Tuberomammillary Nucleus Histamine Neurons
- Tuberomammillary Nucleus Histamine Neurons
- Tuberomammillary Nucleus Histaminergic Neurons
- Tuberomammillary Nucleus Histaminergic Neurons
- Tuberomammillary Nucleus Histaminergic Neurons
- Tuberomammillary Nucleus Histaminergic Neurons
- Tuberomammillary Nucleus in Alzheimer's Disease
- Tuberomammillary Nucleus in Sleep-Wake
- Tuberomammillary Nucleus Neurons
- Tuberomammillary Nucleus Neurons
- Tuberomammillary Nucleus Neurons
- Tuberomammillary Nucleus Neurons in Neurodegeneration
- Tuberous Sclerosis Neurons
- Tufted Cells
- Tyramine/Hypocretin Neurons
- Tyrosine Hydroxylase (TH) Neurons in Neurodegeneration
- Tyrosine Hydroxylase Dopamine Neurons
- Tyrosine Hydroxylase Expressing Interneurons
- Tyrosine Hydroxylase Neurons in Ventral Tegmental Area
- Tyrosine Hydroxylase Positive Striatal Interneurons
- Tyrosine Hydroxylase Th Neurons
- Ubiquitin-Impaired Neurons
- Ubiquitin-Proteasome System (UPS) Neurons
- Ubiquitin-Proteasome System in Neurons
- UCHL1 Ubiquitin C-terminal Hydrolase Neurons
- ULK Complex Neurons
- Unfolded Protein Response (UPR) Neurons
- Unipolar Brush Cells
- Unipolar Brush Cells in Episodic Ataxia
- Unique functional properties of hippocampal O-LM cells in aging and Alzheimer's disease
- Upper Motor Neurons (Cortical)
- Upper Motor Neurons in Amyotrophic Lateral Sclerosis
- Upper Motor Neurons in Primary Lateral Sclerosis
- Upper Motor Neurons in Primary Lateral Sclerosis
- Urocortin 1 Neurons
- Urocortin 2 (UCN2) Neurons
- Urocortin 3 (UCN3) Neurons
- Urocortin Neurons
- Uvula Neurons
- Vagal Afferent Neurons
- Vagal Motor Neurons
- Vagal Nucleus Neurons in Parkinson's Disease
- Vagus Nerve Sensory Neurons
- Vagus Nerve Stimulation-Affected Neurons
- Vagus Preganglionic Neurons
- Value Coding Cells
- Vascular Dementia Neurons
- Vascular Leptomeningeal Cells
- Vascular Smooth Muscle Cells
- Vascular Smooth Muscle Cells in CADASIL
- Vascular Smooth Muscle Cells in CADASIL
- Vasoactive Intestinal Peptide (VIP) Neurons
- Vasoactive Intestinal Peptide (VIP+) Interneurons
- Vasoactive Intestinal Peptide Expressing Interneurons
- Vasoactive Intestinal Peptide Interneurons
- Vasoactive Intestinal Peptide Neurons
- Vasopressin (AVP) Neurons
- Vasopressin Neurons (Expanded)
- Vasopressin Neurons in Social Behavior
- Vasopressin Receptor Neurons
- Vasopressin V1a Receptor Neurons
- Vasopressin V1b Receptor Neurons
- Vasopressin V2 Receptor Neurons
- Ventra Horn Motoneurons
- Ventral Anterior Thalamic Nucleus Expanded v2
- Ventral Anterior Thalamic Nucleus Neurons
- Ventral Cochlear Nucleus Anterior Neurons
- Ventral Cochlear Nucleus Neurons
- Ventral Fornix
- Ventral Horn Motor Neurons
- Ventral Interpeduncular Nucleus
- Ventral Lateral Thalamic Nucleus (VL) Neurons
- Ventral Midbrain Dopamine Neurons Development
- Ventral Pallidal Neurons
- Ventral Pallidal Neurons in Motivation
- Ventral Pallidum (VP) Neurons
- Ventral Pallidum GABAergic Neurons
- Ventral Pallidum GABAergic Neurons
- Ventral Pallidum GABAergic Neurons
- Ventral Pallidum in Motivation
- Ventral Pallidum in Reward Valuation
- Ventral Pallidum Neurons
- Ventral Pallidum Neurons in Motivation
- Ventral Pallidum Neurons in Neurodegeneration
- Ventral Posterior Nucleus in Somatosensation
- Ventral Posterior Thalamic Nucleus (VPL/VPM) Neurons
- Ventral Posterior Thalamic Nucleus in Somatosensation
- Ventral Posterior Thalamic Nucleus in Somatosensation
- Ventral Posterior Thalamic Nucleus Neurons
- Ventral Posterolateral Nucleus
- Ventral Posterolateral Thalamic Nucleus (VPL) Neurons
- Ventral Posteromedial Nucleus
- Ventral Posteromedial Thalamic Nucleus (VPM) Neurons
- Ventral Respiratory Group (VRG) Neurons
- Ventral Respiratory Group Expanded
- Ventral Respiratory Group Neurons
- Ventral Striatum Neurons
- Ventral Tegmental Area (Expanded)
- Ventral Tegmental Area (VTA) Dopaminergic Neurons
- Ventral Tegmental Area Dopamine in Addiction
- Ventral Tegmental Area Dopamine Neurons
- Ventral Tegmental Area Dopamine Neurons
- Ventral Tegmental Area Dopamine Neurons (Expanded)
- Ventral Tegmental Area Dopamine Neurons in Lewy Body Disease
- Ventral Tegmental Area Dopamine Neurons in Neurodegeneration
- Ventral Tegmental Area Dopamine Neurons in Parkinson's Disease
- Ventral Tegmental Area Dopaminergic Neurons
- Ventral Tegmental Area GABAergic Neurons
- Ventral Tegmental Area GABAergic Neurons
- Ventral Tegmental Area Gabaergic Neurons Expanded
- Ventral Tegmental Area Glutamatergic Neurons
- Ventral Tegmental Area in Motivation
- Ventral Terminal Nucleus Neurons
- Ventrolateral Prefrontal Cortex
- Ventrolateral Preoptic Area (VLPO) Neurons
- Ventrolateral Preoptic Area (VLPO) Neurons
- Ventrolateral Preoptic Area Neurons
- Ventrolateral Preoptic GABAergic Neurons
- Ventromedial Hypothalamic Neurons
- Ventromedial Hypothalamic Nucleus (VMH) Neurons
- Ventromedial Hypothalamic Nucleus Neurons
- Ventromedial Hypothalamus
- Ventromedial Hypothalamus in Emotional Behavior
- Ventromedial Hypothalamus in Fear Responses
- Ventromedial Hypothalamus Neurons
- Ventromedial Prefrontal Cortex
- Verbeke Nucleus (Nucleus Basalis Verbeke)
- Vertical Diagonal Band (VDB) Cholinergic Neurons
- Vertical Diagonal Band Cholinergic Neurons
- Vertical Diagonal Band Nucleus Neurons
- Vertical Limb of Diagonal Band Cholinergic Neurons
- Vertical Limb of Diagonal Band in Attention
- Vesicular Acetylcholine Transporter Neurons
- Vesicular GABA Transporter (VGAT) Neurons
- Vesicular Glutamate Transporter (VGLUT) Neurons
- Vesicular Glutamate Transporter (VGLUT) Neurons
- Vesicular Monoamine Transporter 2 (VMAT2) Neurons
- Vesicular Monoamine Transporter Neurons
- Vestibular Ganglion Neurons (Scarpa's Ganglion)
- Vestibular Hair Cells
- Vestibular Hair Cells in Degeneration
- Vestibular Hair Cells in Meniere Disease
- Vestibular Hair Cells in Meniere Disease
- Vestibular Hair Cells in Meniere's Disease
- Vestibular Hair Cells in Neurodegeneration
- Vestibular Nerve Root Entry Zone Neurons
- Vestibular Neurons
- Vestibular Nuclei
- Vestibular Nuclei Complex (Expanded)
- Vestibular Nuclei in Balance
- Vestibular Nuclei Neurons
- Vestibular Nucleus Neurons
- Vestibular Type I Hair Cells
- Vestibular Type II Hair Cells
- Vestibulocerebellum in Balance and Eye Movements
- Vestibulospinal Neurons
- Vestibulospinal Neurons
- Vestibulospinal Tract Fibers
- VGAT Vesicular GABA Transporter Neurons
- VIP-Positive Cortical Interneurons
- VIP-Positive Hippocampal Interneurons
- Visceral Sensory Neurons
- Visceroceptors
- Visual Cortex (V1) Neurons
- Visual Cortex Layer 4C Neurons
- Visual Cortex Layer 5/6 Neurons
- VMAT2 Vesicular Monoamine Transporter Neurons
- Volonte et al. P2X7 receptor: evolution and drug development. Biochem Pharmacol (2021)
- Voltage-Gated Potassium (Kv) Channel Neurons
- Voltage-Gated Sodium (NaV) Channel Neurons
- Vomeronasal Neurons
- Vomeronasal Organ Sensory Neurons
- Von Economo Neurons
- VPAC1 Receptor Neurons
- VPAC2 Receptor Neurons
- VPS35 Mutant Neurons
- VTA Dopamine Neurons
- VTA Dopamine Neurons
- VTA Dopamine Neurons
- VTA Dopamine Neurons
- VTA Dopamine Neurons Expanded
- VTA Dopamine Neurons in Parkinson's Disease
- VTA Dopamine Neurons in Schizophrenia
- VTA Dopamine Neurons in Schizophrenia
- VTA Dopaminergic Neurons
- VTA GABA Neurons
- VTA GABAergic Neurons
- VTA GABAergic Neurons
- VTA GABAergic Neurons
- Vulnerability-Resilient Dopaminergic Neurons
- Vulnerable Dentate Gyrus Granule Cells in Neurodegeneration
- Vulnerable Dopaminergic Neurons in Parkinson's Disease
- Vulnerable Dopaminergic Neurons in Substantia Nigra
- Vulnerable Dopaminergic Neurons in the Ventral Tegmental Area
- Vulnerable Hippocampal CA1 Pyramidal Neurons in Alzheimer's Disease
- Vulnerable Neurons in Alzheimer's Disease
- Vulnerable Neurons in Parkinson's Disease
- Vulnerable Substantia Nigra Dopamine Neurons
- Waddington Axon Guidance
- Wang J, Chen L, Zheng Q. Mechanisms of drug resistance at the blood-brain barrier: Implications for neuroimaging. J Cereb Blood Flow Metab. 2019
- Warburg Astrocytes
- Weng et al. Sigma-1 receptor gene variants and neuropsychiatric symptoms in Alzheimer's disease. Mol Psychiatry (2020)
- Wernickes Area
- White Matter Neurons in Vascular Cognitive Impairment
- Wide Dynamic Range (WDR) Neurons
- Wide-Field Amacrine Cells
- WT1-Expressing Neurons
- X94-like Cortical Interneurons
- XCR1 Neurons
- Xiphoid Nucleus
- Xiphoid Nucleus Neurons
- Xiphoid Thalamic Nucleus
- Y Group Cerebellar Nucleus
- Y-Nucleus (Accessory Optic System)
- Zona Incerta (ZI) Neurons
- Zona Incerta Expanded v2
- Zona Incerta GABAergic Neurons
- Zona Incerta GABAergic Neurons
- Zona Incerta in Movement
- Zona Incerta in Movement Regulation
- Zona Incerta Neurons
- Zona Incerta Neurons
- Zonal Layer Superior Colliculus Neurons
- Zonula of Chievitz
- ''
- ''
- ''(2016). "Mammillary body and anterior thalamic interactions: anatomy, pathology, and behaviour." In The Connected Hippocampus, Springer. . DOI''
- ''BrainSpan Consortium. BrainSpan Atlas Brain Atlas Resources''
- ''NeuroSynth Brain Atlas Resources''
- ''NeuroSynth Brain Atlas Resources''
- ''NeuroSynth''
- ''Pandolfo, M. (2009). Friedreich ataxia: The clinical picture. Journal of Neurology, 256(Suppl 1), 3-8. DOI''
- ''Rivastigmine for gait stability in patients with Parkinson''s Disease (ReSPonD: a randomised, double-blind, placebo-controlled, phase 2 trial''
- (2010). "Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration." Neurology, 75(18), 1627-1633. PubMed
- A physiologically plausible model of action selection and execution in the basal ganglia
- Amygdala
- Basal Forebrain
- Brain Region Connectivity Index
- Brain Region Disease Involvement
- Brain Region Overview
- Brain Region Rankings
- Brain Region Vulnerability Map
- Brain Regions
- Brainstem
- Caudate Nucleus
- Cerebellum
- Cerebral Cortex
- Cerebral Cortex
- Cerebral Ventricles
- Dentate Gyrus
- Dorsal Motor Nucleus of the Vagus
- Entorhinal Cortex
- Entorhinal Cortex in Alzheimer's Disease
- Entorhinal Cortex in Parkinson's Disease
- Fornix
- Globus Pallidus
- Herrington TM, Cheng JJ, Eskandar EN. Mechanisms of deep brain stimulation. J Neurophysiol. 2016;115(1):19-38. DOI
- Hippocampus
- Hypothalamus
- Inferior Olivary Nucleus — Wikipedia
- Insular Cortex
- Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson's Disease
- Motor Cortex
- Nucleus Accumbens
- Nucleus Basalis of Meynert
- Occipital Lobe
- Olfactory Bulb
- Parietal Lobe
- Periaqueductal Gray (PAG)
- Pons
- Raphe Nucleus
- Red Nucleus
- Ressler KJ, Nemeroff CB. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry. 1999;46(9):1219-1233. DOI
- Reticular Formation
- Striatum
- Subthalamic Nucleus
- Superior Colliculus
- Thalamus
- Ventral Tegmental Area
¶ Main Pages
- "Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy"
- '"Visual hallucinations with entacapone." Mov Disord'
- '## See Also'
- '## See Also'
- ''(2007). iTUG test of gait and turning in Parkinson''s disease. J Neurol Neurosurg Psychiatry, 78(8):865-870. DOI: 10.1136/jnnp.2006.098442. PubMed))''
- ''(2023). Rapid health technology assessment of galantamine for the treatment of Alzheimer''s Disease: A review. PMC12150971. PMC)''
- ''(2024). "SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities." The Neuroscientist, 30(4), 341-365. DOI''
- ''(2024). Stem cell therapy in Alzheimer''s Disease: current status and perspectives. Free Radical Biology and Medicine, 225, 10–24. PMC11618239''
- ''(2025). Concurrent nanotherapeutics and regulatory updates for ALS: a focused review for orphan drug (Tofersen). International Journal of Pharmaceutics. PMC12639972''
- ''Brain''
- ''Kurtzke JF. (1983). "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)." Neurology, 33(11): 1444-1452. DOI''
- '-'
- 'APOE and Alzheimer disease risk in Europeans'
- 'Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities'
- 'Clemastine enhances remyelination in a mouse model of multiple sclerosis'
- 'Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria'
- 'Docosahexaenoic acid homeostasis, brain aging and Alzheimer''s disease: can we reconcile the evidence?'
- 'Fasudil hydrochloride in the treatment of cerebral vasospasm'
- 'FTD subtypes differentiation using CSF NfL and p-tau'
- 'Functional connectivity of the amygdala in Parkinson's disease'
- 'FUS proteinopathy in FTD and ALS'
- 'Inflammasome activation in neurodegenerative diseases: the role of AIM2'
- 'KMO inhibition provides neuroprotection in PD models. Neurobiol Dis (2023).'
- 'MCI to Alzheimer''s disease: current diagnostic approaches and emerging therapies'
- 'mTORC1 promotes pudgy degradation and dopaminergic neuron survival'
- 'New treatment approaches for Alzheimer''s disease: preclinical studies and clinical trials'
- 'OCTA findings in Korean Alzheimer's disease patients'
- 'PGC-1alpha mediates mitochondrial quality control in Drosophila and mammals'
- 'pNfH standardization'
- 'Precision medicine framework for neurodegenerative diseases (2023)'
- 'Retromer in neurodegenerative disease: the therapeutic potential'
- 'Stroke prevention in vascular dementia'
- 'Tau passive immunotherapy in animal models'
- 'Tau phosphorylation at threonine 413'
- 'The genetics of Alzheimer disease'
- 'The Paper-Toss Test: enhancing bedside recognition of corticobasal syndrome (2025)'
- 'Unresolved issues in Parkinson disease'
- 'Viral infection induces endoplasmic reticulum stress and UPR in PD models'
- 'Vitamin D and cognition in older adults: updated international recommendations'
- '中国生物医药产业发展报告2024'
- (2022). ISR modulation in ALS models. Nature Neuroscience. PMID:35678901
- 14-3-3 Proteins (CSF) - Biomarker
- 3xTG-AD Triple Transgenic Mouse Model
- 3xTG-AD Triple Transgenic Mouse Model of Alzheimer's Disease
- 4D Molecular Therapeutics
- 4R Tauopathy Biomarker Development
- 4R Tauopathy Differential Biomarkers
- 4R Tauopathy Therapeutics — Investment Landscape Analysis
- 4R-Tau & PSP Therapeutics Pipeline
- 4R-Tau Targeting Therapies for PSP and CBS
- 4R-Tau Targeting Therapy for PSP
- 5-Hydroxymethylcytosine (5-hmC) as a Biomarker for Parkinson's Disease
- 5xFAD Five-Familial AD Mouse Model of Alzheimer's Disease
- 5xFAD Transgenic Mouse Model
- 5xFAD Transgenic Mouse Model
- 6-OHDA Rat Model of Parkinson's Disease
- A multicentre validation study of blood neurofilaments in neurodegenerative diseases
- A30P Alpha-Synuclein Transgenic Mouse Model
- A53T Alpha-Synuclein Transgenic Mouse Model of Parkinson's Disease
- AADC Gene Therapy for Parkinson's Disease
- AADvac1 - Tau Vaccine
- AAIC 2025 Conference
- AAIC 2026 Company Presentations
- AAIC 2026 Conference
- AAIC 2026 Conference
- AAIC 2026 Emerging Therapeutic Targets
- AAIC 2026 ISTAART Sessions
- AAIC 2026 Plenary Sessions
- AAIC 2026 Scientific Sessions
- AAIC 2026 — Neuroinflammation & Microglia in Alzheimer's
- AAIC 2026 — Neurovascular Function and Cerebral Blood Flow in Alzheimer's
- AAIC 2026 — Vascular Contributions to Cognitive Impairment and Dementia
- AAIC 2026 — Vascular Contributions to Cognitive Impairment and Dementia
- AAIC 2026: Amyloid and Tau Imaging Advances
- AAIC 2026: Biomarker-Guided Clinical Trials
- AAIC 2026: Clinical Trials and Drug Development
- AAIC 2026: Cognitive Reserve and Lifestyle Interventions
- AAIC 2026: Combination Therapy and Multi-Target Approaches in Alzheimer's Disease
- AAIC 2026: Early Detection and Preclinical AD
- AAIC 2026: Epigenetic and Genetic Biomarkers in Alzheimer's
- AAIC 2026: Epigenetic Mechanisms in Alzheimer's
- AAIC 2026: Fluid Biomarkers
- AAIC 2026: Gene Therapy Developments
- AAIC 2026: Gene Therapy Developments
- AAIC 2026: Glial Cell Mechanisms
- AAIC 2026: Imaging Advances
- AAIC 2026: Lifestyle Factors and Prevention
- AAIC 2026: Metabolic Approaches
- AAIC 2026: Metabolic Approaches
- AAIC 2026: Multi-Modal Biomarker Integration
- AAIC 2026: Neuroinflammation
- AAIC 2026: Neuropsychology and Cognitive Assessment Advances
- AAIC 2026: Nutrition, Lifestyle, and Prevention Strategies
- AAIC 2026: Prevention Trials
- AAIC 2026: Synaptic Function Preservation
- AAIC 2026: Tau Imaging and Biomarker Validation Studies
- AAIC 2026: Tau Immunotherapy
- AAIC 2026: Therapeutic Approaches
- AAN 2026 Alzheimer's and Parkinson's Updates
- AAN 2026 Blood Biomarkers
- AAN 2026 Clinical Trials
- AAN 2026 Neurodegeneration Sessions
- AAN 2026 Plenary Sessions
- AAN 2026 — Alzheimer's Disease
- AAN 2026 — American Academy of Neurology Annual Meeting
- AAN 2026 — Deep Brain Stimulation and Neurotechnology Advances
- AAN 2026 — Dementia
- AAN 2026 — Parkinson's Disease
- AAN Annual Meeting
- AAN Annual Meeting 2025
- AAV Capsid Engineering for CNS-Targeted Neurodegeneration Therapy
- AAV Gene Therapy for Neurodegeneration — Investment Landscape
- AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives
- AAV Gene Therapy Vectors for Neurodegenerative Diseases
- AAV Serotype CNS Delivery Optimization Therapy
- AAV Serotype Comparison for LRRK2 Knockdown in PD
- AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy
- AAV Vectors for Neurodegenerative Disease Gene Therapy
- AAV Vectors in Neurodegenerative Disease Gene Therapy
- AAV-Delivered RNA Targeting Therapy for Neurodegeneration
- AAV-LRRK2 Gene Delivery Model
- AAV-LRRK2 Gene Therapy IND-Enabling Study Design
- AAV-LRRK2 IND-Enabling Study Design
- AB Science
- Abbott
- Abbott Laboratories
- Abbott Laboratories — Neurology
- ABBV-951 Subcutaneous Infusion for Parkinson's Disease
- AbbVie
- AbbVie BRAIN Platform — Blood-Brain Barrier Delivery Technology
- AbbVie Neuroscience
- ABCA7 and cognitive resilience in Alzheimer's disease
- AC Immune
- AC Immune SA
- Academic Spin-out Companies in Alzheimer’s Disease
- Acadia Pharmaceuticals
- Accerise Inc.
- Aché Laboratórios
- ACI-35 Liposomal Vaccine
- Acid Sphingomyelinase Inhibitors — Small Biotech and Repurposing Landscape
- Acoustoelectric Brain Imaging
- ACSL4 Inhibition for Ferroptosis Prevention in Neurodegeneration
- Actinogen Medical
- Acumen Pharmaceuticals
- Acumen Pharmaceuticals, Inc.
- Acupuncture and TCM for Atypical Parkinsonism
- Acupuncture Therapy for Neurodegeneration
- Acupuncture Therapy for Parkinson's Disease
- Acupuncture Therapy for Parkinson's Disease
- AD AMPK Activator and Energy Metabolism Companies
- AD BBB Modulation and Transport Technologies
- AD Bioinformatics and Genomics Services Companies
- AD Biomarker-to-Mechanism Mapping - Biomarker Guide
- AD Cell Therapy and Regenerative Medicine Companies
- AD cGAS-STING and Innate Immune Pathway Companies
- AD Cholinergic Therapy Companies
- AD Combination Therapy Matrix - 15x15 Scoring
- AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
- AD Diagnostic and Imaging Companies
- AD Exosome and Extracellular Vesicle Companies
- AD GABA Receptor and Excitotoxicity Therapy Companies
- AD Gene Therapy and Genome Editing Companies
- AD Glymphatic System and CSF Dynamics Therapy Companies
- AD JAK-STAT Inhibitor Companies
- AD Kinase Inhibitor Companies
- AD Knowledge Gaps Ranked - Prioritized Research Questions
- AD Metabolic and GLP-1 Based Therapy Companies
- AD Microglial Phagocytosis and Synaptic Pruning Companies
- AD Nasal Spray and Brain Delivery Companies
- AD Neural Stem Cell and Progenitor Cell Therapy Companies
- AD Neural Stem Cell and Progenitor Therapy Companies
- AD Neurogenesis and Neuroregeneration Companies
- AD Neuroimmune Checkpoint and TREM2 Pathway Companies
- AD Neuropeptide and Neuropeptide Receptor Modulator Companies
- AD Neuroprotective Peptide and Peptide-Based Therapy Companies
- AD Neurovascular and Cerebral Vasculature Therapy Companies
- AD Nutraceutical and Dietary Supplement Companies
- AD Organization Landscape
- AD Pipeline
- AD Pipeline Companies
- AD RNA-Based Therapeutics Companies
- AD Sigma-1 Receptor & Molecular Chaperone Therapy Companies
- AD Sphingolipid and Ceramide Signaling Therapy Companies
- AD Synthetic Biology Companies
- AD Tau-Targeting Companies
- AD Therapeutic Approaches Scorecard - 28 Approaches Ranked
- AD WNT Signaling and Developmental Pathway Companies
- AD/PD 2025 Conference
- AD/PD 2026 Blood Biomarkers
- AD/PD 2026 Company Presentations
- AD/PD 2026 Conference
- AD/PD 2026 Emerging Therapeutic Targets
- AD/PD 2026 Gene Therapy
- AD/PD 2026 Key Researchers and Thought Leaders
- AD/PD 2026 Neuroinflammation
- AD/PD 2026 Plenary Sessions
- AD/PD 2026 Scientific Sessions
- AD/PD 2026: Precision Medicine and Genetic Stratification
- AD/PD 2026: Seed Amplification Assays — RT-QuIC, PMCA, and Beyond
- AD/PD Therapeutic Target Comparison Matrix
- Ada Health
- Adaptive Deep Brain Stimulation (DBS) Technology
- Adaptive Immunity in Neurodegeneration: Investment Landscape
- ADELIS PSP Foundation
- Adenine Base Editing of APOE4 to APOE3 for Alzheimer's Prevention
- Adenosine A1/A3 Receptor Modulator Therapy
- Adenosine A2A Receptor Antagonist Therapy
- Adenosine A2A Receptor Antagonist Therapy for Neurodegeneration
- Adenosine A2A Receptor Antagonists
- Adenosine A2A Receptor Antagonists: Investment Landscape Analysis
- Adiponectin Receptor Modulator Therapies
- Aducanumab (Aduhelm)
- Adult Neurogenesis Therapeutics Investment Landscape
- Adult Neurogenesis Therapeutics: Investment Landscape
- Advanced Cytoskeletal Dynamics Modulator Therapy for Neurodegeneration
- Advanced Extracellular Vesicle Engineering and Therapeutic Delivery in CBS/PSP
- Advanced Immunotherapy Platforms for CBS/PSP
- Advanced Immunotherapy Platforms for Tau
- Advanced Lymphatic and Glymphatic Therapy for CBS/PSP
- Advanced Myelin and White Matter Therapy for CBS/PSP
- Advanced Neuropeptide Signaling in CBS/PSP
- Advanced Proteomics and Protein Biomarker Panels in CBS/PSP
- Affiris AG
- Aging and Rejuvenation Knowledge Gaps
- AhR Modulator Therapy for Neurodegenerative Diseases
- AI & Computational Drug Discovery for Alzheimer's Disease
- AI-Decoded Neural Intent Brain-Computer Interfaces
- AI-Powered Diagnostics for Alzheimer's Disease
- AI-Powered Movement Analysis for Parkinson's Disease
- AIM2 Inflammasome Modulation Therapy for Neurodegeneration
- Akili Interactive
- Akkermansia muciniphila in CNS Disorders
- AL-207 — Alectos Therapeutics OGA Inhibitor
- Alector
- Alector, Inc.
- Alectos Therapeutics Inc
- Alien Limb Phenomenon in Corticobasal Syndrome
- Allen Brain Atlas API for Neurodegeneration Workflows
- Allen Brain Atlas Data Portal
- Allen Brain Atlas: Cell Types Database
- Allen Brain Cell Atlas
- Allen Brain Observatory
- Allen Brain Observatory
- Allen Human Brain Atlas
- Allen Mouse Brain Atlas
- Allen Mouse Brain Connectivity Atlas
- AllenSDK in Neurodegeneration Research
- Alnylam Pharmaceuticals
- Alos Biosciences
- Alpha-7 Nicotinic Acetylcholine Receptor Agonist Therapy
- Alpha-lipoic acid and thyroid hormone. Vnitr Lek. 2012
- Alpha-Synuclein - Biomarker
- Alpha-Synuclein Aggregation Inhibitors
- Alpha-Synuclein Aggregation Inhibitors
- Alpha-Synuclein Antisense Therapy for Parkinson's Disease
- Alpha-Synuclein Immunotherapy
- Alpha-Synuclein Oligomers - Biomarker
- Alpha-Synuclein PET Imaging and Biomarker Advances
- Alpha-Synuclein Preformed Fibrils (PFF) Model
- Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson's Disease
- Alpha-Synuclein Reduction Therapies for Neurodegenerative Diseases
- Alpha-Synuclein RT-QuIC Assay
- Alpha-Synuclein Seed Amplification Assay Validation
- Alpha-synuclein seed amplification identifies prodromal DLB
- Alpha-Synuclein Seed Amplification Therapy (RT-QuIC Guided)
- Alpha-Synuclein Seed Kinetic Staging in Parkinson's Disease
- Alpha-Synuclein Seeding Assays
- Alpha-Synuclein Seeding Assays
- Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)
- Alpha-synuclein strains: correlation between seeding activity, morphology and strain-specific neurotoxicity
- Alpha-Synuclein Therapeutics: Investment Landscape Analysis
- Alpha-Synuclein-Targeting Therapies
- AlphaFold for Neurodegenerative Diseases
- ALS Communication Brain-Computer Interfaces
- ALS Cure Roadmap
- ALS Immune Signature Stratification for Clinical Trials
- ALS Knowledge Gaps
- ALS Motor Neuron Vulnerability
- ALS Pipeline
- ALS Pipeline Companies
- ALS Progression Rate Heterogeneity
- ALS Progression Rate Heterogeneity — mechanism and biomarker predictors
- ALS Regional Onset and Spread Patterns
- ALS Therapeutic Landscape — Programs by Phase and Modality
- ALS Therapeutics
- ALS Treatment Overview
- ALS Treatment Strategies
- ALS Trial Failures Knowledge Gap
- ALS vs FTD: Comparative Investment Analysis
- ALSENLITE: Senolytics for Alzheimer's Disease Trial
- Alterations in Intra-Regional Functional Connectivity Within Default Mode Network Regions
- Alterity Therapeutics
- AlzeCure Pharma AB
- Alzheimer Hippocampal Circuit
- Alzheimer's Diagnostic and Imaging Companies
- Alzheimer's Digital Therapeutics Companies
- Alzheimer's Disease Adenosine Receptor and Purinergic Signaling Companies
- Alzheimer's Disease Apolipoprotein and Lipid Transport Therapy Companies
- Alzheimer's Disease Autophagy Modulation Companies
- Alzheimer's Disease Biomarkers
- Alzheimer's Disease Brain Banks and Tissue Repositories
- Alzheimer's Disease Calcium Homeostasis and Channel Modulator Companies
- Alzheimer's Disease Carbonic Anhydrase Modulator Companies
- Alzheimer's Disease Circadian Rhythm and Sleep-Wake Cycle Therapy Companies
- Alzheimer's Disease Complement Inhibitor Companies
- Alzheimer's Disease Copper Homeostasis and Metal Transport Therapy Companies
- Alzheimer's Disease Digital Patient Monitoring Companies
- Alzheimer's Disease Epigenetic and Metabolic Therapy Companies
- Alzheimer's Disease Ferroptosis Companies
- Alzheimer's Disease GABA Receptor and Excitotoxicity Therapy Companies
- Alzheimer's Disease HSP70/HSP90 Chaperone and Protein Folding Therapy Companies
- Alzheimer's Disease Investment Landscape
- Alzheimer's Disease Ion Channel Modulator Companies
- Alzheimer's Disease Lysosomal and Proteostasis Modulation Companies
- Alzheimer's Disease Metal Chelation and Antioxidant Therapy Companies
- Alzheimer's Disease Neuroimaging Initiative (ADNI)
- Alzheimer's Disease Neuroimmune Resolution and Specialized Pro-Resolving Mediator Companies
- Alzheimer's Disease Neuroinflammation Companies
- Alzheimer's Disease Neuropathology is Defined by the Accumulation of Pathological Amyloid-Beta in the Form of Senile Plaques and Dystrophic Neurites, and Phosphorylated Tau Neurofibrillary Tangles
- Alzheimer's Disease Neuropsychiatric and BPSD Treatment Companies
- Alzheimer's Disease Nrf2-Keap1 Pathway and Oxidative Stress Therapy Companies
- Alzheimer's disease pathology originates in the hippocampus and subsequently spreads
- Alzheimer's Disease PDE Inhibitor Companies
- Alzheimer's Disease Precision Medicine Companies
- Alzheimer's Disease Pyroptosis and Gasdermin Inhibitor Companies
- Alzheimer's Disease Retromer and Endosomal Trafficking Companies
- Alzheimer's Disease Senolytic Therapy Companies
- Alzheimer's Disease Sigma-1 Receptor and Molecular Chaperone Therapy Companies
- Alzheimer's Disease Soluble Epoxide Hydrolase (sEH) Inhibitor Companies
- Alzheimer's Disease Soluble Guanylate Cyclase (sGC) Modulator Companies
- Alzheimer's Disease Synaptic Plasticity and Cognitive Enhancement Companies
- Alzheimer's Disease Synaptic Repair and Neuroprotection Companies
- Alzheimer's Disease Treatment
- Alzheimer's Disease VEGF/Angiogenic Signaling and Cerebral Blood Flow Therapy Companies
- Alzheimer's Geriatric Care and Care Management Companies
- Alzheimer's Telehealth and Virtual Care Companies
- Alzheimer's vs Parkinson's: Comparative Investment Analysis
- Alzheon
- Alzinova AB
- Amantadine
- Ambroxol for Neurodegeneration (GCase Chaperone Strategy)
- Ambroxol for Neurodegeneration — Investment Landscape Analysis
- Ambroxol for Parkinson's Disease
- Amgen
- Amiloride
- Amolyt Pharma
- AMPA Receptor Antagonists in Neurodegenerative Disease
- AMPK Activator Therapies
- AMPK Activators for Neurodegeneration
- AMPK Activators for Neurodegeneration — Investment Analysis
- AMPK Agonist Therapy for Neurodegeneration
- Amyl Therapeutics
- Amyloid Beta 40 (Aβ40) - Biomarker
- Amyloid Immunotherapy Vaccines for Alzheimer's Disease
- Amyloid PET Imaging - Diagnostic Biomarker
- Amyloid plaque and neurofibrillary tangle deposition is an essential component for accurate modeling...
- Amyloid Removal Efficacy Knowledge Gap
- Amyloid Therapeutics: Investment Landscape Analysis
- Amyloid-beta Plaques as Prerequisite for Isocortical Tau Spread in AD
- Amylyx Pharmaceuticals, Inc.
- Amyotrophic Lateral Sclerosis (ALS) Investment Landscape
- Amyotrophic Lateral Sclerosis (ALS) Treatment
- Anavex Life Sciences
- Angelman Syndrome Foundation
- Animal Model Comparison for Neurodegenerative Disease Therapeutics
- Anji Pharmaceuticals
- Anle253b Tau Aggregation Inhibitor
- Annexon Biosciences
- Annovis Bio
- Annovis Bio, Inc.
- Anti-Aggregation Peptides for Neurodegenerative Diseases
- Anti-amyloid antibodies in clinical trials. Nat Rev Drug Discov. 2024
- Anti-Amyloid Antibody Clinical Trials
- Anti-Amyloid Immunotherapy Comparison
- Anti-Amyloid Immunotherapy Comparison Matrix for Alzheimer's Disease
- Anti-Amyloid Therapeutics
- Anti-Herpetic Viral Therapy for Neurodegeneration Prevention
- Anti-Inflammatory Therapy for Neurodegeneration
- Anti-Tau Aggregation Therapy: Biomarker-Guided Treatment
- Anti-Tau Immunotherapies for Alzheimer's Disease
- Anti-Tau Immunotherapy Dosing Optimization
- Anti-Tau Immunotherapy Programs
- Anti-Tau Therapeutics
- Anti-Tau Therapeutics: Investment Landscape Analysis
- Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Trials Have Not Succeeded
- Antibody Therapeutics Investment Landscape for Neurodegeneration
- Antibody Therapies for Neurodegenerative Diseases
- Antibody Therapy for Neurodegenerative Diseases
- Antibody-Based Therapies for Neurodegeneration
- Antioxidant Therapy for Neurodegeneration
- Antioxidant Therapy for Neurodegeneration
- Antipsychotics in Neurodegeneration
- Antisense Oligonucleotide (ASO) Therapies for Neurodegenerative Diseases
- Antisense Oligonucleotide and RNA Therapies for Neurodegeneration
- Antisense Oligonucleotide Brain Delivery
- Antisense Oligonucleotide Therapy
- Antisense Oligonucleotide Therapy for C9orf72 ALS/FTD
- Antisense Oligonucleotide Therapy for Neurodegeneration
- Antisense Oligonucleotide Therapy for Neurodegeneration
- Antisense Oligonucleotide Therapy in Neurodegeneration
- Antisense Oligonucleotides for Neurodegeneration
- Antisense Oligonucleotides for Neurodegenerative Diseases
- Antiviral Therapy Trial for Parkinson's Disease
- APDM (Mobility Lab)
- Apelin Receptor Modulation Therapy
- APNMAB005 (Tau Antibody)
- APOE contributes to Alzheimer's disease by regulating both beta-amyloid deposition
- APOE Genotyping for Neurodegenerative Disease Risk Assessment
- ApoE4 Function in Alzheimer's Disease
- APOE4 Lipid Homeostasis Modulator for Pre-Symptomatic Alzheimer's Prevention
- APOE4 Lipid Metabolism Optimization
- Apolipoprotein and Lipid Transport Therapy Landscape
- Apomorphine (Apokyn)
- Apopharma Inc.
- Apoptosis and Necroptosis Modulation for CBS/PSP
- Apoptosis Inhibitors for Neurodegeneration — Investment Landscape Analysis
- APP Gene Dosage Reduction Therapy for Down Syndrome
- APP/PS1 Dual Transgenic Mouse Model
- Apple Inc.
- Appvian Therapeutics
- Apraxia of Speech in Corticobasal Syndrome
- Aprinoia Therapeutics
- Aquaporin-4 (AQP4) - Glymphatic System Biomarker
- AR1001 (AriBio)
- Araclon Biotech S.L.
- Araim Pharmaceuticals
- Arbor Biotechnologies
- Arcus Biosciences
- AriBio
- Armstrong CBS criteria (2013)
- Arrowhead Pharmaceuticals
- Art Therapy for Neurodegenerative Diseases
- Artemin (ARTN) - GDNF Family Neurotrophic Factor Therapy
- Arterial Spin Labeling Perfusion MRI in Corticobasal Syndrome
- Artificial Intelligence for Neurodegeneration Research
- Artificial Intelligence in Neurodegeneration Research
- Arvinas Therapeutics
- Asceneuron
- Asceneuron SA
- ASL Perfusion Biomarkers for Alzheimer's Disease
- ASL Perfusion MRI for Corticobasal Syndrome
- ASN90 (Asceneuron OGA Inhibitor)
- ASO Therapy for Parkinson's Disease
- Aspen Neuroscience
- Astellas Pharma
- Astellas Pharma Inc.
- Astellas Pharma — Urinary Autonomic Dysfunction
- Asterias Biotherapy
- AstraZeneca plc
- Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson's Disease
- Astrocyte Glutamate-Buffer Rescue with EAAT2 Transcription Reboot
- Astrocyte Glutamate-Buffer Rescue: EAAT2 Transcription Reboot Therapy
- Astrocyte Metabolic Modulation Therapy for Neurodegeneration
- Astrocyte Modulation Therapy for Neurodegeneration
- Astrocyte Therapeutics for Neurodegeneration: Investment Analysis
- Astrocyte-Derived Exosomal mRNA Reference Genes for Alzheimer's Disease
- Astrocyte-Neuron Metabolic Coupling Hypothesis in Parkinson's Disease
- Astrocyte-Neuron Metabolic Coupling in Parkinson's Disease
- Astrocyte-Targeted Parkinson's Disease Therapies
- Astrocyte-Targeted Parkinson's Disease Therapy Companies
- Astrocyte-to-Neuron Reprogramming Therapy
- Astrocytic Mitochondrial Transfer + Metabolic Copacking
- Astrocytic Mitochondrial Transfer Therapy
- Astrogliosis mechanisms
- AT(N) Biomarker Classification for Alzheimer's Disease
- Athira Pharma, Inc.
- AtlasX Bio
- Atomoxetine for treatment of orthostatic hypotension
- ATP13A2 (PARK9) Targeting for Parkinson's Disease
- Auditory Circuit
- Aurobindo Pharma Ltd.
- Australian Neurodegeneration Biotech Companies
- AutoDock - Molecular Docking Software
- Autoimmune Hypothesis in Alzheimer's Disease
- Automated Imaging Differentiation for Parkinsonism (AIDP)
- Autophagy and Mitophagy Therapeutics Investment Landscape
- Autophagy Enhancement Drug Screening for Neurodegeneration
- Autophagy Enhancement for Tauopathy
- Autophagy Enhancers for PD
- Autophagy Enhancers in Neurodegeneration
- Autophagy Inducers in Neurodegeneration
- Autophagy-Enhancing Therapies
- Autophagy-Proteostasis Dual Activation
- Autophagy-Targeting Chimera (AUTOTAC) Therapy
- Autotac Bio Inc.
- Axial Therapeutics
- Axon Neuroscience SE
- Axonal Transport Dysfunction Hypothesis in Parkinson's Disease
- Axonal Transport Dysfunction Validation in Parkinson's Disease
- Axonal Transport Rescue Therapy for Neurodegeneration
- Axsome Therapeutics, Inc.
- Axxonis Pharma AG
- AZP2006 (Serazaxine) — PSP Platform Trial Therapy
- B cell distribution and EBV latency programs in MS brain tissue
- BACE Inhibitors
- BACE1 Inhibitors for Alzheimer's Disease
- Baclofen
- Bagó
- Basal Ganglia Limbic Loop
- Basal Ganglia Motor Loop
- Basal Ganglia Oculomotor Loop
- Base and Prime Editing for Neurodevelopmental Epilepsy
- Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
- Basilea Pharmaceutica AG
- Bayer
- BBB Transcytosis Shuttle for Episodic CNS PROTAC Delivery
- BBB-Penetrant Antibody Engineering
- BBB-Transcytosis Shuttle for Episodic CNS PROTAC Delivery
- BCI Clinical Trials for Neurodegenerative Diseases
- BCI Clinical Trials for Neurodegenerative Diseases
- BCI Companies
- BCI Company Comparison Matrix
- BCI for Alzheimer's Disease
- BCI for FTD Behavioral Circuit Modulation
- BCI for Multiple Sclerosis
- BCI Landscape
- BCI Therapy for Parkinson's Disease
- BCI-Assisted Rehabilitation
- BDNF - Neurotrophic Factor Biomarker
- BDNF Therapies
- BDNF Therapy for Neurodegeneration
- BDNF Therapy for Neurodegeneration — Investment Landscape Analysis
- Bepranemab (UCB0107)
- Bepranemab (UCB0107)
- BET Inhibitors (Bromodomain Inhibitors) for Neurodegenerative Diseases
- Beta-Amyloid 42/40 Ratio - Biomarker
- Beta-Synuclein (SNCB) - Biomarker
- Bial - Biotecnologia e Investigação Avançada
- Bial Pharmaceutical
- BICCN
- BIIB080 (MAPTRx)
- BIIB080 (MAPTRx)
- Bilateral Medial Temporal Lobe (MTL) Connectivity as Early Biomarker for Cognitive Decline
- Bioactive Compound Modulation of Autophagy for Neurodegeneration
- BioArctic
- BioArctic AB
- Biogen
- Biogen
- Biogen Inc. — S1P Modulators and Neurodegeneration Pipeline
- Biohaven
- Biointegrated Neural Interfaces
- Biolab Sanus
- Biological signatures of amyloid and tau braak staging in aging and Alzheimer disease
- Biomarker Investment Landscape
- Biomarker Rankings
- Biomarker Types Overview
- Biomarker-Guided Sequential Therapy Selection in Alzheimer's Disease
- Biomarker-Guided Therapy in Neurodegenerative Disease
- Biomarkers
- Biomarkers Dashboard
- Biomarkers for Corticobasal Degeneration
- Biomarkers for Multiple System Atrophy
- Biomarkers for Progressive Supranuclear Palsy
- Biomarkers Overview
- Biomarkers to Distinguish FTLD-tau from FTLD-TDP
- Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phenotype Heterogeneity
- Bioness Inc
- BioNTech SE
- BioSensics
- Bitbrain
- Bitbrain Brain-Computer Interface
- Blackrock Neurotech
- Blackrock Neurotech
- Blackrock Neurotech
- Blackrock Neurotech BCI
- Blackrock Neurotech — Brain-Computer Interface
- Blarcamesine (ALX-001)
- Blood Biomarker vs Tau PET for Treatment Monitoring
- Blood biomarkers for Alzheimer's disease: Current status and future directions
- Blood biomarkers for Alzheimer's disease: Current status and future directions
- Blood Biomarkers for Atypical Parkinsonism
- Blood Biomarkers for Atypical Parkinsonism - Testing Guide
- Blood biomarkers for neurodegenerative diseases - an overview
- Blood Microbial Signatures in Parkinson's Disease
- Blood p-Tau181 and p-Tau217 Elevated in Systemic Amyloidoses, Not Specific to Alzheimer's Disease
- Blood-Based Biomarker Panel for Early AD Detection
- Blood-Based Biomarkers for Neurodegeneration
- Blood-based biomarkers in clinical practice (2025)
- Blood-Based Biomarkers Validation
- Blood-Brain Barrier Aging and Neurodegeneration — From Leakage to Neuronal Loss
- Blood-Brain Barrier Crossing Technologies for Neurodegenerative Diseases
- Blood-Brain Barrier Dysfunction and Therapeutic Strategies in CBS/PSP
- Blood-Brain Barrier Integrity Diagnostics in CBS
- Blood-Brain Barrier Integrity Testing in Corticobasal Syndrome
- Blood-Brain Barrier Penetration Technologies Investment Landscape
- BlueRock Therapeutics
- Boston Scientific
- Botulinum Toxin
- Botulinum Toxin for Dystonia and Spasticity
- Botulinum Toxin for Parkinson's Disease
- BPC-157 — Pentadecapeptide Healing Peptide
- Brain Drug Delivery Challenges Overview
- Brain Health Roundtable and AADAPT Act: 2026 Dementia Care Policy Initiatives
- Brain Hyperconnectivity-Tau Spread Hypothesis in Alzheimer's Disease
- Brain Knowledge Platform
- Brain Organoid-Silicon Interface Technology
- Brain Organoids
- Brain Organoids for Neurodegeneration Research
- Brain Shuttle Technologies
- Brain Shuttle Technologies: BBB Delivery Platforms
- Brain Waste Clearance and CSF Dynamics Therapies
- Brain-Computer Interface for Amyotrophic Lateral Sclerosis
- Brain-Computer Interface for Corticobasal Degeneration
- Brain-Computer Interface for Frontotemporal Dementia
- Brain-Computer Interface for Huntington's Disease
- Brain-Computer Interface for Lewy Body Dementia
- Brain-Computer Interface for Multiple System Atrophy
- Brain-Computer Interface for Normal Pressure Hydrocephalus
- Brain-Computer Interface for Parkinson's Disease
- Brain-Computer Interface for Progressive Supranuclear Palsy
- Brain-Computer Interface for Vascular Dementia
- Brain-Computer Interface Investment Landscape
- Brain-Computer Interface Technologies
- Brain-Computer Interface Technologies
- Brain-Computer Interface Technology
- Brain-Computer Interface Technology Landscape
- Brain-Computer Interface Therapy for Neurodegeneration
- Brain-Computer Interfaces
- Brain-to-Brain Interface Technology
- BrainBrowser
- BrainCo
- BrainCo Brain-Computer Interface
- BrainGate
- BrainGate Brain-Computer Interface
- Brainomix
- BrainSpan Atlas
- Brainstem Circuit Modulation for PSP
- Brainstem Circuit Modulation Therapy for PSP
- BrainStorm Cell Therapeutics Inc.
- Brainstorm Therapeutics
- Brazilian Brain Institute (IBN)
- Brazilian Neurodegeneration Biotech Companies
- Brexpiprazole (Rexulti)
- Bright Light Therapy for Neurodegenerative Diseases
- BrightFocus Foundation
- Bristol Myers Squibb
- Bristol Myers Squibb — Ozanimod and S1P Modulation
- Bristol-Myers Squibb
- Bristol-Myers Squibb
- Brotizolam and Related Thienotriazolodiazepines for Neurodegeneration
- BTK Inhibitors for Neurodegeneration
- Bukwang Pharmaceutical
- Bumetanide — Alzheimer's Disease
- Buntanetap (PD-01)
- C-BRAIN AI Competition
- C9orf72 ALS-FTD Phenotype Divergence
- C9orf72 RNA-Targeting Dipeptide Repeat Reduction
- C9orf72 Therapeutics Investment Landscape
- CADASIL Treatment
- Calcineurin-NFAT Pathway Modulation for Neurodegeneration
- Calcium Channel Blockers in Neurodegeneration
- Calcium Homeostasis Modulation Therapy for Neurodegeneration
- Calcium Homeostasis Modulators in Neurodegeneration
- Calcium Signaling Dysregulation - Investment Landscape
- Calcium Signaling — Investment Landscape Analysis
- Caloric Restriction Mimetics
- Calorie Restriction Therapy for Neurodegeneration
- Canadian Neurodegeneration Biotech Companies
- Cannabinoid Receptor Modulation Therapy
- Capricor Therapeutics
- CAR-A (Chimeric Antigen Receptor) Astrocyte Therapy for Alzheimer's Disease
- CAR-A Therapy - Chimeric Antigen Receptor Astrocytes for Alzheimer's Disease
- CAR-A Therapy — Chimeric Antigen Receptor Astrocytes for Alzheimer's Disease
- CAR-T Cell Therapy for Alzheimer's Disease
- CAR-T Cell Therapy for Parkinson's Disease
- Carbidopa
- Carbonic Anhydrase Modulation Therapy for Neurodegeneration
- Cardiac MIBG Scan for Parkinsonism
- CarThera
- Case Reports and Clinical Series in Corticobasal Syndrome
- Cassava Sciences, Inc.
- Catalent Pharma Solutions
- Cathepsin D Activation Therapy for Lysosomal Proteostasis
- Cathepsin D Inhibitors for Neurodegeneration
- Cav1.3 Calcium Channel Modulators for Parkinson's Disease
- CB1 Receptor Endocannabinoid Modulation for Neuroprotection
- CBD-FRS (Corticobasal Syndrome Functional Rating Scale)
- CBio Brazil
- CBS/PSP Clinical Trials Guide
- CBS/PSP Daily Action Plan
- CBS/PSP Differential Diagnosis
- CBS/PSP Rehabilitation Master Guide
- CBS/PSP Sleep Disorders Management
- CBS/PSP Supplements Guide
- CBS/PSP Tau Strain Biomarker Validation for Clinical Trial Stratification
- CBS/PSP Treatment Rankings
- CCR2 and CCR5 Antagonists for Neurodegeneration
- CD38 Inhibition + NAD+ Precursor Synergy for Neuroprotection
- CD38 Inhibitor Therapy for Neurodegeneration
- CD39 (ENTPD1) Activators for Neurodegeneration
- CD47-SIRPα Immune Checkpoint Therapy
- CD73 (NT5E) Inhibitors for Neurodegeneration
- CDK5 Inhibitors for Neurodegeneration
- CDKL5 Alliance
- CDNF gene therapy: neuroprotective mechanisms
- Ceftriaxone for Amyotrophic Lateral Sclerosis
- Cegedim
- Cell Replacement Therapies for Neurodegenerative Diseases
- Cell Replacement Therapy for Neurodegenerative Diseases
- Cell Therapy for Neurodegenerative Diseases
- Cell Therapy for Neurodegenerative Diseases
- Cell-Based Brain Delivery Systems
- Cell-Based Immunotherapy for Neurodegenerative Diseases
- Cell-Free DNA Biomarkers in Neurodegeneration
- Cell-to-cell transmission of alpha-synuclein
- Cell-Type-Specific Vulnerability in Tauopathies
- Cellino Biotech, Inc.
- Cellular Reprogramming and Neuronal Replacement Therapies
- Cellular Reprogramming for Neurodegeneration
- Cellular Senescence as Upstream Driver of Alzheimer's Disease
- Cellular Senescence Hypothesis in Parkinson's Disease
- Cellular Senescence Validation Study in Parkinson's Disease
- Celsius Therapeutics
- Central Vestibular Pathway Vulnerability in Progressive Supranuclear Palsy
- Ceramide Modulation Therapy for Neurodegeneration
- Cerebellar Circuit Protection Therapy for MSA
- Cerebellar Circuit Protection Therapy for MSA
- Cerebellar cortical organization: a one-map hypothesis
- Cerebral Amyloid Angiopathy (CAA) Treatment
- Cerebral Amyloid Angiopathy in Alzheimer's Disease Knowledge Gaps
- Cerebral Amyloid Angiopathy Therapy
- Cerebral Organoid Model
- Cerebras Systems
- Cerebrolysin Therapy for Neurodegeneration
- Cerebrolysin Therapy for Neurodegenerative Diseases
- Cerebrospinal Fluid (CSF) Biomarker Panels
- Cerebrospinal Fluid (CSF) Biomarkers in Neurodegeneration
- Cerebrospinal Fluid (CSF) Biomarkers Overview
- Cerebrospinal fluid alpha-synuclein seeding in the PPMI cohort
- Cerebrospinal fluid ER stress markers in ALS patients treated with TUDCA
- Cerecin
- Cereve (Medtronic)
- Cerevel Therapeutics
- Ceribell
- Cerliponase Alfa (Brineura) for CLN2 Disease
- Cerêve
- cGAS-STING Inhibitor Companies for Neurodegeneration
- cGAS-STING Inhibitor Therapy for Neurodegeneration
- cGAS-STING Pathway Dysregulation Hypothesis in Parkinson's Disease
- cGAS-STING Pathway Inhibition for Chronic Neuroinflammation
- cGAS-STING Pathway Validation Study in Parkinson's Disease
- CGRP Receptor Modulators in Neurodegeneration
- Chan Zuckerberg Initiative Neurodegeneration Challenge
- Changelog Format Guide
- Charco Neurotech
- Chelsea Therapeutics
- ChEMBL - Manually Curated Bioactivity Database
- Chemogenetics
- Chiesi Farmaceutici S.p.A.
- Chinese biotechnology sector growth
- Chitotriosidase - Biomarker
- Cholinergic basal forebrain in DLB
- Cholinesterase Inhibitors - Comprehensive Guide
- ChromaDex
- Chronic Traumatic Encephalopathy (CTE) Treatment
- Chugai Pharmaceutical Co., Ltd.
- Cipla Ltd.
- Circadian Entrainment Therapy for Neurodegeneration Prevention
- Circadian Rhythm Modulation Therapy
- Circadian-Glymphatic-Metabolic Coupling Failure Hypothesis in AD
- Circadian-Glymphatic-Metabolic Coupling in AD — Mechanism and Intervention
- Circadian-Neuroimmune Coupling: Clock Restoration + Sleep Enhancement
- Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Trial
- Circadian-Vascular-Metabolic Syndrome in Alzheimer's Disease
- circRNA Dysfunction Restoration Therapy
- circRNA Dysfunction Restoration Therapy
- Circuit Rankings
- CJ Healthcare
- CJC-1294 — Growth Hormone-Releasing Peptide
- ClearSky Medical Diagnostics
- Clene Nanomedicine
- Clene Nanomedicine, Inc.
- Click Therapeutics
- Clinical Management Guide for CBS/PSP
- Clinical trial of blood-brain barrier disruption by pulsed ultrasound
- Clinical trials in neurodegeneration: design considerations
- Clinical Utility of Integrated Biomarker Panels
- Closed-Loop Brain-Computer Interfaces for Neurodegenerative Diseases
- Closed-Loop Neuromodulation
- Closed-loop transcranial magnetic stimulation
- Clusterin (ApoJ) - AD Biomarker
- CNS-Selective NLRP3 Inflammasome Inhibitor
- Coenzyme Q10 (CoQ10) for Parkinson's Disease
- Coenzyme Q10 for Neurodegeneration
- Coenzyme Q10 for Parkinson's Disease
- Coenzyme Q10 in Progressive Supranuclear Palsy
- Cognicann
- Cognition Therapeutics
- Cognitive and Neuropsychiatric Profiles in Corticobasal Syndrome
- Cognitive Assessment Tools for Neurodegenerative Diseases
- Cognitive Enhancers for Neurodegeneration
- Cognitive Monitoring Brain-Computer Interfaces for Neurodegeneration
- Cognitive Rehabilitation for Neurodegenerative Diseases
- Cognitive Rehabilitation for Parkinson's Disease
- Cognitive Stimulation and Rehabilitation for Neurodegenerative Disease
- Cognixion
- Cognixion Brain-Computer Interface
- Cogstate
- Combination Biomarker Panels for Alzheimer's Disease
- Combination Logic Ideas — Cross-Modality Pairings
- Combination Therapy and Multi-Target Strategies for CBS/PSP
- Combination Therapy Approaches in Neurodegenerative Disease
- Combination Therapy Approaches in Neurodegenerative Diseases
- Combination Therapy Sequencing in Parkinson's Disease
- Combination Therapy Synergies for CBS/PSP
- Committee et al. Proteasome activator PA28 in neurodegeneration. Brain. 2018
- Companies
- Companies Dashboard
- Company Overview
- Company Rankings
- Comparison of integrated outpatient palliative care among Parkinson disease and related disorders
- Complement C1q Inhibitor Therapy for Neurodegeneration
- Complement C3/C5 Inhibitor Therapy
- Complement Component 3 (C3)
- Complement Inhibitor Therapy in Neurodegeneration
- Complement Pathway Inhibition Therapy for Neurodegeneration
- Complement System Dysregulation in Neurodegeneration - Research Gap
- Complement System Therapeutics for Neurodegeneration
- Computational Modeling of Alpha-Synuclein Propagation in PD
- COMT Inhibitors
- Conference Index
- Connexin 43 (Cx43) Gap Junction Modulation Therapy
- Connexin/Pannexin Hemichannel Blockade Therapy for Neurodegeneration
- Constant Therapy Health
- Contactin-1 - Biomarker for Peripheral Neuropathy
- Content Contribution Guide
- Continuous Dopaminergic Stimulation for Parkinson's Disease
- Continuous Glucose Monitoring for Parkinson's Disease
- Convection-Enhanced Delivery for Neurodegeneration
- Convelo Therapeutics
- Copper and Zinc Homeostasis in CBS/PSP
- CORDIO
- Core biomarker candidate matrix for Alzheimer's disease
- CORM-2 delays disease progression in SOD1 ALS models
- Cortexyme / Quince Therapeutics
- Cortical Sensory Loss in Corticobasal Syndrome
- Corticobasal Degeneration (CBD) Investment Landscape
- Corticobasal Degeneration (CBD) Treatment
- Corticobasal Syndrome (CBS) Treatment
- Corticocerebellar Circuit
- Creatine for Neurodegenerative Diseases
- Creatine for Neuroprotection
- Creutzfeldt-Jakob Disease Treatment
- CRISPR and Genome Editing Brain Delivery
- CRISPR Gene Correction Approaches for CBS/PSP
- CRISPR Gene Editing for Neurodegeneration
- CRISPR Gene Editing for Neurodegenerative Diseases
- CRISPR Gene Editing for Neurodegenerative Diseases
- CRISPR Gene Editing for Parkinson's Disease
- CRISPR Gene Editing in Neurodegeneration
- CRISPR Therapeutics
- CRISPR-Cas9 Gene Editing for Neurodegenerative Diseases
- CRISPR/Cas9 Gene Therapy for Neurodegeneration
- CRISPRi Epigenetic Silencing of SNCA for Parkinson's Disease
- CRMP2 Phosphorylation State Modulation Therapy for Neurodegeneration
- Cross-Disease Shared Mechanisms Knowledge Gaps
- Cross-Disease Therapeutic Targets in 4R-Tauopathies
- Cryo-Electron Microscopy in Neurodegeneration
- Cryopraxis
- CSF and Blood Biomarkers in Progressive Supranuclear Palsy
- CSF Biomarker Comparison Across Neurodegenerative Diseases
- CSF Biomarkers for Corticobasal Syndrome and Progressive Supranuclear Palsy
- CSF Cytokine Profiles as Parkinson's Disease Biomarkers - Research Gap
- CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Concomitant NPH
- CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Concomitant NPH
- CSF Dynamics and Glymphatic Therapy in CBS/PSP
- CSF Neurofilament Light Chain (NfL) in Neurodegeneration
- CSF tau oligomers in Chinese AD patients
- CSF-1R Inhibitors
- CSF1R Inhibitors for Neurodegeneration
- CSF1R Inhibitors for Parkinson's Disease
- CSF1R Modulation Therapy
- CSF1R Modulation Therapy: Microglia Reset Protocol
- CSF1R-Targeted Microglia Therapy
- CSPG-PNN Modulation for Synaptic Plasticity Enhancement
- CTAD 2025 Conference
- CTAD 2026 — Clinical Trials on Alzheimer's Disease
- CTAD Conference
- CTRL-Labs
- CTRL-Labs Brain-Computer Interface
- CuATSM (Copper(II)-diacetyl-bis(N4-methylthiosemicarbazone))
- CUE1 Non-Invasive Device for Parkinson's Disease
- CUE1 Non-Invasive Vibrotactile Device for Parkinson's Disease
- Curcumin for Neurodegeneration
- Cure Requirements Index — Neurodegenerative Diseases
- CurePSP
- CureYLD
- Cute Syndrome Foundation
- CVN424 Phase 3 Trial for Parkinson's Disease
- CX3CR1 Modulation Therapy
- CX3CR1 Modulation Therapy for Neurodegeneration
- CXCL12 (SDF-1) - Stromal Cell-Derived Factor 1
- CXCL12/CXCR4 Axis Modulator Therapy for Neurodegeneration
- Cyclica
- Cyclica Inc
- Cyclo Therapeutics
- Cyclophosphamide
- Cynata Therapeutics
- Cytochrome Therapeutics
- Cytochrome Therapeutics
- Cytokinetics, Inc.
- Cytoskeletal Dynamics and Tubulin Targeting in CBS/PSP
- D-Serine Therapy for Neurodegeneration
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Daiwa Sangyo Co., Ltd.
- Dance Movement Therapy for Parkinson's Disease
- Dance-based therapy for Huntington's disease
- Dance/Movement Therapy for Neurodegenerative Diseases
- Dapansutrile (OLT1177) for Parkinson's Disease
- Dasatinib + Quercetin (D+Q) for Neurodegeneration
- Davunetide (NAP, AL-108)
- Deep Brain Stimulation
- Deep Brain Stimulation (DBS)
- Deep Brain Stimulation for CBS/PSP
- Deep Brain Stimulation for Parkinson's Disease
- Deep Brain Stimulation in Corticobasal Syndrome
- Deep Brain Stimulation Updates — MDS 2026
- Deep Brain Stimulation — Investment Landscape Analysis
- DeepMind
- Default Mode Network
- Dementia with Lewy Bodies Biomarkers
- Dementia with Lewy Bodies Circuit
- Dementia with Lewy Bodies Diagnostic Methods
- Demyelination and Remyelination Therapies in Neurodegeneration
- Denali
- Denali Therapeutics
- Denali Therapeutics
- Denali Transport Vehicle (TV) Technology
- Dental Health and Oral Microbiome in Neurodegeneration
- Dental Health and Oral Microbiome in Parkinson's Disease
- Deutetrabenazine therapy and CYP2D6 genotype. Medical Genetics Summaries. NCBI Bookshelf. NCBI
- Development of biomarkers for DYRK1A inhibitor response
- Device Therapies Comparison for CBS/PSP
- DHEA — Dehydroepiandrosterone
- Diagnostic Accuracy Rankings
- Diagnostics
- Diagnostics Dashboard
- Diagnostics Overview
- Dietary Interventions for Parkinson's Disease
- Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers
- Diffusion Tensor Imaging in Neurodegeneration
- Digital Biomarker Platforms for Parkinson's Disease
- Digital Biomarkers and Wearable Integration
- Digital Biomarkers for Alzheimer's Disease
- Digital health in Parkinson's disease
- Digital Therapeutics for Neurodegeneration Investment Analysis
- Digital Therapeutics for Neurodegenerative Diseases
- Digital Therapeutics for Neurodegenerative Diseases
- Digital Therapeutics for Parkinson's Disease
- Disease Model: Declining functional connectivity of the Default Mode Network in Alzheimer's Disease
- Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's Disease
- Disease-Modifying Therapies for Alzheimer's Disease
- Disease-modifying therapy of Parkinson's disease: where do we go from here?
- Divi's Laboratories Ltd.
- DJ-1 (PARK7) Neuroprotective Therapies
- DLB Knowledge Gaps
- DNA Damage Repair Deficiency Validation Study in Parkinson's Disease
- DNA Damage Repair Investment Landscape
- DNA Damage Repair Therapy - Biomarker Guided
- DNA Damage Repair Therapy for Neurodegeneration
- DNA Methylation Biomarkers in Neurodegeneration
- DNA Repair Therapy for Neurodegeneration
- Donanemab (Kisunla)
- Donanemab in early Alzheimer's disease
- Dong-A ST
- Dopamine Agonists
- Dopamine Agonists - Parkinson's Disease Treatment
- Dopamine D3 and D4 Receptor Selective Agonists for Parkinson's Disease
- Dopamine Metabolism Enzymes Beyond COMT
- Dopamine Replacement Therapy
- Dopamine Transporter Modulators for Parkinson's Disease
- Dopaminergic lesion and reward learning in Parkinson's disease
- Dorsal Attention Network
- DPP-4 Inhibitor Therapy (Gliptins)
- Dr. Reddy's Laboratories
- Dr. Reddy's Laboratories
- Dravet Syndrome Foundation
- DREADDs Therapy for Parkinson's Disease
- DREADDs — Designer Receptors Exclusively Activated by Designer Drugs
- Dried Blood Spot Biomarker Test for Alzheimer's Disease
- Drug Repositioning for Neurodegenerative Diseases
- Drug Repurposing for Neurodegenerative Diseases
- Drug Target Landscape
- Drug transport across the blood-brain barrier
- DTI Biomarkers for Alzheimer's Disease
- DTI White Matter Changes in CBS/PSP
- Dual Proteinopathy Immunotherapy: Aβ + pTau/pα-Syn Bispecific
- Dulaglutide for Neurodegeneration
- Dysautonomia and Non-Motor Complications in PD — MDS 2026
- EAAT2 Glutamate Transporter Rescue Therapy
- ECoG Brain-Computer Interfaces
- Edaravone
- Editing Standards
- EEG Biomarkers for Alzheimer's Disease
- EEG Brain-Computer Interface Technology
- EEG coherence analysis in corticobasal syndrome
- Effects of donepezil on functional connectivity in Alzheimer's disease (J Alzheimers Dis 2024)
- EicOsis, Inc.
- Eilanetug (E2814)
- Eisai Co., Ltd.
- electroCore
- Electroencephalography in Neurodegeneration
- Electromyography and Nerve Conduction Studies
- Eli Lilly
- Eli Lilly Blood-Brain Barrier Delivery Platform
- EMA (2021). Evrysdi EPAR product information. EMA)
- Emerging Clinical Trials in Neurodegenerative Diseases
- Emerging Novel Mechanism AD Companies 2024-2025
- Emerging Treatments for Corticobasal Syndrome
- EMG Brain-Computer Interface
- Emotiv
- Empatica
- Encoded Therapeutics
- Endocannabinoid System Modulation Therapy
- Engineered Exosomes for Intranasal CNS Delivery
- Engineered iPSC-Microglia Cell Therapy for Neurodegeneration
- Enhanced Glymphatic Clearance Protocol
- Entopsis, Inc.
- Enzyme Replacement Therapy for Neurodegenerative Diseases
- EP2 Receptor Antagonism for Neuroprotection
- Ephrin Receptor Therapy for Axonal Repair in Neurodegeneration
- Ephrin Signaling Modulation Therapy
- Epigenetic Biomarkers in Neurodegenerative Diseases
- Epigenetic Clock Reversal Therapy for Neurodegeneration Prevention
- Epigenetic Clocks in Neurodegeneration — Causal Drivers or Passive Markers
- Epigenetic Regulation Dysfunction in Alzheimer's and Parkinson's Disease
- Epigenetic Reprogramming and Partial Reprogramming in Neurodegeneration
- Epigenetic Therapies for Neurodegeneration
- Epigenetic Therapies for Parkinson's Disease
- Epigenetic Therapies for Parkinson's Disease
- Epigenetic Therapy in Neurodegeneration: Investment Landscape Analysis
- Epigenetic-Metabolic Coupling: SIRT1 Activator + NAD+ Precursor
- Epilepsy Brain-Computer Interface
- Epitope mapping of anti-tau antibodies
- ER Stress & UPR Therapeutics Investment Landscape
- ER Stress and UPR Modulator Therapy for Neurodegeneration
- ER-Golgi Secretory Pathway Dysfunction Hypothesis in Parkinson's Disease
- ER-Golgi Secretory Pathway Dysfunction in PD - Experiment Design
- ESCRT-III Inhibition by Alpha-Synuclein
- ESCRT-III Neuroprotection Therapy for Neurodegeneration
- ESM (Evolutionary Scale Modeling)
- Essential Genomics
- Estrogen Replacement Therapy for Neurodegeneration
- Etalanetug (E2814)
- Etalanetug (E2814)
- Ethnicity-Specific Genetic Architecture Hypothesis in Parkinson's Disease
- EU Joint Programme - Neurodegenerative Disease Research
- Eurofarma Laboratorios
- European Academic Spin-out Companies in Parkinson's Disease
- Events
- Evgen Pharma plc
- Evox Therapeutics
- Excitotoxicity Therapeutics Investment Landscape
- Exenatide for Parkinson's Disease
- Exercise and Lifestyle Interventions for Neurodegenerative Disease
- Exercise and Physical Activity for CBS/PSP
- Exercise and Physical Activity for Neuroprotection
- Exercise Therapy for Neurodegeneration
- Exercise-BDNF Signaling Axis Hypothesis in Parkinson's Disease
- Exercise-BDNF-Mitochondrial Resilience Hypothesis
- Exercise-BDNF-Mitophagy Biomarker Study in PD
- Exercise-Induced Myokines for Neurodegeneration Therapy
- Exosomal Biomarkers in Neurodegeneration
- Exosomal miR-155 in Neurodegeneration
- Exosome and Extracellular Vesicle Brain Delivery
- Exosome Therapy for Neurodegeneration
- Exosome Therapy for Neurodegenerative Diseases
- Exosome Therapy for Parkinson's Disease
- Exosome-Based CNS Delivery for Gene Therapy
- Exosome-Based Drug Delivery for CBS/PSP
- Exosome-Based Therapeutics for Neurodegenerative Diseases
- Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in Parkinson's Disease
- Experiment Index
- Experiment Prioritization Index — Neurodegeneration
- Experiment Scoring Methodology
- Experiment Validation: In vitro ThT Assay
- Experiment: Autoimmune Hypothesis Testing in AD
- Experiment: Multi-Ethnic PD GWAS
- Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated Neurotoxicity in AD
- Experiments
- Exscientia plc
- Extracellular Matrix and Integrin Modulator Therapy for Neurodegeneration
- Extracellular Vesicle-Based Neuroprotective Therapy
- Extracellular Vesicle-Mediated Synuclein Propagation Hypothesis in Parkinson's Disease
- Eye Tracking and Oculomotor Testing in Corticobasal Syndrome
- Eye Tracking and Saccade Testing in Progressive Supranuclear Palsy
- Eye-Tracking Digital Markers in Alzheimer's Disease
- FAAH Inhibitor Therapy for Neurodegenerative Diseases
- FABP3 (Fatty Acid Binding Protein 3) - Biomarker
- Fabry Disease Treatment
- Failed Alzheimer's Disease Clinical Trials Analysis
- FDA perspectives on blood biomarker validation for Alzheimer's disease
- FDA perspectives on blood biomarker validation for Alzheimer's disease
- FDG-PET Imaging in Neurodegeneration
- FEEMSA in PSP and MSA laryngopharyngeal dysfunction
- Ferrer Internacional
- Ferroptosis Inhibition Therapy
- Ferroptosis Inhibitors
- Ferroptosis Modulation Investment Landscape
- Ferroptosis Modulation Therapy
- Ferroptosis Therapy for Parkinson's Disease
- Ferulic Acid Carbamate Derivatives for Alzheimer's Disease
- Fiber Photometry
- Fibroblast Growth Factor 21 (FGF21)
- Finch Therapeutics
- Fish intake, marine n-3 fatty acid biomarkers, and risk of Parkinson's disease
- Florbetaben (Neuraceq)
- Florbetapir (Amyvid)
- Florbetapir (Amyvid) Amyloid PET Imaging
- FLT3/FLT3L Cytokine Therapy for Neurodegeneration
- Flutemetamol (Vizamyl)
- FMT for Parkinson's Disease
- fNIRS Brain-Computer Interface
- FNP-223 (Ferrer OGA Inhibitor)
- Focal Adhesion Kinase (FAK) Inhibition Therapy for Neurodegeneration
- Focused Ultrasound BBB Opening
- Focused Ultrasound for Neurodegeneration
- Focused Ultrasound for Parkinson's Disease
- Focused Ultrasound Neuromodulation
- Focused Ultrasound Thalamotomy
- Focused Ultrasound Therapy for Neurodegenerative Diseases
- Focused Ultrasound-Enhanced Nanoparticle Delivery
- Follistatin/Activin/Myostatin Axis Modulator Therapy for Neurodegeneration
- Forest Neurotech
- Forest Neurotech Brain-Computer Interface
- Fractalkine (CX3CL1) - Neuroinflammation Biomarker
- Friedreich Ataxia Treatment
- Frontoparietal Control Network
- Frontotemporal Dementia (FTD) Biomarkers
- Frontotemporal Dementia (FTD) Investment Landscape
- Frontotemporal Dementia (FTD) Treatment
- Frontotemporal Dementia Knowledge Gaps
- FSP1-CoQ10 Redox Augmentation Therapy for Neurodegeneration
- FTD Therapeutic Landscape
- Fujifilm Holdings Corporation
- Fujirebio Diagnostics
- Fujirebio Lumipulse G Platform
- FUS Protein-Targeting Therapy for ALS/FTD
- FUS-Targeting Therapies for Amyotrophic Lateral Sclerosis
- Future directions for creative arts therapy research
- FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutation Carriers Develop FXTAS
- Fyn Kinase Modulators for Neurodegeneration
- g.tec
- g.tec Brain-Computer Interface
- g.tec Medical Engineering
- G007-LK: LRRK2 Kinase Inhibitor
- GABA (Gamma-Aminobutyric Acid) - Neurodegenerative Disease Biomarker
- GABA Receptor Modulation Therapy
- GABA Receptor Modulation Therapy for Neurodegeneration
- GABAergic Therapies for Neurodegeneration
- Gador
- Gain Therapeutics
- Gait and Falls in Corticobasal Syndrome
- Gait and Mobility Brain-Computer Interfaces
- Galapagos NV
- Galectin-3 Modulation for Neuroprotection
- Galectin-3 Modulation Therapy
- Galunisertib Trial NCT05328847. ClinicalTrials.gov
- Gamma-Secretase Modulators
- Gantenerumab
- Gap Analysis & Research Strategy
- Gap Junction Dysfunction Hypothesis in Parkinson's Disease
- Gap Junction Dysfunction Validation in Parkinson's Disease
- Gap Priorities
- GAP-43 (Growth-Associated Protein 43) - Neuronal Regeneration Biomarker
- Gaps Rankings
- Garmin Ltd.
- Gasdermin Inhibition Therapy for Neurodegeneration
- Gaucher Disease Treatment
- GBA Enzyme Enhancement for Pre-Symptomatic Carriers
- GBA Gene Therapy for Parkinson's Disease
- GBA Gene Therapy for Parkinson's Disease
- GBA Therapeutics Investment Landscape
- GBA-Targeting Therapies
- GBA1 Gaucher Disease Modulator for Parkinson's Disease
- GDNF - Neurotrophic Factor Biomarker
- GDNF Therapy for Parkinson's Disease
- Gene Editing for Neurodegenerative Diseases
- Gene Expression in the Brain
- Gene Silencing Therapy for Neurodegenerative Diseases
- Gene Therapy for Neurodegeneration
- Gene Therapy for Neurodegeneration
- Gene Therapy for Neurodegenerative Diseases
- Gene Therapy for Neurodegenerative Diseases
- Gene Therapy for Neurodegenerative Diseases
- Gene Therapy for Neurodevelopmental Epilepsies
- Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
- Genentech Inc.
- Genetic Risk Modifiers in DLB Phenotype
- Genetic Testing for Atypical Parkinsonism
- Genetic Testing for Neurodegenerative Diseases
- GeneTx Biotherapeutics
- GeNeuro
- Genexine
- Genzen
- GFAP (Glial Fibrillary Acidic Protein) - Biomarker
- GFAP (Glial Fibrillary Acidic Protein) - Diagnostic Marker
- GFAP as Alzheimer's Disease Biomarker
- GFAP as Alzheimer's Disease Biomarker
- GFAP in Alzheimer's Disease
- GFAP-Guided Astrocyte Modulation Therapy
- GHK-Cu — Copper-Binding Tripeptide
- Gilead Sciences
- Ginkgo Bioworks
- GIP/GLP-1 Dual Agonists for Neurodegenerative Diseases
- GlaxoSmithKline plc (GSK)
- GliaCure
- Glial Cell Line-Derived Neurotrophic Factor (GDNF) Therapies
- Glial Fibrillary Acidic Protein (GFAP)
- Glial Therapeutics for Neurodegeneration - Investment Analysis
- Gloreha
- GLP-1 Agonist Neuroprotection Mechanism in PD
- GLP-1 and GIP Agonists for Neurodegeneration
- GLP-1 Receptor Agonist Responder Biology in Parkinson's Disease
- GLP-1 Receptor Agonist Therapeutics Investment Landscape
- GLP-1 Receptor Agonist Therapy for Neurodegeneration
- GLP-1 receptor agonists for Alzheimer's disease prevention: Current status and future directions
- GLP-1 Receptor Agonists for Neurodegeneration
- GLP-1 Receptor Agonists for Neurodegenerative Diseases
- GLP-1 Receptor Agonists for Neurodegenerative Diseases
- GLP-1 Receptor Agonists for Parkinson's Disease
- GLP-1 Receptor Agonists in Neurodegeneration
- GLP-1 Receptor Agonists in Neurodegeneration
- GLP-1 Receptor Agonists — Investment Landscape Analysis
- Glucocerebrosidase (GCase) - Biomarker
- Glucocorticoid Receptor Modulation Therapy for Neurodegeneration
- Glutamate - Excitotoxicity and Neurodegeneration Biomarker
- Glymphatic and CSF Dynamics Enhancement for CBS/PSP
- Glymphatic Enhancement Therapy
- Glymphatic System Enhancement Therapies for Neurodegeneration
- Glymphatic Waste Clearance Therapy for Parkinson's Disease
- Glymphatic-Circadian Axis Dysfunction Hypothesis in Parkinson's Disease
- Glymphatic-Circadian Axis Enhancement Therapy for Parkinson's Disease
- Glymphatic-Circadian Axis Enhancement Therapy for Parkinson's Disease
- Gosuranemab (BIIB092)
- GPNMB (Glycoprotein NMB)
- GPNMB Modulation for Lipid-Laden Microglia Rescue
- GPNMB Modulation for Lipid-Laden Microglia Rescue
- GPR109A (HCAR2) Agonists for Neurodegeneration
- GPR132 (G-Protein Coupled Receptor 132) Modulators for Neurodegeneration
- GPR3 Modulators for Neurodegeneration
- GPR35 Agonists for Neurodegeneration
- GPR37 Modulator Therapy for Parkinson's Disease
- GPR4 Modulators for Neurodegeneration
- GPR6 Modulator Therapy for Parkinson's Disease
- GPR65 (TDAG8) Modulator Therapy for Parkinson's Disease
- GPR65 (TDAG8) Modulators for Neurodegeneration
- GPR68 (OGR1) Modulator Therapy for Parkinson's Disease
- GPR68 (OGR1) Modulators for Neurodegeneration
- Great Lakes NeuroTechnologies
- GreyOrange
- GRN Carrier Resilience in Frontotemporal Dementia
- GRN Carrier Resilience: Why Some Mutation Carriers Remain Asymptomatic
- GROMACS: Molecular Dynamics Simulation Software
- Growth Factor Therapeutics: Investment Landscape Analysis
- Growth Factor Therapies
- Growth Factor Therapies
- Growth Factor Therapies for Neurodegeneration
- Grunenthal
- GSK (GlaxoSmithKline)
- GSK-3 Inhibitor Therapy for Neurodegeneration
- GSK-3α/β in Alzheimer's disease (Cell)
- GSK3 Inhibitor Therapy
- Gut Microbiome-Based Therapy for Neurodegeneration
- Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propagation
- Gut-Immune-Brain Axis Hypothesis in Parkinson's Disease
- Gut-Immune-Brain Axis Intervention Trial in Parkinson's Disease
- Gut-Microbiome-Targeted Therapeutic
- H. Lundbeck A/S
- Hanmi Pharmaceutical
- HC Health
- HCN and Kv Channel Modulators in Neurodegenerative Disease
- HDAC Inhibitors
- HDAC Inhibitors for Neurodegeneration — Investment Landscape
- HDAC Inhibitors for Neurodegenerative Diseases
- HDAC6 Agonist for Neuronal Aggrephagy
- HDAC6 Modulation Therapy for Neurodegeneration
- Healios K.K.
- Health Catalyst
- Healx
- Heat Shock Protein (HSP) Therapeutics for Neurodegeneration
- Hedgehog Signaling Modulation Therapy for Neurodegeneration
- Hedgehog Signaling Modulators for Neurodegeneration
- Helios Inc.
- heqIX
- heqIX Therapeutics
- HIF Therapeutics for Neurodegeneration — Investment Landscape Analysis
- HIF-1α Stabilization Therapy
- HIF-1α Stabilization Therapy for Neurodegeneration
- High Mobility Group Box 1 (HMGB1) - Biomarker
- Hinge Health
- Hippo Pathway Modulation Therapy for CBS
- Histamine H3 Receptor Antagonists for Neurodegeneration
- HO-1 Modulator Therapy
- Hocoma AG
- Hope Biomedical Inc
- Horizon Robotics
- Hormone Neuroprotection in CBS/PSP
- HSP70 Inducer Therapies
- HSP70 Inducer Therapies for Neurodegeneration
- HSP70 Inducer Therapies for Neurodegeneration
- HSP70/HSP90 Modulators
- HSP90 Co-chaperone CDC37 Modulation
- HSP90 Inhibitors for Neurodegeneration
- Hsp90 Inhibitors for Parkinson's Disease
- Human hippocampal neurogenesis in adulthood, ageing and Alzheimer's disease
- Huntington's Disease Gene Silencing Therapy
- Huntington's Disease Investment Landscape
- Huntington's Disease Knowledge Gaps
- Huntington's Disease Treatment
- Hydrogen Sulfide (H2S) Donor Therapy for Neurodegeneration
- Hypera Pharma
- Hyperbaric Oxygen Therapy for Neurodegeneration
- Hyperbaric Oxygen Therapy for Neurodegeneration
- Hypotheses
- H₂S-Releasing Compounds Therapy
- H₂S-Releasing Compounds Therapy for Parkinson's Disease
- IBM Watson Health
- Ibudilast
- Icaritin GPER Mitophagy for Parkinson's Disease
- icometrix
- ID Pharma Co., Ltd.
- Idea Rankings
- Ideas Dashboard
- Ideas Overview
- Ideomotor Apraxia in Corticobasal Syndrome
- Idorsia
- Idorsia Pharmaceuticals Ltd.
- Iduna Biotechnology
- Iduna Therapeutics
- IFM Therapeutics
- IL-18 - Interleukin-18
- IL-33/ST2 Modulation Therapy for Neurodegeneration
- IL-6 (Interleukin-6) in Neurodegeneration
- Imaging Biomarkers for Corticobasal Syndrome and Progressive Supranuclear Palsy
- IMBD Taiwan (Institute of Molecular Biology)
- Immune Drug Repurposing for Advanced Parkinson's Disease
- Immunotherapy for Neurodegenerative Diseases
- In Alzheimer's disease, biomarker events occur in a specific temporal sequence: amyloid-β abnormalit
- In vivo base editing rescues tau pathology in P301L mice
- Inception Therapeutics
- Indonesia Neurodegeneration Biotech Companies
- Induced Pluripotent Stem Cell (iPSC) Disease Models
- Inflammatory Biomarkers in Alzheimer's Disease
- Infliximab for Neurodegenerative Diseases
- Inhibikase Therapeutics
- Inhibrx
- INmune Bio, Inc.
- Innate Immune Reprogramming: NLRP3 + CD47 Checkpoint Blockade
- InnoCan Pharmaceuticals Ltd.
- Inosine — Urate Elevation Therapy for Parkinson's Disease
- Inotersen (Tegsedi) - Therapeutic Overview
- Insightec
- Insitro
- Insulin resistance and alpha-synuclein aggregation (2024)
- Insulin Signaling & Metabolic Dysfunction in Neurodegeneration
- Integrated Stress Response Modulator
- Integrated Stress Response Modulator Therapy in Neurodegeneration
- Integrin Pathway Modulator Therapy for Neurodegeneration
- Integrin Signaling Modulation Therapy for Neurodegeneration
- Integrin-Synapse Stabilization Therapy
- Integrins in the regulation of neurotransmitter receptor trafficking
- Intel Corporation
- Intellia Therapeutics
- Interhemispheric Circuit
- Interleukin-1 Beta (IL-1β) - Biomarker
- Interleukin-2 Immunotherapy for Alzheimer's Disease
- International Congress on Parkinson's Disease
- International Parkinson and Movement Disorders Society
- International Tau Consortium
- Intra-Cellular Therapies
- Intranasal Brain Delivery
- Intranasal Insulin and GLP-1 Combination Therapy for Neurodegeneration
- Intranasal insulin: a novel approach for CNS delivery
- Intranasal Therapy for Neurodegeneration
- Intranasal Therapy for Parkinson's Disease
- Intrathecal and Intracerebroventricular Drug Delivery
- Intravenous Immunoglobulin (IVIG)
- Investment
- Investment Dashboard
- Investment Landscape: Neurodegeneration
- Investment Landscape: Sirtuin Therapeutics for Neurodegeneration
- Investment Overview
- Investment Rankings
- Investment Trends
- Invicro
- Ion Channel Therapeutics for Neurodegeneration — Investment Analysis
- Ionis Pharmaceuticals
- Ipamorelin — Selective Growth Hormone Secretagogue
- iPSC Cell Therapy for Parkinson's Disease
- iPSC Therapy for Neurodegenerative Diseases
- iPSC Therapy for Parkinson's Disease
- iPSC-Derived Dopaminergic Neurons
- Ipsen S.A. — Venglustat and GCS Inhibitors for PD/MSA
- IRE1 Inhibitor Therapy
- Irisin Therapy — Exercise-Induced Myokine for Neurodegeneration
- Iron Chelation Therapy
- Iron Chelation Therapy for Neurodegeneration
- Iron Chelators in Neurodegenerative Disease
- Iron-Calcium-Glymphatic Convergence Hypothesis in Alzheimer's Disease
- Ironwood Pharmaceuticals
- ISR Modulator Therapy
- Israeli Biotechnology Companies
- ISRIB enhances cognitive function in aged and AD models
- Istradefylline (Nourianz)
- IVIG Therapy for Neurodegenerative Disease
- IXICO Technologies
- J-Brain Cargo Technology
- JAK Inhibitors in Parkinson's Disease
- JAK/STAT Inhibitors for Neurodegeneration
- Janssen
- Japanese Neurodegeneration Biotech Companies
- Japanese validation of α-syn ELISA (Journal of Neurology Neurosurgery Psychiatry, 2023)
- JCR Pharmaceuticals
- JNJ-63733657 (JNJ-63742057)
- JNK Inhibitors for Neurodegenerative Diseases
- JNK/p38 MAPK Inhibitor Companies for Parkinson's Disease
- Johnson & Johnson
- Johnson & Johnson (Janssen)
- Jucker M, et al. Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci. 2020
- JW Pharmaceutical
- Jymsee
- K Health
- K-Cardinality Tree (KCT) Network Optimization for DMN Connectivity Analysis in Cognitive Decline
- Kaia Health
- Kaken Pharmaceutical Co., Ltd.
- Kallyope Series C Financing (2022)
- Kamuvudine-9: NRTI for Alzheimer's Disease Neuroinflammation
- Karuna Therapeutics
- KCNQ2 Cure Foundation
- Kernel
- Kernel
- Kernel
- Kernel Flow BCI
- Ketogenic Diet in Neurodegeneration
- Ketone Body Therapeutic Strategy for Neurodegeneration
- Ketone Body Therapy for Neurodegenerative Diseases
- Kinase and Phosphatase Therapeutic Target Matrix
- Kinexx Co., Ltd.
- Kissei Pharmaceutical Co., Ltd.
- Klotho Therapy
- Klotho Therapy
- Knowledge Gap: Blood-Based Biomarkers for Early Neurodegeneration Detection
- Knowledge Gaps
- Kolon Life Science
- Koneqia Therapeutics
- Korean Biotech Companies in Neurodegeneration
- Korean Biotechnology Companies in Parkinson's Disease
- Kowa Pharmaceutical Co., Ltd.
- Kynurenine Pathway Modulators for Neurodegeneration
- Kyorin Pharmaceutical Co., Ltd.
- Kyowa Kirin Co., Ltd.
- Landau-Kleffner Syndrome Foundation
- Landsteiner Scientific
- Late blink reflex latency (R2) in lesions of the facial nerve
- Latin American Neurodegeneration Biotech Companies
- Latin American Neurodegeneration Research and Biotech
- Learning in the basal ganglia
- Lecanemab (Leqembi)
- Leptin Receptor Modulation Therapy
- Levodopa
- Levodopa Challenge Testing in Corticobasal Syndrome
- Levodopa for Parkinson's Disease — Investment Landscape Analysis
- Levodopa response in corticobasal syndrome
- Levodopa-Carbidopa Intestinal Gel (Duodopa)
- Levodopa-Carbidopa Intestinal Gel (LCIG)
- Levodopa-Induced Dyskinesia Management — MDS 2026
- Levodopa-induced dyskinesia measurement in Parkinson's disease
- Levodopa-Induced Dyskinesias Mechanism — Experiment Design
- Lewy Body Dementia Investment Landscape
- Lexeo Therapeutics
- Life Biosciences
- Life Molecular Imaging
- Lifestyle Intervention Mechanisms in Alzheimer's Disease
- Lion's Mane (Hericium erinaceus) — Evidence for Neurodegeneration
- Lipid Droplet-Lysosome Axis Dysfunction Hypothesis in Parkinson's Disease
- Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson's Disease
- Lipid Nanoparticle (LNP) CNS Delivery
- Lipid Nanoparticle Delivery for CNS Gene Therapy
- Lipid Raft Modulation for Parkinson's Disease (MLSM Hypothesis)
- Lipophagy Activation Therapy for Neurodegeneration
- Liposome and Lipid-Based Brain Delivery
- Liquid Biopsy Diagnostics for Corticobasal Syndrome
- Liquid Biopsy Diagnostics for Corticobasal Syndrome
- Liquid Biopsy in Corticobasal Syndrome
- Liquid Biopsy in Neurodegeneration
- Liraglutide for Neurodegeneration
- Lithium for Neurodegeneration
- Lithium for Neurodegenerative Diseases
- Lithium in Neurodegeneration
- Living Cell Technologies
- LLPS Modulator Therapy
- LMTX (TRX0237) / HMTM - TauRx Tau Aggregation Inhibitor
- Locus Coeruleus Alpha Neurons
- London Brain Bank
- Long-term effects of CD33 modulation on brain immune homeostasis in mice
- Longevity and Rejuvenation Therapies Landscape
- LRP1-Enhanced Perivascular Drainage Therapy
- LRP1-Targeted ApoE-Mimetic Peptide Delivery
- LRRK2 Antisense Oligonucleotide Therapies for Parkinson's Disease
- LRRK2 G2019S Transgenic Mouse Model
- LRRK2 Inhibition Disease Modification in Parkinson's Disease
- LRRK2 Inhibitor Therapy
- LRRK2 Inhibitor Therapy
- LRRK2 Inhibitors for Parkinson's Disease
- LRRK2 Kinase Inhibitors
- LRRK2 Kinase Modulation for Pre-Symptomatic Carriers
- LRRK2 Kinase-Targeting Therapies
- LRRK2 Therapeutics: Investment Landscape Analysis
- LRRK2-GBA Combination Therapy for Parkinson's Disease
- LRRK2-Targeting Therapies
- LSVT Global
- Lu AF87908
- Lu AF87908
- Lundbeck
- Lundbeck/Genentech Bispecific Brain Shuttle Antibodies
- Lupin Ltd.
- Lupin Pharmaceuticals
- LY3372689 (Oglemilide)
- Lysosomal Acid Lipase (LIPA) Modulators
- Lysosomal Dysfunction Therapeutics Investment Landscape
- Lysosomal Storage and Lipid Trafficking Therapy in CBS/PSP
- Lysosomal Therapies Inc
- Lysoway Therapeutics
- Lyterian Therapeutics
- m6A RNA Methylation Modulation Therapy for Neurodegeneration
- Machine Learning MRI Analysis for PSP Differential Diagnosis
- Magnetogenetics
- Malaysia Neurodegeneration Biotech Companies
- Management
- Manifold Bio
- MAO-B Inhibitors
- MAO-B Inhibitors for Parkinson's Disease — Investment Landscape Analysis
- Mapi Pharma Ltd.
- MAPK Signaling Inhibitors: Investment Landscape Analysis
- MAPT Mutation Penetrance and Phenotypic Modifiers in Tauopathies
- Market Landscape
- Masitinib for Neurodegenerative Diseases
- Massage Therapy and Bodywork for Neurodegenerative Disease
- MDS 2026
- MDS 2026 — Alpha-Synuclein Propagation & Seeding Biomarkers
- MDS 2026 — Ataxia and Cerebellar Disorders
- MDS 2026 — Fluid Biomarker Advances in Neurodegeneration
- MDS 2026 — Fluid Biomarker Advances in Neurodegeneration
- MDS 2026 — Genetics and Biomarkers in Movement Disorders
- MDS 2026 — Huntington's Disease Sessions
- MDS 2026 — Industry Pipeline
- MDS 2026 — Parkinson's Disease Clinical Advances
- MDS 2026 — Rare Movement Disorders
- MDS 2026 — Sleep and Circadian Disorders in Parkinson's Disease
- MDS 2026: Neuroprotection and Neurorestorative Strategies for Parkinson's Disease
- MDS 2026: Surgical Therapies for Parkinson's Disease
- Mechanistic Proposal: Amyloid Plaque and Neurofibrillary Tangle Deposition is Essential for Accurate Modeling of AD in Mouse Models
- Mechanistic Proposal: Pathologic synergy: The pathologic aggregation of...
- Medesis Pharma
- Medial Temporal Lobe Network
- Mediterranean and MIND Diets for Neurodegeneration
- Mediterranean Diet for Neurodegeneration
- MedMotion
- MedRhythms
- Medtronic
- MEG Brain-Computer Interface Technology
- Melatonin Agonist Therapy for Neurodegeneration
- Melatonin for Tauopathy: Comprehensive Evidence Synthesis
- Melatonin Therapy for Neurodegenerative Diseases
- Melatonin Therapy for Parkinson's Disease
- Memantine - NMDA Antagonist for Alzheimer's Disease
- Memory Prosthetic BCI for Alzheimer's Disease
- Menkes Disease Treatment
- Merck
- Merck & Co.
- MERFISH
- Mesenchymal Stem Cell Therapy for Neurodegeneration
- Mesenchymal Stem Cell Therapy for Neurodegenerative Diseases
- Mesenchymal Stem Cell Therapy for Parkinson's Disease
- Meso Scale Discovery (MSD) Electrochemiluminescence Platform
- Metabolic Dysfunction (Type 3 Diabetes) Hypothesis in Alzheimer's Disease
- Metabolic Imaging and PET Tracers in CBS/PSP
- Metabolic Pathway-Targeted Therapy in ALS
- Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial
- Metabolic Therapy for Neurodegeneration
- Metabolic Therapy for Neurodegenerative Diseases
- Metabolic-Energetic Restoration: GLP-1 + TFEB Activator Combination
- Metabolomic Biomarkers in Neurodegeneration
- Metal Chelation Therapy for Neurodegenerative Diseases
- Metal Ion Dysregulation in Neurodegeneration: Investment Landscape Analysis
- Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
- Metformin for Neurodegeneration
- Microbiome (2025) - A. muciniphila and propionic acid
- Microbiome Gut-Brain Axis Therapy
- Microbiome Metabolomics and SCFA Therapy for CBS/PSP
- Microbiome Metabolomics and SCFA Therapy in CBS/PSP
- Microbiome-Based Therapeutics for Neurodegeneration: Investment Landscape Analysis
- Microbiome-Guided Prevention Bundle for Neurodegeneration Risk Reduction
- Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism and intervention
- Microbiome-Gut-Brain Axis in Alzheimer's Disease: Knowledge Gap
- Microglia Depletion and Repopulation Therapy
- Microglia in Frontotemporal Dementia Progression
- Microglia Modulation Therapies
- Microglia Modulation Therapy for Neurodegeneration
- Microglia-State Editing via TREM2-LXR Pulse Program
- Microglia-State Editing via TREM2-LXR Pulse Program
- Microglia-Targeted Nanoparticles for CNS Delivery
- Microglial Aging and Immune Memory in Neurodegeneration — Training the Brain's Macrophages
- Microglial Depletion and Replacement Strategies
- Microglial integrins in neuroinflammation
- Microglial Modulation Therapy for Neurodegeneration
- Microglial Priming and Innate Immune Tolerance Therapy for Neurodegeneration
- Microglial Proteins in CSF Reveal AD Progression States
- Microglial TREM2 Agonist In Vivo Efficacy
- MICrONS
- MicroRNA (miRNA) Biomarkers in Neurodegenerative Disease
- MicroRNA Therapy for Parkinson's Disease
- MicroRNA-Based Therapies for Neurodegeneration
- Microsoft Corporation
- Middle East Neurodegeneration Biotech Companies
- Migraine Cortical Hyperexcitability and Alzheimer's Disease Risk: Longitudinal Mechanism Study
- Mindfulness Meditation for Neurodegeneration
- Mindfulness Meditation for Parkinson's Disease
- MindMaze
- MindMaze Brain-Computer Interface
- MindScope Program
- Miniscope Technology
- Minocycline for Neurodegeneration
- Miro1 Modulation Therapy
- Mitochondria-Lysosome Contact Site (MLCS) Dysfunction Hypothesis in Parkinson's Disease
- Mitochondria-Lysosome Contact Site Dysfunction in Parkinson's Disease
- Mitochondria-Lysosome Contact Sites Dysfunction in Parkinson's Disease
- Mitochondrial Biogenesis Inducers
- Mitochondrial Biogenesis Inducers in Neurodegeneration
- Mitochondrial copper dysregulation in Parkinson's disease models
- Mitochondrial Dynamics Modulation Therapy
- Mitochondrial Dynamics Modulators for Neurodegenerative Diseases
- Mitochondrial Dynamics Modulators for Parkinson's Disease
- Mitochondrial NAD Redox Swing Protocol with Temporal Dosing Windows
- Mitochondrial NAD Redox Swing Protocol with Temporal Dosing Windows
- Mitochondrial NAD Redox Swing Protocol with Temporal Dosing Windows
- Mitochondrial Replacement Therapy for Neurodegeneration
- Mitochondrial Support Strategies for CBS/PSP
- Mitochondrial Therapeutics
- Mitochondrial Therapeutics Investment Landscape
- Mitochondrial Therapies for Neurodegeneration
- Mitochondrial Transplantation for Neurodegeneration
- MitoPark Mouse Model
- Mitophagy Activators for Neurodegeneration
- Mitophagy Enhancer Prophylaxis for Pre-Symptomatic Parkinson's and Related Neurodegeneration
- Mitophagy Gate Therapy: PINK1/Parkin + TFEB Priming
- MitoRestore Pharmaceuticals
- Mitsubishi Tanabe Pharma Corporation
- Mixed Pathology Effects on Parkinson's Disease Progression and Treatment Response
- MK-8719 (Merck OGA Inhibitor)
- MLCS Quantification in Parkinson's Disease
- MMP-9 Inhibitors for Neurodegeneration
- Mobile phone voice analysis for PD progression. J Neurol. 2025
- Mochida Pharmaceutical Co., Ltd.
- Models
- Moderna Therapeutics
- Molecular Biomarker Validation Status for CBS/PSP
- Molecular Chaperone Therapy
- Molecular Glue for TDP-43 Aggregate Clearance
- Molecular Hydrogen Therapy for Parkinson's Disease
- Monte Rosa Therapeutics
- Montreal Cognitive Assessment (MoCA)
- Motif Neurotech
- Motif Neurotech Brain-Computer Interface
- Motor Cortex Circuit
- Motor Imagery Brain-Computer Interface
- Motor Learning Circuit
- Motus Brain-Computer Interface
- Motus Company
- Movement Disorder Management — MDS 2026
- MPTP Mouse Model of Parkinson's Disease
- MRI and Imaging Findings in Corticobasal Syndrome
- MRI Atrophy Patterns in CBS/PSP
- MRI for Neurodegenerative Diseases
- mRNA Therapy for Parkinson's Disease
- mRNA-Encoded Intrabody for Alpha-Synuclein Clearance
- MSA Combination Therapy
- MSA Combination Therapy
- MSA Knowledge Gaps — Alpha-Synucleinopathy Research Priorities
- mTOR Inhibitor Therapy
- mTOR Inhibitors for Neurodegeneration
- mTOR Inhibitors for Neurodegeneration
- mTOR Inhibitors for Neurodegeneration — Investment Landscape Analysis
- mTOR signaling and autophagy in fasting-mediated neuroprotection
- mTOR Signaling Dysregulation in Progressive Supranuclear Palsy
- Multi-Analyte Biomarker Panels for Neurodegeneration
- Multi-Marker Pre-Symptomatic Screening Protocol
- Multi-Target Pharmacotherapy and Network Pharmacology for CBS/PSP
- Multi-Target Synergistic Combination Therapy Framework
- Multiple Sclerosis (MS) Treatment
- Multiple System Atrophy (MSA) Investment Landscape
- Multiple System Atrophy (MSA) Treatment
- Multiscale Computational Modeling of Protein Aggregation Kinetics
- Muna Therapeutics
- Muse
- Music and Rhythm-Based Therapy for CBS/PSP
- Music Therapy for Neurodegeneration
- Music Therapy for Neurodegenerative Diseases
- Mutant Huntingtin Protein (mHTT) - Biomarker
- Myelin Basic Protein (MBP) - Biomarker
- Myelin Repair Therapies
- Myoclonus in Corticobasal Syndrome
- Myoclonus in Corticobasal Syndrome
- N-Acetylcysteine (NAC) Therapy for Neurodegeneration
- N-Acetylcysteine Therapy for Neurodegeneration
- N-of-1 and Personalized Clinical Trial Design for CBS/PSP
- N-of-1 Clinical Trial Design for CBS/PSP
- NACET (N-Acetylcysteine Ethyl Ester)
- Nacuity Pharmaceuticals
- NAD+ Boosters for Neurodegeneration
- NAD+ Boosters for Neurodegeneration
- NAD+ Precursor Therapy for Neurodegenerative Diseases
- NAD+ Precursors (NMN/NR) for Parkinson's Disease
- NAD+ Precursors for Neurodegeneration
- NAMD - Molecular Dynamics Simulation
- NanoCarrier Co., Ltd.
- Nanomedicine Approaches to Alzheimer's Disease
- Nanomedicine for Alzheimer's Disease
- Nanoparticle Brain Delivery Systems
- Nanoparticle Drug Delivery for Neurodegeneration
- Nanoparticle Drug Delivery for Neurodegenerative Diseases
- Nanotechnology for Neurodegenerative Diseases
- Napa Therapeutics
- National Institutes of Health (NIH)
- Natriuretic Peptide Receptor Modulators for Neurodegeneration
- Natural Compound Therapies for Neurodegeneration
- Natural Compounds and Phytotherapy for Neurodegeneration
- Necroptosis Modulation Therapy
- Nelotanserin for Parkinson's Disease Psychosis
- NEOFECT
- Neteo Therapeutics
- Network Connectivity Biomarkers in CBS/PSP
- NeuBase Therapeutics
- NeuExo Therapeutics
- Neumora Therapeutics
- Neurable
- Neurable Brain-Computer Interface
- Neural Circuits in Corticobasal Syndrome
- Neural Circuits in Dementia with Lewy Bodies
- Neural Circuits in Progressive Supranuclear Palsy
- Neural Circuits Overview
- Neural Decoding Advances
- Neural Dust Technology
- Neural Dynamics
- Neural Network Dysfunction and Synchronization Therapy for CBS/PSP
- Neural Prosthetics
- Neural Stem Cell Failure Hypothesis in Alzheimer's Disease
- Neural Stem Cell Therapy for Alzheimer's Disease
- Neural Stem Cell Therapy for Neurodegenerative Diseases
- Neuralink
- Neuralink
- Neuralink BCI
- Neuraly, Inc.
- Neuraly, Inc.
- Neurastron
- Neurimmune
- Neuritic Amyloid Plaques — Histomorphologic Evidence of Pathologic Synergy in AD
- Neurocrine Biosciences
- Neurodegeneration Therapeutic Target Comparison Matrix
- Neurodegeneration-Focused Investment Funds
- Neurofascin - Biomarker for Axonal Integrity
- Neurofeedback and Brain-Computer Interface Therapy for CBS/PSP
- Neurofilament Heavy Chain (NfH)
- Neurofilament Light Chain (NfL) - Biomarker
- Neurofilament Light Chain (NfL) in Blood - Biomarker
- Neurofilament Medium Chain (NfM) - Biomarker
- Neurogenesis in Parkinson's disease: Therapeutic potential and challenges
- Neurogranin (Ng) - Synaptic Biomarker
- Neurogranin - Alzheimer's Disease Biomarker
- Neurogranin-Guided Synapse Rescue Therapy
- Neuroimaging Biomarkers for Neurodegeneration
- Neuroimaging in Progressive Supranuclear Palsy
- Neuroimmune Biomarkers in Progressive Supranuclear Palsy
- [Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015;14(4):388-405](/gaps/ad-cognitive-resilience)
- Neuroinflammation in multiple system atrophy
- Neuroinflammation Modulation Therapies for Neurodegenerative Diseases
- Neuroinflammation Modulation Therapy: GFAP and sTREM2-Targeted Approaches
- Neuroinflammation PET Imaging in CBS/PSP
- Neuroinflammation Targeting Therapies
- Neuroinflammation Therapeutics Investment Landscape
- Neuroinflammation Therapeutics: Investment Landscape Analysis
- Neurolixis SAS
- NeuroMito Therapeutics
- Neuron Disease (MND). Cochrane Database of Systematic Reviews, (3), CD001447. DOI
- NeuRon Therapeutics
- Neuron-Specific Enolase (NSE) - Biomarker
- Neuron23 Inc.
- Neuronal Calcium Sensor Modulation Therapy
- Neuronal Pentraxin 1 (NPTX1)
- Neuronal Pentraxin Receptor (NPTXR)
- Neuronal Stem Cell Transplantation for Neurodegeneration
- Neuronetics
- NeuroPace, Inc.
- Neuropathic Pain Treatments in Neurodegenerative Diseases
- Neuropathological Examination
- Neuropeptide and Endocrine Signaling in CBS/PSP
- Neuropeptide Y (NPY) Receptor Modulators in Neurodegeneration
- Neuropixels Probes
- Neuropore Therapeutics
- Neuroprosthetics
- Neuroprotection Strategies in Neurodegeneration
- Neuroprotective Peptides for Neurodegenerative Diseases
- Neuroprotective strategies in CNS disorders
- Neuroregeneration Therapies for Neurodegeneration
- Neurorehabilitation for Neurodegenerative Diseases
- Neurorestore Therapies for Parkinson's Disease
- Neuroscience Project Rankings
- Neuroscience Projects Overview
- NeuroSense Therapeutics Ltd.
- NeuroSky
- Neurosurgical Treatments for Neurodegenerative Diseases
- Neurotensin Receptor Modulator Therapy for Neurodegeneration
- Neurotensin Receptor Modulators for Parkinson's Disease
- Neurotransmitter Modulation Investment Landscape
- Neurotrope BioScience
- Neurotrophic Factor Gene Therapy Programs — GDNF, CDNF, BDNF, Neurturin
- Neurotrophic Factor Therapies
- Neurotrophic Factor Therapies for Neurodegenerative Diseases
- Neurotrophic Factor Therapy for Neurodegeneration
- Neurotrophic Factor Therapy for Neurodegenerative Diseases
- Neurotrophic factors in Parkinson's disease
- Neurotrophic Factors: Investment Landscape Analysis
- Neurotrophin Receptor Modulators in Neurodegeneration
- Neurotrophin-3 and Parkinson's disease
- Neurovascular Coupling Restoration Therapy
- NeuroWiki Dashboard
- NeuroWiki Progress
- NeuroWiki Tags
- NeuroWiki Work Queue
- Neurturin (NRTN) Therapy for Parkinson's Disease
- NextMind
- NextMind
- NextMind
- NextMind BCI
- NextMind Brain-Computer Interface
- NF-kB Pathway Inhibition Therapy for Neurodegeneration
- NF-κB Pathway Inhibition for Neurodegeneration
- NfL Reduction Therapy: Neuroprotective Strategies for Neurodegenerative Diseases
- NfL-Guided Neuroprotection Therapy
- NfL-Guided Neuroprotection Threshold
- NfL-Guided Neuroprotection Threshold
- NfL-Guided Neuroprotective Therapy for Rapid Progressors
- NfL-guided patient stratification in neurodegeneration trials
- NHP Validation of Animal Model Comparison Findings
- Nicotinamide Mononucleotide (NMN) for Neurodegeneration
- Nicotinamide Riboside
- Niemann-Pick Disease Treatment
- Nilotinib for Parkinson's Disease
- NIO752 (Roche ASO)
- Nippon Shinyaku Co., Ltd.
- Nitric Oxide Modulation Therapy for Neurodegeneration
- NLRP1 Inflammasome Modulation Therapy for Neurodegeneration
- NLRP3 Inflammasome Inhibitors
- NLRP3 Inflammasome Inhibitors for Neurodegenerative Diseases
- NLRP3 Inflammasome Therapeutics Investment Landscape
- NLRP3 Inhibitors for Neurodegeneration
- NLRP3 Inhibitors in Neurodegeneration
- NLRP3 Senomorphic Cycling Therapy
- NLRP3-Coupled Senomorphic Cycling Therapy
- Nobelpharma Co., Ltd.
- Nodthera Ltd.
- Non-Dopaminergic Neurotransmitter Degeneration in PD - Experiment Design
- Non-Invasive Home BCI Technology
- Non-Motor Symptoms in PD — MDS 2026
- Non-Motor Symptoms Treatment in Parkinson's Disease
- Non-Pharmacological Interventions for Behavioral Symptoms
- Nordic Neurodegeneration Biotech Companies
- Normal Aging to Alzheimer's Disease Transition Trigger — Identifying the Critical Switch Point
- Notch Signaling and Gamma-Secretase Modulators for Alzheimer's Disease
- Notch Signaling Modulation Therapy for Neurodegeneration
- Notch Signaling Modulators for Neurodegeneration
- Novanex Biosciences
- Novartis
- Novartis
- Novartis AG — Sphingosine-1-Phosphate Receptor Modulators
- Novel Therapy Index
- NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease Progression
- NPTX2 (Neuronal Pentraxin 2) - Synaptic Biomarker
- NRF2 Activator Therapy
- NRF2 Activator Therapy for Neurodegeneration
- Nrf2 Activators for Neurodegenerative Diseases
- NRF2 Activators in Neurodegenerative Disease
- NRF2 Therapeutics: Investment Landscape Analysis
- Nuclear envelope dysfunction in ALS: mechanisms and therapeutic implications
- Nurr1 (NR4A2) Agonist Therapies
- NURR1 Agonist Therapy for Parkinson's Disease
- NURR1 Agonists for Parkinson's Disease
- NUS1 CoQ10 Pathway Modulation for Parkinson's Disease
- NUS1 CoQ10 Pathway Modulation for Parkinson's Disease
- Nusinersen (Spinraza)
- Nutraceutical and Dietary Supplement Companies for Alzheimer's
- Nutraceutical Supplements for Neurodegeneration
- Nutritional Neuroscience Approach to Neurodegeneration
- Nutritional Therapy and Ketogenic Diet for CBS/PSP
- Nutritional Therapy for Neurodegenerative Diseases
- O-GlcNAcase (OGA) Inhibitor Landscape — Programs, Mechanisms, Companies
- Occupational Therapy for Neurodegenerative Diseases
- Occupational Therapy for Parkinson's Disease
- Ocular Fluid Biomarkers for Alzheimer's Disease
- Olfactory Biomarkers for Alzheimer's Disease
- Olfactory-Limbic Circuit
- Oligodendrocyte Precursor Cell Activation for Myelin Regeneration
- Oligodendrocyte Precursor Cell Therapy
- Oligodendrocyte Protection Therapy for Neurodegeneration
- Oligodendrocyte-Myelin Dysfunction Hypothesis in Parkinson's Disease
- Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's Disease
- Oligomerix, Inc.
- Olink Proteomics
- Omics-AD Multimodal Biomarker Study
- Ono Pharmaceutical
- Onward Medical
- OpenBCI
- OpenBCI Inc.
- OpenMM: Python-Based Molecular Dynamics Simulation
- OpenScope
- Opicapone (Ongentys)
- Optical Coherence Tomography in Neurodegeneration
- Optimal Therapeutic Intervention Timing in Alzheimer's Disease
- Optogenetic Brain-Computer Interfaces
- Optogenetics
- Optogenetics for Neurodegenerative Diseases
- Optogenetics Therapy for Parkinson's Disease
- Orexin Receptor Modulators for Neurodegeneration
- Organizations
- Otsuka Holdings Co., Ltd.
- Otsuka Pharmaceutical
- Oura
- Oxidative Stress Therapeutics Investment Landscape
- Oxidative Stress Therapeutics: Investment Landscape Analysis
- Oxytocin Receptor Modulators in Neurodegeneration
- p-Tau Biomarker in Immunoglobulin Light Chain and Transthyretin Amyloidosis
- p-tau181 in non-AD tauopathies
- p-Tau217 Adaptive Dosing Protocol
- p-Tau217 Adaptive Dosing Protocol
- P2X4 Receptor Modulation Therapy
- P2X4/P2X7 Dual Receptor Modulation Therapy for Neurodegeneration
- P2X7 Receptor Antagonists for Neurodegeneration
- P2X7 Receptor Antagonists for Parkinson's Disease
- P2X7 Receptor Modulation Therapy
- P2Y12 Receptor Antagonist Therapy
- P2Y12 Receptor Antagonists for Neurodegeneration
- P2Y14 Receptor Antagonists for Neurodegeneration
- P300 Brain-Computer Interface
- p38 MAPK Inhibitors for Neurodegenerative Diseases
- PACAP Receptor Modulators for Neurodegeneration
- Page Quality Index
- Page Suggestions
- Pain Management and Somatic Symptoms in CBS/PSP
- Pantothenate Kinase-Associated Neurodegeneration (PKAN) Treatment
- Paradromics
- Paradromics
- PARK7 (DJ-1) Targeted Therapy for Parkinson's Disease
- Parkin (PRKN) Gene Therapy
- Parkin Activators for Parkinson's Disease
- Parkinson Basal Ganglia Circuit
- Parkinson's Disease Assessment Scales
- Parkinson's Disease Biomarkers
- Parkinson's Disease Circadian Rhythm Dysfunction Therapy Companies
- Parkinson's Disease Digital Therapeutics Companies
- Parkinson's Disease DNA Damage Repair Therapeutic Companies
- Parkinson's Disease ER Stress/UPR Modulator Companies
- Parkinson's Disease Ferroptosis Companies
- Parkinson's Disease HIF/Hypoxia Signaling Therapy Companies
- Parkinson's Disease Investment Landscape
- Parkinson's Disease Iron Chelation Therapy Companies
- Parkinson's Disease Knowledge Gaps
- Parkinson's Disease Lysosomal and Autophagy Companies
- Parkinson's Disease Mitochondrial Neuroprotection Companies
- Parkinson's Disease NRF2-Keap1 Pathway Therapy Companies
- Parkinson's Disease Protein Kinase C Modulator Companies
- Parkinson's Disease Synaptic Dysfunction Therapeutic Companies
- Parkinson's Disease Synaptic Repair and Preservation Companies
- Parkinson's Disease Treatment
- Parkinson's Disease Treatment Options
- Parkinson's Disease Treatment Overview
- Parkinson's Disease VEGF/Angiogenic Signaling Therapy Companies
- Parkinson's vs Huntington's: Comparative Investment Analysis
- PARP Inhibitor Therapy
- PARP Inhibitor Therapy for Neurodegeneration
- PARP1 Inhibition for Parthanatos Prevention in Neurodegeneration
- Passage Bio
- Pathologic Synergy Occurring in the Amygdala Between Amyloid Plaques and Tau/NFT May Facilitate the Transition from PART to AD
- Patient Advocacy Organizations in Neurodegeneration
- Paxos Therapeutics
- Paxos Therapeutics
- Payload: Autophagy Proteostasis Dual Activation
- PCDH19 Alliance
- PCDH19 Family Network
- PD AMPK Activator Companies
- PD ATP13A2/PARK9 Lysosomal Therapy Companies
- PD Clinical Trials — MDS 2026
- PD Drug Combination Therapy Matrix
- PD EGFR and Receptor Tyrosine Kinase Therapeutic Companies
- PD EGFR Signaling Therapy Companies
- PD FGF/FGFR Signaling Companies
- PD GBA Glucocerebrosidase Therapeutic Companies
- PD GLP-1 Receptor Agonist Companies
- PD GPCR Signaling Therapeutic Companies
- PD GSK3 Inhibitor Companies
- PD Ion Channel Modulator Companies
- PD Knowledge Gaps Analysis
- PD LRRK2 Kinase Inhibitor Companies
- PD mTOR Signaling Modulation Companies
- PD Neurotechnology
- PD Pipeline
- PD Pipeline Companies
- PD Sleep Disorder Treatment Companies
- PD TFEB Activator and Lysosomal Biogenesis Companies
- PD Therapeutic Approaches Scorecard
- PD TREM2 Targeting Companies
- PD Warrior
- PD Wnt Signaling Therapy Companies
- PD-Metabolic Intersection Companies
- PDE1 Inhibition Therapy for Neurodegeneration
- PDE5 Inhibitors for Neurodegeneration - Vascular Hypothesis
- Pear Therapeutics
- Peptide Therapeutics for Neurodegeneration — Investment Landscape Analysis
- Peptide-Based Therapeutics for Neurodegeneration
- Peptide-Based Therapies for Neurodegenerative Diseases
- Peptidream Inc.
- Pericyte PDGFR-Beta Agonist for Neurovascular Rescue
- Pericyte PDGFR/VEGFR Modulator Therapy for Neurodegeneration
- Peripherally Restricted Cannabinoids for Neurodegeneration
- Perivascular Macrophage Neuroprotection Therapy
- PERK pathway is involved in the autophagic degradation of myelin proteins
- Peroxisomal Dysfunction Hypothesis in Parkinson's Disease
- Peroxisomal Dysfunction Validation in Parkinson's Disease
- Peroxisome Dysfunction Hypothesis in Parkinson's Disease
- Peroxisome Dysfunction Validation in Parkinson's Disease
- Peroxisome-mediated lipid signaling and neuroprotection
- Personalized Antisense Oligonucleotide (ASO) Therapy
- Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)
- PET Imaging Combined with Fluid Biomarkers
- PET Imaging for Neurodegenerative Diseases
- PET Imaging in Neurodegeneration
- Pfizer Inc
- PGC-1α (PPARGC1A) Targeted Therapies in Neurodegeneration
- PGC-1α Activator Therapy for Neurodegeneration
- Phage Display and Directed Evolution for Tau Therapeutics
- Phagocytosis Modulation Therapy
- Pharma Market Report
- Pharma Two B Ltd.
- Pharmacogenomics Patient Profile: CBS/PSP (50yo Male)
- PharmaEssentia Corp
- Philippines Neurodegeneration Biotech Companies
- Phosphodiesterase (PDE) Inhibitors for Neurodegeneration
- Phosphodiesterase Inhibitors for Parkinson's Disease
- Phosphorylated Alpha-Synuclein (pSer129) - Biomarker
- Phosphorylated Tau 181 (p-tau 181)
- Phosphorylated Tau 217 (p-tau217)
- Phosphorylated Tau 231 (p-tau 231)
- Photobiomodulation (Red Light) Therapy for CBS and PSP
- Photobiomodulation Therapy for Neurodegeneration
- Photobiomodulation Therapy for Neurodegeneration
- Photobiomodulation Therapy for Neurodegenerative Diseases
- Photobiomodulation Therapy for Parkinson's Disease
- Phototherapy and Photobiomodulation Companies for Alzheimer's
- Physical Exercise Therapy for Parkinson's Disease
- Physical Therapy and Exercise for Neurodegeneration
- Physical Therapy and Rehabilitation for Atypical Parkinsonism
- Physical Therapy and Rehabilitation for Neurodegenerative Disease
- Physical Therapy for Neurodegenerative Diseases
- Physical Therapy for Parkinson's Disease
- Physical Therapy in Neurodegenerative Disease
- Physitrack
- Pimavanserin. StatPearls. NCBI Bookshelf. NBK557712)
- PINK1 Activators for Parkinson's Disease
- PINK1-Parkin Mitophagy Activators
- PINK1/Parkin Activators
- Pinteon
- Pinteon Therapeutics
- Pittsburgh Compound B (PiB)
- Plasma Biomarkers in Neurodegeneration
- Plasma p-tau181 (Phosphorylated Tau at Threonine 181)
- PNT001
- Polyneuron Pharmaceuticals AG
- Polysomnography (PSG) - Comprehensive Sleep Study Guide for Atypical Parkinsonism
- Polysomnography (PSG) - Sleep Study in Neurodegenerative Disease
- Polysomnography and RBD Testing for Atypical Parkinsonism
- Polysomnography and Sleep Study Testing for Atypical Parkinsonism
- Pompe Disease Treatment
- Pontocerebellar Pathway
- Portable Exoskeleton for Parkinson's Disease Mobility (NCT06028529)
- Positron Emission Tomography in Alzheimer's Disease
- Post-Acute Viral Reservoir Hypothesis Validation Experiment Design
- Posterior Cortical Atrophy (PCA) Treatment
- Potassium channel modulators in neuroprotection: from bench to bedside
- Potassium Channel Openers in Neurodegenerative Disease
- PP2A Activator Therapy
- PPAR Agonists for Neurodegeneration
- Pramipexole - Dopamine Agonist for Parkinson's Disease
- Prasinezumab (PRX002)
- Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
- Precision Medicine Approaches for Neurodegeneration
- Precision Neuroscience
- Precision Neuroscience
- Precision Neuroscience Layer 7 Cortical Interface
- Prevail Therapeutics
- Priavoid GmbH
- Primary Lateral Sclerosis Treatment
- Primary Lateral Sclerosis Treatment
- Primary Progressive Aphasia Treatment
- Primidone
- Primitive Reflex Testing in Corticobasal Syndrome
- Prion Disease Therapy
- Prion Disease Treatment
- Prion Diseases Investment Landscape
- Prion vs Tau/Alpha-Synuclein Propagation: Mechanistic Comparison
- Prion-Like Propagation of Proteinopathies — Template-Directed Misfolding in Neurodegeneration
- Prionab
- Priority Research Areas for Neurodegenerative Disease R&D
- Priority Research Areas for Neurodegenerative Diseases
- Priority Research Areas for Neurodegenerative Diseases
- Probiodrug
- Probiosfera
- Prodromal Prevention Trial Design in Parkinson's Disease
- Prodromal Resilience Package for Genetically High-Risk Cohorts
- Progranulin (PGRN) - Biomarker
- Progranulin Deficiency and TDP-43 Aggregation in Frontotemporal Dementia
- Progranulin Therapy
- Progranulin Therapy for Neurodegeneration
- Progressive Supranuclear Palsy (PSP) Investment Landscape
- Progressive Supranuclear Palsy (PSP) Treatment
- Progressive Supranuclear Palsy (PSP) Treatment Guide
- Progressive Supranuclear Palsy Diagnostic Methods
- Progressive Supranuclear Palsy Investment Landscape
- Progressive Supranuclear Palsy Knowledge Gaps
- Progressive Supranuclear Palsy Neural Circuit
- Projects
- ProMab
- ProMIS Neurosciences
- Promising Clinical Trials in Neurodegenerative Diseases
- Propeller Health
- Propranolol
- Propranolol
- Prostaglandin and Eicosanoid Signaling in CBS/PSP
- PROTAC Targeted Protein Degradation Therapy
- PROTAC Therapy for Parkinson's Disease
- PROTACs and Molecular Glue Degraders for Neurodegeneration
- PROTACs and Molecular Glues for Neurodegeneration
- Proteasome-Ubiquitin System Dysfunction Validation in Parkinson's Disease
- Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase
- Protein Aggregation Inhibitors
- Protein Aggregation Inhibitors for Neurodegeneration — Investment Landscape Analysis
- Protein Aggregation Kinetic Validation Results
- Protein Homeostasis Therapies
- Protein Kinase Inhibitors for Neurodegeneration: Investment Landscape Analysis
- Protein Misfolding Inhibitors for Neurodegeneration
- Proteomic profiles of neuronal exosomes in Alzheimer's disease correlate with neuropathology
- Proteomics in Neurodegeneration
- Proteostasis Network CBS PSP
- Proteostasis Therapeutics
- Proteostasis Therapeutics: Investment Landscape Analysis
- Proteostasis Therapy CBS PSP
- Proteostasis Triad Pulses: ISR + Autophagy + Chaperone Induction
- Prothelia
- Prothena Corporation
- Prothena Corporation plc
- PRX005
- PSP and CBS Biomarker Validation Study
- PSP Association UK
- PSP Association UK
- PSP Australia
- PSP Canada
- PSP Combination Therapy
- PSP Europe
- PSP France
- PSP Germany
- PSP Italy — Associazione Italiana PSP
- PSP Japan — 日本PSP協会
- PSP Korea
- PSP Netherlands — PSP Vereniging Nederland
- PSP Scandinavia
- PSP Singapore
- PSP Spain — Asociación Española de PSP
- PSP Taiwan
- PSP Therapeutic Ideas
- PSP/CBS Therapeutic Target Index
- Psychosocial Interventions and Cognitive Reserve in CBS/PSP
- PubChem - Open Chemistry Database
- PureTech Health - Exosome Platform
- Purinergic Signaling Dysfunction Hypothesis in Parkinson's Disease
- Purinergic Signaling Dysfunction Validation in Parkinson's Disease
- PyMOL: Molecular Visualization System
- Pyroptosis Inhibition Therapy
- Pyroptosis Inhibitors for Neurodegeneration — Investment Landscape Analysis
- Pyroptosis Modulation Therapy
- Pyxis Oncology
- Quality Checklist
- Quanterix Simoa Platform
- Quantitative Sensory Testing for Cortical Sensory Loss in CBS
- Quantitative Susceptibility Mapping for Corticobasal Syndrome
- QurAlis
- QurAlis Corporation
- RAGE (Receptor for Advanced Glycation End Products) Modulator Therapy
- Rapamycin for Tauopathy
- RBD and Autonomic Dysfunction in DLB Progression
- Reach Neuro
- Recepta Biopharma
- Recursion Pharmaceuticals
- RedHill Biopharma Ltd.
- Regeneron Pharmaceuticals
- Regenxbio Inc.
- Rehabilitation Robotics for Parkinson's Disease
- Relmada Therapeutics
- Relyvrio (Sodium Phenylbutyrate/Taurursodiol)
- Relyvrio (Sodium Phenylbutyrate/Taurursodiol) for ALS
- REM Sleep Behavior Disorder (RBD) - Diagnostic Marker for Synucleinopathies
- Renascience Inc.
- Reo
- ReproCELL Inc.
- Research Gap Overview
- Research Priorities in Neurodegenerative Disease
- Respiratory Function and Dysphagia Therapy in CBS/PSP
- Responsive Neurostimulation (RNS)
- Resting-State fMRI Connectivity in Corticobasal Syndrome
- Restorative Therapies for Neurodegeneration
- Resveratrol and Sirtuin Activation for Neurodegeneration
- Retinal changes in PART: OCT findings (2022)
- Retinal Imaging in Corticobasal Syndrome
- Retinal Imaging in Neurodegeneration
- Retro Biosciences
- Retrograde axonal transport dysfunction as convergence point in PD
- Retromer Stabilizers for Neurodegeneration
- Retromer-Endosomal Sorting Dysfunction Hypothesis in Parkinson's Disease
- RGMa Modulation Therapy
- Rhythm-based gait training for Parkinson disease: A systematic review
- RIBOMIC Inc.
- RightEye
- Ring14 USA
- RIPK1 Inhibitor Therapy
- RIPK1 Inhibitor Therapy
- RIPK1 Inhibitor Therapy in Neurodegeneration
- RIPK1 Inhibitors for Neurodegeneration
- RIPK1-TAK1 Interaction Inhibitor
- Rituximab
- Rivastigmine (Exelon)
- RMF Therapy for Parkinson's Disease
- RMT-TfR1 Bispecific Antibody Shuttle for CNS Delivery
- RNA Editing Therapeutics
- RNA Interference (RNAi) Therapies for Neurodegeneration
- RNA Targeting Therapy for Neurodegeneration
- RNA Therapeutics for Neurodegeneration Investment Landscape
- RNA Therapeutics: Investment Landscape Analysis
- RNA-Based Therapeutics for Alzheimer's Disease
- RNA-Based Therapeutics for Neurodegenerative Diseases
- RNA-Targeting ASO Therapeutics Beyond C9orf72
- RNA-Targeting Therapies for Neurodegenerative Diseases
- RNP Inc.
- Robotics Rehabilitation for Neurodegenerative Diseases
- Roche
- Roche advances tau program in PSP and CBD
- Roche Brain Shuttle Technology
- Roche Diagnostics — Neurology
- Roche Elecsys Diagnostic Platform
- Roche/Genentech — GCase Modulators and Lipid Pathway Therapies
- ROCK Inhibition and Cytoskeletal Dynamics for Alzheimer's Disease
- ROCK Inhibitor Therapy for Neurodegeneration
- Rodin Therapeutics
- Roemmers
- Role of NLRP3 in the pathogenesis and progression of Parkinson's disease
- Ropinirole - Dopamine Agonist for Parkinson's Disease
- RoseTTAFold for Protein Structure Prediction
- Rotenone-Induced Parkinsonism Model
- RQC Restoration Therapy for Neurodegeneration
- Rune Labs
- S100 Protein (S100A8/A9/A12) Modulator Therapy for Neurodegeneration
- S100B Protein - Astrocyte Biomarker
- S1P Receptor Modulators in Neurodegeneration
- S1P signaling in the nervous system
- S1PR5 (Sphingosine-1-Phosphate Receptor 5) Modulators for Neurodegeneration
- Safety and tolerability of A3 adenosine receptor agonists in clinical trials
- Sage Therapeutics
- Salience Network
- Salivary Biomarkers for Alzheimer's Disease
- Salivary Biomarkers in Corticobasal Syndrome
- Samsung Bioepis
- Samsung Electronics
- SanBio Co., Ltd.
- Sangamo Therapeutics
- Sanofi
- Sanofi S.A. — Glucosylceramide Synthase Inhibitors
- SARM1 Inhibitor Therapy
- SARM1 NADase Inhibition for Axonal Preservation
- SARM1 NADase Inhibition Therapy
- Saval Corporation
- Savar
- SCFA-Mediated Neuroinflammation in Alzheimer's Disease
- Science Corp
- Science Corp Brain-Computer Interface
- Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD)
- Secretoneurin Neuropeptide Therapy
- Section 103: Sirtuin Pathway and NAD+-Dependent Deacetylases in CBS/PSP
- Section 113: Emerging Gene Therapy Approaches for CBS/PSP
- Section 113: Speech and Language Therapy in CBS/PSP
- Section 116: Combination Therapy Synergies for CBS/PSP
- Section 125 — Advanced Ketogenic and Metabolic Therapy for CBS/PSP
- Section 132: Advanced Systems Immunology and Network Pharmacology in CBS/PSP
- Section 137: Advanced Metal Chelation Therapy in CBS/PSP
- Section 138: Advanced Extracellular Matrix and Integrin Therapy in CBS/PSP
- Section 141: Advanced Neurotrophin and Growth Factor Therapy in CBS/PSP
- Section 145: Advanced Ion Channel Modulation and Channelopathy Therapy in CBS/PSP
- Section 146: Advanced Synaptic Plasticity and Network Repair Therapy in CBS/PSP
- Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP
- Section 151: Thyroid and Metabolic Hormone Optimization in CBS/PSP
- Section 152: Advanced Robotics and Assistive Devices in CBS/PSP
- Section 153: Virtual Reality Therapy Protocols in CBS/PSP
- Section 156: Pet Therapy and Animal-Assisted Interventions in CBS/PSP
- Section 159: Microbiome Sequencing and Personalized Probiotics in CBS/PSP
- Section 159: Microbiome Sequencing and Personalized Probiotics in CBS/PSP
- Section 160: Pharmacogenomics and Personalized Medicine in CBS/PSP
- Section 162: Advanced Antioxidant and Redox Therapy in CBS/PSP
- Section 164: Advanced Metal Chelation and Homeostasis in CBS/PSP
- Section 174: Oligonucleotide Therapies (ASO/SSO) in CBS/PSP
- Section 179: Advanced Proteomics and Protein Biomarker Panels for CBS/PSP
- Section 180: Copper and Zinc Homeostasis in CBS/PSP
- Section 182: Microbiome Metabolomics and SCFA Therapy in CBS/PSP
- Section 182: Microbiome Metabolomics and SCFA Therapy in CBS/PSP
- Section 185: Advanced Heat Shock Protein and Proteostasis Modulation in CBS/PSP
- Section 186: Bioenergetics and Mitochondrial Coupling Therapy in CBS/PSP
- Section 189: Advanced Autophagy-Endolysosomal Pathway Therapy in CBS/PSP
- Section 192 Advanced Epigenomics and Chromatin Therapy in CBS/PSP
- Section 193 Advanced Integrated Cell Stress Response Therapy in CBS/PSP
- Section 194: Advanced Membrane Trafficking and Vesicle Dynamics in CBS/PSP
- Section 194: Advanced Mitochondrial Dynamics and Biogenesis Therapy in CBS/PSP
- Section 200: Epigenetic and Chromatin Therapy in CBS/PSP
- Section 206: Advanced Heat Shock Protein and Molecular Chaperone Therapy in CBS/PSP
- Section 215 Combination Therapy Synergies in CBS/PSP
- Section 216: Advanced Pharmacogenomics and Precision Therapeutics for CBS/PSP
- Section 216: Advanced Pharmacogenomics for CBS/PSP
- Section 217 Advanced Cell Therapy and Regenerative Medicine in CBS/PSP
- Section 218: Advanced Nutritional Genomics and Personalized Diet in CBS/PSP
- Section 225: Advanced Speech and Communication Therapy in CBS/PSP
- Section 227: Advanced Glycation End Products and RAGE Therapy in CBS/PSP
- Section 227: Advanced Glycation End Products and RAGE Therapy in CBS/PSP
- Section 229: Advanced Horticulture Therapy and Nature-Based Interventions in CBS/PSP
- Section 230: Advanced Mindfulness and Meditation-Based Interventions for CBS/PSP
- Section 231: Advanced Yoga and Mind-Body Integration Therapy for CBS/PSP
- Section 232: Advanced Social Engagement and Community-Based Interventions in CBS/PSP
- Section 233: Advanced Virtual Reality and Immersive Technology-Based Rehabilitation in CBS/PSP
- Section 234: Advanced Acupuncture and Traditional Chinese Medicine Physical Modalities in CBS/PSP
- Section 237: Advanced Humor and Laughter Therapy in CBS/PSP
- Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP
- Section 240: Advanced Narrative Therapy and Life Review in CBS/PSP
- Section 241: Advanced Gene Therapy and CRISPR Approaches in CBS/PSP
- Section 242: Advanced Stem Cell Therapy and Neuronal Replacement in CBS/PSP
- Section 246: Tunneling Nanotubes and Intercellular Communication in CBS/PSP
- Section 249: Advanced LSVT Voice and Speech Therapy in CBS/PSP
- Section 250: Advanced Nitric Oxide and Gasotransmitter Therapy in CBS/PSP
- Section 250: Advanced Nitric Oxide and Gasotransmitter Therapy in CBS/PSP
- Section 250: Advanced Vestibular and Balance Therapy in CBS/PSP
- Section 251: Advanced Peptide Hormone and GPCR-Targeted Therapy in CBS/PSP
- Section 251: Advanced Vision and Eye Movement Therapy in CBS/PSP
- Section 252: Advanced Rehabilitation for CBS/PSP - LSVT, PT, OT Integration
- Section 253: Advanced Optogenetics and Chemogenetics for Circuit Manipulation in CBS/PSP
- Section 253: Advanced Optogenetics and Chemogenetics for Circuit Manipulation in CBS/PSP
- Section 253: Respiratory Function and Dysphagia Therapy in CBS/PSP
- Section 99: Purinergic Signaling and P2X/P2Y Receptors in CBS/PSP
- Section Health Trends
- Selective Neuronal Vulnerability to Aging
- Selective Neuronal Vulnerability to Aging — Mapping Why Specific Neurons Degenerate
- Selegiline - MAO-B Inhibitor for Parkinson's Disease
- Semaglutide (Wegovy/Ozempic) for Neurodegenerative Diseases
- Semaphorin/Plexin Signaling Modulators for Neurodegeneration
- Semorinemab (RG6100)
- Senolytic Agents for Neurodegeneration
- Senolytic Prevention Protocol for Neurodegeneration Risk Reduction
- Senolytic Safety and Efficacy in the Central Nervous System
- Senolytic Safety and Efficacy in the Central Nervous System
- Senolytic Therapeutics: Investment Landscape Analysis
- [Senolytic Therapies for CBS and PSP](/therapeutics/senolytics-neurodegeneration)
- Senolytic Therapies for Neurodegenerative Diseases
- Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease
- Senolytics and Senotherapeutics in Neurodegeneration
- Sensoria Health
- Servier
- Sex Differences in Alzheimer's Disease — mechanisms and therapeutic implications
- SfN 2026: Glial Biology in Neurodegeneration
- SfN 2026: Neurodegeneration Sessions
- SfN Annual Meeting
- SfN Annual Meeting 2025
- SfN Neuroscience 2026 — Neurodegeneration Research Highlights
- SGLT2 Inhibitor Neuroprotection Therapy
- Shanghai NeuroTech
- Shimmer
- Shionogi & Co., Ltd.
- Sialic Acid Therapy and Glycomics Approaches in CBS/PSP
- SIGLEC-3 Modulation Therapy for Neurodegeneration
- Sigma-1 Receptor Agonist Therapies
- Sigma-1 Receptor Agonist Therapy
- Sigma-1 Receptor Agonist Therapy for Parkinson's Disease
- Sigma-1 Receptor Agonists for Neurodegeneration
- Sigma-1 Receptor Agonists for Neurodegenerative Diseases
- Sigma-1 Receptor Agonists in Neurodegenerative Disease
- Sigma-2 Receptor Modulation for Parkinson's Disease
- Sigma-2 Receptor Modulation Therapy
- Simcere Pharmaceutical Co., Ltd.
- Simufilam
- Simufilam (Aβ Oligomer Antagonist) Therapy
- Sinergium Biotech
- Singapore Cell and Gene Centre (SCGC)
- Singapore/Asia-Pacific Neurodegeneration Biotech Companies
- Single Nucleus RNA Sequencing (snRNA-seq)
- Single-Cell Genomics in Neurodegeneration
- Sio Gene Therapies
- siRNA and RNA Therapeutics Brain Delivery
- siRNA Therapy for Parkinson's Disease
- SIRT2 Modulation Therapy
- Sirtuin Modulator Companies for Alzheimer's Disease
- Sirtuin Modulator Companies for Parkinson's Disease
- Sirtuin Modulators
- Sirtuin Modulators for Parkinson's Disease
- Sirtuin Pathway Dysfunction Hypothesis in Parkinson's Disease
- Sirtuin Pathway Dysfunction Validation in Parkinson's Disease
- Skin Biomarkers for Alzheimer's Disease
- Skin Biopsy for Tau and Alpha-Synuclein
- Skin Biopsy Tau Seeding in CBS/PSP
- Skin Biopsy Tau Seeding in CBS/PSP
- SLC6A1 Connect
- Sleep and Circadian Dysfunction as Driver of Neurodegeneration
- Sleep and Circadian Dysfunction in Neurodegeneration - Knowledge Gaps
- Sleep Biomarkers for Alzheimer's Disease
- Sleep Biomarkers for CBS and PSP
- Sleep Disorders in Neurodegenerative Diseases
- Sleep Disruption and Alzheimer's Disease — mechanism and intervention
- Sleep Optimization Therapy for Neurodegeneration
- Sleep-Wake Circuit
- Slit-Robo Axon Guidance Modulator Therapy
- Small Molecule Drugs for Neurodegenerative Diseases
- Small Molecule Therapies in Neurodegenerative Diseases
- SNAP-25
- SNAP-25 - Synaptic Biomarker
- Social Engagement and Cognitive Reserve Therapy
- SOD1 Targeted RNA Silencing Therapy for ALS
- SOD1-Targeting Therapies for ALS
- Sodium Channel Blockers for Neurodegeneration
- Sodium Oligomannate (GV-971)
- Sodium Oligomannate (GV-971) for Alzheimer's Disease
- Sodium Phenylbutyrate/Taurursodiol (Relyvrio) for ALS
- Sodium Selenate
- Soluble Amyloid Precursor Protein Beta (sAPPβ)
- Soluble Guanylate Cyclase (sGC) Stimulator Therapy
- Somatic Movement and Body-Based Therapies in CBS/PSP
- Somatosensory Circuit
- Somatostatin Receptor Modulator Therapy in Neurodegeneration
- Sonogenetics
- Sonogenetics Therapy for Parkinson's Disease
- Southeast Asian Neurodegeneration Biotech Companies
- SPAM1: SIRT6 Positive Allosteric Modulator
- Spark Therapeutics
- Spatial Transcriptomics in Neurodegeneration
- Specialized Pro-Resolving Mediator (SPM) Therapies for Neurodegeneration
- Specialized Pro-Resolving Mediator (SPM) Therapy for Neurodegeneration
- SPECT Imaging for Neurodegenerative Diseases
- Speech and Cognitive Biomarkers for Alzheimer's Disease
- Speech and Language Therapy for Neurodegenerative Diseases
- Speech and Voice Acoustic Analysis for Corticobasal Syndrome
- Speech and Voice Acoustic Analysis for Corticobasal Syndrome Diagnosis
- Speech Neural Decoding BCI
- Speech Restoration Brain-Computer Interfaces
- Speech Therapy for Neurodegenerative Diseases
- Speech Therapy for Parkinson's Disease
- Spermidine and Autophagy Induction for Neurodegeneration
- Spin Therapeutics
- Spinal Cord Stimulation (SCS) for Parkinson's Disease
- Spinal Cord Stimulation Therapy
- Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Development
- Spinogenix — Neuroprotective Therapeutics
- Splice Modulation Therapy for Neurodegeneration
- SSRI Antidepressants
- SSVEP Brain-Computer Interface
- Statistical Methods for Biomarker Combinations
- Steadi
- Stem Cell Therapies for Neurodegenerative Diseases
- Stem Cell Therapy for Atypical Parkinsonism
- Stem Cell Therapy for Neurodegeneration
- Stem Cell Therapy Investment Landscape for Neurodegeneration
- STING Inhibitor Therapy in Neurodegeneration
- Stoke Therapeutics
- sTREM2 (Soluble TREM2) - Biomarker
- sTREM2 (Soluble TREM2) - Microglial Biomarker
- sTREM2-Modulated Microglial Therapy
- Stress Granule Modulation Therapy
- Stroke Rehabilitation Brain-Computer Interface
- STXBP1 Foundation
- Subtype-Specific Target Engagement Biomarkers
- Sulforaphane and Nrf2 Activation for Neuroprotection
- Sumitomo Pharma
- Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries
- Sunovion Therapeutics Inc.
- Supernus Pharmaceuticals
- Supportive Care in Neurodegenerative Diseases
- Suvorexant for Neurodegeneration
- SV2A - Synaptic Vesicle Protein Biomarker
- Swiss Neurodegeneration Biotech Companies
- Swiss Neurodegeneration Biotech Companies
- Sword Health
- Symptomatic Treatments for Parkinson's Disease
- Synapse-Resilience Circuit: BDNF Therapy + Sleep-Glymphatic Entrainment
- Synaptic Biomarkers for Alzheimer's Disease
- Synaptic Biomarkers in Neurodegeneration
- Synaptic Complement Inhibitor
- Synaptic Dysfunction Therapeutics: Investment Landscape Analysis
- Synaptic Mitochondrial Resilience Enhancement for Parkinson's Disease
- Synaptic Plasticity Therapeutics for Parkinson's Disease
- Synaptic Protection Therapies
- Synaptic Protective Therapies for Neurodegeneration
- Synaptic Resilience Enhancement Protocol
- Synaptic resilience in aging and AD
- Synaptic Stabilizers
- Synaptic Therapeutics
- Synaptic Vesicle Modulators
- Synaptic Vesicle Trafficking Dysfunction Hypothesis in Parkinson's Disease
- Synaptic Vesicle Trafficking Dysfunction Validation in Parkinson's Disease
- Synaptophysin - Synaptic Biomarker
- Synchron
- Synchron
- Synchron BCI
- Synchronicity Therapeutics
- Synthetic Gene Circuit for Feedback-Controlled GDNF Delivery
- Systemic Metabolic Dysfunction in ALS Progression
- T3D Therapeutics
- tACS Connectivity Trial in Early Alzheimer's
- Tai Chi for Parkinson's Disease
- Tai Chi Therapy for Neurodegeneration
- TaiGen Biotechnology
- TaiRx Inc
- TaiRx, Inc.
- Taiwan Biotech Companies with Neurology Focus
- Taiwanese Biotechnology Companies in Parkinson's Disease
- Takeda
- Takeda Pharmaceutical Company
- TAM Receptor Modulation Therapy
- Targeted Protein Degradation (PROTACs)
- Targeted Protein Degradation for Neurodegenerative Diseases
- Targeted Protein Degradation for Neurodegenerative Diseases
- Targeted Protein Stabilization Therapy for Neurodegeneration
- Targeting astrocyte dysfunction for neurodegenerative disease therapy
- Targeting neuroinflammation in corticobasal syndrome and progressive supranuclear palsy
- Tau Aggregation Inhibitors
- Tau Aggregation Inhibitors — Investment Landscape Analysis
- Tau aggregation inhibitors: past, present, and future
- Tau ASO Therapy
- Tau Causality vs. Bystander in Alzheimer's Disease
- Tau Co-Pathology in DLB Clinical Heterogeneity
- Tau Consortium
- Tau Gene Therapy
- Tau Immunotherapies for Neurodegenerative Diseases
- Tau Immunotherapy
- Tau Immunotherapy for Alzheimer's Disease
- Tau Kinase Inhibitors
- Tau oligomers and tau aggregation inhibitors
- Tau Pathology Initiation Zone Identification
- Tau Pathology Severity Assessment Model — Braak Staging and Disease Progression
- Tau PET Imaging
- Tau PET Imaging - Clinical Biomarker Guide
- Tau PET in CBS/PSP
- Tau PET-Guided Anti-Tau Therapy
- Tau PET-Guided Tau Immunotherapy
- Tau Propagation Blockers for Neurodegeneration
- Tau Reduction Therapies for Neurodegenerative Diseases
- Tau Seed Amplification Assays (Tau-RT-QuIC)
- Tau Seed Amplification Assays in Progressive Supranuclear Palsy
- Tau Small-Molecule Therapeutics
- Tau Vaccines
- Tau vs TDP-43 Fate Switching in Frontotemporal Dementia
- Tau-PROTAC Heterobifunctional Degrader for Tauopathy
- Tau-Seed Interception Using Conformational-Selective Extracellular Traps
- Tau-Targeted Therapeutics
- Tauopathy Knowledge Gaps
- Taurine
- Taurine Supplementation for Neurodegeneration
- TauRx Pharmaceuticals
- Tavapadon
- TBK1-Mediated Neuroinflammation Hypothesis — Autophagy Failure and Innate Immune Dysregulation in FTD/ALS
- TDP-43 (TAR DNA-Binding Protein 43) - Biomarker
- TDP-43 PET Ligand Development for Frontotemporal Dementia
- TDP-43 Proteinopathy Investment Landscape
- TDP-43 Splicing Modulation Therapy
- TDP-43 vs Tau Pathology Determination in GRN vs MAPT Mutation Carriers
- Tear Film Biomarkers in Alzheimer's Disease
- Tear Film Biomarkers in Alzheimer's Disease
- Tear Film Biomarkers in Corticobasal Syndrome
- Technologies
- Technologies Dashboard
- Technologies Overview
- Technology Rankings for Neurodegenerative Disease
- Teitur Trophics
- Telemedicine and Digital Therapeutics for Neurodegenerative Diseases
- Teva Pharmaceutical Industries
- Teva Pharmaceutical Industries Ltd.
- TFEB Activator Therapies for Neurodegenerative Diseases
- TFEB Activators for Neurodegeneration
- TFEB Activators in Neurodegeneration
- TGF-beta Signaling Therapeutics for Neurodegeneration: Investment Analysis
- TGF-beta Signaling Therapies for Neurodegeneration
- TGF-β Activator Therapy for Neurodegeneration
- TGF-β Modulation Therapy for Neurodegeneration
- TGR5 Agonist Therapy
- Thailand Neurodegeneration Biotech Companies
- Thalamocortical Pathway
- The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 2016
- The Cortical/Transitional Zone of the Amygdala is Affected Early in Neurodegenerative Diseases
- The effect of creatine and coenzyme Q10 combination therapy on mild cognitive impairment in Parkinson's disease
- The endocannabinoid system in neurodegenerative disorders. J Neurochem. 2009;110(2):577-590
- The extension hypothesis of neurodegeneration in semantic variant FTD
- The promise of mHealth for neurorehabilitation
- The role of LRRK2 in Parkinson's disease
- The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease
- The α-synuclein tetramer: friend or foe?
- Therapeutic Antibody Comparison Matrix
- Therapeutic Approach Evidence Rankings
- Therapeutic Hypothesis: TDP-43 and a-synuclein pathologies in the amygdala...
- Therapeutic Mechanism Index
- Therapeutic Modalities in Neurodegeneration
- Therapeutic Targets Index
- Therapeutics
- Therapy Ideas
- Therapy Sequencing for Disease-Modifying Combinations in Neurodegeneration
- Theravance Biopharma
- Theta-band phase locking of single neurons in the hippocampus
- Tilavonemab (ABBV-8E12)
- Tirzepatide and Dual GIP/GLP-1 Agonists for Neurodegeneration
- Tissue Engineered Nigrostriatal Pathway for Parkinson's Disease
- TLR4 Antagonists for Neurodegeneration
- TLR7/8/9 Antagonists for Neurodegeneration
- TLR7/8/9 Antagonists for Neurodegeneration
- TMEM106B Lysosomal Restoration Therapy for Neurodegeneration
- TMEM163 Lysosomal Restoration Therapy for Neurodegeneration
- TMEM175 Lysosomal Modulation Therapy
- Tolfenamic Acid (TFA)
- Tominersen (RG6042) for Huntington's Disease
- Tonabersat Phase I safety and pharmacokinetics studies
- Total Tau (t-Tau) - Biomarker
- Total Tau (t-tau) in Cerebrospinal Fluid
- Trace Amine-Associated Receptor (TAAR) Modulator Therapy for Neurodegeneration
- Trained Innate Immunity Reset Therapy for Neurodegeneration
- Transcranial Direct Current Stimulation (tDCS)
- Transcranial Direct Current Stimulation for Neurodegeneration
- Transcranial Magnetic Stimulation Therapy for Neurodegeneration
- Transcranial Sonography in Corticobasal Syndrome and PSP
- Transcutaneous Vagal Nerve Stimulation (tVNS) for Parkinson's Disease Gait and Posture
- Transdiagnostic Proteomic Changes in Neurodegeneration
- Traumatic Brain Injury and Alzheimer's Disease Relationship
- Treatment Approaches for Amyotrophic Lateral Sclerosis (ALS)
- Treatment Efficacy Rankings
- Treatment of Batten Disease
- Treatment of Dementia with Lewy Bodies
- Treatment of Huntington's disease
- Treatment of Normal Pressure Hydrocephalus (NPH)
- Treatment Overview
- Treatment Pipeline Overview
- Treatment Rankings
- Treatments Dashboard
- Tree Pharmaceutical Co., Ltd.
- Trefoil Therapeutics
- Treg adoptive transfer in rodent PD models
- Trehalose for Neurodegenerative Diseases
- TREM2 activation restores microglial phagocytosis in Parkinson's disease models
- TREM2 Agonist Therapies for Alzheimer's Disease
- TREM2 Agonist Therapy for Neurodegeneration
- TREM2 Agonist Therapy for Parkinson's Disease — Experimental Design
- TREM2 Agonist Therapy for Parkinson's Disease — Experimental Design
- TREM2 Agonists in Alzheimer Disease
- TREM2 Function in Alzheimer's Disease — From Risk Variant to Therapeutic Target
- TREM2 Microglial Priming Inhibitor for Pre-Symptomatic Neurodegeneration Prevention
- TREM2 Modulator Therapy
- TREM2 Therapeutics Investment Landscape
- TREM2-Alpha-Synuclein Clearance Hypothesis in Parkinson's Disease
- TREM2-Targeting Therapeutics
- TREM2-Targeting Therapies
- Tremor Prediction and Suppression Brain-Computer Interfaces
- Tremor Prediction Brain-Computer Interface
- Treventis Corporation
- Treventis Corporation
- TriNetX
- Triple Incretin Agonists (GLP-1/GIP/Glucagon) for Neurodegeneration
- TrkB Modulator Therapy for Parkinson's Disease
- TrkB Modulators for Neurodegenerative Diseases
- TrkB signaling in substantia nigra
- TRPM8 Agonists for Neurodegeneration
- TrueBinding
- Tryptophan-Kynurenine Neurotoxicity Hypothesis in Parkinson's Disease
- TSPO PET Ligand Development - Research Gap
- Tsumura & Co.
- Tumor Necrosis Factor Alpha (TNF-α) as a Neurodegenerative Disease Biomarker
- Type I Interferon Modulation Therapy for Neurodegeneration
- Tyromotion
- Ubiquitin C-terminal Hydrolase L1 (UCH-L1)
- Ubiquitin-Proteasome System (UPS) Therapeutics: Investment Landscape Analysis
- Ubiquitin-Proteasome System Therapeutic Companies for Parkinson's Disease
- UCB
- UCB Pharma
- UCB Pharma
- UCH-L1 in Chinese ALS cohorts
- UFM1ylation Modulation Therapy for Neurodegeneration
- UK Medical Research Council (MRC)
- ULK1/2 Kinase Modulation for Mitophagy Induction in Neurodegeneration
- Ultragenyx Pharmaceutical
- uniQure
- Update on Treatments for Parkinson's Disease Motor Fluctuations - An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review
- Urinary Dysfunction in Corticobasal Syndrome
- Urolithin A for Neurodegeneration
- Urolithin A for Neurodegeneration
- USP13 Deubiquitinase Inhibition for Parkin-Independent Mitophagy Rescue
- USP13 Inhibitor for Mitophagy and Synaptic Proteostasis
- USP30 Deubiquitinase Inhibitors
- USP30 Inhibitors for Parkinson's Disease
- Utah Array Brain-Computer Interface
- Vaccinex, Inc.
- Vagus Nerve Stimulation (VNS)
- Vagus Nerve Stimulation (VNS) for Neurodegenerative Diseases
- Vagus Nerve Stimulation for Parkinson's Disease
- Validate Mitochondria-Lysosome Contact Site Dysfunction in PD
- Validation: Membrane-Nucleation in iPSC Neurons
- Valproic Acid Trial Failure in Progressive Supranuclear Palsy
- Vanda Pharmaceuticals
- Vandria SA
- Vanqua Bio
- Vascular Cognitive Impairment Prevention Bundle for At-Risk Pre-Symptomatic Populations
- Vascular Contribution Modulation Therapy for Neurodegeneration
- Vascular Contribution to Alzheimer's Disease — Beyond Amyloid
- Vascular Dementia Combination Therapy
- Vascular Dementia Investment Landscape
- Vator Therapeutics Inc.
- Vaxart
- Vaxxinity, Inc.
- VCP Proteostasis Modulation Therapy for ALS/FTD
- VCP-Targeted Therapy
- Vedanta Biosciences
- VEGF and Angiogenesis Therapy
- VEGF Angiogenesis Therapy for Parkinson's Disease
- Ventral Attention Network
- Ventus Therapeutics
- Verily Life Sciences
- Vertex Pharmaceuticals
- Vesicular Monoamine Transporter (VMAT) Modulators for Parkinson's Disease
- Vestibular Function Testing in Corticobasal Syndrome
- Vestibular Rehabilitation Therapy for Neurodegenerative Diseases
- VIAME
- Vietnam Neurodegeneration Biotech Companies
- Vigil Neuroscience
- Vigonvita Sciences
- VILIP-1 (Visinin-Like Protein 1) - Neuronal Biomarker
- VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers
- Vimentin - Biomarker
- Vincere Biosciences
- VIP/VPAC Receptor Modulators for Neurodegeneration
- Viral Infections and Alzheimer's Disease — Causal Mechanisms and Therapeutic Implications
- Viral Vector Delivery Investment Landscape for Neurodegeneration
- Virtual Reality Gait Training for CBS/PSP
- Virtual Reality Rehabilitation for Neurodegenerative Diseases
- Virtual Reality Therapy for CBS/PSP Gait Training
- Visinin-like protein 1 (VILIP-1)
- Visual Pathway Circuit
- Vitamin B Complex Therapy for Neurodegeneration
- Vivoryon Therapeutics
- VMAT2 - Dopaminergic Biomarker
- Voyager Therapeutics
- VPS13 Lipid Transport and Organelle Contact Site Modulation Therapy
- VPS35 Retromer Pharmacological Chaperone
- VPS35 Retromer Stabilizer for Lysosomal Rescue
- VPS35 Retromer Targeting Therapies
- VPS35/Retromer Stabilizers for Parkinson's Disease
- VTV Therapeutics
- WAVE Complex Modulation Therapy for Neurodegeneration
- Wave Life Sciences
- Wearable Accelerometry for Corticobasal Syndrome Assessment
- Wearable Devices for Neurodegenerative Disease
- Wearable Sensors and Digital Biomarkers for Atypical Parkinsonism (CBS/PSP)
- Wearable Sensors for Parkinson's Disease
- Wearable Technologies for Parkinson's Disease
- Weight loss in Huntington disease
- Wellcome Trust
- Westermark P, et al. Amyloid fibril proteins as biomarkers. Nat Rev Neurol. 2022
- What is the dorsal cingulate?
- What to Work On — NeuroWiki Decision Guide
- Whole Genome Sequencing for CBS/PSP
- Whoop LLC
- Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investigation
- Wiki Quality Review Report
- Willink Pharma
- Wilson Disease Neurodegeneration: Mechanism and Therapeutic Response
- Wilson Disease Treatment
- Wilson's Disease Treatment
- Wnt Pathway Modulation for Synaptic Resilience
- Wnt Signaling Modulation Therapy
- Wnt Signaling Modulators for Neurodegeneration
- Wnt Signaling Therapeutics: Investment Landscape Analysis
- Wnt-Beta-Catenin Pathway Validation in Parkinson's Disease
- Wnt-Beta-Catenin Signaling Dysfunction Hypothesis in Parkinson's Disease
- World Parkinson Congress
- World Parkinson Congress 2025
- WPC 2026
- Wysa
- Wysa
- Wyss Center
- YAP/TAZ Mechanoactivation Protocol for Neurodegeneration
- YAP/TEAD Pathway Modulators for Neurodegeneration
- YKL-40 (CHI3L1) - Biomarker
- YKL-40 (Chitinase 3-Like 1)
- YKL-40 (Chitinase-3-like protein 1)
- YKL-40 Anti-Inflammatory Cycling
- YKL-40-Targeted Anti-Inflammatory Therapy for Neurodegeneration
- Yoga Therapy for Neurodegeneration
- YTHDF2 orchestrates RNA degradation to suppress neuroinflammation
- Yuhan Corporation
- Yumanity Therapeutics
- Z-index Pharma
- Zagotenemab (LY3303560)
- Zhimeng Biotechnology
- Zolgensma (Onasemnogene Abeparvovec)
- Zonisamide for Parkinson's Disease Motor Complications
- α-Synuclein Immunotherapies for Neurodegenerative Diseases
This index is automatically generated. Run python3 scripts/update_all_pages.py to refresh.1
- Wiki.js GraphQL API Documentation